data_2m07_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m07 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.6 p . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m -132.82 141.97 48.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.342 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.45 115.26 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.1 m -128.17 139.69 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.83 140.85 12.23 Favored Glycine 0 N--CA 1.461 0.352 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.88 167.28 28.27 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.018 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -115.15 140.58 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -122.46 141.19 51.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.968 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -118.72 131.9 56.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 t -112.76 134.74 54.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.81 142.14 37.16 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.115 0.884 . . . . 0.0 110.844 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.494 -176.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -131.59 157.55 43.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.606 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.36 146.98 17.84 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.53 143.22 14.29 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.96 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -109.77 134.42 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -127.39 137.67 52.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.579 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.8 tp -122.6 134.3 54.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.117 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -128.35 143.82 51.06 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.07 0.462 . . . . 0.0 111.826 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -123.65 138.61 54.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.405 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -131.4 144.06 50.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.86 0.362 . . . . 0.0 111.118 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -103.93 143.21 33.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.58 125.07 37.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -133.06 153.2 51.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.694 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.83 -178.4 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.177 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.46 -38.61 69.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -85.73 -25.99 0.35 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.81 142.38 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.58 1.52 . . . . 0.0 112.525 163.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 74.5 mt -78.06 165.04 24.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.005 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.09 140.12 14.92 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.18 125.47 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.364 0.582 . . . . 0.0 109.947 -174.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.17 135.5 62.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.66 138.02 10.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 t -131.71 137.33 48.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.813 0.307 . . . . 0.0 111.063 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -115.27 129.11 56.53 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 m -125.9 137.74 53.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.679 0.276 . . . . 0.0 110.731 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -126.06 132.58 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.771 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 m -101.49 146.01 28.22 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.533 -177.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -127.1 135.73 51.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.43 135.38 7.57 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.569 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.58 119.35 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.1 p -123.23 153.67 39.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.036 0.21 . . . . 0.0 110.507 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.17 146.22 30.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.01 167.37 40.08 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.875 -1.155 . . . . 0.0 112.999 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -97.18 124.21 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.276 1.984 . . . . 0.0 112.855 175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.79 142.25 33.94 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.77 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 . . . . . 0 C--N 1.331 -0.215 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.523 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 CA--C 1.522 -0.113 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.22 129.77 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -127.97 133.86 49.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.75 137.89 11.13 Favored Glycine 0 N--CA 1.465 0.62 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.79 145.95 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.557 0.679 . . . . 0.0 111.445 -172.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.35 140.93 47.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.28 175.07 26.83 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.444 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.42 127.22 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.69 137.56 11.32 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.19 157.91 45.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.098 0.449 . . . . 0.0 111.45 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.668 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.71 149.29 33.13 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.731 0.644 . . . . 0.0 110.817 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.0 161.62 27.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -101.67 127.17 48.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -113.66 145.47 41.26 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.034 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -131.16 139.47 49.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.41 161.32 27.96 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.732 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 148.91 35.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.95 164.52 29.2 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.857 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.6 tp -109.07 145.91 34.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -138.44 134.22 33.78 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.83 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -135.45 115.22 12.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.54 124.46 19.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -102.88 176.15 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.796 2.331 . . . . 0.0 109.294 157.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.2 mtm -55.38 164.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 66.48 -171.94 0.19 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.721 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.29 -11.42 4.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.1 t -78.32 17.91 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -166.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.43 130.61 52.31 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.331 -0.856 . . . . 0.0 110.231 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -124.59 146.29 49.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.819 -171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -137.15 139.54 41.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.411 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.98 131.17 47.41 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -140.24 154.09 46.76 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.663 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -118.32 140.37 49.93 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -126.81 136.62 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.193 0.308 . . . . 0.0 110.387 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -119.33 130.83 55.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.321 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.9 t -108.09 144.6 35.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -89.37 145.97 24.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -159.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.0 tt -87.89 100.96 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 123.526 1.631 . . . . 0.0 113.678 -146.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -89.8 -176.7 5.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.18 -2.282 . . . . 0.0 106.597 157.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -52.16 -14.54 0.44 Allowed 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.339 -0.851 . . . . 0.0 112.206 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.02 132.59 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.362 0.528 . . . . 0.0 109.859 167.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -115.01 139.12 50.11 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.35 133.59 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.707 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.33 3.88 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.9 m -126.12 134.16 51.41 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.61 0.705 . . . . 0.0 111.12 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -117.29 130.92 56.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.98 144.9 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.855 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.52 127.18 30.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -135.63 153.09 21.17 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.612 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.3 p -128.54 139.91 50.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.02 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.809 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -137.33 165.08 27.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.675 -0.763 . . . . 0.0 110.173 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -121.68 148.97 43.9 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.7 p90 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.075 -0.964 . . . . 0.0 112.453 -174.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.523 -0.068 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 t -135.1 151.83 51.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.947 0.404 . . . . 0.0 110.845 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.49 124.37 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.415 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 m -128.31 139.44 52.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 110.676 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.71 140.71 13.47 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.23 168.21 28.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.185 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -117.68 133.02 56.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -115.56 138.7 50.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.412 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -119.16 131.99 55.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.0 139.1 48.94 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.72 142.12 37.32 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.822 0.701 . . . . 0.0 111.218 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.283 -176.531 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.7 mttt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.642 0.258 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.3 mmm -128.8 155.79 44.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.294 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.48 143.35 14.98 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.54 143.17 14.22 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.909 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.38 131.38 54.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -119.66 135.19 54.92 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.296 0.373 . . . . 0.0 111.529 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tt -118.4 135.95 54.04 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -117.87 143.87 45.92 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.208 0.317 . . . . 0.0 111.32 -173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -133.49 130.28 38.33 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -138.32 144.08 40.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.178 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -109.83 143.15 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -92.63 129.3 38.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.516 0.674 . . . . 0.0 110.769 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -133.09 153.47 51.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.109 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.54 -178.56 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.718 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -55.7 -33.4 64.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.327 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 t -93.38 -25.89 0.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.78 139.18 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.746 1.631 . . . . 0.0 111.952 164.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.11 152.76 32.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.304 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.03 140.38 16.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.3 m -103.55 127.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 117.779 0.789 . . . . 0.0 110.113 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.17 140.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.87 143.53 13.87 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -142.06 155.03 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.584 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -131.61 142.01 49.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.906 173.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 m -127.03 137.7 53.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.88 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -118.49 133.02 56.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.035 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 m -107.76 144.65 34.61 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 110.867 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 -178.345 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.949 0.404 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -132.61 131.7 41.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.592 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.16 146.34 18.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.052 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.14 127.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.9 p -123.2 154.88 38.13 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.139 0.274 . . . . 0.0 110.803 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.95 148.88 37.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.74 160.89 31.88 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 119.865 -1.159 . . . . 0.0 113.335 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -94.05 124.07 0.45 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.018 1.812 . . . . 0.0 112.061 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.71 138.8 36.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.218 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 C--N 1.333 -0.146 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.482 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 CA--C 1.519 -0.231 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.38 129.96 70.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.087 0.47 . . . . 0.0 110.447 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -120.01 134.03 55.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.99 137.58 11.21 Favored Glycine 0 N--CA 1.466 0.668 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.67 150.99 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.259 0.53 . . . . 0.0 111.822 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.09 140.77 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.27 175.01 26.85 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.459 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.64 127.53 73.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.52 144.67 16.11 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -138.0 154.28 49.35 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.111 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.71 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -108.56 149.64 28.59 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.526 0.517 . . . . 0.0 111.593 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 164.03 26.94 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -104.24 128.13 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.99 0.395 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.3 m -114.37 141.01 48.18 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.677 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -140.52 144.09 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.11 176.59 35.9 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.227 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.05 150.6 30.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.661 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.12 28.04 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.274 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.19 149.93 35.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -121.6 138.67 54.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 112.128 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -125.99 109.95 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.73 124.34 27.14 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -105.51 176.06 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.373 2.716 . . . . 0.0 109.351 155.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.5 mtm -61.16 158.2 14.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.782 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 67.27 -165.95 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.537 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -58.43 -11.67 3.11 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.9 t -78.41 17.77 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -167.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.43 138.02 41.44 Favored 'General case' 0 C--N 1.344 0.37 0 O-C-N 121.153 -0.967 . . . . 0.0 110.057 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.68 151.41 49.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.709 0.29 . . . . 0.0 111.269 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.96 139.66 41.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.364 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -122.22 129.12 51.95 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -140.21 154.02 46.77 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.313 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -124.52 142.7 51.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -128.78 146.84 50.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -128.5 135.51 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.046 0.45 . . . . 0.0 110.621 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.4 p -100.57 144.78 29.15 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -89.29 145.94 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -160.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -87.77 99.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.638 1.208 . . . . 0.0 112.924 -144.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -89.88 -176.99 5.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 112.528 -2.124 . . . . 0.0 107.499 156.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.2 t -52.17 -16.18 0.74 Allowed 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 112.078 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.32 130.69 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -114.92 139.04 50.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.375 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.37 135.97 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.597 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.64 5.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.06 134.18 51.48 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.652 0.726 . . . . 0.0 111.396 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -115.0 132.83 56.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.03 134.8 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.18 123.3 39.32 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.08 20.56 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.823 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.2 140.17 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 178.02 32.08 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.676 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.56 165.09 24.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.139 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -117.96 149.0 41.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.614 -178.756 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 CA--C 1.524 -0.036 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -136.01 155.18 50.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.921 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 p -129.98 132.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.187 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 m -128.08 140.12 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.32 140.74 12.27 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.78 30.58 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.355 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -117.16 136.31 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.683 -0.759 . . . . 0.0 109.11 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.31 138.07 52.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.384 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -126.15 132.04 51.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 p -115.57 141.31 48.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -78.94 127.02 31.46 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.063 0.852 . . . . 0.0 111.233 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.466 179.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? . . . . . 0 C--O 1.232 0.133 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.32 159.74 35.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.285 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.23 151.4 18.36 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.08 143.22 11.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.784 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.11 132.98 52.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -126.7 135.91 51.76 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.459 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.8 mt -122.25 139.3 53.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -135.07 142.5 46.31 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 111.538 -173.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.43 136.6 54.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.402 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -136.78 144.11 43.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -104.49 143.09 33.5 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.57 123.57 35.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.122 0.487 . . . . 0.0 110.112 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.04 153.47 41.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.975 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.32 -178.58 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.836 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -55.37 -41.53 72.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 m -82.29 -26.1 0.4 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -102.83 126.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.531 1.487 . . . . 0.0 112.04 160.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 156.59 32.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.97 140.28 19.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -101.62 124.93 55.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 117.292 0.546 . . . . 0.0 109.861 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.7 mt -117.44 134.93 59.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.9 133.26 7.53 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.1 t -132.84 140.51 47.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.041 0.421 . . . . 0.0 111.315 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.77 132.29 55.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.9 p -128.75 142.57 50.96 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.94 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -125.48 135.51 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.168 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -109.51 144.83 37.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.785 0.326 . . . . 0.0 111.061 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.475 -178.822 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.899 0.38 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -123.27 129.36 51.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.38 134.81 7.98 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.44 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.23 123.75 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.5 p -123.24 153.44 40.16 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.154 0.284 . . . . 0.0 110.602 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.78 144.86 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.01 168.14 40.58 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 119.775 -1.202 . . . . 0.0 113.178 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -96.99 126.08 0.25 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.434 2.089 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.84 140.45 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.667 170.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.2 t80 . . . . . 0 C--N 1.332 -0.184 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.441 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 tt -128.95 133.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.789 -171.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -128.39 146.86 50.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.959 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.2 137.73 9.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.14 153.77 36.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.828 0.314 . . . . 0.0 110.97 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.24 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.15 175.03 26.73 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.305 -176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.7 t -118.35 133.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 131.93 9.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -120.85 142.02 50.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 0.0 110.405 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.634 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 175.156 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.7 t0 . . . . . 0 N--CA 1.46 0.036 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -123.85 150.79 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.057 0.456 . . . . 0.0 111.769 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.06 26.17 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -103.89 129.94 51.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.088 0.444 . . . . 0.0 110.449 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.4 m -112.39 141.73 45.77 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.661 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -131.93 139.06 48.6 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.44 155.02 26.3 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.792 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.23 148.89 30.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -151.81 162.26 29.62 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.893 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.96 150.31 27.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -135.03 139.65 44.99 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.576 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -137.95 120.69 16.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.1 124.4 26.49 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -105.19 175.99 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.087 2.525 . . . . 0.0 109.712 157.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.32 157.77 10.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.935 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 67.24 -167.61 0.2 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.694 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.41 -11.4 2.81 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 t -78.23 17.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -169.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.1 136.45 43.7 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.3 mt -125.18 147.24 49.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.898 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -132.53 136.74 46.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.151 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.26 130.44 52.74 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -139.91 154.07 47.14 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.996 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -124.83 143.13 50.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.965 0.412 . . . . 0.0 110.669 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -127.95 136.15 50.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.18 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -111.44 144.76 40.13 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 171.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -89.25 146.4 24.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.224 0.952 . . . . 0.0 109.667 -158.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.2 mt -87.84 105.81 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 122.73 1.253 . . . . 0.0 112.879 -141.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -89.75 -176.74 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.314 156.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 t -52.16 -14.48 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.822 -0.549 . . . . 0.0 112.262 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.02 130.9 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.404 0.547 . . . . 0.0 110.337 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -115.02 139.19 50.06 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.12 143.86 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.315 -173.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.1 122.61 4.72 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 171.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.7 m -125.9 134.19 51.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.545 0.673 . . . . 0.0 111.352 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -109.29 132.23 54.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.2 mt -122.5 133.5 68.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 123.209 0.318 . . . . 0.0 110.286 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.85 126.17 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.53 153.02 20.85 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.137 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.14 140.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 177.87 32.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.372 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -141.53 163.08 33.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.837 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -123.26 149.0 45.32 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.256 0.347 . . . . 0.0 110.54 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.63 -178.879 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.458 -0.041 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.4 p -125.17 155.4 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.378 . . . . 0.0 110.43 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.83 125.06 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.588 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -128.15 141.48 51.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 111.036 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.68 140.74 12.05 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.9 165.45 28.48 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.316 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -115.44 134.58 54.95 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.99 138.97 51.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.5 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -120.88 132.95 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -115.89 144.47 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -78.59 142.17 37.49 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.867 0.729 . . . . 0.0 111.13 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.313 -175.33 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.64 155.21 39.53 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.885 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.4 140.5 12.08 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.42 143.24 14.02 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.817 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.66 136.78 50.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -131.47 142.41 49.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.989 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.4 tp -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.137 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -127.23 141.96 51.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.009 0.433 . . . . 0.0 111.512 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.68 137.32 54.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.443 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -134.45 144.1 47.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 110.823 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -109.32 143.25 39.08 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.77 120.3 33.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.277 0.561 . . . . 0.0 111.157 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -133.86 153.63 51.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.962 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.51 -178.44 3.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.863 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -53.01 -33.87 53.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -91.4 -26.02 0.28 Allowed Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -102.79 133.0 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.683 1.589 . . . . 0.0 111.65 162.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.97 158.31 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.245 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.08 140.3 19.12 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.67 125.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 117.478 0.639 . . . . 0.0 109.784 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.54 137.77 53.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.15 137.38 9.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -135.91 140.97 44.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.085 0.442 . . . . 0.0 111.093 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.36 132.77 56.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.4 m -129.43 139.05 51.76 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.284 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -124.97 129.8 51.07 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 m -124.75 145.95 49.45 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.978 0.353 . . . . 0.0 110.991 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.369 -178.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.7 t80 . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.932 0.396 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -134.82 127.78 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.607 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.01 140.32 11.09 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.649 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -122.08 122.57 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -123.21 147.27 47.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.79 147.33 31.76 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.11 171.02 42.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.886 -1.15 . . . . 0.0 113.162 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -93.51 128.05 0.65 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.149 1.899 . . . . 0.0 112.905 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.5 138.57 36.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.188 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.8 t80 . . . . . 0 C--O 1.234 0.28 0 O-C-N 123.77 0.669 . . . . 0.0 109.228 173.525 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 CA--C 1.517 -0.324 0 CA-C-O 120.792 0.329 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.96 129.56 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.1 m-30 -122.6 135.35 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.03 137.65 11.24 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.4 m -142.43 153.44 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 117.801 0.801 . . . . 0.0 112.021 -173.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.05 140.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.13 171.86 27.71 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.524 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.62 125.82 74.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.6 146.43 16.19 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -139.1 155.13 48.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.861 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.656 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.222 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.45 0.167 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -109.59 149.7 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 124.024 0.827 . . . . 0.0 110.217 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.16 159.36 27.05 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -99.51 124.31 44.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -110.06 141.01 43.49 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.764 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -127.95 140.3 52.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.16 159.26 27.86 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.1 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.12 148.88 32.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.987 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.45 161.89 29.66 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.36 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.68 150.47 49.75 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -127.79 146.52 50.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.601 0.715 . . . . 0.0 112.582 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -124.07 112.56 17.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.43 124.21 29.76 Favored Pre-proline 0 N--CA 1.462 0.17 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -107.03 176.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.452 2.768 . . . . 0.0 109.342 155.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -62.88 156.06 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.763 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 67.84 -166.48 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.588 173.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -58.64 -11.42 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.37 17.73 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.48 138.17 41.26 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.34 -0.85 . . . . 0.0 110.145 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.87 147.42 46.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.545 -170.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -132.61 136.41 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.385 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.36 130.7 54.51 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -140.18 154.03 46.81 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.321 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -128.15 145.29 51.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -133.84 146.6 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.178 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -129.5 136.06 49.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.9 t -104.13 144.72 31.2 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -89.28 146.03 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -161.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.7 mt -87.9 106.71 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 122.76 1.266 . . . . 0.0 112.901 -142.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -89.68 -176.71 5.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 112.301 -2.227 . . . . 0.0 107.227 156.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.1 p -52.11 -13.32 0.3 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.611 . . . . 0.0 112.496 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.82 133.49 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.383 0.538 . . . . 0.0 109.83 167.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.87 139.37 45.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.342 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.06 132.5 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.615 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 124.11 5.2 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.07 134.28 51.43 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.337 0.569 . . . . 0.0 111.298 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.36 134.83 54.74 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.9 mt -125.34 135.73 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.429 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 124.79 43.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.07 20.56 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.19 139.78 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.01 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.748 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.12 163.69 31.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.905 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -119.65 148.79 42.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.602 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.972 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.803 0.335 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 m -128.93 139.86 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.112 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.71 128.93 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.135 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.5 m -128.15 142.29 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.53 140.8 12.07 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.19 -169.89 27.28 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.169 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -129.21 158.5 38.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.262 -0.469 . . . . 0.0 109.931 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.51 148.18 47.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.973 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -126.35 132.8 51.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -118.52 142.03 48.0 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -79.04 125.07 28.91 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.872 0.732 . . . . 0.0 111.408 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.461 179.067 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 pttp . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 86.0 mtp -115.17 143.31 45.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.07 140.15 16.03 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.45 143.28 14.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.823 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -111.3 137.81 48.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -125.92 133.88 51.74 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.193 0.308 . . . . 0.0 111.576 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.2 mt -118.01 141.86 48.0 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.779 0.674 . . . . 0.0 109.482 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -127.72 143.01 51.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.301 -174.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -132.15 132.54 43.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -138.55 144.2 39.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 -176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -108.37 142.45 38.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.59 131.03 38.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.274 0.559 . . . . 0.0 111.289 -174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -143.86 153.57 42.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.497 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.43 -178.4 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.136 -173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -51.08 -37.78 47.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -89.13 -25.98 0.31 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -102.73 126.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.716 1.611 . . . . 0.0 111.869 161.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.4 mt -76.63 158.39 31.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.963 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.05 140.12 18.99 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.66 124.96 58.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.487 0.644 . . . . 0.0 109.28 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.3 pt -122.46 144.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.379 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.84 136.2 8.49 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -127.88 140.93 51.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.671 0.272 . . . . 0.0 110.811 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.74 131.2 56.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.1 m -126.44 134.8 50.88 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.247 0.342 . . . . 0.0 110.83 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -127.04 137.05 52.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.436 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -108.5 148.28 30.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.017 0.436 . . . . 0.0 111.351 -175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.525 -177.793 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.9 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.715 0.293 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -138.02 132.98 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.993 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.97 19.58 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.519 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 127.37 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 p -123.21 154.99 38.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.655 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.62 148.28 34.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.09 170.92 42.25 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.968 -1.111 . . . . 0.0 113.337 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -99.15 122.65 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.628 2.219 . . . . 0.0 112.717 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.78 139.93 35.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.077 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 C--N 1.332 -0.157 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.789 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.19 129.93 17.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -127.84 141.98 51.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.2 137.91 10.99 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.69 153.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.953 0.376 . . . . 0.0 111.182 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.68 140.84 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.21 175.21 26.69 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.339 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.62 129.66 75.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.08 145.47 16.66 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -138.68 160.02 40.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.1 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 . . . . . 0 N--CA 1.458 -0.074 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -139.42 158.99 43.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.009 0.433 . . . . 0.0 111.566 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.09 167.06 26.16 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.16 125.7 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -111.98 145.54 39.45 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.638 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -142.64 144.52 32.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.12 173.38 35.96 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.912 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.9 28.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.457 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.94 160.49 27.1 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.141 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mp -113.13 151.06 31.3 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -121.98 133.62 54.82 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.802 -174.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -128.24 109.92 11.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -140.53 124.64 10.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -167.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.29 176.11 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.629 2.219 . . . . 0.0 109.125 155.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -55.71 174.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.555 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -174.7 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.256 0.551 . . . . 0.0 112.126 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -62.95 -11.35 18.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.47 18.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.27 141.92 35.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.461 0.573 . . . . 0.0 110.162 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -124.02 148.99 46.58 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.84 -170.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -136.94 137.52 39.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.22 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -128.63 132.06 48.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.4 t -140.4 154.14 46.58 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.581 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.85 139.95 49.34 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -126.76 140.66 52.21 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 123.344 0.403 . . . . 0.0 110.453 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -124.23 136.03 53.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.284 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -109.1 144.84 36.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -89.19 145.94 25.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -160.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 pt -88.01 105.13 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 123.09 1.424 . . . . 0.0 114.689 -143.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -89.84 -176.97 5.11 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 112.703 -2.044 . . . . 0.0 106.845 157.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 t -52.06 -15.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.476 -0.765 . . . . 0.0 112.237 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.59 127.26 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 118.215 0.461 . . . . 0.0 109.808 168.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -103.9 139.19 39.41 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.13 131.16 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.32 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.19 118.48 3.29 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.2 m -126.2 134.2 51.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.347 0.573 . . . . 0.0 110.866 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -115.73 133.03 56.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.0 pt -121.98 145.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 123.247 0.342 . . . . 0.0 110.896 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -136.19 125.41 24.68 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.27 153.22 21.8 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.784 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 51.1 t -111.26 139.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.48 158.77 23.86 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.983 -172.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.32 152.86 46.9 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.136 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -117.81 140.37 49.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.8 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.702 179.682 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.2 p -122.3 156.22 34.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.416 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.01 115.99 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.555 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.6 m -128.3 142.91 51.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 0.0 110.769 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.37 140.92 11.92 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.58 -179.6 30.81 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.024 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -129.07 141.15 51.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.28 147.15 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -115.3 132.11 56.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -112.53 130.26 56.07 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.35 128.97 34.18 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.058 0.849 . . . . 0.0 110.86 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.866 -179.063 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt . . . . . 0 C--O 1.231 0.127 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.78 151.78 51.92 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.021 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.35 128.14 7.48 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -121.69 143.21 15.71 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.868 -173.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.1 133.77 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -126.52 133.7 51.07 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.073 0.233 . . . . 0.0 111.574 -174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -118.93 136.25 54.17 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -136.7 139.08 41.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.428 . . . . 0.0 111.632 -172.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.18 137.88 54.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -133.16 144.14 49.68 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -107.11 142.18 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -92.78 127.65 38.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.214 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -137.03 153.46 50.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.883 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -74.77 -178.56 3.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.87 -36.62 65.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -91.6 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -170.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -102.81 135.06 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 111.891 164.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.03 156.76 29.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.119 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.48 140.15 16.48 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -101.58 125.17 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.415 0.608 . . . . 0.0 109.427 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.8 pt -125.8 144.87 34.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.248 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 140.58 9.26 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.05 146.03 35.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.395 -175.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -119.61 132.69 55.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.445 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -126.97 133.84 50.5 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.126 0.266 . . . . 0.0 110.805 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -127.16 135.7 51.05 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.9 p -103.44 148.23 26.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.196 0.522 . . . . 0.0 111.294 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.578 -179.004 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.871 0.367 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -135.22 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.91 141.47 12.2 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.711 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.79 122.5 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.0 p -123.28 151.11 42.72 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.088 0.242 . . . . 0.0 111.14 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.05 146.29 30.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.04 171.14 42.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.071 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -97.33 124.0 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.314 2.009 . . . . 0.0 112.718 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.64 145.41 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.395 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 62.5 t80 . . . . . 0 C--O 1.233 0.202 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.304 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.521 -0.171 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.02 133.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.144 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -128.18 144.03 51.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.9 137.81 10.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -135.44 155.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 -174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.58 140.99 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.24 175.06 26.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.534 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.17 129.96 69.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.9 137.57 13.61 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.76 138.29 54.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.683 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -117.09 146.39 43.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 111.141 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.21 167.02 26.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.22 127.62 49.09 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -112.44 145.38 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 110.898 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -129.82 138.38 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.54 156.34 26.78 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.613 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.97 148.93 32.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.11 157.35 27.3 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.568 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.87 148.96 30.58 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -121.86 139.19 53.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.806 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.61 109.94 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -133.5 124.31 17.98 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -95.37 176.2 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.526 2.151 . . . . 0.0 109.534 156.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -65.72 150.48 48.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.779 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 78.35 -167.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -61.02 -11.99 10.07 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.75 17.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -170.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.44 138.91 40.13 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.574 -0.704 . . . . 0.0 109.883 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.62 151.83 51.83 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.322 -170.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.06 147.35 46.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.316 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.54 134.62 50.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -140.17 154.04 46.82 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.036 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.84 140.88 50.12 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -128.6 140.09 51.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.787 0.327 . . . . 0.0 110.562 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -124.51 135.99 53.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.081 0.467 . . . . 0.0 111.042 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 t -116.19 144.69 43.85 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -89.35 146.15 24.88 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.805 0.691 . . . . 0.0 109.58 -161.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.79 101.1 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.817 1.294 . . . . 0.0 112.682 -144.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.71 -176.8 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 112.195 -2.275 . . . . 0.0 106.777 158.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 84.2 p -52.13 -13.1 0.28 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.25 133.54 65.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 118.295 0.498 . . . . 0.0 109.733 168.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -113.05 139.15 48.93 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.28 128.26 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.722 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.2 116.79 2.79 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 22.0 m -126.06 134.05 51.52 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.778 0.789 . . . . 0.0 111.355 -173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.8 t90 -120.32 128.48 53.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.1 tt -130.23 144.53 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.225 -173.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.17 132.17 45.94 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.78 153.16 23.02 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.545 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.5 m -125.18 144.67 34.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.19 178.13 32.02 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.195 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -132.52 173.21 11.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.695 -0.752 . . . . 0.0 109.927 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -117.83 149.09 41.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.39 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.574 -178.943 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 C--O 1.231 0.101 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -123.17 156.15 35.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.389 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.91 131.44 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.162 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.0 m -128.19 143.0 51.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.838 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 140.9 12.23 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.71 -173.28 29.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.22 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -124.08 156.22 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.136 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.41 145.94 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.483 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -128.18 131.97 48.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -114.77 131.74 56.69 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.376 0.422 . . . . 0.0 110.413 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.05 126.59 36.18 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.8 0.687 . . . . 0.0 110.923 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.801 -179.716 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.2 mttp . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.476 0.179 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -134.19 158.23 44.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.801 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.18 151.58 16.88 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.65 143.3 12.47 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.089 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.33 139.08 50.3 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -127.99 133.47 49.17 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.602 -174.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.07 137.84 54.47 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -135.97 147.11 47.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.094 0.473 . . . . 0.0 111.542 -173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -132.61 143.66 49.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.83 144.04 37.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.696 0.284 . . . . 0.0 111.018 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -105.89 143.17 34.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.56 125.8 37.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.5 0.667 . . . . 0.0 110.852 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -125.58 153.29 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.889 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.62 -178.32 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.305 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -53.07 -35.51 59.65 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.0 m -92.07 -25.94 0.28 Allowed Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -102.85 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.639 1.56 . . . . 0.0 112.39 162.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -78.12 164.25 25.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.073 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.27 140.13 15.55 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.73 125.02 55.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 117.649 0.724 . . . . 0.0 109.699 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.73 138.13 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.26 135.45 8.33 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -129.5 142.01 50.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.027 0.414 . . . . 0.0 111.068 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.37 128.25 55.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.7 m -120.82 131.26 54.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.577 0.227 . . . . 0.0 110.661 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.04 137.13 55.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.189 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -97.69 147.58 24.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.148 0.499 . . . . 0.0 111.067 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--O 1.236 0.378 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 -175.71 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 p90 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 121.442 0.639 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -117.66 134.74 54.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.149 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.84 132.08 7.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.9 mm -119.03 118.44 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -123.22 151.33 42.37 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.907 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.04 146.17 32.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.08 168.18 40.63 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.116 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.22 124.33 0.28 Allowed 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.394 2.063 . . . . 0.0 112.81 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.8 143.01 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.463 170.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.528 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 CA--C 1.522 -0.13 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.26 129.88 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.842 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -138.87 142.47 38.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.218 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.04 137.84 9.75 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.9 m -133.8 156.71 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 111.014 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.94 140.9 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.15 175.07 26.71 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.798 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.14 133.39 60.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.7 131.69 9.66 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -118.71 118.99 33.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -176.6 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 C--O 1.231 0.118 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.66 142.97 32.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.023 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.18 157.67 26.57 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.62 125.45 51.01 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.5 m -109.61 135.4 50.64 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.936 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -126.75 137.26 53.21 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.55 27.72 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.884 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.39 148.83 32.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.99 164.63 29.22 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.073 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -108.97 146.94 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -136.25 131.92 35.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.532 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -137.85 125.2 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -133.92 124.56 17.71 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -98.08 176.18 0.49 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.57 2.18 . . . . 0.0 109.615 158.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.3 ttm -56.12 145.87 24.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.114 0.483 . . . . 0.0 111.55 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 74.26 -157.12 0.06 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.383 0.673 . . . . 0.0 111.17 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.02 -11.32 13.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.54 17.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.15 135.96 44.67 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.309 -0.869 . . . . 0.0 110.212 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -125.49 146.21 49.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -137.14 138.32 40.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -128.31 133.92 48.82 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.2 m -140.05 154.14 46.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.599 -0.441 . . . . 0.0 112.015 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -123.81 141.89 51.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.67 149.85 46.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.981 0.419 . . . . 0.0 110.383 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -128.07 136.03 50.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.484 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -115.56 144.7 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -89.31 145.96 25.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -158.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 12.5 tt -87.97 97.62 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 123.512 1.625 . . . . 0.0 113.655 -146.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.79 -176.77 5.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 112.144 -2.298 . . . . 0.0 107.476 157.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -52.22 -14.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.83 -0.544 . . . . 0.0 112.325 -175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.29 129.52 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.335 0.516 . . . . 0.0 109.897 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -115.05 139.18 50.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.18 132.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.816 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 117.76 3.06 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.0 m -126.15 134.26 51.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.798 0.799 . . . . 0.0 110.966 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -123.81 138.08 54.56 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.52 151.14 34.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 O-C-N 123.141 0.276 . . . . 0.0 111.411 -174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.1 131.11 27.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.8 153.29 23.64 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.991 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.38 143.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.06 178.12 31.92 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -142.08 169.38 17.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.187 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -118.02 146.51 43.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.338 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 66.5 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.558 -179.163 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.6 p -125.24 156.07 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.125 0.488 . . . . 0.0 110.83 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.27 126.77 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.377 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.17 140.94 12.2 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.9 174.81 31.62 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.217 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -116.68 138.95 51.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.91 -0.645 . . . . 0.0 109.597 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.41 138.82 51.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.089 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -127.71 131.97 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -111.36 145.1 39.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.64 137.42 37.83 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.891 0.744 . . . . 0.0 111.562 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.0 -177.179 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 C--O 1.231 0.117 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.8 mtt -112.72 144.38 42.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.366 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 137.44 12.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.94 143.14 14.55 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.866 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -107.18 134.42 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -125.44 133.12 52.56 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.374 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.0 tp -121.55 134.76 55.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.253 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -128.48 148.79 50.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.316 0.579 . . . . 0.0 111.86 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -126.3 140.05 52.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.744 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -139.48 144.14 37.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.751 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.93 143.1 44.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.67 128.27 38.46 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -129.86 153.49 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.402 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.69 -178.51 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.921 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -52.87 -36.27 58.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.429 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 m -93.71 -25.81 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 135.16 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.692 1.594 . . . . 0.0 112.219 165.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.97 160.69 28.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.82 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.12 140.3 22.08 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.48 124.97 56.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 117.482 0.641 . . . . 0.0 109.36 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.27 143.45 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.391 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.35 145.31 16.1 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 t -137.71 141.19 41.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.167 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.53 131.58 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -125.84 135.77 52.33 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.678 0.275 . . . . 0.0 110.988 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -126.99 131.93 50.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.337 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 m -112.78 147.73 36.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.001 0.429 . . . . 0.0 111.41 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.181 179.508 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 121.014 0.435 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -138.39 130.52 28.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.468 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.09 148.67 20.04 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.941 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.5 123.4 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 t -123.5 155.07 38.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.25 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.51 152.92 41.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 171.14 42.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.93 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -96.58 125.61 0.27 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.232 1.955 . . . . 0.0 112.502 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.73 144.2 32.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.767 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.774 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.3 tt -154.59 133.82 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.298 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.72 150.03 44.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.444 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.03 137.87 9.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.11 152.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.264 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.53 141.18 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.11 175.14 26.64 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.9 129.29 73.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.94 143.94 17.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -134.84 146.98 49.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.862 0.331 . . . . 0.0 110.705 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 176.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.457 -0.114 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -107.34 147.1 30.74 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.146 0.279 . . . . 0.0 111.173 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 162.84 27.14 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.33 127.08 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.929 0.364 . . . . 0.0 110.189 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.4 t -115.6 138.11 51.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.255 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -141.34 149.39 41.1 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.16 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.14 174.44 36.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.99 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.86 33.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.71 155.98 26.09 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.424 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 tp -109.06 145.85 34.95 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -144.24 143.63 31.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.286 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -135.71 129.9 33.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 172.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.2 124.62 9.97 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -170.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -102.32 176.19 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.572 2.182 . . . . 0.0 109.252 157.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.2 mtt -55.53 167.17 0.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.872 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 65.45 -173.79 0.18 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.866 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.69 -11.31 4.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.6 t -78.44 17.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -167.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.32 134.13 48.06 Favored 'General case' 0 C--N 1.341 0.232 0 O-C-N 121.535 -0.728 . . . . 0.0 109.882 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -133.42 148.42 51.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.637 -171.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.11 148.04 46.43 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.526 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.77 134.67 47.07 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -140.11 154.12 46.92 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.677 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -117.57 139.95 50.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.01 151.06 46.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.959 0.409 . . . . 0.0 110.611 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -127.48 136.1 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.283 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.9 t -113.95 144.75 42.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 146.16 24.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.131 0.491 . . . . 0.0 109.733 -159.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -87.94 102.64 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.728 1.251 . . . . 0.0 112.908 -144.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -89.68 -176.76 5.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 112.436 -2.166 . . . . 0.0 107.438 156.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.9 p -52.33 -14.21 0.44 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.797 -0.564 . . . . 0.0 112.338 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.16 126.9 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.344 0.52 . . . . 0.0 110.147 168.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -103.54 139.17 39.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.149 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.14 134.01 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.594 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.08 122.14 4.55 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -125.99 134.2 51.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.496 0.648 . . . . 0.0 111.251 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -115.14 132.94 56.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.9 pt -128.56 145.02 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.81 131.63 37.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.278 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.89 153.1 23.04 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.752 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.35 144.82 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.15 177.95 32.09 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.437 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -140.06 166.24 25.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.52 -0.84 . . . . 0.0 110.005 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -117.97 149.08 41.53 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.324 0.39 . . . . 0.0 110.554 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.6 t80 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.65 -179.177 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.848 0.356 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.2 m -130.28 140.29 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.235 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.08 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.356 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.8 p -128.13 143.31 51.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.47 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.1 140.79 12.35 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.4 172.62 29.4 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.184 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.49 138.39 50.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.744 -0.728 . . . . 0.0 109.108 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.54 140.03 51.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.658 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.96 131.93 54.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -114.3 135.14 54.39 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.253 0.346 . . . . 0.0 110.375 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -84.31 123.16 29.87 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.995 0.809 . . . . 0.0 111.177 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.471 179.056 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.668 0.271 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -126.48 159.63 32.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.734 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.32 146.96 17.86 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.33 143.21 13.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.009 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -108.26 132.57 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -123.88 132.96 53.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.385 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tt -125.87 131.04 52.45 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -128.07 146.54 50.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.129 0.49 . . . . 0.0 111.887 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.35 132.78 55.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -135.91 144.0 45.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.175 0.297 . . . . 0.0 111.357 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -113.0 139.03 49.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.81 128.62 38.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.342 0.591 . . . . 0.0 110.657 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -134.76 153.4 52.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.789 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.46 -178.6 3.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.671 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -53.92 -33.47 56.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.39 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -94.27 -25.85 0.26 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 134.94 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.748 1.632 . . . . 0.0 111.904 164.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.17 156.0 30.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.191 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.07 140.26 15.08 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.58 127.27 56.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.47 0.635 . . . . 0.0 109.877 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.6 tt -124.4 135.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.58 134.48 7.7 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t -129.28 139.06 51.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.84 0.32 . . . . 0.0 111.202 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.11 131.45 56.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -127.95 136.94 52.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -124.85 136.17 53.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.285 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.8 m -112.42 146.95 37.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 -178.575 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.3 t80 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.946 0.403 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -137.1 117.89 14.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.355 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.43 138.43 10.15 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.666 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.1 126.92 73.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.0 p -123.26 152.03 41.75 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.255 0.347 . . . . 0.0 110.172 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.99 146.49 31.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.95 170.95 42.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.267 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -98.01 123.67 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.486 2.124 . . . . 0.0 112.667 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 145.56 31.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.886 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.504 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 CA--C 1.52 -0.174 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.25 129.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -133.55 145.23 49.92 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.9 137.69 9.71 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.75 154.56 37.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.722 0.296 . . . . 0.0 111.181 -174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.19 140.75 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.2 175.09 26.75 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.76 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.81 130.5 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.09 136.08 12.41 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.436 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 C--O 1.231 0.089 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -130.45 153.98 48.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.972 0.415 . . . . 0.0 111.405 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.11 26.16 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.86 126.99 53.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.6 m -106.38 137.2 44.77 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.897 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.44 132.23 48.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -143.16 157.14 26.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.874 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.52 148.86 32.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.85 162.4 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.504 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -108.97 149.42 29.24 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -134.94 137.01 42.71 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.488 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.03 127.81 16.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -142.07 124.51 9.2 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -100.72 176.16 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.759 2.306 . . . . 0.0 109.385 156.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -53.99 177.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 63.73 -175.06 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.236 0.541 . . . . 0.0 112.193 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -62.95 -11.39 18.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.11 17.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -165.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.92 138.38 40.57 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.454 0.57 . . . . 0.0 109.798 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.69 153.83 50.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.009 0.433 . . . . 0.0 111.97 -168.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -137.16 140.4 41.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.032 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.74 132.24 53.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.8 p -140.13 154.17 46.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.88 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -123.79 141.02 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -120.33 138.6 53.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.539 0.524 . . . . 0.0 110.451 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -123.96 135.0 53.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.079 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -118.26 144.93 45.42 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -89.29 146.53 24.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -157.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.7 97.07 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.906 1.336 . . . . 0.0 112.215 -144.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.79 -176.92 5.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.046 -2.343 . . . . 0.0 107.446 157.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.8 p -52.27 -13.46 0.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.04 132.11 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.386 0.539 . . . . 0.0 110.195 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.72 139.2 43.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.23 -0.414 . . . . 0.0 109.991 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.13 122.72 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.13 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.31 114.74 2.22 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -125.81 134.13 51.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.752 0.776 . . . . 0.0 111.244 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.61 131.23 56.77 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 141' ' ' ILE . 61.9 mt -123.06 134.81 65.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 O-C-N 123.182 0.301 . . . . 0.0 110.259 -175.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.4 125.1 40.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.0 153.2 21.66 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.855 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.26 146.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.28 173.13 27.53 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.242 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -128.88 154.64 46.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.465 -1.368 . . . . 0.0 109.376 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -118.0 149.11 41.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.966 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.5 t80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.033 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.795 0.331 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -128.02 140.66 51.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.772 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.68 136.99 58.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.036 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.95 140.61 11.94 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 173.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 168.4 30.1 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.365 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -121.94 135.87 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.03 50.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.19 134.39 54.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.18 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -112.86 142.59 45.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 142.1 37.66 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.649 0.593 . . . . 0.0 110.93 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.423 -174.593 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.9 pttt . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.65 159.29 40.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.856 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.17 142.11 14.73 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.57 143.15 14.74 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.64 135.19 54.42 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -126.58 133.22 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 111.367 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.0 tp -120.03 134.95 55.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.019 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -130.22 145.77 51.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 112.066 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -120.34 137.82 54.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.042 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -135.26 144.28 46.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.834 0.35 . . . . 0.0 111.378 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -106.64 142.19 36.69 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -92.67 126.93 37.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.311 0.577 . . . . 0.0 110.373 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.99 153.62 41.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.735 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.38 -178.42 3.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.601 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -57.2 -35.42 69.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -87.04 -26.11 0.34 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -102.86 130.17 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.569 1.513 . . . . 0.0 112.105 160.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.2 mt -77.74 155.24 31.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.996 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.64 140.06 18.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -99.79 124.93 53.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 117.397 0.599 . . . . 0.0 109.83 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -120.27 132.88 68.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.77 134.17 8.61 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.3 p -127.36 141.98 51.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -113.01 128.08 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.769 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.0 m -124.45 132.7 53.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.12 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -127.09 136.03 51.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.487 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 m -117.81 145.21 44.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 110.955 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.006 179.564 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 121.115 0.483 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -128.8 119.15 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.221 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.19 135.18 8.19 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.272 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.02 117.29 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -123.28 148.65 45.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.768 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.82 31.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.13 168.93 41.14 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.114 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -98.41 122.9 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.555 2.17 . . . . 0.0 113.062 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 146.56 30.76 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.328 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.5 t80 . . . . . 0 C--N 1.333 -0.148 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.494 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 CA--C 1.519 -0.23 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.59 129.99 14.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.539 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -131.18 140.26 49.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.0 137.75 11.3 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.46 152.64 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.974 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.17 140.95 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.17 174.95 26.78 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.57 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.54 133.09 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.64 131.32 9.45 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -114.92 132.28 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.642 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.077 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.42 0.152 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.11 142.89 39.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.299 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.12 162.36 27.17 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -108.5 125.76 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.6 m -108.93 137.94 46.05 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.63 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -125.92 138.89 53.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.73 157.64 27.33 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.841 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.8 148.78 32.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.82 160.37 28.47 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.102 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.96 147.11 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.57 141.07 41.34 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.934 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -133.12 116.29 16.11 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -117.62 124.24 29.07 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.38 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -107.03 176.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.102 2.535 . . . . 0.0 109.423 157.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.33 170.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.182 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 65.39 -171.35 0.19 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.056 0.455 . . . . 0.0 111.956 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -61.51 -11.3 10.32 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.3 t -78.38 18.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.13 0.572 . . . . 0.0 112.431 -164.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.91 137.61 41.66 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.233 -0.917 . . . . 0.0 109.662 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.77 148.77 50.88 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -168.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -137.13 142.04 42.26 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -126.32 132.14 51.69 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -140.15 154.08 46.86 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.863 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.14 140.6 52.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -121.56 141.67 50.84 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 123.372 0.42 . . . . 0.0 110.093 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -125.9 132.84 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.575 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.1 m -115.77 144.57 43.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -89.45 146.03 24.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -161.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 10.5 tt -87.76 101.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 123.616 1.674 . . . . 0.0 113.697 -146.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -89.74 -176.7 5.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.244 157.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.14 -13.94 0.37 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.821 -0.549 . . . . 0.0 112.354 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.98 132.03 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.392 0.542 . . . . 0.0 109.747 166.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.08 139.22 50.07 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.15 127.68 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.767 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.41 116.1 2.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.1 m -126.1 134.14 51.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.477 0.639 . . . . 0.0 111.235 -175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -122.64 133.78 54.51 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.6 146.11 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.636 0.255 . . . . 0.0 111.269 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.01 133.95 53.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.38 153.13 21.81 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.074 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.82 140.0 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -138.91 163.89 25.85 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.395 -173.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -134.15 152.33 51.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 113.485 -1.357 . . . . 0.0 108.801 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -136.76 149.0 47.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.531 -179.627 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.972 0.415 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.7 m -132.51 139.27 47.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.332 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.58 120.53 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.5 m -128.25 143.09 51.0 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.31 140.86 12.13 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.23 179.81 31.82 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.159 -175.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.6 144.57 46.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -0.622 . . . . 0.0 109.847 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -122.74 138.52 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.944 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -125.46 131.92 52.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -116.81 145.74 43.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 139.31 38.66 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.827 0.704 . . . . 0.0 111.253 -173.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.115 -177.009 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 pttt . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.545 0.212 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.8 mtt -117.63 146.38 43.71 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.57 135.29 10.78 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.52 143.15 14.45 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.607 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -110.95 135.8 50.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -131.63 144.57 51.14 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.945 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.6 mt -124.41 140.51 52.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.239 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.16 141.89 51.04 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.043 0.449 . . . . 0.0 111.084 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -121.03 130.21 53.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -134.39 144.08 47.99 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.265 0.353 . . . . 0.0 110.657 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -107.49 143.22 36.18 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.68 119.16 31.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.195 0.522 . . . . 0.0 109.981 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.45 153.4 46.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.991 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.7 -178.62 3.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.541 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -56.37 -32.96 65.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.315 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.2 m -93.38 -25.94 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -102.83 136.3 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.728 1.619 . . . . 0.0 111.848 164.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.6 mt -78.06 154.27 31.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.93 140.38 16.38 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.09 127.5 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.501 0.651 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.9 tt -123.36 138.39 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.28 139.77 10.58 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 p -135.41 144.93 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.067 0.434 . . . . 0.0 111.424 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -124.68 128.65 49.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.109 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.8 p -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.855 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -127.28 137.12 52.77 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -111.54 150.73 29.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 111.202 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--O 1.235 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.141 -179.209 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 . . . . . 0 CA--C 1.523 -0.064 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.17 128.25 41.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.45 128.15 5.29 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.65 122.61 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.3 p -123.3 154.95 38.17 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.864 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.72 147.6 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.16 42.3 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.512 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -97.29 127.79 0.27 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.452 2.101 . . . . 0.0 112.818 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.66 138.55 36.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.652 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.0 t80 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.568 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.93 129.95 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.282 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -115.76 133.9 55.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.17 137.71 10.88 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 172.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.77 153.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 117.559 0.679 . . . . 0.0 111.976 -173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.5 t -125.71 140.84 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.41 174.95 27.0 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.661 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.3 128.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.3 131.26 8.53 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -139.06 155.91 47.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.097 0.448 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.714 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.445 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.23 0.056 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -136.02 159.86 40.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 111.403 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.02 167.11 26.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -93.2 124.86 37.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -113.07 140.55 47.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.039 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.2 139.38 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.5 161.9 28.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.152 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.34 148.94 31.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.368 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.04 162.0 28.68 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.61 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.87 152.64 27.73 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -116.47 133.47 55.98 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 111.693 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.56 109.74 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -140.59 124.71 10.58 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -165.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -101.23 176.14 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.381 2.054 . . . . 0.0 109.258 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.7 mtp -58.69 176.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 61.64 -174.45 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.901 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -60.63 -11.56 7.62 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.8 t -78.4 17.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -167.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.24 138.02 41.3 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.27 145.52 48.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -168.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.66 131.35 44.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.661 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -124.06 129.79 51.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -140.12 154.11 46.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.606 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -121.61 139.98 52.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.94 150.95 46.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.889 0.376 . . . . 0.0 110.742 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -131.84 136.02 47.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -113.32 144.57 42.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.194 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -89.21 146.24 24.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.782 0.676 . . . . 0.0 109.519 -160.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 pt -87.88 98.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 123.309 1.528 . . . . 0.0 114.032 -145.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -89.67 -176.74 5.08 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 112.2 -2.273 . . . . 0.0 106.903 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.3 p -52.32 -12.78 0.28 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.324 -0.86 . . . . 0.0 112.616 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.07 133.89 65.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.334 0.516 . . . . 0.0 109.837 168.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -115.0 139.1 50.13 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -108.18 129.77 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.743 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.23 117.18 2.9 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 169.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.6 m -126.14 134.26 51.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.862 0.831 . . . . 0.0 111.476 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -115.85 135.13 54.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.6 pt -130.84 144.71 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.286 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.49 128.69 25.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.471 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.07 21.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.612 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.01 140.96 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.13 178.1 31.98 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.401 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -139.8 162.78 34.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.444 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -141.52 149.06 40.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.534 -179.675 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.461 0.08 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.4 m -126.0 139.74 53.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.918 0.389 . . . . 0.0 110.353 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.6 122.59 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.608 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.14 143.06 51.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.34 140.83 12.16 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.89 179.29 31.06 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.031 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -131.16 146.44 52.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.27 149.16 50.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.004 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -116.22 136.3 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -112.9 139.48 48.5 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.79 127.78 32.51 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.88 0.738 . . . . 0.0 111.02 -174.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.582 -176.533 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.671 0.272 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -129.04 160.95 31.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.666 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.83 148.22 17.58 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.14 14.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.755 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -112.77 135.06 53.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -131.12 138.29 49.44 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.833 -174.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.4 mt -122.26 139.61 53.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.289 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -130.7 142.57 50.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.915 0.388 . . . . 0.0 111.427 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -122.26 133.15 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -137.08 144.09 42.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.079 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.09 143.2 33.59 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.59 125.83 37.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.277 0.561 . . . . 0.0 110.188 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.99 153.38 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.56 -178.6 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.715 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.04 -33.53 65.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.427 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -93.25 -26.06 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -102.77 135.28 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.756 1.637 . . . . 0.0 111.889 164.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.97 160.29 28.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.25 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.46 140.21 14.91 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.41 125.51 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.341 0.571 . . . . 0.0 109.935 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.3 mt -119.2 136.12 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.87 136.46 8.57 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.1 p -138.2 149.08 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.41 0.605 . . . . 0.0 111.59 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -122.2 135.56 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.969 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -130.13 140.04 50.83 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.144 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -125.64 136.99 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.59 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 m -101.27 145.31 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.344 -177.79 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.2 t80 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -130.11 133.12 46.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.83 135.51 7.87 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.89 123.57 67.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.5 p -123.23 153.4 40.18 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.052 0.22 . . . . 0.0 111.001 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 143.95 30.23 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.15 169.56 41.52 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.995 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -97.27 124.92 0.22 Allowed 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 122.471 2.114 . . . . 0.0 112.914 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.81 147.02 30.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.719 169.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 t80 . . . . . 0 C--N 1.332 -0.157 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 172.827 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.0 pt -136.83 144.38 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.463 -167.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -137.1 147.34 46.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.847 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 137.87 9.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.67 156.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.76 0.314 . . . . 0.0 111.015 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.49 140.94 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.21 175.08 26.76 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.696 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.75 129.72 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.56 137.88 11.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -139.05 151.8 47.06 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.558 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.623 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.94 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 C--O 1.23 0.046 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -132.06 153.17 50.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.227 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.29 167.07 26.22 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.99 125.91 47.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.1 m -110.24 142.2 42.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.15 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -124.9 137.06 54.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.34 153.43 23.47 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.678 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.25 148.85 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.72 160.04 28.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.377 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.6 mt -108.86 146.04 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -125.75 140.59 52.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 111.805 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -139.97 110.0 6.48 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -132.85 124.29 18.63 Favored Pre-proline 0 CA--C 1.529 0.136 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.472 -170.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -102.04 176.21 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.992 2.462 . . . . 0.0 109.255 156.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -57.77 166.42 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.512 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 65.39 -174.47 0.18 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.16 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -58.74 -11.66 3.41 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.3 m -78.42 17.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -170.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.74 143.04 33.64 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.66 155.8 42.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.369 -174.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -137.09 148.09 46.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.602 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -126.15 127.53 45.88 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 64.9 p -140.23 154.21 46.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.444 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -120.87 150.13 41.53 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -124.72 137.95 54.31 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.487 0.492 . . . . 0.0 110.525 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -122.42 129.22 51.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.301 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.5 m -120.18 144.56 47.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -89.51 146.12 24.82 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.531 0.519 . . . . 0.0 109.602 -163.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.8 tt -87.72 95.91 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 123.705 1.717 . . . . 0.0 113.422 -147.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -89.66 -176.84 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.434 157.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -52.01 -16.27 0.72 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.83 -0.544 . . . . 0.0 112.141 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.33 127.51 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 167.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -115.1 139.16 50.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.2 125.96 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.979 -171.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 108.83 1.12 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 167.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.4 m -126.08 134.26 51.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 117.633 0.716 . . . . 0.0 111.352 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -123.21 132.23 53.97 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 16.4 tt -130.28 143.77 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.188 0.305 . . . . 0.0 111.079 -171.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.2 53.53 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.82 153.11 20.95 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.709 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.3 141.18 47.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.28 178.05 32.14 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.78 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -139.77 171.8 13.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.691 -0.754 . . . . 0.0 110.277 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -117.88 148.95 41.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.503 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.0 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.618 -179.368 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.821 0.343 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 m -129.71 143.11 50.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.511 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.98 127.0 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -128.41 143.17 50.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.899 0.381 . . . . 0.0 111.313 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.67 140.87 12.13 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.78 -175.91 30.23 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.32 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.52 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.85 148.92 50.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.508 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -121.85 135.25 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.618 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.93 143.77 44.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -78.46 138.63 38.56 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.674 0.609 . . . . 0.0 111.078 -173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 -175.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.6 mtm -119.55 153.42 35.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.551 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.18 140.64 13.68 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.11 143.19 14.58 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.813 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.12 132.18 54.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -127.12 139.02 53.27 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.165 0.291 . . . . 0.0 111.716 -173.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.99 132.81 49.15 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -136.18 147.65 47.77 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.02 0.438 . . . . 0.0 110.825 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -132.69 151.18 52.04 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -150.98 144.45 24.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.144 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -105.78 143.24 34.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -92.4 124.38 36.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.308 0.575 . . . . 0.0 110.091 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -121.37 153.32 37.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.871 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.64 -178.46 3.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.843 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -50.66 -42.33 56.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 p -90.26 -25.86 0.3 Allowed Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -102.83 131.95 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.497 1.465 . . . . 0.0 112.218 162.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.4 mt -78.07 162.04 26.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.672 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.19 140.22 23.55 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.32 124.79 54.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 117.821 0.811 . . . . 0.0 109.401 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.82 142.7 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -146.34 134.41 5.33 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -141.93 154.92 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.909 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -132.93 141.15 48.2 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -130.07 141.29 50.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.168 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -118.65 134.39 55.15 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.6 m -109.77 145.83 35.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.993 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.268 179.559 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.6 133.21 49.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.649 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.29 136.34 8.69 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -125.28 124.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 p -123.31 154.7 38.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.315 -175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.81 147.98 41.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.27 171.02 36.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.42 -175.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -99.3 123.48 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.774 2.316 . . . . 0.0 111.945 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.6 143.56 33.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.4 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 t80 . . . . . 0 C--O 1.234 0.253 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.893 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -132.57 129.81 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.576 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -132.18 133.75 44.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.88 137.64 10.59 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.22 151.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 117.468 0.634 . . . . 0.0 112.382 -172.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.78 140.93 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.17 175.14 26.69 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.361 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m -112.56 134.45 55.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.83 10.95 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -122.14 133.35 54.75 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 176.205 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -109.04 142.89 39.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.25 159.47 27.1 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -102.54 126.1 49.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 m -116.44 143.91 44.98 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.698 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -143.08 153.07 42.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.03 175.55 35.97 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.12 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.84 148.99 29.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.001 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.81 159.85 27.89 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.953 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.53 147.63 45.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -134.42 141.04 46.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.273 0.559 . . . . 0.0 111.851 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -130.6 114.05 14.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -134.51 124.69 17.19 Favored Pre-proline 0 N--CA 1.463 0.216 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -98.79 176.24 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.465 2.11 . . . . 0.0 109.146 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.2 mtt -55.93 169.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.798 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -175.91 0.18 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.209 0.528 . . . . 0.0 112.298 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.87 -11.52 5.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.26 18.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -169.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.19 136.74 43.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.281 0.491 . . . . 0.0 109.863 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.5 mt -119.68 142.85 48.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.488 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -135.69 136.21 40.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.288 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.33 134.62 52.15 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 m -140.09 154.0 46.91 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.419 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -120.77 141.6 50.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.76 140.91 50.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 110.239 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -125.06 136.15 53.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.213 0.53 . . . . 0.0 111.346 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.6 m -103.94 144.71 31.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -89.28 145.96 25.04 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -158.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.8 96.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 122.732 1.253 . . . . 0.0 112.533 -145.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -89.85 -176.84 5.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 112.174 -2.285 . . . . 0.0 106.871 157.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.32 -13.36 0.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.387 -0.821 . . . . 0.0 112.537 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -119.06 129.64 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.424 0.556 . . . . 0.0 110.092 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -115.15 139.12 50.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.617 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.11 134.66 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.525 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.22 121.58 4.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.4 m -126.13 134.18 51.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.529 0.665 . . . . 0.0 111.256 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -120.57 130.54 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -131.25 144.62 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.136 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.66 132.91 45.7 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.32 153.31 21.86 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.773 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.63 139.92 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.48 178.03 30.71 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.343 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -141.0 161.85 36.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.786 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -121.03 145.2 48.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.529 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.508 -179.403 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.741 0.305 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -121.76 140.06 52.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.507 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.52 128.51 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.2 m -128.14 142.11 51.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.408 . . . . 0.0 111.193 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.28 140.9 12.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.55 -179.9 31.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.374 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -122.27 140.23 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.65 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.39 138.87 54.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.504 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -125.75 131.78 52.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.5 p -115.92 143.59 45.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.42 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.82 129.42 34.58 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 124.116 0.885 . . . . 0.0 111.374 -173.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.994 -179.14 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt . . . . . 0 C--O 1.231 0.095 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.4 mtt -129.74 154.01 47.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.614 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.5 147.9 16.73 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 143.33 12.28 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.46 133.46 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -127.38 136.63 52.14 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.433 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 tp -130.6 136.31 48.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -139.34 155.32 47.77 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.281 0.562 . . . . 0.0 112.197 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.92 140.37 52.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.097 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -132.62 144.35 50.3 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.212 0.32 . . . . 0.0 110.899 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.42 141.8 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -92.81 123.2 35.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.85 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.44 -178.5 3.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.882 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -54.77 -40.4 69.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 m -84.45 -26.19 0.38 Allowed Pre-proline 0 N--CA 1.467 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -169.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.62 126.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.531 1.487 . . . . 0.0 112.069 160.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.6 mt -76.31 154.64 34.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.25 140.17 18.89 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.97 126.13 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 117.206 0.503 . . . . 0.0 109.647 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.57 134.99 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.89 137.29 9.02 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -141.77 154.86 45.53 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.004 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.34 141.48 50.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.8 p -130.11 143.19 50.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.481 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.76 137.04 55.04 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -115.57 148.55 39.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.005 179.377 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.2 t80 . . . . . 0 CA--C 1.524 -0.044 0 CA-C-O 120.918 0.389 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -131.44 120.41 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.77 135.49 8.54 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 tt -126.04 122.57 62.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -123.48 152.37 41.78 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.102 0.252 . . . . 0.0 110.602 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.0 146.39 30.97 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.51 41.46 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.287 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -99.02 122.3 0.13 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.734 2.289 . . . . 0.0 112.944 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.84 146.68 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.396 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 C--O 1.232 0.155 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.156 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.2 mt -141.55 129.85 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.898 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -134.15 142.77 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.82 143.91 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.045 0.423 . . . . 0.0 110.82 -172.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.36 140.91 47.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.15 175.15 26.67 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.431 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -115.49 130.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 134.91 11.59 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -122.12 136.2 54.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 176.046 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.4 t70 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -109.64 151.23 27.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.99 166.99 26.15 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.66 127.16 51.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.841 0.321 . . . . 0.0 110.349 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.4 t -105.52 132.07 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.566 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -126.48 134.71 50.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.68 158.9 27.81 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.789 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.67 148.87 32.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.6 159.84 28.32 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.375 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mp -112.1 148.52 33.76 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -137.5 137.24 38.46 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.279 -171.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -133.91 131.16 38.77 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -138.74 124.48 12.31 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -99.04 176.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.718 2.279 . . . . 0.0 109.746 159.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.5 ttm -54.51 138.27 40.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.138 0.494 . . . . 0.0 111.861 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 71.81 -153.73 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.457 171.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.97 -11.65 8.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -166.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 t -78.68 17.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -166.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.39 143.02 33.55 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.062 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.37 153.81 40.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 111.403 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p30 -137.29 148.1 46.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.885 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.37 131.72 54.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 m -139.98 154.2 47.1 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.759 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -121.28 141.14 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.72 142.32 47.79 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.547 0.53 . . . . 0.0 110.314 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.46 131.54 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.584 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -110.7 144.73 39.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -89.23 146.1 24.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 123.79 0.681 . . . . 0.0 109.348 -158.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.6 mt -87.83 100.38 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.712 1.244 . . . . 0.0 112.636 -143.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -89.68 -177.0 5.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 112.392 -2.185 . . . . 0.0 107.555 156.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 t -52.25 -15.31 0.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.851 -0.531 . . . . 0.0 112.273 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.39 129.39 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.392 0.542 . . . . 0.0 110.079 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.85 139.24 38.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 119.065 -0.493 . . . . 0.0 109.787 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.69 129.76 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.26 116.94 2.83 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.9 m -126.15 134.27 51.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.714 0.757 . . . . 0.0 111.19 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -109.34 134.14 52.18 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.26 136.34 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 O-C-N 123.131 0.269 . . . . 0.0 110.434 -174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.14 127.46 43.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.38 153.08 22.27 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.05 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.3 t -127.26 145.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.36 178.06 30.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.32 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -135.84 170.29 16.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.745 -0.728 . . . . 0.0 110.409 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.501 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 117.977 -1.011 . . . . 0.0 112.396 178.887 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.1 p -124.29 157.45 34.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.167 0.508 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.62 125.95 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.505 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.6 m -128.19 143.11 51.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.54 140.73 12.0 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.61 176.49 33.14 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.394 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.03 149.84 41.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.941 -0.63 . . . . 0.0 109.667 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.36 141.71 50.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.187 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -128.0 131.91 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -116.1 145.93 42.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -78.72 142.05 37.4 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.782 0.676 . . . . 0.0 110.944 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.217 -176.187 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.698 0.285 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.2 ttm -123.92 146.46 48.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.307 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 134.67 10.8 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.07 143.35 14.27 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -118.61 144.42 46.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -143.96 153.23 42.05 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.752 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -123.2 142.91 50.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.521 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -136.22 138.42 41.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 111.016 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.93 140.45 49.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -133.66 144.21 49.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.975 0.417 . . . . 0.0 110.683 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -101.29 143.29 31.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -92.38 117.39 29.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.545 0.688 . . . . 0.0 110.407 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -126.2 153.55 44.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.631 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.59 -178.63 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.773 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -56.69 -33.42 66.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.29 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -102.78 140.98 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.714 1.61 . . . . 0.0 111.823 164.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.16 159.97 28.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.061 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.16 140.05 14.88 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.79 127.58 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.527 0.663 . . . . 0.0 109.948 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.27 144.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.388 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.99 137.87 8.73 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.3 t -136.53 141.35 43.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.019 0.41 . . . . 0.0 111.308 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.94 131.63 54.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -130.0 142.99 50.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.622 0.249 . . . . 0.0 111.554 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.18 136.38 51.99 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.8 p -121.17 152.32 38.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.946 0.403 . . . . 0.0 111.175 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.56 -178.859 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.78 133.62 54.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.57 128.64 5.42 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.8 mt -122.18 120.06 60.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 p -123.28 151.72 42.09 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.139 0.274 . . . . 0.0 111.047 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.97 145.27 30.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.15 170.09 41.81 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.882 -1.151 . . . . 0.0 113.085 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -98.72 126.03 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.379 2.053 . . . . 0.0 112.688 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.57 142.84 33.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.482 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 t80 . . . . . 0 C--N 1.332 -0.17 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.167 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 CA--C 1.52 -0.2 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 tt -131.92 136.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.28 -167.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -129.14 143.33 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.96 137.72 10.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.25 154.64 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.915 0.358 . . . . 0.0 111.296 -173.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.58 140.81 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.08 172.95 27.41 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.758 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.87 132.53 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 132.52 10.11 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -127.22 134.06 50.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.261 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.549 0.214 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -110.1 144.23 39.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.996 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.96 158.84 26.86 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.85 125.34 50.79 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -110.94 143.36 41.71 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.302 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -130.79 134.72 47.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.57 161.26 28.0 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.963 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.35 148.92 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.55 160.34 28.34 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.377 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.6 mt -108.89 151.21 26.59 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -123.69 132.11 53.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.759 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.21 111.44 15.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -130.74 124.42 20.82 Favored Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -169.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -96.41 176.05 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.739 2.293 . . . . 0.0 109.341 156.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -65.57 147.1 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 79.31 -164.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.761 0.825 . . . . 0.0 110.817 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.62 -11.88 8.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.67 17.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 134.67 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.525 0.602 . . . . 0.0 109.844 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.11 140.72 47.79 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.752 0.311 . . . . 0.0 111.184 -168.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -125.43 145.18 50.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.334 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -125.92 129.71 49.84 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.9 t -140.2 154.0 46.77 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.512 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -117.1 145.49 43.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -128.31 132.33 48.66 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.271 0.357 . . . . 0.0 110.043 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -118.75 134.6 55.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.856 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.0 m -115.65 144.75 43.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.52 146.02 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.64 0.587 . . . . 0.0 109.484 -160.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -87.74 95.95 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.708 1.242 . . . . 0.0 112.383 -146.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -89.91 -176.92 5.08 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.375 -2.193 . . . . 0.0 106.669 157.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.8 t -52.17 -16.02 0.71 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.303 -0.873 . . . . 0.0 112.179 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.63 129.38 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.251 0.478 . . . . 0.0 109.811 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -115.06 139.06 50.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.406 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.0 t -108.26 128.43 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.578 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.4 112.08 1.62 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 169.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -126.08 134.32 51.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.815 0.808 . . . . 0.0 111.176 -173.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -116.25 136.24 53.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.3 pt -130.13 147.22 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.169 -175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.5 128.5 25.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.2 153.1 23.21 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.519 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -125.81 145.88 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.07 32.11 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.133 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.43 165.95 23.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.81 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -118.06 148.65 42.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.703 0.287 . . . . 0.0 110.45 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.618 -179.656 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.61 0.243 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.9 p -131.09 155.7 46.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.474 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.04 120.25 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.744 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.8 m -128.34 142.96 50.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.818 0.342 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.33 140.86 12.18 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.24 167.91 28.99 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.994 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.08 138.85 53.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.88 149.11 51.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.083 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -124.03 138.98 54.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -115.93 140.77 48.91 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.311 0.382 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.78 126.29 30.52 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.8 0.687 . . . . 0.0 111.381 -173.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.747 -179.291 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 mttm . . . . . 0 C--O 1.231 0.084 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.6 mmm -125.3 155.12 40.71 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.251 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.37 148.35 16.76 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.04 143.03 14.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.717 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.85 135.78 48.79 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.602 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.3 mt -120.31 140.25 51.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -129.65 143.66 50.92 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.887 0.375 . . . . 0.0 111.37 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -125.32 132.29 52.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -139.93 144.15 36.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -98.47 143.44 28.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.75 136.05 33.57 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.241 0.543 . . . . 0.0 111.119 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -133.42 153.65 51.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.519 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.18 -178.3 3.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.334 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -51.14 -28.41 10.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -97.13 -25.82 0.24 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -102.82 148.08 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.817 1.678 . . . . 0.0 112.983 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.11 164.96 24.54 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.4 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.34 140.24 14.77 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -111.04 125.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.7 tt -126.72 138.38 54.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.54 142.72 14.24 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.8 p -138.91 148.79 44.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.092 0.446 . . . . 0.0 111.668 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -121.42 133.71 55.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.218 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -128.95 137.19 51.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.65 0.262 . . . . 0.0 111.125 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -120.57 136.94 54.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.866 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.6 m -98.58 137.69 36.87 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.696 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.756 -175.375 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.135 0.493 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -123.08 124.82 43.95 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.88 139.49 11.14 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.639 -176.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -125.09 124.21 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -123.26 154.34 38.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.774 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.01 145.62 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.05 171.21 42.34 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.994 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -97.15 127.1 0.26 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.144 1.896 . . . . 0.0 112.821 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 143.39 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.177 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.637 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.4 mt -129.9 130.13 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -169.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.46 140.39 51.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.73 137.82 9.75 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.48 156.99 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 -175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.03 140.83 47.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.19 175.2 26.68 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.067 -174.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.01 134.86 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.92 133.64 10.79 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -122.54 141.26 51.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.874 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 . . . . . 0 CA--C 1.524 -0.024 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.512 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.2 166.02 26.49 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.98 127.98 53.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.948 0.374 . . . . 0.0 110.032 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.8 p -113.89 146.33 40.19 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -137.41 143.12 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.93 159.91 28.17 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.728 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.06 149.02 30.41 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.53 161.65 28.86 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.756 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.1 mt -108.92 147.48 32.14 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.04 132.62 54.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.649 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -125.32 109.93 13.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -120.13 124.29 27.88 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -100.14 176.24 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.353 2.702 . . . . 0.0 109.332 155.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 84.9 mtp -60.07 138.01 57.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.267 0.556 . . . . 0.0 112.245 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 68.15 -148.31 0.14 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.731 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -61.15 -12.08 11.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.44 17.29 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.21 139.39 39.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.036 0.835 . . . . 0.0 110.282 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.5 tp -132.62 141.46 48.67 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -168.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -133.7 146.43 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.792 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -121.34 134.11 55.13 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -140.16 154.02 46.82 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.351 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -120.47 145.62 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -127.12 140.0 52.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.383 . . . . 0.0 110.462 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -127.95 136.02 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.125 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.9 t -112.98 144.74 42.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -89.18 146.19 24.94 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 124.436 1.085 . . . . 0.0 109.384 -158.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.1 mt -87.56 104.03 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.947 1.356 . . . . 0.0 112.749 -142.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -89.76 -176.58 5.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 112.056 -2.338 . . . . 0.0 107.304 156.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.5 p -52.39 -12.69 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 p -123.24 131.51 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 110.296 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -115.08 139.17 50.11 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.8 m -108.23 140.59 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.242 -174.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.17 119.49 3.6 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.3 m -126.0 134.17 51.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.637 0.718 . . . . 0.0 111.132 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -119.12 132.13 55.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 tt -131.79 144.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.569 0.223 . . . . 0.0 111.163 -174.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.53 132.5 48.3 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.6 153.16 22.92 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.811 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.5 144.51 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 176.95 32.58 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.814 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -135.38 170.25 16.23 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.59 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.08 149.05 37.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.686 0.279 . . . . 0.0 110.82 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.884 -179.119 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.785 0.326 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 m -125.11 141.24 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.09 128.52 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.39 140.85 11.68 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.69 -168.75 26.18 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.134 -1.032 . . . . 0.0 111.566 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -132.05 153.94 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.175 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.0 142.29 50.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.006 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -118.59 131.92 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 t -111.05 140.56 45.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.58 128.0 32.91 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.931 0.769 . . . . 0.0 111.298 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.152 -177.074 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 mttp . . . . . 0 C--O 1.231 0.113 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.613 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.14 136.82 11.45 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.84 143.25 14.88 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.38 137.4 44.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.32 134.35 50.01 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.295 0.372 . . . . 0.0 111.66 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.54 138.69 54.49 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -134.9 143.06 46.74 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.089 0.471 . . . . 0.0 111.617 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -120.42 134.55 55.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.244 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttm105 -135.59 144.16 46.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 0.0 110.985 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.72 143.16 35.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.4 124.33 36.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 109.786 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.88 153.41 48.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.1 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.55 -178.62 3.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.566 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -57.73 -30.72 65.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 p -95.76 -25.74 0.25 Allowed Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -102.89 136.97 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.71 1.606 . . . . 0.0 111.956 165.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.13 155.13 30.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.1 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.28 15.54 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -101.99 125.93 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 117.346 0.573 . . . . 0.0 110.004 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.1 mt -118.44 132.08 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.62 132.55 8.0 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 t -133.54 140.59 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.112 0.456 . . . . 0.0 111.388 -173.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.17 132.98 55.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.4 m -130.07 134.6 47.48 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.83 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.15 137.16 52.9 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -107.6 152.15 24.67 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 111.359 -172.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.878 -179.746 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -131.24 132.49 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.02 149.88 20.66 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.7 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.7 tt -125.6 125.49 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 p -123.16 155.01 37.89 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.031 0.207 . . . . 0.0 110.52 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.56 143.97 30.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.16 159.17 31.66 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.881 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -95.15 124.09 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.969 1.78 . . . . 0.0 112.481 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.63 144.77 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.341 170.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.019 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.641 0.257 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.2 mt -128.93 132.71 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -130.77 146.79 52.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.621 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.464 0.525 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -140.15 144.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 117.121 0.46 . . . . 0.0 110.986 -170.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -131.99 140.83 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.28 175.09 26.82 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.14 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 130.04 74.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.94 144.13 18.31 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -134.96 148.39 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.724 0.262 . . . . 0.0 110.692 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.749 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 . . . . . 0 C--O 1.231 0.119 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -117.21 147.61 42.35 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.304 0.377 . . . . 0.0 111.045 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 159.4 27.03 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -104.66 126.05 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.968 0.384 . . . . 0.0 110.062 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 94.0 p -108.22 137.29 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.969 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -127.75 140.73 51.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.28 169.2 32.67 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.465 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.67 148.98 30.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.789 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.86 158.95 27.84 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.615 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.9 tp -109.22 145.87 35.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -128.16 135.99 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.296 0.498 . . . . 0.0 111.471 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.39 129.73 25.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -140.99 124.67 10.17 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -96.09 176.16 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.533 2.156 . . . . 0.0 109.193 156.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -61.19 150.68 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.52 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 72.98 -160.48 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -61.43 -11.37 10.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.49 17.4 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.4 139.52 39.23 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.88 153.64 51.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.934 0.397 . . . . 0.0 111.078 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -137.06 143.84 42.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.046 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.98 132.61 53.24 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.1 t -140.04 153.92 46.94 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.582 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.27 140.11 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -127.84 146.98 50.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.285 0.366 . . . . 0.0 110.04 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -129.31 135.92 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -107.39 144.68 33.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -89.19 145.99 25.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -159.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.3 mt -87.98 101.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.656 1.217 . . . . 0.0 112.779 -144.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -89.86 -176.89 5.08 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 112.405 -2.18 . . . . 0.0 107.418 156.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.3 p -52.04 -15.45 0.56 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.778 -0.577 . . . . 0.0 112.358 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.85 129.22 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.894 -0.504 . . . . 0.0 109.729 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.2 139.15 46.82 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.19 133.96 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.879 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.22 3.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 170.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -126.36 134.24 51.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.795 0.798 . . . . 0.0 110.883 -176.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -119.05 136.09 54.31 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.7 mt -121.01 140.1 46.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.404 -172.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.1 123.34 25.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.76 153.31 22.57 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.787 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.13 147.1 29.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.17 32.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.216 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -138.88 167.18 22.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.714 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.605 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.495 -179.383 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.797 0.332 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.4 m -125.3 140.66 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.58 126.33 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.073 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.4 m -128.34 140.28 51.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.878 0.371 . . . . 0.0 110.67 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.77 140.82 12.1 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 108.446 -1.861 . . . . 0.0 108.446 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.38 -172.73 30.19 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.781 -1.199 . . . . 0.0 112.877 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -134.2 143.82 48.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.727 -0.736 . . . . 0.0 109.575 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.03 149.13 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.228 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -118.73 138.46 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.804 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -111.01 140.15 45.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.57 128.36 33.41 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.925 0.766 . . . . 0.0 111.322 -171.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.03 -177.497 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.619 0.247 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.2 mtm -126.89 156.06 42.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.235 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.31 149.49 17.46 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.11 12.64 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -112.75 139.07 48.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -130.59 147.07 52.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -173.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.2 mt -115.95 142.22 47.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.826 170.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -129.7 141.92 50.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.433 -170.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -133.98 147.39 51.01 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -144.28 144.16 31.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.761 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -110.39 140.95 44.11 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 175.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -92.96 125.58 37.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.227 0.536 . . . . 0.0 110.573 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -145.05 153.62 41.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.816 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.48 -178.49 3.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.038 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -53.48 -34.82 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.94 -26.05 0.3 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -102.8 127.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.673 1.582 . . . . 0.0 111.567 161.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 76.9 mt -75.77 153.4 37.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.169 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.26 22.69 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.92 125.0 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 117.304 0.552 . . . . 0.0 109.695 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.0 pt -125.36 147.55 30.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.245 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.46 147.44 17.57 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 p -141.8 146.1 35.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.874 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -120.17 127.63 52.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.6 p -128.82 142.98 50.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.213 -177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -127.27 137.33 52.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.896 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -97.74 147.51 24.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.098 0.475 . . . . 0.0 111.28 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 C--O 1.235 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 -175.776 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.1 p90 . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.61 0.719 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -125.85 140.08 52.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.088 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.33 137.51 9.5 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.0 117.95 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -123.29 150.05 44.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.329 -175.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.15 149.08 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 171.0 41.32 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 119.855 -1.164 . . . . 0.0 113.067 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -97.74 126.92 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.563 2.175 . . . . 0.0 112.662 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.53 139.49 36.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.548 170.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 C--N 1.331 -0.235 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.135 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.515 0.198 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.5 tt -138.94 129.92 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -141.71 152.52 43.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.864 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.94 137.84 11.38 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 p -138.11 143.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 117.223 0.511 . . . . 0.0 111.01 -171.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.84 140.77 48.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.06 172.34 27.54 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.529 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t -115.03 130.71 69.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 131.71 9.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.35 140.06 50.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.602 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 40.2 p30 . . . . . 0 N--CA 1.458 -0.047 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -132.9 151.97 51.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.034 0.445 . . . . 0.0 111.545 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.03 165.98 26.45 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -106.13 125.79 51.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.886 0.343 . . . . 0.0 110.12 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.6 p -107.54 144.41 34.57 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -130.76 136.77 49.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.92 166.72 28.86 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.49 148.9 35.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.02 161.04 28.51 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.236 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.419 0.628 . . . . 0.0 111.971 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.75 109.95 12.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 168.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -121.04 124.58 27.35 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -166.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -97.51 176.12 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.658 2.239 . . . . 0.0 109.59 156.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.0 ttm -64.91 141.22 58.85 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.182 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 79.28 -162.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.696 0.799 . . . . 0.0 111.225 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -59.43 -11.54 4.6 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 m -78.63 17.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.14 134.32 47.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.54 0.609 . . . . 0.0 109.893 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.7 mt -114.96 144.17 44.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.916 -169.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -130.95 140.23 50.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.848 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.82 136.02 40.3 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 t -140.4 154.03 46.54 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.443 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.22 139.82 49.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -135.97 134.99 39.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.752 0.31 . . . . 0.0 110.229 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -124.74 134.84 52.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.124 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.3 p -96.79 144.78 26.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -89.16 145.9 25.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -162.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.7 tt -87.87 102.33 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 123.364 1.554 . . . . 0.0 114.08 -144.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -89.66 -176.86 5.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 112.367 -2.197 . . . . 0.0 107.277 156.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -52.11 -15.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.785 -0.572 . . . . 0.0 112.271 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.4 129.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 168.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -113.71 139.15 49.32 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.58 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.9 t -108.21 134.7 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 124.71 5.39 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -126.21 134.14 51.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 117.459 0.63 . . . . 0.0 111.269 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -119.88 127.59 52.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.0 tt -130.5 143.44 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.385 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.38 136.39 43.32 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.91 153.26 23.68 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.683 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 m -116.47 139.95 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -154.91 177.29 32.26 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.471 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.564 -0.818 . . . . 0.0 110.083 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -118.02 147.17 43.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.298 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.5 t80 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.58 -179.181 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.725 0.298 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.4 m -124.92 140.21 53.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.154 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.44 119.99 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -128.22 141.81 51.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.33 140.69 12.47 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.1 165.11 28.21 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.037 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -121.62 145.86 47.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.58 149.03 50.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.903 0.382 . . . . 0.0 111.179 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -122.39 135.05 54.62 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 m -115.14 132.92 56.45 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.154 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.82 123.83 30.9 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.316 1.01 . . . . 0.0 110.93 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 179.509 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt . . . . . 0 N--CA 1.462 0.135 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.48 153.07 47.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.943 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.17 135.19 11.46 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.23 14.22 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -118.8 139.81 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.9 145.11 45.95 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.959 -176.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.32 132.05 53.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -125.56 143.06 51.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 111.377 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.95 138.24 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -130.72 144.08 51.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.967 0.413 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.69 143.14 45.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.66 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.29 129.32 38.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.289 0.566 . . . . 0.0 110.543 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -131.03 153.49 49.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.763 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.6 -178.54 3.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -53.61 -34.35 58.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.605 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -94.56 -25.89 0.26 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -102.92 134.22 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.764 1.643 . . . . 0.0 111.877 163.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.1 160.59 27.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.83 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.43 140.17 24.1 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.12 124.88 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.319 0.56 . . . . 0.0 110.026 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.4 mt -120.49 135.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.51 140.1 11.35 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -142.13 150.08 40.65 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.323 0.562 . . . . 0.0 111.774 -175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.49 133.22 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.087 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -130.07 137.31 50.14 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.967 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.18 136.66 52.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -116.67 137.26 52.32 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.028 0.376 . . . . 0.0 110.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -175.619 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.002 0.429 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -122.33 123.0 40.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 132.29 7.93 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.8 mt -120.53 117.54 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.8 p -123.3 155.26 37.59 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.886 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.19 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.5 157.34 28.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.632 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -95.6 122.39 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.992 1.795 . . . . 0.0 111.94 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.77 144.02 32.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.866 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.858 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.4 pt -133.06 146.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.643 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.21 155.03 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.452 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.81 137.95 11.5 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.2 t -131.9 139.03 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.854 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.39 140.73 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.28 174.89 26.91 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.647 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.25 128.12 72.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.86 10.34 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -118.26 130.63 56.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.617 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 . . . . . 0 C--O 1.23 0.034 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -106.66 148.31 28.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.193 0.521 . . . . 0.0 112.385 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 162.49 27.16 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -103.15 126.99 50.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.195 0.497 . . . . 0.0 110.619 -178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -109.43 135.71 50.03 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.629 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -130.3 145.32 51.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.04 175.09 36.04 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.452 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.05 31.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.018 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.53 158.05 27.41 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.009 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.2 tp -117.8 145.81 44.27 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -123.95 132.26 53.69 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.569 0.622 . . . . 0.0 112.228 -174.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.05 122.87 40.27 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 171.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -142.14 124.55 9.16 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -95.96 176.19 0.8 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.724 2.282 . . . . 0.0 109.364 155.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.1 mtp -55.17 138.59 44.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.289 0.566 . . . . 0.0 112.338 -174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 71.46 -145.25 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.74 -11.85 29.86 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -166.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.8 17.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -168.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.49 137.8 41.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.607 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -130.17 140.98 50.7 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.297 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -125.53 137.11 53.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -118.56 132.6 56.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -139.65 151.44 45.96 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.715 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -122.23 139.82 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -132.25 151.16 51.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -131.71 136.1 47.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.012 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 t -109.08 144.85 36.57 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.076 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -89.13 146.19 24.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.201 0.601 . . . . 0.0 109.406 -156.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.3 mm -87.66 96.0 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 122.841 1.305 . . . . 0.0 112.225 -142.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -91.9 -177.1 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.141 -2.299 . . . . 0.0 107.974 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.0 m -52.27 -17.61 1.21 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.022 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.33 131.0 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -114.97 138.8 50.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.32 132.43 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.989 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.33 120.25 3.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 168.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.3 m -126.12 134.22 51.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.951 0.875 . . . . 0.0 111.543 -173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -112.94 131.39 55.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.4 mt -123.53 139.02 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 123.118 0.261 . . . . 0.0 110.616 -174.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.58 124.01 24.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.58 153.2 21.94 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.609 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 p -128.65 142.68 43.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 177.98 32.09 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -130.93 164.43 25.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.395 -0.903 . . . . 0.0 109.952 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -118.36 149.1 41.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.75 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 72.7 t80 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.957 -178.846 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--O 1.231 0.114 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.0 p -126.96 155.45 43.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.08 121.16 45.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.772 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.1 m -128.29 140.63 51.77 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.828 0.347 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.64 140.85 12.16 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.06 170.52 30.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.1 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.11 139.24 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.92 149.06 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.052 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -118.16 138.59 52.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.265 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 t -111.97 137.3 50.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.68 142.01 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.973 0.795 . . . . 0.0 111.388 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.029 -177.352 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 C--O 1.231 0.084 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.39 159.75 38.35 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.807 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.07 144.42 15.41 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.89 142.96 14.14 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.864 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -113.65 133.91 55.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -129.14 138.83 52.01 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.28 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.5 tt -130.16 130.2 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.56 154.54 47.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.279 0.562 . . . . 0.0 112.235 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -123.21 141.89 51.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.806 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -132.76 144.03 49.99 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.561 0.538 . . . . 0.0 110.216 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.26 143.31 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -92.68 122.45 35.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 109.735 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -132.52 153.32 51.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.061 -172.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.7 -178.53 3.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.221 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.07 -25.92 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -170.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -102.85 135.71 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.802 1.668 . . . . 0.0 111.941 165.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.98 158.33 29.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.858 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.22 140.25 15.05 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.5 127.2 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 117.418 0.609 . . . . 0.0 110.06 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.9 mt -120.71 133.1 68.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.19 137.19 8.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 t -140.56 145.35 36.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.147 0.474 . . . . 0.0 111.44 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.92 135.08 54.32 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -126.81 141.09 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.634 0.254 . . . . 0.0 110.637 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -127.02 134.6 50.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.8 m -115.29 141.76 47.59 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.688 0.28 . . . . 0.0 110.48 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.89 -177.792 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.044 0.45 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -122.9 132.97 54.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.226 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.27 135.27 8.05 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.71 124.43 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.2 p -123.18 149.41 44.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.126 0.266 . . . . 0.0 110.847 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.52 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.03 166.98 39.83 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.711 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.1 128.06 0.43 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 122.066 1.844 . . . . 0.0 112.769 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.61 142.17 34.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.061 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.6 t80 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.785 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.231 0.106 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 tt -140.51 129.87 26.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -142.74 154.08 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.441 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.51 137.79 9.81 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.3 155.04 38.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 117.143 0.471 . . . . 0.0 111.296 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.05 141.08 47.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.11 175.03 26.69 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.049 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.42 134.0 66.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 133.35 10.61 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -121.95 136.77 54.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 C--O 1.23 0.063 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -125.1 148.6 48.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 111.35 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.05 161.66 27.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.22 125.09 50.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 84.2 p -107.9 146.96 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.25 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -130.5 138.48 50.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.58 162.01 28.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.195 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.86 148.92 39.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.94 152.91 25.0 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.134 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.06 145.87 47.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -137.93 136.74 37.3 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.438 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.63 122.13 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -116.06 124.22 30.0 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -106.24 176.17 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.68 2.92 . . . . 0.0 109.112 154.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -63.26 151.47 40.44 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.747 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 68.58 -165.31 0.19 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.495 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -57.88 -11.25 2.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 t -78.21 17.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -167.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 138.61 40.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.174 -0.954 . . . . 0.0 110.162 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.91 144.46 51.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.615 -171.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -134.8 144.06 47.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.385 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.38 137.97 52.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 t -140.15 152.1 45.8 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.523 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.26 139.69 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.12 141.23 50.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.743 0.306 . . . . 0.0 110.865 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -127.36 136.18 51.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.399 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.8 m -113.07 144.69 42.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -89.4 146.3 24.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.616 0.572 . . . . 0.0 109.678 -159.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.1 pt -87.8 95.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 123.229 1.49 . . . . 0.0 114.117 -145.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -89.78 -176.76 5.06 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 112.27 -2.241 . . . . 0.0 107.737 157.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.0 t -52.21 -16.03 0.72 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.73 132.56 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 118.187 0.449 . . . . 0.0 110.147 168.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -112.47 139.12 48.31 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.416 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.14 129.03 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.571 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.27 119.2 3.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.4 m -126.04 134.15 51.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.757 0.779 . . . . 0.0 111.054 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -122.21 129.59 52.41 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.1 tt -129.89 144.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.631 0.253 . . . . 0.0 111.362 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -126.11 132.98 51.77 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.26 152.99 21.33 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.863 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.11 139.83 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.11 178.05 31.99 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.542 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.78 163.98 28.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.733 -0.734 . . . . 0.0 110.032 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -117.88 149.02 41.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.656 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.4 p90 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.492 179.422 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 64.5 p 48.74 33.62 4.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.965 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.6 p -143.85 148.18 35.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m -132.82 141.97 48.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.342 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.45 115.26 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.1 m -128.17 139.69 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.83 140.85 12.23 Favored Glycine 0 N--CA 1.461 0.352 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.88 167.28 28.27 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.018 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -115.15 140.58 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -122.46 141.19 51.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.968 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -118.72 131.9 56.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 t -112.76 134.74 54.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.81 142.14 37.16 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.115 0.884 . . . . 0.0 110.844 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.84 143.17 31.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.494 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.7 153.5 20.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.55 143.34 10.23 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.043 -171.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 65.12 37.16 6.81 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.977 0.511 . . . . 0.0 111.225 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.8 mtt -149.66 173.97 13.08 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -115.81 164.82 13.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.954 0.407 . . . . 0.0 111.455 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -75.05 161.82 29.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.1 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -131.59 157.55 43.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.606 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.36 146.98 17.84 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.53 143.22 14.29 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.96 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -109.77 134.42 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -127.39 137.67 52.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.579 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.8 tp -122.6 134.3 54.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.117 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -128.35 143.82 51.06 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.07 0.462 . . . . 0.0 111.826 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -123.65 138.61 54.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.405 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -131.4 144.06 50.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.86 0.362 . . . . 0.0 111.118 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -103.93 143.21 33.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.58 125.07 37.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -133.06 153.2 51.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.694 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.83 -178.4 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.177 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.46 -38.61 69.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -85.73 -25.99 0.35 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.81 142.38 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.58 1.52 . . . . 0.0 112.525 163.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 74.5 mt -78.06 165.04 24.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.005 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.09 140.12 14.92 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.18 125.47 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.364 0.582 . . . . 0.0 109.947 -174.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.17 135.5 62.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.66 138.02 10.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 t -131.71 137.33 48.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.813 0.307 . . . . 0.0 111.063 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -115.27 129.11 56.53 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 m -125.9 137.74 53.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.679 0.276 . . . . 0.0 110.731 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -126.06 132.58 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.771 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 m -101.49 146.01 28.22 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -142.72 146.44 34.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.533 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -137.0 136.86 38.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.637 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.7 p -65.43 156.31 32.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.574 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -56.8 148.53 20.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.655 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -112.21 176.55 4.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.225 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 146.99 30.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.297 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 p 62.98 132.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.581 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.6 m -81.04 12.93 3.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.78 -36.08 66.3 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.93 96.38 2.85 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.099 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -133.38 137.49 45.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.431 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.5 p30 35.12 31.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.73 -35.98 81.4 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -97.39 129.56 44.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.382 . . . . 0.0 111.482 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -126.13 148.06 49.48 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.28 138.26 54.67 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -127.1 135.73 51.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.43 135.38 7.57 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.569 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.58 119.35 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.1 p -123.23 153.67 39.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.036 0.21 . . . . 0.0 110.507 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.17 146.22 30.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.01 167.37 40.08 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.875 -1.155 . . . . 0.0 112.999 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -97.18 124.21 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.276 1.984 . . . . 0.0 112.855 175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.79 142.25 33.94 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.77 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -115.59 123.89 49.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -95.82 108.71 21.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.352 0.596 . . . . 0.0 111.928 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.47 131.46 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.214 170.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -61.43 -34.34 75.23 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.188 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.44 -176.93 2.03 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -86.16 46.28 1.32 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.346 0.593 . . . . 0.0 110.507 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.14 22.43 10.21 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.247 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.2 t -68.95 149.69 48.57 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.276 0.489 . . . . 0.0 109.887 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.22 129.77 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -127.97 133.86 49.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.75 137.89 11.13 Favored Glycine 0 N--CA 1.465 0.62 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.79 145.95 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.557 0.679 . . . . 0.0 111.445 -172.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.35 140.93 47.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.28 175.07 26.83 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.444 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.42 127.22 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.69 137.56 11.32 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.19 157.91 45.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.098 0.449 . . . . 0.0 111.45 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.7 138.81 12.55 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -142.79 146.16 33.96 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.613 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -100.04 129.62 46.11 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -112.37 144.91 41.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.944 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 m -71.85 139.07 48.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.323 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.1 m -57.03 -49.8 74.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.914 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -175.78 -69.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.944 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.58 -53.4 0.21 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.86 -176.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.77 99.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.519 1.479 . . . . 0.0 112.897 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.2 m -86.26 131.3 34.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.726 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.2 165.15 37.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.428 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -121.92 65.77 0.91 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.626 0.727 . . . . 0.0 110.264 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -124.55 -3.58 7.82 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.71 145.78 55.59 Favored 'General case' 0 C--O 1.231 0.079 0 O-C-N 122.029 -0.419 . . . . 0.0 110.785 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -137.55 157.52 46.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.643 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 t -136.04 142.0 44.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -151.68 142.19 22.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.129 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.71 149.29 33.13 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.731 0.644 . . . . 0.0 110.817 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.0 161.62 27.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -101.67 127.17 48.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -113.66 145.47 41.26 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.034 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -131.16 139.47 49.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.41 161.32 27.96 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.732 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 148.91 35.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.95 164.52 29.2 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.857 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.6 tp -109.07 145.91 34.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -138.44 134.22 33.78 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.83 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -135.45 115.22 12.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.54 124.46 19.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -102.88 176.15 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.796 2.331 . . . . 0.0 109.294 157.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.2 mtm -55.38 164.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 66.48 -171.94 0.19 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.721 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.29 -11.42 4.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.1 t -78.32 17.91 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -166.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.43 130.61 52.31 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.331 -0.856 . . . . 0.0 110.231 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -124.59 146.29 49.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.819 -171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -137.15 139.54 41.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.411 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.98 131.17 47.41 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -140.24 154.09 46.76 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.663 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -118.32 140.37 49.93 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -126.81 136.62 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.193 0.308 . . . . 0.0 110.387 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -119.33 130.83 55.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.321 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.9 t -108.09 144.6 35.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -89.37 145.97 24.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -159.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.0 tt -87.89 100.96 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 123.526 1.631 . . . . 0.0 113.678 -146.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -89.8 -176.7 5.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.18 -2.282 . . . . 0.0 106.597 157.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -52.16 -14.54 0.44 Allowed 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.339 -0.851 . . . . 0.0 112.206 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.02 132.59 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.362 0.528 . . . . 0.0 109.859 167.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -115.01 139.12 50.11 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.35 133.59 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.707 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.33 3.88 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.9 m -126.12 134.16 51.41 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.61 0.705 . . . . 0.0 111.12 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -117.29 130.92 56.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.98 144.9 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.855 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.52 127.18 30.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -135.63 153.09 21.17 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.612 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.3 p -128.54 139.91 50.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.02 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.809 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -137.33 165.08 27.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.675 -0.763 . . . . 0.0 110.173 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -121.68 148.97 43.9 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.7 p90 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.075 -0.964 . . . . 0.0 112.453 -174.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.5 m -122.61 144.59 49.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.519 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p -155.35 169.23 24.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.664 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 t -135.1 151.83 51.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.947 0.404 . . . . 0.0 110.845 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.49 124.37 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.415 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 m -128.31 139.44 52.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 110.676 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.71 140.71 13.47 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.23 168.21 28.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.185 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -117.68 133.02 56.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -115.56 138.7 50.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.412 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -119.16 131.99 55.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.0 139.1 48.94 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.72 142.12 37.32 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.822 0.701 . . . . 0.0 111.218 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.24 143.27 32.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.283 -176.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -89.9 153.06 20.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.6 151.73 3.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.27 -0.49 . . . . 0.0 111.961 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 69.86 -0.58 2.65 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 91.7 mmm -129.4 171.79 12.17 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 121.456 -0.778 . . . . 0.0 110.149 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -113.06 170.0 8.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.917 0.389 . . . . 0.0 111.242 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -82.79 171.05 14.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.597 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.3 mmm -128.8 155.79 44.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.294 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.48 143.35 14.98 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.54 143.17 14.22 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.909 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.38 131.38 54.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -119.66 135.19 54.92 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.296 0.373 . . . . 0.0 111.529 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tt -118.4 135.95 54.04 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -117.87 143.87 45.92 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.208 0.317 . . . . 0.0 111.32 -173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -133.49 130.28 38.33 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -138.32 144.08 40.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.178 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -109.83 143.15 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -92.63 129.3 38.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.516 0.674 . . . . 0.0 110.769 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -133.09 153.47 51.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.109 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.54 -178.56 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.718 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -55.7 -33.4 64.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.327 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 t -93.38 -25.89 0.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.78 139.18 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.746 1.631 . . . . 0.0 111.952 164.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.11 152.76 32.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.304 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.03 140.38 16.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.3 m -103.55 127.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 117.779 0.789 . . . . 0.0 110.113 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.17 140.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.87 143.53 13.87 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -142.06 155.03 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.584 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -131.61 142.01 49.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.906 173.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 m -127.03 137.7 53.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.88 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -118.49 133.02 56.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.035 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 m -107.76 144.65 34.61 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 110.867 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -142.29 157.96 44.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -133.58 136.89 45.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.776 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.4 m 62.36 -81.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.519 0.512 . . . . 0.0 111.128 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 64.98 55.54 1.14 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.642 0.734 . . . . 0.0 110.001 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.5 m -127.09 140.03 52.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.033 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.88 93.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.275 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.6 t -142.94 147.14 34.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -59.18 -27.55 65.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.026 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.82 -25.9 74.93 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.36 -0.447 . . . . 0.0 112.509 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 59.26 58.27 3.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.572 0.701 . . . . 0.0 110.282 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -53.79 -33.36 55.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.567 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -61.32 138.06 58.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 110.556 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.35 -68.01 0.46 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.282 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -98.27 142.04 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 111.184 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -125.98 148.99 49.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.639 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.18 140.15 53.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.949 0.404 . . . . 0.0 110.878 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -132.61 131.7 41.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.592 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.16 146.34 18.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.052 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.14 127.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.9 p -123.2 154.88 38.13 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.139 0.274 . . . . 0.0 110.803 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.95 148.88 37.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.74 160.89 31.88 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 119.865 -1.159 . . . . 0.0 113.335 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -94.05 124.07 0.45 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.018 1.812 . . . . 0.0 112.061 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.71 138.8 36.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.218 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -116.53 129.67 56.32 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -95.86 110.57 22.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.258 0.551 . . . . 0.0 112.072 -169.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.7 mm -96.17 131.3 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.483 172.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -61.37 -34.81 75.94 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.12 -175.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -75.81 -172.51 1.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 34.7 p-90 -86.06 47.94 1.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.45 0.643 . . . . 0.0 110.179 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.2 22.77 10.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.222 -175.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -68.73 147.56 51.64 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.38 129.96 70.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.087 0.47 . . . . 0.0 110.447 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -120.01 134.03 55.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.99 137.58 11.21 Favored Glycine 0 N--CA 1.466 0.668 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.67 150.99 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.259 0.53 . . . . 0.0 111.822 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.09 140.77 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.27 175.01 26.85 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.459 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.64 127.53 73.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.52 144.67 16.11 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -138.0 154.28 49.35 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.111 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.98 141.88 13.24 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -144.26 154.04 42.67 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.399 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -100.61 135.48 41.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.608 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -100.95 127.92 47.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.372 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 m -107.82 135.39 49.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.43 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.2 m -162.77 -66.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 110.908 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.14 -38.63 76.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -158.79 152.47 19.27 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.478 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -89.81 153.09 5.03 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.759 1.639 . . . . 0.0 112.009 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.9 t -135.43 151.48 50.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -67.01 -38.38 85.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.183 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -97.97 137.27 37.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.624 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -130.23 125.98 36.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.648 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.92 -32.58 67.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.621 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.6 t 47.14 -169.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.119 0.568 . . . . 0.0 111.71 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.6 t -96.35 124.92 40.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.262 0.553 . . . . 0.0 111.679 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -136.73 142.03 43.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.854 173.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -108.56 149.64 28.59 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.526 0.517 . . . . 0.0 111.593 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 164.03 26.94 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -104.24 128.13 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.99 0.395 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.3 m -114.37 141.01 48.18 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.677 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -140.52 144.09 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.11 176.59 35.9 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.227 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.05 150.6 30.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.661 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.12 28.04 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.274 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.19 149.93 35.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -121.6 138.67 54.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 112.128 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -125.99 109.95 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.73 124.34 27.14 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -105.51 176.06 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.373 2.716 . . . . 0.0 109.351 155.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.5 mtm -61.16 158.2 14.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.782 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 67.27 -165.95 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.537 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -58.43 -11.67 3.11 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.9 t -78.41 17.77 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -167.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.43 138.02 41.44 Favored 'General case' 0 C--N 1.344 0.37 0 O-C-N 121.153 -0.967 . . . . 0.0 110.057 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.68 151.41 49.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.709 0.29 . . . . 0.0 111.269 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.96 139.66 41.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.364 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -122.22 129.12 51.95 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -140.21 154.02 46.77 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.313 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -124.52 142.7 51.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -128.78 146.84 50.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -128.5 135.51 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.046 0.45 . . . . 0.0 110.621 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.4 p -100.57 144.78 29.15 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -89.29 145.94 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -160.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -87.77 99.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.638 1.208 . . . . 0.0 112.924 -144.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -89.88 -176.99 5.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 112.528 -2.124 . . . . 0.0 107.499 156.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.2 t -52.17 -16.18 0.74 Allowed 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 112.078 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.32 130.69 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -114.92 139.04 50.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.375 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.37 135.97 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.597 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.64 5.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.06 134.18 51.48 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.652 0.726 . . . . 0.0 111.396 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -115.0 132.83 56.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.03 134.8 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.18 123.3 39.32 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.08 20.56 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.823 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.2 140.17 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 178.02 32.08 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.676 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.56 165.09 24.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.139 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -117.96 149.0 41.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.614 -178.756 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.5 m -122.57 142.71 50.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.347 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -152.52 164.3 37.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.085 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -136.01 155.18 50.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.921 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 p -129.98 132.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.187 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 m -128.08 140.12 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.32 140.74 12.27 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.78 30.58 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.355 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -117.16 136.31 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.683 -0.759 . . . . 0.0 109.11 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.31 138.07 52.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.384 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -126.15 132.04 51.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 p -115.57 141.31 48.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -78.94 127.02 31.46 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.063 0.852 . . . . 0.0 111.233 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.72 143.16 32.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.466 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -89.8 153.19 20.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.5 109.79 1.02 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.885 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 155.58 -44.45 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.668 1.587 . . . . 0.0 109.1 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 87.1 mtp -127.57 168.28 15.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.184 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.01 162.17 14.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.96 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -58.15 170.66 0.64 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.281 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.32 159.74 35.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.285 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.23 151.4 18.36 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.08 143.22 11.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.784 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.11 132.98 52.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -126.7 135.91 51.76 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.459 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.8 mt -122.25 139.3 53.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -135.07 142.5 46.31 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 111.538 -173.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.43 136.6 54.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.402 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -136.78 144.11 43.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -104.49 143.09 33.5 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.57 123.57 35.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.122 0.487 . . . . 0.0 110.112 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.04 153.47 41.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.975 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.32 -178.58 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.836 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -55.37 -41.53 72.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 m -82.29 -26.1 0.4 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -102.83 126.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.531 1.487 . . . . 0.0 112.04 160.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 156.59 32.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.97 140.28 19.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -101.62 124.93 55.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 117.292 0.546 . . . . 0.0 109.861 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.7 mt -117.44 134.93 59.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.9 133.26 7.53 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.1 t -132.84 140.51 47.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.041 0.421 . . . . 0.0 111.315 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.77 132.29 55.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.9 p -128.75 142.57 50.96 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.94 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -125.48 135.51 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.168 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -109.51 144.83 37.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.785 0.326 . . . . 0.0 111.061 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -141.17 145.24 35.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.475 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -134.76 145.79 48.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.288 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.6 p -110.95 141.94 43.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.679 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -139.59 146.82 40.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.369 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.4 m -61.78 146.88 48.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.378 . . . . 0.0 109.996 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.0 130.19 45.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.945 0.403 . . . . 0.0 110.527 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -164.91 -176.59 4.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.53 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.0 p -60.15 -28.59 68.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.84 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.96 -15.79 74.33 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.042 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 61.93 -174.4 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.72 0.76 . . . . 0.0 110.863 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -54.54 -175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.376 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -52.14 133.7 33.37 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.456 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -60.78 -38.64 85.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.448 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -146.94 171.51 15.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.135 0.493 . . . . 0.0 111.723 -175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -126.1 157.99 36.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.547 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -118.45 135.97 54.06 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.899 0.38 . . . . 0.0 111.025 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -123.27 129.36 51.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.38 134.81 7.98 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.44 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.23 123.75 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.5 p -123.24 153.44 40.16 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.154 0.284 . . . . 0.0 110.602 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.78 144.86 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.01 168.14 40.58 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 119.775 -1.202 . . . . 0.0 113.178 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -96.99 126.08 0.25 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.434 2.089 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.84 140.45 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.667 170.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -116.04 131.76 56.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -95.88 115.65 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.539 . . . . 0.0 111.76 -169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.5 mt -96.27 131.13 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.437 173.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -61.76 -30.81 71.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -86.44 38.46 0.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.836 0.35 . . . . 0.0 111.83 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 51.59 40.79 27.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.529 0.68 . . . . 0.0 111.362 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.0 22.76 10.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.138 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -68.58 145.43 53.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.037 -161.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 tt -128.95 133.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.789 -171.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -128.39 146.86 50.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.959 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.2 137.73 9.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.14 153.77 36.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.828 0.314 . . . . 0.0 110.97 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.24 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.15 175.03 26.73 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.305 -176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.7 t -118.35 133.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 131.93 9.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -120.85 142.02 50.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 0.0 110.405 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.98 131.15 10.51 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -126.57 133.27 51.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.683 0.278 . . . . 0.0 110.757 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -102.1 145.11 29.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.025 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -96.75 139.2 33.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.99 0.424 . . . . 0.0 110.429 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 m -76.2 144.3 40.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.145 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -178.28 3.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -51.8 -35.14 43.01 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -74.45 148.03 85.47 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -92.53 87.58 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.983 1.788 . . . . 0.0 112.553 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.2 m -125.71 129.99 50.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.402 . . . . 0.0 110.557 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.95 -33.85 70.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.682 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -57.18 -35.94 70.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.506 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -55.19 -37.64 67.33 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.232 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -69.64 132.41 46.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.748 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.1 m -129.43 141.33 51.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.181 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 t -128.94 135.05 48.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.119 0.485 . . . . 0.0 111.069 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -150.91 144.66 25.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.381 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -123.85 150.79 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.057 0.456 . . . . 0.0 111.769 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.06 26.17 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -103.89 129.94 51.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.088 0.444 . . . . 0.0 110.449 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.4 m -112.39 141.73 45.77 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.661 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -131.93 139.06 48.6 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.44 155.02 26.3 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.792 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.23 148.89 30.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -151.81 162.26 29.62 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.893 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.96 150.31 27.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -135.03 139.65 44.99 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.576 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -137.95 120.69 16.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.1 124.4 26.49 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -105.19 175.99 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.087 2.525 . . . . 0.0 109.712 157.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.32 157.77 10.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.935 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 67.24 -167.61 0.2 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.694 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.41 -11.4 2.81 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 t -78.23 17.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -169.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.1 136.45 43.7 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.3 mt -125.18 147.24 49.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.898 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -132.53 136.74 46.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.151 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.26 130.44 52.74 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -139.91 154.07 47.14 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.996 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -124.83 143.13 50.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.965 0.412 . . . . 0.0 110.669 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -127.95 136.15 50.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.18 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -111.44 144.76 40.13 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 171.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -89.25 146.4 24.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.224 0.952 . . . . 0.0 109.667 -158.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 58.2 mt -87.84 105.81 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 122.73 1.253 . . . . 0.0 112.879 -141.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -89.75 -176.74 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.314 156.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 t -52.16 -14.48 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.822 -0.549 . . . . 0.0 112.262 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.02 130.9 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.404 0.547 . . . . 0.0 110.337 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -115.02 139.19 50.06 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.12 143.86 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.315 -173.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.1 122.61 4.72 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 171.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.7 m -125.9 134.19 51.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.545 0.673 . . . . 0.0 111.352 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -109.29 132.23 54.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.2 mt -122.5 133.5 68.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 123.209 0.318 . . . . 0.0 110.286 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.85 126.17 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.53 153.02 20.85 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.137 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.14 140.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 177.87 32.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.372 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -141.53 163.08 33.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.837 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -123.26 149.0 45.32 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.256 0.347 . . . . 0.0 110.54 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.63 -178.879 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.5 p -148.85 -58.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.535 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.7 p -158.62 157.64 32.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.244 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.4 p -125.17 155.4 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.378 . . . . 0.0 110.43 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.83 125.06 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.588 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -128.15 141.48 51.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 111.036 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.68 140.74 12.05 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.9 165.45 28.48 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.316 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -115.44 134.58 54.95 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.99 138.97 51.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.5 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -120.88 132.95 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -115.89 144.47 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -78.59 142.17 37.49 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.867 0.729 . . . . 0.0 111.13 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.62 143.19 30.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.313 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.73 153.37 20.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.777 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.69 142.57 11.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.028 -173.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 62.94 36.03 12.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.309 -0.445 . . . . 0.0 111.431 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.7 mtt -149.51 169.14 21.6 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -106.93 152.15 24.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.026 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.66 166.9 12.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.962 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.64 155.21 39.53 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.885 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.4 140.5 12.08 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.42 143.24 14.02 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.817 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.66 136.78 50.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -131.47 142.41 49.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.989 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.4 tp -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.137 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -127.23 141.96 51.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.009 0.433 . . . . 0.0 111.512 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.68 137.32 54.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.443 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -134.45 144.1 47.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 110.823 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -109.32 143.25 39.08 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.77 120.3 33.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.277 0.561 . . . . 0.0 111.157 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -133.86 153.63 51.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.962 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.51 -178.44 3.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.863 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -53.01 -33.87 53.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -91.4 -26.02 0.28 Allowed Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -102.79 133.0 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.683 1.589 . . . . 0.0 111.65 162.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.97 158.31 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.245 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.08 140.3 19.12 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.67 125.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 117.478 0.639 . . . . 0.0 109.784 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.54 137.77 53.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.15 137.38 9.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -135.91 140.97 44.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.085 0.442 . . . . 0.0 111.093 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.36 132.77 56.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.4 m -129.43 139.05 51.76 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.284 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -124.97 129.8 51.07 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 m -124.75 145.95 49.45 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.978 0.353 . . . . 0.0 110.991 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -132.29 153.55 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.369 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -115.74 145.45 42.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.038 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 m -56.81 138.74 52.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.851 0.357 . . . . 0.0 110.878 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.01 -36.18 82.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.409 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.9 m -69.78 125.44 26.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.021 0.438 . . . . 0.0 111.153 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.18 149.33 51.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.778 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.0 t -60.38 -52.5 64.99 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.571 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m -99.07 -38.16 9.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.222 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.9 -27.03 72.92 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.705 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 66.66 -79.56 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.045 0.423 . . . . 0.0 110.948 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -113.63 126.7 55.56 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -135.08 151.58 50.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.877 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -137.03 120.9 17.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.274 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -129.62 128.52 42.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.252 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -111.7 132.83 54.35 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -124.19 136.07 53.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.932 0.396 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -134.82 127.78 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.607 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.01 140.32 11.09 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.649 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -122.08 122.57 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -123.21 147.27 47.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.79 147.33 31.76 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.11 171.02 42.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.886 -1.15 . . . . 0.0 113.162 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -93.51 128.05 0.65 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.149 1.899 . . . . 0.0 112.905 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.5 138.57 36.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.188 171.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -100.13 149.62 23.34 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.77 0.669 . . . . 0.0 109.228 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -95.38 135.7 36.67 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.561 0.696 . . . . 0.0 112.028 -160.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.69 131.23 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.057 -170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -81.86 -43.72 17.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.352 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -165.31 85.57 0.38 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.051 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.0 m95 54.01 48.69 20.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.769 0.795 . . . . 0.0 110.298 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.07 22.93 10.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.27 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 t -68.48 145.1 54.36 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.656 -160.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.96 129.56 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.1 m-30 -122.6 135.35 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.03 137.65 11.24 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.4 m -142.43 153.44 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 117.801 0.801 . . . . 0.0 112.021 -173.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.05 140.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.13 171.86 27.71 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.524 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.62 125.82 74.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.6 146.43 16.19 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -139.1 155.13 48.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.861 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.05 144.95 15.45 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -141.96 142.69 32.99 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.732 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -96.23 128.73 43.4 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.187 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -115.88 147.99 40.47 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.037 0.446 . . . . 0.0 111.041 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.5 p -85.47 159.15 20.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.413 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 t -122.17 -25.97 4.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -123.37 156.89 34.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.817 0.342 . . . . 0.0 110.515 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -49.38 -45.06 76.73 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.227 -0.892 . . . . 0.0 112.971 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.97 99.57 1.0 Allowed 'Trans proline' 0 N--CA 1.496 1.672 0 CA-C-N 120.907 1.359 . . . . 0.0 110.958 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -118.19 163.27 16.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.083 0.468 . . . . 0.0 110.939 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -117.72 150.89 38.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.315 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -54.66 -31.85 58.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.566 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -49.74 97.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 112.006 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -137.23 138.18 39.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.213 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.9 m -127.77 135.61 50.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.958 0.409 . . . . 0.0 111.26 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.1 p -139.65 138.91 36.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.874 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -162.97 151.77 14.6 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.973 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -109.59 149.7 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 124.024 0.827 . . . . 0.0 110.217 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.16 159.36 27.05 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -99.51 124.31 44.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -110.06 141.01 43.49 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.764 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -127.95 140.3 52.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.16 159.26 27.86 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.1 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.12 148.88 32.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.987 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.45 161.89 29.66 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.36 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.68 150.47 49.75 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -127.79 146.52 50.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.601 0.715 . . . . 0.0 112.582 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -124.07 112.56 17.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.43 124.21 29.76 Favored Pre-proline 0 N--CA 1.462 0.17 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -107.03 176.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.452 2.768 . . . . 0.0 109.342 155.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -62.88 156.06 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.763 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 67.84 -166.48 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.588 173.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -58.64 -11.42 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.37 17.73 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.48 138.17 41.26 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.34 -0.85 . . . . 0.0 110.145 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.87 147.42 46.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.545 -170.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -132.61 136.41 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.385 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.36 130.7 54.51 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -140.18 154.03 46.81 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.321 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -128.15 145.29 51.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -133.84 146.6 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.178 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -129.5 136.06 49.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.9 t -104.13 144.72 31.2 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -89.28 146.03 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -161.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.7 mt -87.9 106.71 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 122.76 1.266 . . . . 0.0 112.901 -142.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -89.68 -176.71 5.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 112.301 -2.227 . . . . 0.0 107.227 156.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.1 p -52.11 -13.32 0.3 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.611 . . . . 0.0 112.496 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.82 133.49 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.383 0.538 . . . . 0.0 109.83 167.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.87 139.37 45.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.342 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.06 132.5 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.615 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 124.11 5.2 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.07 134.28 51.43 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.337 0.569 . . . . 0.0 111.298 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.36 134.83 54.74 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.9 mt -125.34 135.73 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.429 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 124.79 43.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.07 20.56 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.19 139.78 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.01 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.748 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.12 163.69 31.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.905 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -119.65 148.79 42.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.602 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.972 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.2 p -123.03 160.0 27.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -162.2 166.33 25.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.35 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 m -128.93 139.86 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.112 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.71 128.93 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.135 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.5 m -128.15 142.29 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.53 140.8 12.07 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.19 -169.89 27.28 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.169 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -129.21 158.5 38.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.262 -0.469 . . . . 0.0 109.931 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.51 148.18 47.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.973 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -126.35 132.8 51.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -118.52 142.03 48.0 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -79.04 125.07 28.91 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.872 0.732 . . . . 0.0 111.408 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.19 143.29 34.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.461 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -89.64 149.23 22.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.01 109.55 0.68 Allowed Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.272 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 170.5 -52.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.3 mtm -128.28 174.04 9.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.661 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -91.84 162.22 14.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.865 0.364 . . . . 0.0 110.738 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -49.5 163.78 0.1 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.9 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 86.0 mtp -115.17 143.31 45.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.07 140.15 16.03 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.45 143.28 14.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.823 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -111.3 137.81 48.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -125.92 133.88 51.74 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.193 0.308 . . . . 0.0 111.576 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.2 mt -118.01 141.86 48.0 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.779 0.674 . . . . 0.0 109.482 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -127.72 143.01 51.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.301 -174.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -132.15 132.54 43.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -138.55 144.2 39.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 -176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -108.37 142.45 38.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.59 131.03 38.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.274 0.559 . . . . 0.0 111.289 -174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -143.86 153.57 42.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.497 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.43 -178.4 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.136 -173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -51.08 -37.78 47.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -89.13 -25.98 0.31 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -102.73 126.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.716 1.611 . . . . 0.0 111.869 161.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 73.4 mt -76.63 158.39 31.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.963 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.05 140.12 18.99 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.66 124.96 58.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.487 0.644 . . . . 0.0 109.28 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.3 pt -122.46 144.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.379 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.84 136.2 8.49 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -127.88 140.93 51.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.671 0.272 . . . . 0.0 110.811 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.74 131.2 56.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.1 m -126.44 134.8 50.88 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.247 0.342 . . . . 0.0 110.83 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -127.04 137.05 52.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.436 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -108.5 148.28 30.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.017 0.436 . . . . 0.0 111.351 -175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.38 140.8 47.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.525 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -133.08 142.4 48.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.226 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.8 t -140.59 133.06 28.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.445 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -98.44 -68.9 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.228 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.0 p -127.59 163.63 23.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.125 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.25 113.49 19.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.272 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.7 m -124.84 148.48 48.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.529 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -59.0 -36.06 74.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.225 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.53 16.9 16.39 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.214 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 62.23 152.3 0.03 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.524 0.662 . . . . 0.0 111.381 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -60.62 156.79 15.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.59 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -173.58 111.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.988 0.423 . . . . 0.0 111.089 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -147.43 -74.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.555 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -135.3 146.78 48.83 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.682 0.277 . . . . 0.0 110.597 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -119.54 144.21 47.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -132.31 135.9 46.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.715 0.293 . . . . 0.0 110.414 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -138.02 132.98 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.993 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.97 19.58 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.519 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 127.37 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 p -123.21 154.99 38.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.655 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.62 148.28 34.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.09 170.92 42.25 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.968 -1.111 . . . . 0.0 113.337 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -99.15 122.65 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.628 2.219 . . . . 0.0 112.717 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.78 139.93 35.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.077 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.38 124.93 46.71 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -99.98 116.46 32.08 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.4 mt -96.26 131.25 43.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.988 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -61.57 -30.52 70.72 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -171.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -87.52 54.1 3.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.138 0.494 . . . . 0.0 111.119 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 40.39 29.51 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.08 22.78 15.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.209 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.5 m -68.75 159.53 32.11 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.943 -166.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.19 129.93 17.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -127.84 141.98 51.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.2 137.91 10.99 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.69 153.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.953 0.376 . . . . 0.0 111.182 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.68 140.84 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.21 175.21 26.69 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.339 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.62 129.66 75.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.08 145.47 16.66 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -138.68 160.02 40.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.77 150.01 17.11 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -133.61 132.44 40.81 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -104.82 125.68 51.12 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -108.9 114.41 28.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.752 0.31 . . . . 0.0 110.818 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -108.13 140.32 41.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.495 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 m -80.91 130.45 35.04 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 54.09 63.57 2.13 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.544 0.688 . . . . 0.0 110.628 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -70.45 152.86 95.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.715 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.0 -56.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.621 1.547 . . . . 0.0 112.214 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -127.23 161.4 28.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.533 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -59.21 -38.18 79.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.164 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -54.89 -32.45 60.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.65 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -53.83 -38.54 64.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.669 0.271 . . . . 0.0 111.222 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.6 144.74 57.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.061 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -114.92 135.62 54.0 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -143.65 133.68 24.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -162.96 161.08 25.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.841 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -139.42 158.99 43.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.009 0.433 . . . . 0.0 111.566 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.09 167.06 26.16 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.16 125.7 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -111.98 145.54 39.45 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.638 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -142.64 144.52 32.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.12 173.38 35.96 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.912 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.9 28.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.457 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.94 160.49 27.1 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.141 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mp -113.13 151.06 31.3 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -121.98 133.62 54.82 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.802 -174.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -128.24 109.92 11.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -140.53 124.64 10.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -167.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.29 176.11 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.629 2.219 . . . . 0.0 109.125 155.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -55.71 174.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.555 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -174.7 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.256 0.551 . . . . 0.0 112.126 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -62.95 -11.35 18.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.47 18.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.27 141.92 35.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.461 0.573 . . . . 0.0 110.162 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -124.02 148.99 46.58 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.84 -170.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -136.94 137.52 39.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.22 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -128.63 132.06 48.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.4 t -140.4 154.14 46.58 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.581 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.85 139.95 49.34 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -126.76 140.66 52.21 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 123.344 0.403 . . . . 0.0 110.453 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -124.23 136.03 53.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.284 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -109.1 144.84 36.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -89.19 145.94 25.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -160.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 pt -88.01 105.13 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 123.09 1.424 . . . . 0.0 114.689 -143.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -89.84 -176.97 5.11 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 112.703 -2.044 . . . . 0.0 106.845 157.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 t -52.06 -15.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.476 -0.765 . . . . 0.0 112.237 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.59 127.26 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 118.215 0.461 . . . . 0.0 109.808 168.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -103.9 139.19 39.41 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.13 131.16 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.32 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.19 118.48 3.29 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.2 m -126.2 134.2 51.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.347 0.573 . . . . 0.0 110.866 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -115.73 133.03 56.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.0 pt -121.98 145.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 123.247 0.342 . . . . 0.0 110.896 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -136.19 125.41 24.68 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.27 153.22 21.8 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.784 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 51.1 t -111.26 139.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.48 158.77 23.86 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.983 -172.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.32 152.86 46.9 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.136 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -117.81 140.37 49.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.8 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.702 179.682 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 m -123.45 147.44 47.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.356 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -151.98 148.85 28.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.372 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.2 p -122.3 156.22 34.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.416 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.01 115.99 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.555 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.6 m -128.3 142.91 51.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 0.0 110.769 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.37 140.92 11.92 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.58 -179.6 30.81 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.024 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -129.07 141.15 51.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.28 147.15 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -115.3 132.11 56.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -112.53 130.26 56.07 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.35 128.97 34.18 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.058 0.849 . . . . 0.0 110.86 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.26 143.14 32.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.866 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -89.88 153.42 20.65 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.64 151.52 4.02 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.239 -171.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 66.03 29.81 9.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.192 -0.504 . . . . 0.0 111.804 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 69.1 mtm -151.05 174.03 13.65 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -111.44 147.78 34.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.484 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -77.88 164.17 25.39 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.78 151.78 51.92 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.021 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.35 128.14 7.48 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -121.69 143.21 15.71 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.868 -173.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.1 133.77 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -126.52 133.7 51.07 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.073 0.233 . . . . 0.0 111.574 -174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -118.93 136.25 54.17 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -136.7 139.08 41.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.428 . . . . 0.0 111.632 -172.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.18 137.88 54.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -133.16 144.14 49.68 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -107.11 142.18 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -92.78 127.65 38.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.214 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -137.03 153.46 50.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.883 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -74.77 -178.56 3.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.87 -36.62 65.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -91.6 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -170.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -102.81 135.06 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 111.891 164.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.03 156.76 29.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.119 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.48 140.15 16.48 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -101.58 125.17 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.415 0.608 . . . . 0.0 109.427 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.8 pt -125.8 144.87 34.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.248 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 140.58 9.26 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.05 146.03 35.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.395 -175.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -119.61 132.69 55.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.445 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -126.97 133.84 50.5 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.126 0.266 . . . . 0.0 110.805 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -127.16 135.7 51.05 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.9 p -103.44 148.23 26.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.196 0.522 . . . . 0.0 111.294 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -143.08 152.73 42.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.578 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -133.08 136.92 46.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.176 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.5 p -166.22 34.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.242 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -60.25 -40.19 89.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.725 0.298 . . . . 0.0 110.586 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.3 m -128.48 139.03 52.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.283 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.91 94.12 9.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.518 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.0 t -141.05 136.85 32.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.522 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.0 p -62.43 -28.66 69.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.029 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.79 -38.4 66.14 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.775 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -147.87 88.83 1.7 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.404 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -135.72 125.42 25.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.9 t30 55.91 43.24 27.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.206 0.527 . . . . 0.0 110.776 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -91.37 152.63 20.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.504 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t30 61.79 109.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -115.32 145.03 42.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.008 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -134.22 135.95 43.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.871 0.367 . . . . 0.0 110.499 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -135.22 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.91 141.47 12.2 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.711 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.79 122.5 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.0 p -123.28 151.11 42.72 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.088 0.242 . . . . 0.0 111.14 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.05 146.29 30.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.04 171.14 42.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.071 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -97.33 124.0 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.314 2.009 . . . . 0.0 112.718 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.64 145.41 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.395 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -117.22 123.64 47.13 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -100.97 108.75 20.56 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.465 0.65 . . . . 0.0 112.244 -171.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.8 pt -96.51 131.76 42.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.683 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -61.26 -14.98 30.31 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -71.78 175.22 5.92 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 170.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -87.47 40.77 0.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.212 0.53 . . . . 0.0 110.987 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.26 23.02 9.97 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.17 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t -68.78 146.58 52.78 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -166.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.02 133.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.144 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -128.18 144.03 51.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.9 137.81 10.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -135.44 155.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 -174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.58 140.99 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.24 175.06 26.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.534 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.17 129.96 69.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.9 137.57 13.61 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.76 138.29 54.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.91 139.43 12.03 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -134.49 138.52 44.76 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.84 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -109.08 134.17 52.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.409 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -104.37 140.41 37.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 110.844 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.1 m -107.99 137.91 45.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.233 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.4 p -112.3 30.11 7.35 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 54.79 88.13 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -132.29 166.91 25.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.979 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -45.42 -29.87 5.18 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.477 1.452 . . . . 0.0 112.691 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.1 m -81.69 140.27 34.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.197 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -93.25 112.39 24.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.956 0.407 . . . . 0.0 110.311 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -138.33 156.41 47.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.893 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -129.29 159.1 37.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.713 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.87 122.04 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.186 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 t -134.64 153.37 52.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.889 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -126.36 143.27 51.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -137.14 147.2 45.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.649 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -117.09 146.39 43.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 111.141 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.21 167.02 26.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.22 127.62 49.09 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -112.44 145.38 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 110.898 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -129.82 138.38 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.54 156.34 26.78 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.613 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.97 148.93 32.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.11 157.35 27.3 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.568 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.87 148.96 30.58 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -121.86 139.19 53.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.806 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.61 109.94 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -133.5 124.31 17.98 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -95.37 176.2 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.526 2.151 . . . . 0.0 109.534 156.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -65.72 150.48 48.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.779 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 78.35 -167.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -61.02 -11.99 10.07 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.75 17.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -170.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.44 138.91 40.13 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.574 -0.704 . . . . 0.0 109.883 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mp -132.62 151.83 51.83 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.322 -170.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.06 147.35 46.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.316 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.54 134.62 50.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -140.17 154.04 46.82 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.036 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.84 140.88 50.12 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -128.6 140.09 51.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.787 0.327 . . . . 0.0 110.562 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -124.51 135.99 53.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.081 0.467 . . . . 0.0 111.042 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 t -116.19 144.69 43.85 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -89.35 146.15 24.88 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.805 0.691 . . . . 0.0 109.58 -161.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.79 101.1 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.817 1.294 . . . . 0.0 112.682 -144.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.71 -176.8 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 112.195 -2.275 . . . . 0.0 106.777 158.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 84.2 p -52.13 -13.1 0.28 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.25 133.54 65.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 118.295 0.498 . . . . 0.0 109.733 168.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -113.05 139.15 48.93 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.28 128.26 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.722 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.2 116.79 2.79 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 22.0 m -126.06 134.05 51.52 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.778 0.789 . . . . 0.0 111.355 -173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.8 t90 -120.32 128.48 53.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.1 tt -130.23 144.53 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.225 -173.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.17 132.17 45.94 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.78 153.16 23.02 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.545 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.5 m -125.18 144.67 34.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.19 178.13 32.02 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.195 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -132.52 173.21 11.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.695 -0.752 . . . . 0.0 109.927 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -117.83 149.09 41.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.39 -175.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.574 -178.943 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.0 p -122.98 160.98 25.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.577 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p -162.28 162.73 28.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.071 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -123.17 156.15 35.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.389 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.91 131.44 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.162 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.0 m -128.19 143.0 51.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.838 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 140.9 12.23 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.71 -173.28 29.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.22 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -124.08 156.22 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.136 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.41 145.94 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.483 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -128.18 131.97 48.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -114.77 131.74 56.69 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.376 0.422 . . . . 0.0 110.413 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.05 126.59 36.18 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.8 0.687 . . . . 0.0 110.923 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.4 143.2 33.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.801 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.77 153.06 20.98 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.0 109.49 0.66 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.126 -170.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 165.08 -54.55 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.6 mtt -128.24 171.99 11.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.79 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -100.23 165.09 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 111.154 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -60.73 167.12 2.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.693 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -134.19 158.23 44.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.801 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.18 151.58 16.88 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.65 143.3 12.47 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.089 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.33 139.08 50.3 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -127.99 133.47 49.17 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.602 -174.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.07 137.84 54.47 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -135.97 147.11 47.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.094 0.473 . . . . 0.0 111.542 -173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -132.61 143.66 49.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.83 144.04 37.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.696 0.284 . . . . 0.0 111.018 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -105.89 143.17 34.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.56 125.8 37.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.5 0.667 . . . . 0.0 110.852 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -125.58 153.29 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.889 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.62 -178.32 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.305 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -53.07 -35.51 59.65 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.0 m -92.07 -25.94 0.28 Allowed Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -102.85 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.639 1.56 . . . . 0.0 112.39 162.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -78.12 164.25 25.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.073 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.27 140.13 15.55 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.73 125.02 55.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 117.649 0.724 . . . . 0.0 109.699 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.73 138.13 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.26 135.45 8.33 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -129.5 142.01 50.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.027 0.414 . . . . 0.0 111.068 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.37 128.25 55.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.7 m -120.82 131.26 54.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.577 0.227 . . . . 0.0 110.661 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.04 137.13 55.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.189 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -97.69 147.58 24.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.148 0.499 . . . . 0.0 111.067 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -116.63 145.72 43.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -104.8 -177.33 3.33 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 124.295 0.997 . . . . 0.0 110.294 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.0 m -55.99 147.82 18.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.007 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -167.3 -68.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.01 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.2 m -134.57 83.91 2.07 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.23 158.1 44.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.432 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 m -57.6 159.62 4.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.113 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.4 p -58.93 -35.0 72.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.349 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.11 -36.86 64.03 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -88.45 118.16 27.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.952 0.406 . . . . 0.0 111.873 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -125.42 146.91 49.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.039 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -111.83 132.9 54.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 110.801 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -137.07 148.35 46.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.778 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 66.91 140.12 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -126.17 148.27 49.46 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -151.73 157.9 42.64 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.844 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -117.66 134.74 54.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.149 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.84 132.08 7.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.9 mm -119.03 118.44 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -123.22 151.33 42.37 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.907 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.04 146.17 32.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.08 168.18 40.63 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.116 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.22 124.33 0.28 Allowed 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.394 2.063 . . . . 0.0 112.81 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.8 143.01 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.463 170.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -117.11 128.86 55.55 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -95.9 108.96 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.194 0.521 . . . . 0.0 112.346 -169.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.39 131.39 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.475 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -61.63 -35.53 78.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.28 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -78.98 -168.61 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 44.3 p90 -85.49 45.05 1.15 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.356 0.598 . . . . 0.0 110.477 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.03 22.41 10.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.223 -175.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -68.61 154.9 41.04 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -173.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.26 129.88 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.842 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -138.87 142.47 38.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.218 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.04 137.84 9.75 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.9 m -133.8 156.71 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 111.014 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.94 140.9 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.15 175.07 26.71 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.798 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.14 133.39 60.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.7 131.69 9.66 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -118.71 118.99 33.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.52 149.96 16.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -161.47 168.03 24.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.642 0.258 . . . . 0.0 110.947 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -104.56 127.55 52.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.451 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -116.42 136.72 52.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.389 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 m -98.35 142.72 29.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.384 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.3 m -55.8 -41.91 74.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.893 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -104.35 -71.62 0.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.293 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -156.62 154.42 26.8 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.486 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.96 112.99 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.291 1.327 . . . . 0.0 111.816 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.8 m -57.34 -42.69 82.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.543 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -174.1 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.449 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -98.58 137.39 37.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.534 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -137.02 134.71 36.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.896 0.379 . . . . 0.0 110.602 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -59.07 -34.32 71.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.419 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 m 67.18 169.94 0.25 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.72 0.295 . . . . 0.0 110.247 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.3 p -68.98 152.13 45.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.109 0.481 . . . . 0.0 111.239 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -152.8 142.75 22.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.553 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.66 142.97 32.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.023 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.18 157.67 26.57 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.62 125.45 51.01 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.5 m -109.61 135.4 50.64 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.936 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -126.75 137.26 53.21 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.55 27.72 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.884 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.39 148.83 32.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.99 164.63 29.22 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.073 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -108.97 146.94 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -136.25 131.92 35.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.532 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -137.85 125.2 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -133.92 124.56 17.71 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -98.08 176.18 0.49 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.57 2.18 . . . . 0.0 109.615 158.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.3 ttm -56.12 145.87 24.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.114 0.483 . . . . 0.0 111.55 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 74.26 -157.12 0.06 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.383 0.673 . . . . 0.0 111.17 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.02 -11.32 13.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.54 17.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.15 135.96 44.67 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.309 -0.869 . . . . 0.0 110.212 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -125.49 146.21 49.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -171.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -137.14 138.32 40.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -128.31 133.92 48.82 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.2 m -140.05 154.14 46.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.599 -0.441 . . . . 0.0 112.015 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -123.81 141.89 51.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.67 149.85 46.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.981 0.419 . . . . 0.0 110.383 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -128.07 136.03 50.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.484 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -115.56 144.7 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -89.31 145.96 25.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -158.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 12.5 tt -87.97 97.62 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 123.512 1.625 . . . . 0.0 113.655 -146.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.79 -176.77 5.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 112.144 -2.298 . . . . 0.0 107.476 157.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -52.22 -14.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.83 -0.544 . . . . 0.0 112.325 -175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.29 129.52 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.335 0.516 . . . . 0.0 109.897 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -115.05 139.18 50.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.18 132.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.816 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 117.76 3.06 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.0 m -126.15 134.26 51.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.798 0.799 . . . . 0.0 110.966 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -123.81 138.08 54.56 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.52 151.14 34.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 O-C-N 123.141 0.276 . . . . 0.0 111.411 -174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.1 131.11 27.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.8 153.29 23.64 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.991 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.38 143.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.06 178.12 31.92 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -142.08 169.38 17.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.187 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -118.02 146.51 43.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.338 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 66.5 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.558 -179.163 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.6 p -124.03 165.48 17.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.419 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p -152.31 160.65 43.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.992 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.6 p -125.24 156.07 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.125 0.488 . . . . 0.0 110.83 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.27 126.77 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.377 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.17 140.94 12.2 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.9 174.81 31.62 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.217 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -116.68 138.95 51.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.91 -0.645 . . . . 0.0 109.597 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.41 138.82 51.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.089 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -127.71 131.97 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -111.36 145.1 39.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.64 137.42 37.83 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.891 0.744 . . . . 0.0 111.562 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.82 143.44 39.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.0 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -89.7 153.48 20.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.64 146.8 7.11 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.259 -170.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 63.62 40.0 8.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.276 -0.462 . . . . 0.0 110.967 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.5 mtp -148.35 171.59 15.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -108.18 138.95 43.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -65.29 164.15 14.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.064 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.8 mtt -112.72 144.38 42.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.366 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 137.44 12.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.94 143.14 14.55 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.866 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -107.18 134.42 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -125.44 133.12 52.56 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.374 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.0 tp -121.55 134.76 55.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.253 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -128.48 148.79 50.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.316 0.579 . . . . 0.0 111.86 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -126.3 140.05 52.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.744 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -139.48 144.14 37.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.751 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.93 143.1 44.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.67 128.27 38.46 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -129.86 153.49 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.402 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.69 -178.51 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.921 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -52.87 -36.27 58.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.429 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 m -93.71 -25.81 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 135.16 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.692 1.594 . . . . 0.0 112.219 165.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.97 160.69 28.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.82 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.12 140.3 22.08 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.48 124.97 56.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 117.482 0.641 . . . . 0.0 109.36 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.27 143.45 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.391 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.35 145.31 16.1 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 t -137.71 141.19 41.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.167 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.53 131.58 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -125.84 135.77 52.33 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.678 0.275 . . . . 0.0 110.988 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -126.99 131.93 50.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.337 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 m -112.78 147.73 36.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.001 0.429 . . . . 0.0 111.41 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -134.35 141.32 46.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.181 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -133.94 150.81 51.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.252 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 t -141.62 129.14 21.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.728 0.299 . . . . 0.0 110.518 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -61.38 -42.07 98.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 110.529 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.2 p -133.37 164.14 27.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.93 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.52 93.84 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.327 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.6 t -166.6 140.53 4.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.651 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.2 m -60.03 -35.63 75.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.281 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.73 -29.04 69.91 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.382 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.33 115.31 19.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.149 0.474 . . . . 0.0 110.93 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -120.49 139.76 52.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.332 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -102.3 129.42 48.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 110.456 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -59.09 -33.57 70.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.022 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -60.88 109.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.58 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -116.37 133.42 56.04 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -123.58 138.64 54.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.014 0.435 . . . . 0.0 111.118 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -138.39 130.52 28.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.468 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.09 148.67 20.04 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.941 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.5 123.4 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 t -123.5 155.07 38.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.25 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.51 152.92 41.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 171.14 42.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.93 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -96.58 125.61 0.27 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.232 1.955 . . . . 0.0 112.502 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.73 144.2 32.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.767 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -112.67 159.23 19.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.4 mtm-85 -95.29 135.39 36.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.801 0.81 . . . . 0.0 112.242 -159.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.6 tt -73.73 130.95 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.042 -172.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -94.72 -43.6 8.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.849 170.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -173.75 96.49 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.073 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 53.27 26.98 5.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.627 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.22 22.4 10.16 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 t -68.73 152.5 45.24 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.3 tt -154.59 133.82 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.298 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.72 150.03 44.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.444 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.03 137.87 9.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.11 152.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.264 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.53 141.18 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.11 175.14 26.64 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.9 129.29 73.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.94 143.94 17.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -134.84 146.98 49.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.862 0.331 . . . . 0.0 110.705 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.8 149.64 17.3 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -135.43 139.21 43.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.582 0.23 . . . . 0.0 110.463 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.56 141.22 45.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.852 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -132.71 136.17 46.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.989 0.423 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 t -108.21 159.14 16.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.269 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.4 m -118.56 127.75 53.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.35 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 45.71 23.26 0.14 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -139.46 77.83 28.25 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -87.95 96.99 0.41 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.733 1.622 . . . . 0.0 112.062 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -137.76 158.19 44.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 111.301 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 51.3 -91.65 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.649 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -111.62 134.3 53.29 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 118.615 0.643 . . . . 0.0 110.879 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -61.92 -44.05 97.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.49 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -152.67 151.17 30.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.615 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 m -126.84 137.34 53.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.946 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.5 p -147.94 156.12 42.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.224 0.535 . . . . 0.0 111.84 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.06 144.17 29.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.28 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -107.34 147.1 30.74 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.146 0.279 . . . . 0.0 111.173 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 162.84 27.14 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.33 127.08 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.929 0.364 . . . . 0.0 110.189 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.4 t -115.6 138.11 51.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.255 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -141.34 149.39 41.1 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.16 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.14 174.44 36.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.99 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.86 33.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.71 155.98 26.09 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.424 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 tp -109.06 145.85 34.95 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -144.24 143.63 31.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.286 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -135.71 129.9 33.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 172.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.2 124.62 9.97 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -170.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -102.32 176.19 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.572 2.182 . . . . 0.0 109.252 157.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.2 mtt -55.53 167.17 0.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.872 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 65.45 -173.79 0.18 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.866 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.69 -11.31 4.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.6 t -78.44 17.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -167.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.32 134.13 48.06 Favored 'General case' 0 C--N 1.341 0.232 0 O-C-N 121.535 -0.728 . . . . 0.0 109.882 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mp -133.42 148.42 51.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.637 -171.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.11 148.04 46.43 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.526 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.77 134.67 47.07 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -140.11 154.12 46.92 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.677 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -117.57 139.95 50.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.01 151.06 46.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.959 0.409 . . . . 0.0 110.611 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -127.48 136.1 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.283 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.9 t -113.95 144.75 42.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 146.16 24.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.131 0.491 . . . . 0.0 109.733 -159.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -87.94 102.64 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.728 1.251 . . . . 0.0 112.908 -144.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -89.68 -176.76 5.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 112.436 -2.166 . . . . 0.0 107.438 156.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.9 p -52.33 -14.21 0.44 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.797 -0.564 . . . . 0.0 112.338 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.16 126.9 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.344 0.52 . . . . 0.0 110.147 168.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -103.54 139.17 39.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.149 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.14 134.01 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.594 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.08 122.14 4.55 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -125.99 134.2 51.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.496 0.648 . . . . 0.0 111.251 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -115.14 132.94 56.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.9 pt -128.56 145.02 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.81 131.63 37.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.278 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.89 153.1 23.04 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.752 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.35 144.82 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.15 177.95 32.09 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.437 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -140.06 166.24 25.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.52 -0.84 . . . . 0.0 110.005 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -117.97 149.08 41.53 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.324 0.39 . . . . 0.0 110.554 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.6 t80 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.65 -179.177 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.7 p -116.33 -36.77 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -150.88 134.29 16.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.571 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.2 m -130.28 140.29 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.235 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.08 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.356 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.8 p -128.13 143.31 51.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.47 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.1 140.79 12.35 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.4 172.62 29.4 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.184 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.49 138.39 50.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.744 -0.728 . . . . 0.0 109.108 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.54 140.03 51.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.658 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.96 131.93 54.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -114.3 135.14 54.39 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.253 0.346 . . . . 0.0 110.375 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -84.31 123.16 29.87 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.995 0.809 . . . . 0.0 111.177 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.12 143.15 33.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.471 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -89.69 153.2 20.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.07 109.59 0.69 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.103 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 169.58 -54.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.3 mtm -128.92 174.08 9.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.956 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -91.97 162.01 14.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.759 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -56.65 168.54 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.543 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -126.48 159.63 32.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.734 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.32 146.96 17.86 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.33 143.21 13.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.009 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -108.26 132.57 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -123.88 132.96 53.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.385 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tt -125.87 131.04 52.45 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -128.07 146.54 50.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.129 0.49 . . . . 0.0 111.887 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.35 132.78 55.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -135.91 144.0 45.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.175 0.297 . . . . 0.0 111.357 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -113.0 139.03 49.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.81 128.62 38.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.342 0.591 . . . . 0.0 110.657 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -134.76 153.4 52.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.789 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.46 -178.6 3.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.671 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -53.92 -33.47 56.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.39 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -94.27 -25.85 0.26 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 134.94 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.748 1.632 . . . . 0.0 111.904 164.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.17 156.0 30.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.191 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.07 140.26 15.08 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.58 127.27 56.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.47 0.635 . . . . 0.0 109.877 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.6 tt -124.4 135.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.58 134.48 7.7 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t -129.28 139.06 51.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.84 0.32 . . . . 0.0 111.202 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.11 131.45 56.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -127.95 136.94 52.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -124.85 136.17 53.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.285 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.8 m -112.42 146.95 37.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -138.49 146.5 42.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -129.82 136.84 50.04 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 p -119.26 -26.65 5.82 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -125.2 116.27 21.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.952 0.406 . . . . 0.0 111.034 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -132.4 141.88 49.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.183 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.58 93.92 7.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.349 . . . . 0.0 110.398 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.0 p -159.45 173.11 16.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.461 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -58.87 -36.89 75.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.987 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.83 -33.98 66.12 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.5 t0 80.53 -40.18 0.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.159 0.984 . . . . 0.0 111.948 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -117.15 127.14 53.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.782 0.325 . . . . 0.0 110.646 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -130.51 156.41 44.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.245 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -133.22 124.36 27.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.0 0.428 . . . . 0.0 110.794 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -115.97 144.76 43.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.594 176.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -109.02 125.96 52.63 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -125.8 135.92 52.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.455 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -137.1 117.89 14.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.355 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.43 138.43 10.15 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.666 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.1 126.92 73.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.0 p -123.26 152.03 41.75 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.255 0.347 . . . . 0.0 110.172 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.99 146.49 31.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.95 170.95 42.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.267 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -98.01 123.67 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.486 2.124 . . . . 0.0 112.667 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 145.56 31.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.886 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -122.98 132.51 54.18 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -95.83 112.4 24.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -168.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.4 mm -96.4 131.41 43.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.505 169.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -61.88 -29.81 70.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -118.55 86.62 2.57 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.3 t90 45.64 25.55 0.27 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 170.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.24 22.49 10.12 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m -68.51 151.99 46.02 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.25 129.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -133.55 145.23 49.92 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.9 137.69 9.71 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.75 154.56 37.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.722 0.296 . . . . 0.0 111.181 -174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.19 140.75 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.2 175.09 26.75 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.76 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.81 130.5 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.09 136.08 12.41 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.03 142.82 13.97 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -127.37 137.05 52.67 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -110.32 131.04 55.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.715 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.65 126.33 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.3 m -86.61 130.73 34.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.463 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.9 p -74.28 -35.99 63.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.394 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -70.61 -69.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.934 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -176.34 149.42 0.94 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.221 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.52 53.93 0.84 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.702 1.601 . . . . 0.0 111.928 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.8 m -56.77 -42.15 78.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.131 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.2 -58.26 3.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.021 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -135.24 146.52 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.874 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -56.01 -40.59 73.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -161.07 165.71 29.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.403 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.6 m -116.12 135.35 54.01 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.9 p -135.51 154.35 51.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.251 0.548 . . . . 0.0 111.651 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -159.86 159.69 32.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.304 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -130.45 153.98 48.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.972 0.415 . . . . 0.0 111.405 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.11 26.16 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.86 126.99 53.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.6 m -106.38 137.2 44.77 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.897 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.44 132.23 48.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -143.16 157.14 26.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.874 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.52 148.86 32.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.85 162.4 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.504 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -108.97 149.42 29.24 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -134.94 137.01 42.71 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.488 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.03 127.81 16.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -142.07 124.51 9.2 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -100.72 176.16 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.759 2.306 . . . . 0.0 109.385 156.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -53.99 177.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 63.73 -175.06 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.236 0.541 . . . . 0.0 112.193 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -62.95 -11.39 18.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.11 17.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -165.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.92 138.38 40.57 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.454 0.57 . . . . 0.0 109.798 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.69 153.83 50.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.009 0.433 . . . . 0.0 111.97 -168.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -137.16 140.4 41.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.032 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.74 132.24 53.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.8 p -140.13 154.17 46.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.88 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -123.79 141.02 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -120.33 138.6 53.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.539 0.524 . . . . 0.0 110.451 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -123.96 135.0 53.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.079 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -118.26 144.93 45.42 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -89.29 146.53 24.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -157.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.7 97.07 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.906 1.336 . . . . 0.0 112.215 -144.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.79 -176.92 5.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.046 -2.343 . . . . 0.0 107.446 157.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.8 p -52.27 -13.46 0.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.04 132.11 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.386 0.539 . . . . 0.0 110.195 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.72 139.2 43.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.23 -0.414 . . . . 0.0 109.991 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.13 122.72 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.13 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.31 114.74 2.22 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -125.81 134.13 51.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.752 0.776 . . . . 0.0 111.244 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.61 131.23 56.77 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 141' ' ' ILE . 61.9 mt -123.06 134.81 65.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 O-C-N 123.182 0.301 . . . . 0.0 110.259 -175.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.4 125.1 40.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.0 153.2 21.66 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.855 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.26 146.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.28 173.13 27.53 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.242 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -128.88 154.64 46.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.465 -1.368 . . . . 0.0 109.376 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -118.0 149.11 41.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.966 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.5 t80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.033 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.4 p -83.37 164.13 20.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.692 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t -157.62 155.07 29.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.658 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -128.02 140.66 51.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.772 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.68 136.99 58.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.036 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.95 140.61 11.94 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 173.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 168.4 30.1 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.365 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -121.94 135.87 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.59 149.03 50.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.19 134.39 54.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.18 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -112.86 142.59 45.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 142.1 37.66 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.649 0.593 . . . . 0.0 110.93 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.41 143.21 28.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.423 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -89.7 153.13 20.95 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.68 142.47 11.93 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.092 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 62.47 35.31 14.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.691 0.396 . . . . 0.0 111.394 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.0 mtt -149.76 167.85 25.34 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -107.68 146.08 32.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.72 0.295 . . . . 0.0 110.921 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -56.42 172.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.564 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.65 159.29 40.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.856 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.17 142.11 14.73 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.57 143.15 14.74 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.64 135.19 54.42 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -126.58 133.22 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 111.367 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.0 tp -120.03 134.95 55.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.019 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -130.22 145.77 51.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 112.066 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -120.34 137.82 54.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.042 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -135.26 144.28 46.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.834 0.35 . . . . 0.0 111.378 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -106.64 142.19 36.69 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -92.67 126.93 37.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.311 0.577 . . . . 0.0 110.373 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.99 153.62 41.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.735 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.38 -178.42 3.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.601 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -57.2 -35.42 69.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -87.04 -26.11 0.34 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -102.86 130.17 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.569 1.513 . . . . 0.0 112.105 160.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.2 mt -77.74 155.24 31.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.996 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.64 140.06 18.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -99.79 124.93 53.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 117.397 0.599 . . . . 0.0 109.83 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -120.27 132.88 68.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.77 134.17 8.61 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.3 p -127.36 141.98 51.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -113.01 128.08 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.769 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.0 m -124.45 132.7 53.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.12 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -127.09 136.03 51.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.487 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 m -117.81 145.21 44.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 110.955 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -130.13 141.69 50.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.006 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -109.21 137.68 46.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.193 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.7 p -65.41 157.86 28.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.532 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -57.67 139.23 54.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.628 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.5 p -130.61 162.67 28.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.104 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.13 94.03 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.167 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 m -161.9 174.26 13.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.552 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.8 p -58.97 -31.23 68.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.58 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.84 -30.18 68.46 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.027 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 75.35 -75.18 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.308 0.643 . . . . 0.0 111.31 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -135.26 161.86 34.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.806 0.336 . . . . 0.0 110.962 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 56.93 54.02 7.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.54 0.686 . . . . 0.0 110.591 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -55.49 -39.34 70.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.034 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -144.83 158.85 43.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 111.18 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -125.97 147.85 49.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.082 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -123.99 135.96 53.98 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.115 0.483 . . . . 0.0 110.919 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -128.8 119.15 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.221 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.19 135.18 8.19 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.272 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.02 117.29 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -123.28 148.65 45.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.768 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.82 31.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.13 168.93 41.14 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.114 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -98.41 122.9 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.555 2.17 . . . . 0.0 113.062 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 146.56 30.76 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.328 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -121.02 128.93 53.14 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -95.84 108.91 21.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.385 0.612 . . . . 0.0 112.281 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.8 mt -96.27 131.29 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.177 171.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -61.43 -35.0 76.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.162 -174.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -69.68 -178.2 1.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -87.4 40.84 0.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 110.778 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.19 22.51 10.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.26 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.2 p -68.68 165.07 20.19 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -171.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.59 129.99 14.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.539 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -131.18 140.26 49.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.0 137.75 11.3 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.46 152.64 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.974 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.17 140.95 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.17 174.95 26.78 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.57 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.54 133.09 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.64 131.32 9.45 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -114.92 132.28 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -115.95 127.85 7.73 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -126.43 145.27 50.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.595 0.236 . . . . 0.0 110.435 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -88.45 145.0 26.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.02 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -96.9 117.96 32.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.982 0.42 . . . . 0.0 110.398 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.8 m -108.12 149.07 28.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.365 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.9 m -58.4 151.12 20.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.066 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.92 -37.62 85.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.907 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -56.02 -55.59 39.82 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.114 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -42.13 126.95 3.84 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.932 1.755 . . . . 0.0 113.141 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.8 m -60.09 -37.56 80.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.335 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -90.63 135.91 33.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 111.225 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -113.35 156.06 24.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 61.2 71.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.394 0.616 . . . . 0.0 110.151 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.29 -41.36 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.452 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 66.0 p -131.21 153.8 49.1 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.005 0.431 . . . . 0.0 111.108 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.3 m -140.98 145.04 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.144 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -150.01 142.11 24.01 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.678 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.11 142.89 39.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.299 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.12 162.36 27.17 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -108.5 125.76 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.6 m -108.93 137.94 46.05 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.63 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -125.92 138.89 53.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.73 157.64 27.33 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.841 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.8 148.78 32.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.82 160.37 28.47 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.102 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.96 147.11 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.57 141.07 41.34 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.934 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -133.12 116.29 16.11 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -117.62 124.24 29.07 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.38 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -107.03 176.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.102 2.535 . . . . 0.0 109.423 157.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.33 170.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.182 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 65.39 -171.35 0.19 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.056 0.455 . . . . 0.0 111.956 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -61.51 -11.3 10.32 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.3 t -78.38 18.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.13 0.572 . . . . 0.0 112.431 -164.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.91 137.61 41.66 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.233 -0.917 . . . . 0.0 109.662 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.77 148.77 50.88 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -168.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -137.13 142.04 42.26 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -126.32 132.14 51.69 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -140.15 154.08 46.86 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.863 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.14 140.6 52.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -121.56 141.67 50.84 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 123.372 0.42 . . . . 0.0 110.093 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -125.9 132.84 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.575 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.1 m -115.77 144.57 43.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -89.45 146.03 24.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -161.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 10.5 tt -87.76 101.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 123.616 1.674 . . . . 0.0 113.697 -146.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -89.74 -176.7 5.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.244 157.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.14 -13.94 0.37 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.821 -0.549 . . . . 0.0 112.354 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.98 132.03 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.392 0.542 . . . . 0.0 109.747 166.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.08 139.22 50.07 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.15 127.68 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.767 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.41 116.1 2.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.1 m -126.1 134.14 51.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.477 0.639 . . . . 0.0 111.235 -175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -122.64 133.78 54.51 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.6 146.11 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.636 0.255 . . . . 0.0 111.269 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.01 133.95 53.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.38 153.13 21.81 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.074 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.82 140.0 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -138.91 163.89 25.85 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.395 -173.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -134.15 152.33 51.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 113.485 -1.357 . . . . 0.0 108.801 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -136.76 149.0 47.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.531 -179.627 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -132.7 153.75 50.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.511 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 p -159.92 157.59 29.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.907 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.7 m -132.51 139.27 47.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.332 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.58 120.53 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.5 m -128.25 143.09 51.0 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.31 140.86 12.13 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.23 179.81 31.82 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.159 -175.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.6 144.57 46.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -0.622 . . . . 0.0 109.847 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -122.74 138.52 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.944 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -125.46 131.92 52.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -116.81 145.74 43.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 139.31 38.66 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.827 0.704 . . . . 0.0 111.253 -173.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.78 143.31 35.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.115 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -89.68 153.41 20.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.5 152.03 3.59 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.602 -0.333 . . . . 0.0 112.392 -168.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 63.75 31.35 14.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.896 -0.652 . . . . 0.0 111.787 -174.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 69.2 mtm -151.19 167.3 28.21 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -109.35 146.18 34.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.848 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -54.37 168.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.167 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.8 mtt -117.63 146.38 43.71 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.57 135.29 10.78 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.52 143.15 14.45 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.607 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -110.95 135.8 50.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -131.63 144.57 51.14 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.945 -173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.6 mt -124.41 140.51 52.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.239 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.16 141.89 51.04 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.043 0.449 . . . . 0.0 111.084 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -121.03 130.21 53.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -134.39 144.08 47.99 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.265 0.353 . . . . 0.0 110.657 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -107.49 143.22 36.18 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.68 119.16 31.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.195 0.522 . . . . 0.0 109.981 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.45 153.4 46.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.991 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.7 -178.62 3.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.541 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -56.37 -32.96 65.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.315 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.2 m -93.38 -25.94 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -102.83 136.3 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.728 1.619 . . . . 0.0 111.848 164.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.6 mt -78.06 154.27 31.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.93 140.38 16.38 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.09 127.5 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.501 0.651 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.9 tt -123.36 138.39 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.28 139.77 10.58 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 p -135.41 144.93 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.067 0.434 . . . . 0.0 111.424 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -124.68 128.65 49.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.109 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.8 p -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.855 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -127.28 137.12 52.77 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -111.54 150.73 29.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 111.202 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.24 151.55 50.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.141 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.05 147.0 31.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.116 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.3 p -123.31 138.29 54.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 0.0 110.17 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -150.88 151.24 31.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.612 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 p -75.53 166.97 22.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.06 178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.06 134.29 56.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.446 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 t -157.63 171.58 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.776 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.0 p -59.65 -25.27 64.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.137 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.78 -8.28 63.43 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 119.579 -0.567 . . . . 0.0 113.349 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 59.44 52.68 5.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.069 0.935 . . . . 0.0 110.563 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.7 t80 63.92 139.29 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.185 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.35 117.68 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.493 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -102.32 110.02 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.165 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -133.82 150.24 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.741 175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -126.13 142.83 51.36 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.689 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -129.9 138.04 50.71 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.17 128.25 41.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.45 128.15 5.29 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tp -124.65 122.61 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.3 p -123.3 154.95 38.17 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.864 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.72 147.6 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.16 42.3 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.512 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -97.29 127.79 0.27 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.452 2.101 . . . . 0.0 112.818 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.66 138.55 36.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.652 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -116.87 128.14 54.96 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -95.85 109.41 21.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.327 0.584 . . . . 0.0 111.852 -170.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.7 mt -96.31 131.52 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.948 171.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -61.4 -29.22 69.79 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.705 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -73.97 -179.32 3.68 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -86.82 48.24 1.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.598 0.713 . . . . 0.0 110.076 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.2 22.62 10.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.003 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t -68.5 148.97 49.81 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -166.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.93 129.95 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.282 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -115.76 133.9 55.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.17 137.71 10.88 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 172.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.77 153.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 117.559 0.679 . . . . 0.0 111.976 -173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.5 t -125.71 140.84 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.41 174.95 27.0 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.661 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.3 128.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.3 131.26 8.53 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -139.06 155.91 47.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.097 0.448 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.22 150.05 17.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -134.68 146.26 49.32 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -98.63 127.21 44.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.845 0.355 . . . . 0.0 110.424 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -105.42 118.61 36.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.475 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.9 m -108.16 140.52 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.209 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.1 m -121.16 135.45 55.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.592 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 62.17 55.46 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.583 0.706 . . . . 0.0 110.19 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -146.89 162.39 33.48 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.286 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.13 129.17 33.45 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.371 1.381 . . . . 0.0 111.933 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -66.56 -28.1 68.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.059 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -59.76 -31.51 69.72 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -55.89 -39.46 71.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.612 0.244 . . . . 0.0 110.823 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 63.69 144.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.996 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.29 178.41 7.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.803 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -124.62 141.15 52.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.927 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.2 p -140.41 155.89 46.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.182 0.515 . . . . 0.0 111.559 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.92 159.0 26.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.465 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -136.02 159.86 40.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 111.403 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.02 167.11 26.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -93.2 124.86 37.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -113.07 140.55 47.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.039 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.2 139.38 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.5 161.9 28.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.152 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.34 148.94 31.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.368 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.04 162.0 28.68 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.61 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.87 152.64 27.73 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -116.47 133.47 55.98 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 111.693 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.56 109.74 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -140.59 124.71 10.58 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -165.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -101.23 176.14 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.381 2.054 . . . . 0.0 109.258 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.7 mtp -58.69 176.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 61.64 -174.45 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.901 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -60.63 -11.56 7.62 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.8 t -78.4 17.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -167.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.24 138.02 41.3 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.27 145.52 48.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -168.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.66 131.35 44.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.661 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -124.06 129.79 51.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -140.12 154.11 46.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.606 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -121.61 139.98 52.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.94 150.95 46.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.889 0.376 . . . . 0.0 110.742 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -131.84 136.02 47.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -113.32 144.57 42.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.194 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -89.21 146.24 24.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.782 0.676 . . . . 0.0 109.519 -160.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 pt -87.88 98.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 123.309 1.528 . . . . 0.0 114.032 -145.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -89.67 -176.74 5.08 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 112.2 -2.273 . . . . 0.0 106.903 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.3 p -52.32 -12.78 0.28 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.324 -0.86 . . . . 0.0 112.616 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.07 133.89 65.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.334 0.516 . . . . 0.0 109.837 168.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -115.0 139.1 50.13 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -108.18 129.77 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.743 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.23 117.18 2.9 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 169.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.6 m -126.14 134.26 51.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.862 0.831 . . . . 0.0 111.476 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -115.85 135.13 54.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.6 pt -130.84 144.71 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.286 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.49 128.69 25.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.471 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.95 153.07 21.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.612 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.01 140.96 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.13 178.1 31.98 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.401 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -139.8 162.78 34.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.444 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -141.52 149.06 40.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.534 -179.675 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.7 m -124.85 -62.16 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.465 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -128.79 148.63 50.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.207 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.4 m -126.0 139.74 53.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.918 0.389 . . . . 0.0 110.353 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.6 122.59 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.608 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.14 143.06 51.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.34 140.83 12.16 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.89 179.29 31.06 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.031 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -131.16 146.44 52.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.27 149.16 50.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.004 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -116.22 136.3 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -112.9 139.48 48.5 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.79 127.78 32.51 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.88 0.738 . . . . 0.0 111.02 -174.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.0 143.31 29.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.582 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.74 153.34 20.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 146.89 6.87 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.107 -171.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 61.65 39.07 14.83 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.951 0.442 . . . . 0.0 110.687 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.4 ttm -158.04 153.42 25.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.979 176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -101.94 149.36 24.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -55.71 166.17 0.74 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.741 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -129.04 160.95 31.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.666 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.83 148.22 17.58 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.14 14.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.755 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -112.77 135.06 53.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -131.12 138.29 49.44 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.833 -174.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.4 mt -122.26 139.61 53.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.289 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -130.7 142.57 50.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.915 0.388 . . . . 0.0 111.427 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -122.26 133.15 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -137.08 144.09 42.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.079 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.09 143.2 33.59 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.59 125.83 37.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.277 0.561 . . . . 0.0 110.188 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.99 153.38 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.56 -178.6 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.715 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.04 -33.53 65.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.427 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -93.25 -26.06 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -102.77 135.28 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.756 1.637 . . . . 0.0 111.889 164.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.97 160.29 28.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.25 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.46 140.21 14.91 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.41 125.51 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.341 0.571 . . . . 0.0 109.935 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.3 mt -119.2 136.12 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.87 136.46 8.57 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.1 p -138.2 149.08 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.41 0.605 . . . . 0.0 111.59 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -122.2 135.56 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.969 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -130.13 140.04 50.83 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.144 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -125.64 136.99 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.59 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 m -101.27 145.31 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -130.95 147.07 52.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.344 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -134.43 136.94 43.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.72 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -105.55 135.85 46.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 111.017 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -134.33 169.1 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.355 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 p -70.24 168.0 16.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.087 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.01 117.78 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.908 0.385 . . . . 0.0 110.447 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.3 p -159.58 178.94 9.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.579 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.2 p -59.48 -24.82 63.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.241 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.76 -14.12 72.51 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.148 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 59.51 48.32 9.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.934 0.867 . . . . 0.0 110.721 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 59.31 30.61 20.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.846 178.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -128.46 117.58 21.59 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.766 0.317 . . . . 0.0 110.745 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -95.08 -68.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.161 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -139.87 172.81 12.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.141 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -125.97 143.09 51.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -135.29 135.97 41.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -130.11 133.12 46.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.83 135.51 7.87 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.89 123.57 67.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.5 p -123.23 153.4 40.18 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.052 0.22 . . . . 0.0 111.001 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 143.95 30.23 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.15 169.56 41.52 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.995 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -97.27 124.92 0.22 Allowed 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 122.471 2.114 . . . . 0.0 112.914 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.81 147.02 30.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.719 169.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -121.58 129.31 52.77 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 172.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -95.85 108.84 21.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.384 0.612 . . . . 0.0 111.661 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.26 131.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.242 172.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -61.59 -34.72 76.1 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.956 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -65.71 -179.25 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -88.05 37.47 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 111.19 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.07 22.47 10.25 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m -68.92 150.58 47.58 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.0 pt -136.83 144.38 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.463 -167.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -137.1 147.34 46.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.847 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 137.87 9.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -134.67 156.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.76 0.314 . . . . 0.0 111.015 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.49 140.94 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.21 175.08 26.76 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.696 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.75 129.72 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.56 137.88 11.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -139.05 151.8 47.06 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.558 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.07 150.18 17.54 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -125.93 133.08 51.97 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -106.88 131.76 53.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -109.77 139.08 45.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.089 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.6 p -108.02 151.9 25.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 0.0 110.783 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.8 p -72.96 -34.88 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -98.59 143.71 28.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.804 0.335 . . . . 0.0 110.423 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -121.79 80.25 40.83 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.527 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.59 -31.52 5.43 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.395 1.397 . . . . 0.0 112.183 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.2 m -112.58 146.02 39.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.015 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -56.63 -38.72 72.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.847 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -128.9 120.66 26.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.696 0.284 . . . . 0.0 110.461 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -150.5 126.27 10.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.727 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -164.96 158.56 17.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.699 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.5 m -128.82 137.57 51.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.109 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.1 t -139.62 133.09 30.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.932 0.396 . . . . 0.0 111.114 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -140.07 155.14 47.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.5 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -132.06 153.17 50.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.227 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.29 167.07 26.22 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.99 125.91 47.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.1 m -110.24 142.2 42.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.15 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -124.9 137.06 54.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.34 153.43 23.47 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.678 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.25 148.85 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.72 160.04 28.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.377 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.6 mt -108.86 146.04 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -125.75 140.59 52.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 111.805 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -139.97 110.0 6.48 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -132.85 124.29 18.63 Favored Pre-proline 0 CA--C 1.529 0.136 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.472 -170.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -102.04 176.21 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.992 2.462 . . . . 0.0 109.255 156.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -57.77 166.42 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.512 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 65.39 -174.47 0.18 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.16 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -58.74 -11.66 3.41 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.3 m -78.42 17.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -170.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.74 143.04 33.64 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.66 155.8 42.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.369 -174.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -137.09 148.09 46.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.602 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -126.15 127.53 45.88 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 64.9 p -140.23 154.21 46.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.444 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -120.87 150.13 41.53 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -124.72 137.95 54.31 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.487 0.492 . . . . 0.0 110.525 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -122.42 129.22 51.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.301 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.5 m -120.18 144.56 47.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -89.51 146.12 24.82 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.531 0.519 . . . . 0.0 109.602 -163.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.8 tt -87.72 95.91 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 123.705 1.717 . . . . 0.0 113.422 -147.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -89.66 -176.84 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.434 157.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -52.01 -16.27 0.72 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.83 -0.544 . . . . 0.0 112.141 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.33 127.51 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 167.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -115.1 139.16 50.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.2 125.96 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.979 -171.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 108.83 1.12 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 167.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.4 m -126.08 134.26 51.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 117.633 0.716 . . . . 0.0 111.352 -174.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -123.21 132.23 53.97 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 16.4 tt -130.28 143.77 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.188 0.305 . . . . 0.0 111.079 -171.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.2 53.53 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.82 153.11 20.95 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.709 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.3 141.18 47.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.28 178.05 32.14 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.78 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -139.77 171.8 13.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.691 -0.754 . . . . 0.0 110.277 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -117.88 148.95 41.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.503 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.0 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.618 -179.368 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.5 p -122.96 163.85 19.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.407 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -153.99 163.1 40.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 m -129.71 143.11 50.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.511 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.98 127.0 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -128.41 143.17 50.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.899 0.381 . . . . 0.0 111.313 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.67 140.87 12.13 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.78 -175.91 30.23 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.32 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.52 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.85 148.92 50.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.508 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -121.85 135.25 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.618 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.93 143.77 44.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -78.46 138.63 38.56 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.674 0.609 . . . . 0.0 111.078 -173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.76 143.36 34.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -89.61 153.29 20.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.014 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.76 151.98 3.9 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.168 -171.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 68.57 21.35 8.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.462 -0.369 . . . . 0.0 111.984 -172.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -150.09 166.03 31.0 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -108.59 156.96 18.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.76 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.52 164.68 7.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.206 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.6 mtm -119.55 153.42 35.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.551 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.18 140.64 13.68 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.11 143.19 14.58 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.813 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.12 132.18 54.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -127.12 139.02 53.27 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.165 0.291 . . . . 0.0 111.716 -173.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.99 132.81 49.15 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -136.18 147.65 47.77 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.02 0.438 . . . . 0.0 110.825 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -132.69 151.18 52.04 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -150.98 144.45 24.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.144 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -105.78 143.24 34.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -92.4 124.38 36.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.308 0.575 . . . . 0.0 110.091 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -121.37 153.32 37.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.871 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.64 -178.46 3.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.843 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -50.66 -42.33 56.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 p -90.26 -25.86 0.3 Allowed Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -102.83 131.95 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.497 1.465 . . . . 0.0 112.218 162.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.4 mt -78.07 162.04 26.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.672 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.19 140.22 23.55 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.32 124.79 54.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 117.821 0.811 . . . . 0.0 109.401 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.82 142.7 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -146.34 134.41 5.33 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -141.93 154.92 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.909 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -132.93 141.15 48.2 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -130.07 141.29 50.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.168 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -118.65 134.39 55.15 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.6 m -109.77 145.83 35.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.993 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -133.81 140.19 46.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.268 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -145.23 136.8 25.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.749 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t -141.05 137.38 32.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.788 0.327 . . . . 0.0 110.806 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -93.37 -59.87 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.277 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.5 p -127.84 160.36 32.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.159 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.26 102.75 15.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.428 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -124.46 141.67 51.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.587 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -62.56 -36.2 81.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.396 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.51 -45.93 5.65 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.895 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -97.8 116.3 29.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.928 0.394 . . . . 0.0 111.594 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -129.92 126.87 38.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.267 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 55.22 89.05 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 111.045 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -58.68 -38.97 79.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.223 -176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -141.7 151.54 43.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.802 0.334 . . . . 0.0 110.935 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -126.16 149.12 49.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.229 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -130.51 136.47 48.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.423 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.6 133.21 49.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.649 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.29 136.34 8.69 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -125.28 124.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 p -123.31 154.7 38.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.315 -175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.81 147.98 41.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.27 171.02 36.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.42 -175.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -99.3 123.48 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.774 2.316 . . . . 0.0 111.945 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.6 143.56 33.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.4 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -124.02 159.89 28.87 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -95.16 135.64 36.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.951 0.881 . . . . 0.0 112.873 -162.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.5 tt -73.92 131.02 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.041 -173.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -94.82 -66.52 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.423 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.29 93.52 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.678 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 t90 52.68 34.85 16.89 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 111.246 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.97 22.53 10.31 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.67 146.46 52.97 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -132.57 129.81 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.576 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -132.18 133.75 44.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.88 137.64 10.59 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.22 151.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 117.468 0.634 . . . . 0.0 112.382 -172.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.78 140.93 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.17 175.14 26.69 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.361 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m -112.56 134.45 55.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.83 10.95 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -122.14 133.35 54.75 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.79 138.96 15.27 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -128.79 135.25 48.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.757 0.278 . . . . 0.0 110.356 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -106.94 130.61 54.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.601 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -105.65 128.55 53.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.388 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.7 p -82.73 157.44 23.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.478 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.9 p -68.59 -37.08 79.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.16 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -115.99 130.52 56.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 110.726 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 51.2 68.78 3.02 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.489 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.76 88.97 1.34 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.365 1.377 . . . . 0.0 111.738 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.5 p -122.41 165.29 16.55 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.035 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -57.4 -35.03 69.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.41 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -53.74 -37.58 63.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.576 0.226 . . . . 0.0 111.254 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -129.05 114.64 16.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.871 0.367 . . . . 0.0 110.396 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -170.88 173.06 5.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.4 m -121.09 136.41 54.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.131 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -138.14 141.1 40.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.896 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -142.22 141.84 32.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.466 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -109.04 142.89 39.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.25 159.47 27.1 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -102.54 126.1 49.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 m -116.44 143.91 44.98 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.698 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -143.08 153.07 42.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.03 175.55 35.97 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.12 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.84 148.99 29.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.001 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.81 159.85 27.89 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.953 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.53 147.63 45.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -134.42 141.04 46.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.273 0.559 . . . . 0.0 111.851 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -130.6 114.05 14.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -134.51 124.69 17.19 Favored Pre-proline 0 N--CA 1.463 0.216 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -98.79 176.24 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.465 2.11 . . . . 0.0 109.146 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.2 mtt -55.93 169.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.798 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -175.91 0.18 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.209 0.528 . . . . 0.0 112.298 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.87 -11.52 5.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.26 18.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -169.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.19 136.74 43.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.281 0.491 . . . . 0.0 109.863 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.5 mt -119.68 142.85 48.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.488 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -135.69 136.21 40.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.288 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.33 134.62 52.15 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 m -140.09 154.0 46.91 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.419 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -120.77 141.6 50.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.76 140.91 50.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 110.239 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -125.06 136.15 53.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.213 0.53 . . . . 0.0 111.346 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.6 m -103.94 144.71 31.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -89.28 145.96 25.04 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -158.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.8 96.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 122.732 1.253 . . . . 0.0 112.533 -145.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -89.85 -176.84 5.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 112.174 -2.285 . . . . 0.0 106.871 157.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.32 -13.36 0.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.387 -0.821 . . . . 0.0 112.537 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -119.06 129.64 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.424 0.556 . . . . 0.0 110.092 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -115.15 139.12 50.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.617 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.11 134.66 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.525 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.22 121.58 4.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.4 m -126.13 134.18 51.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.529 0.665 . . . . 0.0 111.256 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -120.57 130.54 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 tt -131.25 144.62 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.136 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.66 132.91 45.7 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.32 153.31 21.86 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.773 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.63 139.92 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.48 178.03 30.71 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.343 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -141.0 161.85 36.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.786 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -121.03 145.2 48.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.529 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.508 -179.403 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.3 m -82.02 142.01 32.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.57 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -140.78 155.59 46.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.46 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -121.76 140.06 52.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.507 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.52 128.51 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.2 m -128.14 142.11 51.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.408 . . . . 0.0 111.193 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.28 140.9 12.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.55 -179.9 31.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.374 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -122.27 140.23 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.65 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.39 138.87 54.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.504 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -125.75 131.78 52.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.5 p -115.92 143.59 45.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.42 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.82 129.42 34.58 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 124.116 0.885 . . . . 0.0 111.374 -173.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.74 143.31 33.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.994 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -89.8 153.4 20.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.217 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.65 152.16 3.69 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.992 -0.443 . . . . 0.0 111.992 -172.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 83.49 -28.09 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.529 1.132 . . . . 0.0 111.724 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 86.2 mtp -112.83 162.9 15.26 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -106.98 159.98 15.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.914 0.388 . . . . 0.0 111.081 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -64.62 167.97 6.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.353 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.4 mtt -129.74 154.01 47.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.614 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.5 147.9 16.73 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 143.33 12.28 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.46 133.46 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -127.38 136.63 52.14 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.433 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 tp -130.6 136.31 48.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -139.34 155.32 47.77 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.281 0.562 . . . . 0.0 112.197 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.92 140.37 52.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.097 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -132.62 144.35 50.3 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.212 0.32 . . . . 0.0 110.899 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.42 141.8 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -92.81 123.2 35.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.85 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.44 -178.5 3.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.882 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -54.77 -40.4 69.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 m -84.45 -26.19 0.38 Allowed Pre-proline 0 N--CA 1.467 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -169.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.62 126.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.531 1.487 . . . . 0.0 112.069 160.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.6 mt -76.31 154.64 34.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.25 140.17 18.89 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.97 126.13 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 117.206 0.503 . . . . 0.0 109.647 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.57 134.99 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.89 137.29 9.02 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -141.77 154.86 45.53 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.004 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.34 141.48 50.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.8 p -130.11 143.19 50.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.481 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.76 137.04 55.04 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -115.57 148.55 39.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -132.81 149.29 52.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.005 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -116.11 155.55 28.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.322 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.9 t -97.66 126.44 42.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 110.175 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -149.74 148.03 28.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.487 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.4 m -58.23 148.15 28.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.271 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.84 138.16 55.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 110.596 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.2 p -152.94 167.44 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -59.0 -33.92 71.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.563 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.01 3.11 14.29 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.508 -0.607 . . . . 0.0 113.608 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 64.52 144.23 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 117.987 0.894 . . . . 0.0 111.044 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -58.1 165.75 1.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.772 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.63 43.97 15.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.096 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -57.75 -37.62 73.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.777 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -99.83 143.17 30.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -125.46 146.42 49.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.429 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -123.5 135.91 54.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.384 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -131.44 120.41 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.77 135.49 8.54 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 tt -126.04 122.57 62.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -123.48 152.37 41.78 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.102 0.252 . . . . 0.0 110.602 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.0 146.39 30.97 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.51 41.46 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.287 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -99.02 122.3 0.13 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.734 2.289 . . . . 0.0 112.944 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.84 146.68 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.396 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.47 126.54 52.79 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -95.88 108.69 21.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.624 0.726 . . . . 0.0 112.008 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.5 131.46 43.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.95 167.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -61.34 -31.01 70.87 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.289 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -86.71 -177.16 6.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.886 0.374 . . . . 0.0 110.41 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -62.98 -7.02 4.44 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.85 22.26 0.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.7 p -68.76 158.31 34.57 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.2 mt -141.55 129.85 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.898 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -134.15 142.77 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.82 143.91 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.045 0.423 . . . . 0.0 110.82 -172.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.36 140.91 47.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.15 175.15 26.67 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.431 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -115.49 130.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 134.91 11.59 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -122.12 136.2 54.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.0 127.62 7.06 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -133.63 157.76 44.93 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 117.075 0.438 . . . . 0.0 111.598 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -98.47 133.57 42.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.43 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -97.74 132.04 43.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.498 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.8 t -86.19 159.16 19.57 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.541 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 p -81.96 164.3 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.49 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.46 -35.36 73.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.265 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -61.97 140.66 95.75 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.941 -0.552 . . . . 0.0 109.73 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.78 112.2 1.57 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.262 1.308 . . . . 0.0 111.877 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.0 m -123.02 138.92 54.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.42 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -62.31 -34.99 77.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.495 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -56.93 143.25 38.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.472 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -117.81 174.4 6.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.646 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -78.36 125.2 29.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.974 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.5 m -125.97 138.85 53.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.656 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.6 p -146.92 166.18 27.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.279 0.561 . . . . 0.0 111.938 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -142.09 153.03 43.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.667 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -109.64 151.23 27.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.99 166.99 26.15 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.66 127.16 51.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.841 0.321 . . . . 0.0 110.349 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.4 t -105.52 132.07 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.566 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -126.48 134.71 50.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.68 158.9 27.81 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.789 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.67 148.87 32.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.6 159.84 28.32 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.375 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mp -112.1 148.52 33.76 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -137.5 137.24 38.46 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.279 -171.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -133.91 131.16 38.77 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -138.74 124.48 12.31 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -99.04 176.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.718 2.279 . . . . 0.0 109.746 159.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.5 ttm -54.51 138.27 40.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.138 0.494 . . . . 0.0 111.861 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 71.81 -153.73 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.457 171.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.97 -11.65 8.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -166.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 t -78.68 17.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -166.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.39 143.02 33.55 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.062 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.37 153.81 40.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 111.403 -174.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p30 -137.29 148.1 46.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.885 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -122.37 131.72 54.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 m -139.98 154.2 47.1 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.759 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -121.28 141.14 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.72 142.32 47.79 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.547 0.53 . . . . 0.0 110.314 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.46 131.54 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.584 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -110.7 144.73 39.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -89.23 146.1 24.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 123.79 0.681 . . . . 0.0 109.348 -158.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.6 mt -87.83 100.38 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.712 1.244 . . . . 0.0 112.636 -143.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -89.68 -177.0 5.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 112.392 -2.185 . . . . 0.0 107.555 156.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 t -52.25 -15.31 0.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.851 -0.531 . . . . 0.0 112.273 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.39 129.39 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.392 0.542 . . . . 0.0 110.079 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.85 139.24 38.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 119.065 -0.493 . . . . 0.0 109.787 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.69 129.76 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.26 116.94 2.83 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.9 m -126.15 134.27 51.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.714 0.757 . . . . 0.0 111.19 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -109.34 134.14 52.18 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.26 136.34 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 O-C-N 123.131 0.269 . . . . 0.0 110.434 -174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.14 127.46 43.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.38 153.08 22.27 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.05 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.3 t -127.26 145.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.36 178.06 30.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.32 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -135.84 170.29 16.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.745 -0.728 . . . . 0.0 110.409 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.501 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 117.977 -1.011 . . . . 0.0 112.396 178.887 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.1 p -85.93 163.26 18.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.941 0.401 . . . . 0.0 110.779 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p -161.52 170.84 19.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.044 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.1 p -124.29 157.45 34.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.167 0.508 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.62 125.95 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.505 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.6 m -128.19 143.11 51.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.54 140.73 12.0 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.61 176.49 33.14 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.394 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.03 149.84 41.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.941 -0.63 . . . . 0.0 109.667 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.36 141.71 50.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.187 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -128.0 131.91 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -116.1 145.93 42.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -78.72 142.05 37.4 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.782 0.676 . . . . 0.0 110.944 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.04 143.23 28.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.217 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -89.9 153.3 20.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.49 147.67 6.27 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.321 -171.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 68.05 23.08 8.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.739 0.415 . . . . 0.0 111.572 -175.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 69.0 mtm -149.36 166.2 29.73 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.757 -0.589 . . . . 0.0 110.487 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -109.6 155.31 21.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.04 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -58.05 168.96 0.87 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.151 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.2 ttm -123.92 146.46 48.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.307 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 134.67 10.8 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.07 143.35 14.27 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -118.61 144.42 46.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -143.96 153.23 42.05 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.752 -174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -123.2 142.91 50.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.521 176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -136.22 138.42 41.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 111.016 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.93 140.45 49.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -133.66 144.21 49.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.975 0.417 . . . . 0.0 110.683 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -101.29 143.29 31.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -92.38 117.39 29.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.545 0.688 . . . . 0.0 110.407 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -126.2 153.55 44.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.631 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.59 -178.63 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.773 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -56.69 -33.42 66.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.29 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -102.78 140.98 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.714 1.61 . . . . 0.0 111.823 164.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.16 159.97 28.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.061 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.16 140.05 14.88 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.79 127.58 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.527 0.663 . . . . 0.0 109.948 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.27 144.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.388 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.99 137.87 8.73 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.3 t -136.53 141.35 43.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.019 0.41 . . . . 0.0 111.308 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.94 131.63 54.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -130.0 142.99 50.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.622 0.249 . . . . 0.0 111.554 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.18 136.38 51.99 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.8 p -121.17 152.32 38.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.946 0.403 . . . . 0.0 111.175 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -138.94 157.94 45.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.56 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -119.0 147.84 43.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.81 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -141.61 84.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 0.0 110.361 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -58.54 -43.84 89.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.475 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.1 m -138.17 142.63 40.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.486 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.2 94.08 4.05 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.9 m -136.02 161.91 34.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.9 m -58.94 -28.05 65.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.904 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.72 -15.25 73.38 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 121.281 -0.485 . . . . 0.0 113.107 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 60.96 62.54 1.42 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 117.822 0.811 . . . . 0.0 110.929 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -55.05 145.27 21.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.862 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -159.13 -73.84 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.24 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 52.55 33.42 13.43 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -175.16 120.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.569 0.223 . . . . 0.0 110.946 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -126.08 142.02 51.7 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -136.81 136.1 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 110.355 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.78 133.62 54.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.57 128.64 5.42 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.8 mt -122.18 120.06 60.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 p -123.28 151.72 42.09 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.139 0.274 . . . . 0.0 111.047 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.97 145.27 30.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.15 170.09 41.81 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.882 -1.151 . . . . 0.0 113.085 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -98.72 126.03 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.379 2.053 . . . . 0.0 112.688 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.57 142.84 33.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.482 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -119.99 137.61 53.97 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -95.84 115.79 27.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.518 0.675 . . . . 0.0 112.602 -170.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.23 131.6 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.937 170.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -61.27 -35.34 77.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.761 -174.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.5 -178.47 1.43 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 171.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -86.09 48.7 1.65 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.599 0.714 . . . . 0.0 110.026 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.9 22.56 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.251 -174.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 m -68.56 145.86 53.6 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -167.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 tt -131.92 136.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.28 -167.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -129.14 143.33 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.96 137.72 10.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.25 154.64 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.915 0.358 . . . . 0.0 111.296 -173.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.58 140.81 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.08 172.95 27.41 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.758 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.87 132.53 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 132.52 10.11 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -127.22 134.06 50.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.13 142.76 14.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -138.58 139.97 38.82 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.68 139.69 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 110.741 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -106.6 144.43 33.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -108.05 137.97 45.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.443 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.6 m -57.25 -39.23 75.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.861 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -86.0 -173.97 4.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.362 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -53.32 154.54 5.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.134 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.51 121.47 8.57 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.348 1.365 . . . . 0.0 112.252 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -137.41 162.23 34.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.488 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -59.38 -36.97 76.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.987 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -73.68 139.64 45.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.676 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 t60 80.75 -42.7 0.2 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.392 1.058 . . . . 0.0 111.72 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.58 112.18 22.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.851 0.358 . . . . 0.0 110.53 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.0 p -131.17 161.79 31.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.609 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.2 p -132.67 149.07 52.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.293 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -153.72 143.97 22.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.915 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -110.1 144.23 39.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.996 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.96 158.84 26.86 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.85 125.34 50.79 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -110.94 143.36 41.71 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.302 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -130.79 134.72 47.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.57 161.26 28.0 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.963 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.35 148.92 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.55 160.34 28.34 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.377 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.6 mt -108.89 151.21 26.59 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -123.69 132.11 53.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.759 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.21 111.44 15.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -130.74 124.42 20.82 Favored Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -169.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -96.41 176.05 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.739 2.293 . . . . 0.0 109.341 156.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -65.57 147.1 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 79.31 -164.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.761 0.825 . . . . 0.0 110.817 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.62 -11.88 8.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.67 17.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 134.67 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.525 0.602 . . . . 0.0 109.844 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.11 140.72 47.79 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.752 0.311 . . . . 0.0 111.184 -168.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -125.43 145.18 50.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.334 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -125.92 129.71 49.84 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.9 t -140.2 154.0 46.77 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.512 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -117.1 145.49 43.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -128.31 132.33 48.66 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.271 0.357 . . . . 0.0 110.043 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -118.75 134.6 55.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.856 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.0 m -115.65 144.75 43.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.52 146.02 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.64 0.587 . . . . 0.0 109.484 -160.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -87.74 95.95 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.708 1.242 . . . . 0.0 112.383 -146.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -89.91 -176.92 5.08 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.375 -2.193 . . . . 0.0 106.669 157.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.8 t -52.17 -16.02 0.71 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.303 -0.873 . . . . 0.0 112.179 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.63 129.38 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.251 0.478 . . . . 0.0 109.811 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -115.06 139.06 50.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.406 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.0 t -108.26 128.43 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.578 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.4 112.08 1.62 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 169.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -126.08 134.32 51.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.815 0.808 . . . . 0.0 111.176 -173.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -116.25 136.24 53.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.3 pt -130.13 147.22 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.169 -175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.5 128.5 25.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.2 153.1 23.21 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.519 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -125.81 145.88 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.07 32.11 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.133 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.43 165.95 23.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.81 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -118.06 148.65 42.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.703 0.287 . . . . 0.0 110.45 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.618 -179.656 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.9 p 48.96 43.12 21.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.15 0.5 . . . . 0.0 111.635 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.3 p -147.06 150.86 35.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.435 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.9 p -131.09 155.7 46.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.474 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.04 120.25 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.744 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.8 m -128.34 142.96 50.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.818 0.342 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.33 140.86 12.18 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.24 167.91 28.99 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.994 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.08 138.85 53.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.88 149.11 51.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.083 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -124.03 138.98 54.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -115.93 140.77 48.91 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.311 0.382 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.78 126.29 30.52 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.8 0.687 . . . . 0.0 111.381 -173.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.63 143.33 31.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.747 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -89.58 153.53 20.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.761 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.53 152.19 3.55 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.49 -167.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 68.54 22.72 7.58 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.491 -0.855 . . . . 0.0 112.652 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.5 mtm -149.88 166.52 29.32 Favored 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -100.91 148.77 24.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 111.397 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -63.32 169.56 3.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.145 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.6 mmm -125.3 155.12 40.71 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.251 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.37 148.35 16.76 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.04 143.03 14.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.717 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.85 135.78 48.79 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.602 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.3 mt -120.31 140.25 51.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -129.65 143.66 50.92 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.887 0.375 . . . . 0.0 111.37 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -125.32 132.29 52.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -139.93 144.15 36.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -98.47 143.44 28.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.75 136.05 33.57 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.241 0.543 . . . . 0.0 111.119 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -133.42 153.65 51.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.519 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.18 -178.3 3.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.334 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -51.14 -28.41 10.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -97.13 -25.82 0.24 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -102.82 148.08 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.817 1.678 . . . . 0.0 112.983 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.11 164.96 24.54 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.4 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.34 140.24 14.77 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p -111.04 125.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.7 tt -126.72 138.38 54.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.54 142.72 14.24 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.8 p -138.91 148.79 44.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.092 0.446 . . . . 0.0 111.668 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -121.42 133.71 55.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.218 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -128.95 137.19 51.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.65 0.262 . . . . 0.0 111.125 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -120.57 136.94 54.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.866 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.6 m -98.58 137.69 36.87 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.696 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -143.2 149.11 37.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.756 -175.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -110.25 141.91 42.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -84.03 4.59 29.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 47.99 93.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.426 0.557 . . . . 0.0 112.206 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.1 p -120.7 162.0 20.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.336 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.53 93.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.553 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.5 t -178.34 -175.34 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.807 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.7 p -58.93 -32.94 70.04 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.126 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.19 22.34 10.25 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 121.673 -0.299 . . . . 0.0 112.418 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -53.49 -34.19 57.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.59 0.695 . . . . 0.0 111.565 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -106.14 133.72 50.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -55.67 170.16 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -134.65 -155.18 0.64 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.252 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -48.73 140.56 8.31 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.236 -0.29 . . . . 0.0 111.489 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -112.53 152.61 28.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.047 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -120.81 137.4 54.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.135 0.493 . . . . 0.0 111.147 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -123.08 124.82 43.95 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.88 139.49 11.14 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.639 -176.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -125.09 124.21 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -123.26 154.34 38.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.774 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.01 145.62 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.05 171.21 42.34 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.994 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -97.15 127.1 0.26 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.144 1.896 . . . . 0.0 112.821 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 143.39 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.177 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -112.55 132.41 55.13 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -95.87 109.03 21.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.409 0.623 . . . . 0.0 111.537 -169.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.6 mm -96.22 131.48 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.343 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -61.41 -34.93 76.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.729 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.77 174.98 5.35 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -85.72 49.79 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.617 0.722 . . . . 0.0 110.346 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.07 22.76 10.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.151 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m -68.62 150.56 47.84 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.835 -163.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.4 mt -129.9 130.13 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -169.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.46 140.39 51.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.73 137.82 9.75 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.48 156.99 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 -175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.03 140.83 47.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.19 175.2 26.68 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.067 -174.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.01 134.86 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.92 133.64 10.79 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -122.54 141.26 51.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.89 146.08 16.27 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.26 142.71 41.99 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -101.26 129.45 47.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.914 0.387 . . . . 0.0 111.052 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -127.8 148.15 50.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.297 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.8 p -108.08 150.4 27.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.937 0.398 . . . . 0.0 110.628 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -81.16 -27.35 35.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.181 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.13 -36.57 75.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.587 0.232 . . . . 0.0 111.379 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -142.71 157.13 62.42 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.742 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.29 -44.38 0.43 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.335 1.357 . . . . 0.0 111.534 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.5 m -83.66 138.98 33.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.126 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -113.88 129.82 56.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 110.811 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -64.87 -40.85 95.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.722 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -139.61 164.21 30.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.957 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -159.6 171.35 19.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.669 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.9 m -125.24 136.08 53.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.004 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -127.69 139.84 52.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.176 0.512 . . . . 0.0 111.511 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -140.76 155.5 46.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.846 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.512 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.2 166.02 26.49 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.98 127.98 53.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.948 0.374 . . . . 0.0 110.032 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.8 p -113.89 146.33 40.19 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -137.41 143.12 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.93 159.91 28.17 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.728 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.06 149.02 30.41 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.53 161.65 28.86 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.756 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.1 mt -108.92 147.48 32.14 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.04 132.62 54.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.649 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -125.32 109.93 13.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -120.13 124.29 27.88 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -100.14 176.24 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.353 2.702 . . . . 0.0 109.332 155.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 84.9 mtp -60.07 138.01 57.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.267 0.556 . . . . 0.0 112.245 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 68.15 -148.31 0.14 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.731 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -61.15 -12.08 11.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.44 17.29 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.21 139.39 39.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.036 0.835 . . . . 0.0 110.282 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.5 tp -132.62 141.46 48.67 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -168.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -133.7 146.43 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.792 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -121.34 134.11 55.13 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -140.16 154.02 46.82 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.351 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -120.47 145.62 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -127.12 140.0 52.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.383 . . . . 0.0 110.462 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -127.95 136.02 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.125 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.9 t -112.98 144.74 42.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -89.18 146.19 24.94 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 124.436 1.085 . . . . 0.0 109.384 -158.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.1 mt -87.56 104.03 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.947 1.356 . . . . 0.0 112.749 -142.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -89.76 -176.58 5.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 112.056 -2.338 . . . . 0.0 107.304 156.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.5 p -52.39 -12.69 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 p -123.24 131.51 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 110.296 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -115.08 139.17 50.11 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.8 m -108.23 140.59 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.242 -174.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.17 119.49 3.6 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.3 m -126.0 134.17 51.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.637 0.718 . . . . 0.0 111.132 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -119.12 132.13 55.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 tt -131.79 144.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.569 0.223 . . . . 0.0 111.163 -174.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.53 132.5 48.3 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.6 153.16 22.92 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.811 -176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.5 144.51 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 176.95 32.58 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.814 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -135.38 170.25 16.23 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.59 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.08 149.05 37.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.686 0.279 . . . . 0.0 110.82 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.884 -179.119 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.5 p -122.97 160.12 26.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.406 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -166.39 147.21 6.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.538 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 m -125.11 141.24 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.09 128.52 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.39 140.85 11.68 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.69 -168.75 26.18 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.134 -1.032 . . . . 0.0 111.566 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -132.05 153.94 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.175 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.0 142.29 50.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.006 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -118.59 131.92 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 t -111.05 140.56 45.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.58 128.0 32.91 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.931 0.769 . . . . 0.0 111.298 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.88 143.33 27.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.152 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -89.63 153.44 20.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.41 151.93 3.54 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.487 -0.387 . . . . 0.0 112.345 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 62.79 33.0 15.66 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.632 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.3 mtt -151.12 170.41 19.48 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -110.19 152.92 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.33 . . . . 0.0 110.826 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -65.28 165.01 12.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.14 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.613 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.14 136.82 11.45 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.84 143.25 14.88 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.38 137.4 44.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.32 134.35 50.01 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.295 0.372 . . . . 0.0 111.66 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.54 138.69 54.49 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -134.9 143.06 46.74 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.089 0.471 . . . . 0.0 111.617 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -120.42 134.55 55.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.244 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttm105 -135.59 144.16 46.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 0.0 110.985 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.72 143.16 35.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.4 124.33 36.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 109.786 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.88 153.41 48.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.1 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.55 -178.62 3.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.566 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -57.73 -30.72 65.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 p -95.76 -25.74 0.25 Allowed Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -102.89 136.97 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.71 1.606 . . . . 0.0 111.956 165.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.13 155.13 30.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.1 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.28 15.54 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -101.99 125.93 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 117.346 0.573 . . . . 0.0 110.004 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.1 mt -118.44 132.08 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.62 132.55 8.0 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 t -133.54 140.59 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.112 0.456 . . . . 0.0 111.388 -173.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.17 132.98 55.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.4 m -130.07 134.6 47.48 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.83 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.15 137.16 52.9 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -107.6 152.15 24.67 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 111.359 -172.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -138.29 158.4 44.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.878 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.85 165.65 10.93 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.7 p -59.9 -24.73 64.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.6 mtm-85 58.18 39.53 25.83 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.089 0.471 . . . . 0.0 110.825 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.6 m -123.95 145.16 49.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.951 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.85 124.41 19.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.889 0.376 . . . . 0.0 110.534 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -154.3 151.95 29.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.528 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.6 p -62.29 -32.08 72.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.73 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.13 -45.98 1.12 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -84.51 112.73 20.66 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.821 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -156.59 100.12 1.92 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.828 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.6 m120 56.52 48.57 16.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.316 0.579 . . . . 0.0 110.846 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -68.51 162.62 25.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.621 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -67.16 173.96 3.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.984 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -121.1 150.89 40.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.722 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -119.74 136.0 54.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.001 0.429 . . . . 0.0 110.996 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -131.24 132.49 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.02 149.88 20.66 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.7 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.7 tt -125.6 125.49 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 p -123.16 155.01 37.89 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.031 0.207 . . . . 0.0 110.52 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.56 143.97 30.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.16 159.17 31.66 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.881 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -95.15 124.09 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.969 1.78 . . . . 0.0 112.481 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.63 144.77 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.341 170.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -111.77 132.95 54.31 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -95.77 108.93 21.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.522 0.677 . . . . 0.0 111.668 -168.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.9 mt -96.23 131.42 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.042 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.29 -35.07 76.32 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.752 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -67.88 174.71 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -86.77 48.55 1.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.54 0.685 . . . . 0.0 110.205 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.96 22.69 10.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.363 -174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -68.6 147.54 51.78 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 118.416 0.553 . . . . 0.0 110.382 -163.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.2 mt -128.93 132.71 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -130.77 146.79 52.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.621 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.464 0.525 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -140.15 144.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 117.121 0.46 . . . . 0.0 110.986 -170.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -131.99 140.83 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.28 175.09 26.82 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.14 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 130.04 74.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.94 144.13 18.31 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -134.96 148.39 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.724 0.262 . . . . 0.0 110.692 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.19 138.38 14.44 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -137.58 147.01 44.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -98.73 127.54 44.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.954 0.407 . . . . 0.0 110.587 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -127.22 148.14 50.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.45 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.1 m -103.8 142.98 33.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 m -95.79 152.59 18.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.778 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 63.94 -83.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.129 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -124.17 152.34 67.18 Favored Pre-proline 0 N--CA 1.464 0.262 0 O-C-N 122.176 -0.327 . . . . 0.0 110.303 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -90.78 122.5 0.84 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.749 1.632 . . . . 0.0 112.711 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.8 p -125.3 145.46 50.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.372 -0.376 . . . . 0.0 109.992 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 46.44 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -75.48 129.79 37.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.57 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -173.27 43.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.352 0.596 . . . . 0.0 110.549 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.64 142.84 58.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.338 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.1 p -125.28 156.16 39.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.425 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.9 m -131.58 142.09 49.83 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -154.52 141.83 19.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.58 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -117.21 147.61 42.35 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.304 0.377 . . . . 0.0 111.045 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 159.4 27.03 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -104.66 126.05 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.968 0.384 . . . . 0.0 110.062 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 94.0 p -108.22 137.29 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.969 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -127.75 140.73 51.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.28 169.2 32.67 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.465 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.67 148.98 30.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.789 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.86 158.95 27.84 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.615 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.9 tp -109.22 145.87 35.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -128.16 135.99 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.296 0.498 . . . . 0.0 111.471 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.39 129.73 25.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -140.99 124.67 10.17 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -96.09 176.16 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.533 2.156 . . . . 0.0 109.193 156.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -61.19 150.68 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.52 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 72.98 -160.48 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -61.43 -11.37 10.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.49 17.4 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.4 139.52 39.23 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.88 153.64 51.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.934 0.397 . . . . 0.0 111.078 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -137.06 143.84 42.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.046 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.98 132.61 53.24 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.1 t -140.04 153.92 46.94 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.582 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.27 140.11 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -127.84 146.98 50.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.285 0.366 . . . . 0.0 110.04 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -129.31 135.92 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -107.39 144.68 33.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -89.19 145.99 25.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -159.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.3 mt -87.98 101.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.656 1.217 . . . . 0.0 112.779 -144.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -89.86 -176.89 5.08 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 112.405 -2.18 . . . . 0.0 107.418 156.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.3 p -52.04 -15.45 0.56 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.778 -0.577 . . . . 0.0 112.358 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.85 129.22 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.894 -0.504 . . . . 0.0 109.729 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.2 139.15 46.82 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.19 133.96 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.879 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.22 3.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 170.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -126.36 134.24 51.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.795 0.798 . . . . 0.0 110.883 -176.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -119.05 136.09 54.31 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.7 mt -121.01 140.1 46.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.404 -172.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.1 123.34 25.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.76 153.31 22.57 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.787 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.13 147.1 29.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.17 32.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.216 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -138.88 167.18 22.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.714 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.605 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.495 -179.383 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 m -159.14 -50.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.659 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t -150.71 147.45 27.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.4 m -125.3 140.66 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.58 126.33 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.073 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.4 m -128.34 140.28 51.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.878 0.371 . . . . 0.0 110.67 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.77 140.82 12.1 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 108.446 -1.861 . . . . 0.0 108.446 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.38 -172.73 30.19 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.781 -1.199 . . . . 0.0 112.877 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -134.2 143.82 48.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.727 -0.736 . . . . 0.0 109.575 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.03 149.13 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.228 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -118.73 138.46 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.804 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -111.01 140.15 45.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.57 128.36 33.41 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.925 0.766 . . . . 0.0 111.322 -171.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.53 143.31 26.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.03 -177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -89.48 153.34 20.88 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 148.58 5.73 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.302 -170.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 63.43 36.24 11.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.256 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.2 mtt -150.08 174.04 13.19 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -115.85 137.8 51.75 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 110.919 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.37 167.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.2 mtm -126.89 156.06 42.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.235 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.31 149.49 17.46 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.11 12.64 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -112.75 139.07 48.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -130.59 147.07 52.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -173.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.2 mt -115.95 142.22 47.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.826 170.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -129.7 141.92 50.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.433 -170.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -133.98 147.39 51.01 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -144.28 144.16 31.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.761 -175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -110.39 140.95 44.11 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 175.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -92.96 125.58 37.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.227 0.536 . . . . 0.0 110.573 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -145.05 153.62 41.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.816 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.48 -178.49 3.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.038 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -53.48 -34.82 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.94 -26.05 0.3 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -102.8 127.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.673 1.582 . . . . 0.0 111.567 161.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 76.9 mt -75.77 153.4 37.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.169 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.26 22.69 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.92 125.0 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 117.304 0.552 . . . . 0.0 109.695 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.0 pt -125.36 147.55 30.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.245 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.46 147.44 17.57 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 p -141.8 146.1 35.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.874 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -120.17 127.63 52.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.6 p -128.82 142.98 50.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.213 -177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -127.27 137.33 52.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.896 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -97.74 147.51 24.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.098 0.475 . . . . 0.0 111.28 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -129.93 148.39 51.79 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -129.34 164.03 24.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.86 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -139.95 106.42 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.485 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -133.17 154.22 50.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.694 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.7 p -119.43 164.91 15.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.677 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.08 95.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 110.592 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -125.25 145.26 50.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.628 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.4 p -66.29 -27.98 68.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.178 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.9 -45.98 48.09 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -171.16 155.55 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.349 . . . . 0.0 111.054 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -149.24 144.66 26.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 59.28 83.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.586 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -74.4 -179.99 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.47 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -84.13 155.99 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.495 . . . . 0.0 111.52 -173.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -126.13 158.12 36.33 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -149.1 155.23 40.41 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 121.61 0.719 . . . . 0.0 112.214 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -125.85 140.08 52.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.088 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.33 137.51 9.5 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.0 117.95 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 p -123.29 150.05 44.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.329 -175.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.15 149.08 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 171.0 41.32 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 119.855 -1.164 . . . . 0.0 113.067 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -97.74 126.92 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.563 2.175 . . . . 0.0 112.662 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.53 139.49 36.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.548 170.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -131.21 160.06 35.94 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.8 mmt-85 -104.42 108.66 20.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.154 0.502 . . . . 0.0 111.03 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.0 tt -96.39 131.33 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.512 171.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -61.6 -31.98 72.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.642 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.03 -37.83 75.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.649 0.261 . . . . 0.0 111.414 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -126.45 -169.67 2.06 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.26 -18.68 14.78 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t -149.48 137.48 20.47 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 118.148 0.431 . . . . 0.0 111.188 172.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.5 tt -138.94 129.92 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -141.71 152.52 43.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.864 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.94 137.84 11.38 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.5 p -138.11 143.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 117.223 0.511 . . . . 0.0 111.01 -171.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.84 140.77 48.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.06 172.34 27.54 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.529 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t -115.03 130.71 69.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 131.71 9.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.35 140.06 50.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.17 150.07 17.52 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -132.92 134.93 45.2 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -103.23 137.49 41.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.62 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -102.66 146.14 28.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.342 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 m -89.89 137.5 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.497 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.2 p -103.95 26.59 8.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.097 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 49.66 26.46 1.81 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.2 -54.48 0.1 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-O 119.284 -0.389 . . . . 0.0 111.102 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.51 -68.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.357 1.371 . . . . 0.0 112.48 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p -125.49 162.83 24.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 110.376 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -58.25 -41.52 84.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.643 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -136.19 128.05 29.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.568 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -135.12 133.56 39.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.263 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -155.59 122.2 5.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.81 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.4 m -126.29 141.0 52.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.041 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.1 m -123.13 143.81 49.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.961 0.41 . . . . 0.0 110.949 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -157.34 157.38 34.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.639 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -132.9 151.97 51.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.034 0.445 . . . . 0.0 111.545 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.03 165.98 26.45 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -106.13 125.79 51.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.886 0.343 . . . . 0.0 110.12 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.6 p -107.54 144.41 34.57 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -130.76 136.77 49.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.92 166.72 28.86 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.49 148.9 35.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.02 161.04 28.51 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.236 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.6 mp -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.419 0.628 . . . . 0.0 111.971 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.75 109.95 12.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 168.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -121.04 124.58 27.35 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -166.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -97.51 176.12 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.658 2.239 . . . . 0.0 109.59 156.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.0 ttm -64.91 141.22 58.85 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.182 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 79.28 -162.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.696 0.799 . . . . 0.0 111.225 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -59.43 -11.54 4.6 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 m -78.63 17.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.14 134.32 47.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.54 0.609 . . . . 0.0 109.893 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.7 mt -114.96 144.17 44.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.916 -169.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -130.95 140.23 50.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.848 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.82 136.02 40.3 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 t -140.4 154.03 46.54 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.443 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.22 139.82 49.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -135.97 134.99 39.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.752 0.31 . . . . 0.0 110.229 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -124.74 134.84 52.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.124 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.3 p -96.79 144.78 26.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -89.16 145.9 25.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -162.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.7 tt -87.87 102.33 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 123.364 1.554 . . . . 0.0 114.08 -144.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -89.66 -176.86 5.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 112.367 -2.197 . . . . 0.0 107.277 156.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -52.11 -15.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.785 -0.572 . . . . 0.0 112.271 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.4 129.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 168.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -113.71 139.15 49.32 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.58 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.9 t -108.21 134.7 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 124.71 5.39 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -126.21 134.14 51.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 117.459 0.63 . . . . 0.0 111.269 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -119.88 127.59 52.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.0 tt -130.5 143.44 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.385 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.38 136.39 43.32 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.91 153.26 23.68 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.683 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.8 m -116.47 139.95 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -154.91 177.29 32.26 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.471 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.564 -0.818 . . . . 0.0 110.083 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -118.02 147.17 43.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.298 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.5 t80 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.58 -179.181 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.8 m -52.46 -36.91 55.79 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.696 0.284 . . . . 0.0 111.517 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t -148.3 133.15 18.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.533 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.4 m -124.92 140.21 53.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.154 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.44 119.99 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -128.22 141.81 51.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.33 140.69 12.47 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.1 165.11 28.21 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.037 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -121.62 145.86 47.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.58 149.03 50.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.903 0.382 . . . . 0.0 111.179 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -122.39 135.05 54.62 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 m -115.14 132.92 56.45 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.154 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.82 123.83 30.9 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.316 1.01 . . . . 0.0 110.93 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.48 143.2 33.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -89.71 153.12 20.96 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.44 109.39 0.68 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.138 -171.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 167.65 -52.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.2 mtm -128.48 173.95 9.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.186 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -91.97 170.07 10.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.305 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -65.63 165.12 12.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.754 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.48 153.07 47.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.943 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.17 135.19 11.46 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.23 14.22 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -118.8 139.81 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.9 145.11 45.95 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.959 -176.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.32 132.05 53.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -125.56 143.06 51.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 111.377 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.95 138.24 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -130.72 144.08 51.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.967 0.413 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.69 143.14 45.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.66 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.29 129.32 38.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.289 0.566 . . . . 0.0 110.543 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -131.03 153.49 49.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.763 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.6 -178.54 3.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -53.61 -34.35 58.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.605 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -94.56 -25.89 0.26 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -102.92 134.22 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.764 1.643 . . . . 0.0 111.877 163.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.1 160.59 27.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.83 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.43 140.17 24.1 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.12 124.88 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.319 0.56 . . . . 0.0 110.026 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.4 mt -120.49 135.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.51 140.1 11.35 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -142.13 150.08 40.65 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.323 0.562 . . . . 0.0 111.774 -175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.49 133.22 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.087 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -130.07 137.31 50.14 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.967 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.18 136.66 52.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -116.67 137.26 52.32 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.028 0.376 . . . . 0.0 110.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -143.36 172.69 12.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -136.62 138.27 40.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.118 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 t -93.63 130.16 39.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.091 0.472 . . . . 0.0 110.917 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -107.35 -174.76 2.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.872 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.9 p -59.42 156.85 12.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.014 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.4 117.23 6.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.621 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.4 p -150.97 149.82 30.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.434 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.9 m -64.27 -36.22 83.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.88 -38.29 65.26 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 -175.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 56.68 101.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.754 0.311 . . . . 0.0 110.48 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -55.93 -74.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.29 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 53.89 44.22 29.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.349 0.595 . . . . 0.0 110.861 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -57.35 -43.97 83.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.997 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -108.93 123.87 49.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.622 0.249 . . . . 0.0 110.865 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -126.14 143.34 51.16 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -125.65 135.97 52.73 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.002 0.429 . . . . 0.0 110.768 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -122.33 123.0 40.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 132.29 7.93 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.8 mt -120.53 117.54 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.8 p -123.3 155.26 37.59 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.886 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.19 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.5 157.34 28.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.632 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -95.6 122.39 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.992 1.795 . . . . 0.0 111.94 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.77 144.02 32.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.866 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -117.87 130.09 56.04 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -96.03 108.95 21.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.463 0.649 . . . . 0.0 111.863 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.6 mt -96.26 131.5 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.083 171.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -61.37 -34.42 75.29 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.823 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.28 174.64 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 171.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -85.61 48.05 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.573 0.701 . . . . 0.0 110.437 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.05 22.63 10.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.17 -175.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.2 m -68.58 147.39 52.01 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -164.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.4 pt -133.06 146.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.643 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.21 155.03 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.452 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.81 137.95 11.5 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.2 t -131.9 139.03 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.854 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.39 140.73 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.28 174.89 26.91 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.647 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.25 128.12 72.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.86 10.34 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -118.26 130.63 56.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.74 134.89 12.47 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -141.32 140.41 33.79 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.004 -176.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -106.94 134.37 50.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.081 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -98.03 146.86 25.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.72 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 m -108.08 141.25 40.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.672 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 t -100.32 175.82 5.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.135 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -64.53 86.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.796 0.331 . . . . 0.0 110.636 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -154.97 168.45 12.03 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.742 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -47.9 172.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.422 1.414 . . . . 0.0 112.109 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.4 m -70.74 131.75 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 110.694 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -139.03 142.64 38.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.402 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -80.99 130.53 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.765 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -134.93 156.64 48.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.842 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -60.91 -28.16 68.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.49 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 64.1 p 53.34 -173.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.628 0.251 . . . . 0.0 110.775 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -62.98 134.77 56.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.257 0.551 . . . . 0.0 111.685 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -153.63 141.8 20.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.903 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -106.66 148.31 28.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.193 0.521 . . . . 0.0 112.385 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 162.49 27.16 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -103.15 126.99 50.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.195 0.497 . . . . 0.0 110.619 -178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -109.43 135.71 50.03 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.629 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -130.3 145.32 51.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.04 175.09 36.04 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.452 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.05 31.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.018 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.53 158.05 27.41 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.009 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.2 tp -117.8 145.81 44.27 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -123.95 132.26 53.69 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.569 0.622 . . . . 0.0 112.228 -174.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.05 122.87 40.27 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 171.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -142.14 124.55 9.16 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -95.96 176.19 0.8 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.724 2.282 . . . . 0.0 109.364 155.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.1 mtp -55.17 138.59 44.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.289 0.566 . . . . 0.0 112.338 -174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 71.46 -145.25 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.74 -11.85 29.86 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -166.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.8 17.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -168.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.49 137.8 41.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.607 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -130.17 140.98 50.7 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.297 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -125.53 137.11 53.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -118.56 132.6 56.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -139.65 151.44 45.96 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.715 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -122.23 139.82 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -132.25 151.16 51.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -131.71 136.1 47.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.012 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 t -109.08 144.85 36.57 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.076 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -89.13 146.19 24.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.201 0.601 . . . . 0.0 109.406 -156.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.3 mm -87.66 96.0 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 122.841 1.305 . . . . 0.0 112.225 -142.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -91.9 -177.1 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.141 -2.299 . . . . 0.0 107.974 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.0 m -52.27 -17.61 1.21 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.022 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.33 131.0 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -114.97 138.8 50.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.32 132.43 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.989 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.33 120.25 3.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 168.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.3 m -126.12 134.22 51.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.951 0.875 . . . . 0.0 111.543 -173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -112.94 131.39 55.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.4 mt -123.53 139.02 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 123.118 0.261 . . . . 0.0 110.616 -174.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.58 124.01 24.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.58 153.2 21.94 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.609 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 p -128.65 142.68 43.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 177.98 32.09 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -130.93 164.43 25.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.395 -0.903 . . . . 0.0 109.952 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -118.36 149.1 41.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.75 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 72.7 t80 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.957 -178.846 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.2 p -123.06 160.55 26.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.514 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 m -158.66 150.52 21.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.27 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.0 p -126.96 155.45 43.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.08 121.16 45.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.772 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.1 m -128.29 140.63 51.77 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.828 0.347 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.64 140.85 12.16 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.06 170.52 30.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.1 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.11 139.24 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.92 149.06 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.052 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -118.16 138.59 52.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.265 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 t -111.97 137.3 50.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.68 142.01 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.973 0.795 . . . . 0.0 111.388 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.84 143.25 33.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.029 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -89.83 153.27 20.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.62 139.46 16.67 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.283 -0.484 . . . . 0.0 111.996 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 66.08 37.17 5.34 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.398 -0.401 . . . . 0.0 111.166 -175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 80.1 mtp -149.55 173.92 13.09 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 173.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -109.43 160.19 16.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.871 0.367 . . . . 0.0 111.249 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -86.21 171.69 11.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.921 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.39 159.75 38.35 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.807 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.07 144.42 15.41 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.89 142.96 14.14 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.864 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -113.65 133.91 55.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -129.14 138.83 52.01 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.28 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.5 tt -130.16 130.2 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.56 154.54 47.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.279 0.562 . . . . 0.0 112.235 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -123.21 141.89 51.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.806 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -132.76 144.03 49.99 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.561 0.538 . . . . 0.0 110.216 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.26 143.31 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -92.68 122.45 35.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 109.735 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -132.52 153.32 51.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.061 -172.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.7 -178.53 3.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.221 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.07 -25.92 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -170.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -102.85 135.71 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.802 1.668 . . . . 0.0 111.941 165.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.98 158.33 29.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.858 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.22 140.25 15.05 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.5 127.2 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 117.418 0.609 . . . . 0.0 110.06 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.9 mt -120.71 133.1 68.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.19 137.19 8.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 t -140.56 145.35 36.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.147 0.474 . . . . 0.0 111.44 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.92 135.08 54.32 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.4 p -126.81 141.09 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.634 0.254 . . . . 0.0 110.637 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -127.02 134.6 50.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.8 m -115.29 141.76 47.59 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.688 0.28 . . . . 0.0 110.48 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -142.97 147.81 35.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.89 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -172.31 136.67 0.83 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.477 172.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.1 p -177.92 -176.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.005 0.431 . . . . 0.0 110.487 -176.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -79.56 154.37 28.83 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.8 t -47.19 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 112.307 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.31 158.14 44.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.584 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 p -59.0 171.76 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.0 m -58.78 -36.0 73.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.306 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.81 -16.29 31.43 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.173 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.07 132.82 37.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.71 0.755 . . . . 0.0 111.448 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 59.12 -94.8 0.05 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.166 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.1 m120 58.39 48.06 12.87 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.9 0.773 . . . . 0.0 109.953 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -58.69 139.1 56.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.338 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.1 m120 60.43 103.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.221 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -119.3 134.93 54.95 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.76 141.57 51.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.044 0.45 . . . . 0.0 111.333 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -122.9 132.97 54.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.226 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.27 135.27 8.05 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.71 124.43 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.2 p -123.18 149.41 44.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.126 0.266 . . . . 0.0 110.847 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.52 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.03 166.98 39.83 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.711 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.1 128.06 0.43 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 122.066 1.844 . . . . 0.0 112.769 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.61 142.17 34.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.061 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -140.91 160.18 40.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -112.06 108.63 17.99 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.32 0.581 . . . . 0.0 111.473 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.8 mt -96.68 131.49 43.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 165.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -61.21 -25.11 66.82 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.174 -168.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -59.44 -40.71 87.67 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.767 0.258 . . . . 0.0 111.648 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -119.24 158.3 26.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.73 -18.93 42.57 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.608 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 t -149.75 138.1 20.63 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.151 0.432 . . . . 0.0 110.509 169.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 tt -140.51 129.87 26.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -142.74 154.08 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.441 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.51 137.79 9.81 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.3 155.04 38.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 117.143 0.471 . . . . 0.0 111.296 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.05 141.08 47.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.11 175.03 26.69 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.049 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.42 134.0 66.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 133.35 10.61 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -121.95 136.77 54.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.2 145.58 17.14 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -132.86 134.31 44.45 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.585 0.231 . . . . 0.0 110.437 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -109.99 130.27 55.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -121.31 132.65 54.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.79 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.8 m -108.07 133.43 52.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.213 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.5 p -139.95 21.54 2.46 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.53 -53.82 42.02 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.572 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.27 -55.11 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.45 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -85.43 166.66 10.58 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.555 1.504 . . . . 0.0 112.224 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.9 p -125.01 154.3 41.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.411 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -175.01 -67.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.077 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -58.78 -34.43 71.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.377 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 64.07 -84.1 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.172 0.295 . . . . 0.0 110.935 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -144.45 140.37 28.92 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.891 0.377 . . . . 0.0 110.872 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.4 m -122.97 134.14 54.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.847 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -125.91 142.52 51.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.041 0.448 . . . . 0.0 111.286 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -150.26 141.96 23.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.271 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -125.1 148.6 48.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 111.35 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.05 161.66 27.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.22 125.09 50.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 84.2 p -107.9 146.96 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.25 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -130.5 138.48 50.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.58 162.01 28.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.195 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.86 148.92 39.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.94 152.91 25.0 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.134 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.06 145.87 47.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -137.93 136.74 37.3 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.438 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.63 122.13 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -116.06 124.22 30.0 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -106.24 176.17 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.68 2.92 . . . . 0.0 109.112 154.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -63.26 151.47 40.44 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.747 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 68.58 -165.31 0.19 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.495 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -57.88 -11.25 2.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 t -78.21 17.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -167.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 138.61 40.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.174 -0.954 . . . . 0.0 110.162 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.91 144.46 51.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.615 -171.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -134.8 144.06 47.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.385 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.38 137.97 52.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 t -140.15 152.1 45.8 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.523 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.26 139.69 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.12 141.23 50.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.743 0.306 . . . . 0.0 110.865 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -127.36 136.18 51.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.399 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.8 m -113.07 144.69 42.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -89.4 146.3 24.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.616 0.572 . . . . 0.0 109.678 -159.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.1 pt -87.8 95.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 123.229 1.49 . . . . 0.0 114.117 -145.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -89.78 -176.76 5.06 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 112.27 -2.241 . . . . 0.0 107.737 157.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.0 t -52.21 -16.03 0.72 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.73 132.56 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 118.187 0.449 . . . . 0.0 110.147 168.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -112.47 139.12 48.31 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.416 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.14 129.03 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.571 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.27 119.2 3.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.4 m -126.04 134.15 51.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.757 0.779 . . . . 0.0 111.054 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -122.21 129.59 52.41 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.1 tt -129.89 144.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.631 0.253 . . . . 0.0 111.362 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -126.11 132.98 51.77 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.26 152.99 21.33 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.863 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.11 139.83 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.11 178.05 31.99 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.542 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.78 163.98 28.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.733 -0.734 . . . . 0.0 110.032 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -117.88 149.02 41.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.656 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.4 p90 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.492 179.422 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.6 p . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m -132.82 141.97 48.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.342 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.45 115.26 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.468 HG23 ' C ' ' A' ' 144' ' ' VAL . 6.1 m -128.17 139.69 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.83 140.85 12.23 Favored Glycine 0 N--CA 1.461 0.352 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.88 167.28 28.27 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.018 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -115.15 140.58 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.634 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -122.46 141.19 51.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.968 -178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -118.72 131.9 56.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 t -112.76 134.74 54.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.81 142.14 37.16 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.115 0.884 . . . . 0.0 110.844 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.494 -176.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -131.59 157.55 43.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.606 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.36 146.98 17.84 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.53 143.22 14.29 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.96 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -109.77 134.42 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -127.39 137.67 52.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.579 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD21 ' OH ' ' A' ' 28' ' ' TYR . 14.8 tp -122.6 134.3 54.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.117 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -128.35 143.82 51.06 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.07 0.462 . . . . 0.0 111.826 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.453 ' OH ' HD21 ' A' ' 26' ' ' LEU . 94.2 m-85 -123.65 138.61 54.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.405 174.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -131.4 144.06 50.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.86 0.362 . . . . 0.0 111.118 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -103.93 143.21 33.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.58 125.07 37.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -133.06 153.2 51.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.694 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.83 -178.4 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.177 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.46 -38.61 69.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -85.73 -25.99 0.35 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.81 142.38 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.58 1.52 . . . . 0.0 112.525 163.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.437 HD22 ' CD2' ' A' ' 71' ' ' TYR . 74.5 mt -78.06 165.04 24.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.005 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.09 140.12 14.92 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.18 125.47 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.364 0.582 . . . . 0.0 109.947 -174.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.17 135.5 62.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.66 138.02 10.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 t -131.71 137.33 48.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.813 0.307 . . . . 0.0 111.063 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -115.27 129.11 56.53 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 m -125.9 137.74 53.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.679 0.276 . . . . 0.0 110.731 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -126.06 132.58 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.771 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 m -101.49 146.01 28.22 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.533 -177.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -127.1 135.73 51.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.43 135.38 7.57 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.569 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.58 119.35 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.698 HG22 ' HA3' ' A' ' 84' ' ' GLY . 20.1 p -123.23 153.67 39.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.036 0.21 . . . . 0.0 110.507 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.17 146.22 30.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.01 167.37 40.08 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.875 -1.155 . . . . 0.0 112.999 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.417 ' HB2' HD13 ' A' ' 37' ' ' LEU . 92.6 Cg_endo -97.18 124.21 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.276 1.984 . . . . 0.0 112.855 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.79 142.25 33.94 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.77 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.437 ' CD2' HD22 ' A' ' 37' ' ' LEU . 80.9 m-85 . . . . . 0 C--N 1.331 -0.215 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 CA--C 1.522 -0.113 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.22 129.77 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -127.97 133.86 49.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.75 137.89 11.13 Favored Glycine 0 N--CA 1.465 0.62 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 66' ' ' THR . 8.2 p -142.79 145.95 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.557 0.679 . . . . 0.0 111.445 -172.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.441 HG12 ' HD1' ' A' ' 109' ' ' TYR . 27.7 m -129.35 140.93 47.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 175.07 26.83 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.444 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.42 127.22 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.69 137.56 11.32 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.19 157.91 45.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.098 0.449 . . . . 0.0 111.45 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.668 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.71 149.29 33.13 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.731 0.644 . . . . 0.0 110.817 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.0 161.62 27.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -101.67 127.17 48.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -113.66 145.47 41.26 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.034 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.441 ' HD1' HG12 ' A' ' 83' ' ' VAL . 77.4 t80 -131.16 139.47 49.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.41 161.32 27.96 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.732 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 148.91 35.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.95 164.52 29.2 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.857 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.6 tp -109.07 145.91 34.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -138.44 134.22 33.78 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.83 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -135.45 115.22 12.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.54 124.46 19.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -102.88 176.15 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.796 2.331 . . . . 0.0 109.294 157.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.2 mtm -55.38 164.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 66.48 -171.94 0.19 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.721 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.29 -11.42 4.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.1 t -78.32 17.91 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -166.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.614 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.43 130.61 52.31 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.331 -0.856 . . . . 0.0 110.231 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.614 HD22 ' C ' ' A' ' 122' ' ' ALA . 4.5 mm? -124.59 146.29 49.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.819 -171.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -137.15 139.54 41.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.411 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.98 131.17 47.41 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -140.24 154.09 46.76 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.663 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -118.32 140.37 49.93 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -126.81 136.62 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.193 0.308 . . . . 0.0 110.387 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -119.33 130.83 55.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.321 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.9 t -108.09 144.6 35.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -89.37 145.97 24.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -159.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 132' ' ' ILE . 13.0 tt -87.89 100.96 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 123.526 1.631 . . . . 0.0 113.678 -146.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -89.8 -176.7 5.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.18 -2.282 . . . . 0.0 106.597 157.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -52.16 -14.54 0.44 Allowed 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.339 -0.851 . . . . 0.0 112.206 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.02 132.59 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.362 0.528 . . . . 0.0 109.859 167.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -115.01 139.12 50.11 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.35 133.59 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.707 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.33 3.88 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.9 m -126.12 134.16 51.41 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.61 0.705 . . . . 0.0 111.12 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -117.29 130.92 56.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.634 HG22 ' HB2' ' A' ' 10' ' ' ALA . 2.6 pp -124.98 144.9 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.855 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.52 127.18 30.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.497 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -135.63 153.09 21.17 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.612 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.468 ' C ' HG23 ' A' ' 6' ' ' THR . 9.3 p -128.54 139.91 50.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.02 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.809 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -137.33 165.08 27.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.675 -0.763 . . . . 0.0 110.173 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -121.68 148.97 43.9 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.7 p90 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.075 -0.964 . . . . 0.0 112.453 -174.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.523 -0.068 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.706 HG22 ' HB3' ' A' ' 29' ' ' ARG . 14.9 t -135.1 151.83 51.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.947 0.404 . . . . 0.0 110.845 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.49 124.37 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.415 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 m -128.31 139.44 52.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 110.676 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.71 140.71 13.47 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.23 168.21 28.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.185 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -117.68 133.02 56.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -115.56 138.7 50.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.412 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -119.16 131.99 55.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.0 139.1 48.94 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.72 142.12 37.32 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.822 0.701 . . . . 0.0 111.218 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.283 -176.531 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.7 mttt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.642 0.258 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.3 mmm -128.8 155.79 44.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.294 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.48 143.35 14.98 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.54 143.17 14.22 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.909 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.38 131.38 54.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' HG23 ' A' ' 44' ' ' THR . 71.0 m-20 -119.66 135.19 54.92 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.296 0.373 . . . . 0.0 111.529 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tt -118.4 135.95 54.04 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -117.87 143.87 45.92 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.208 0.317 . . . . 0.0 111.32 -173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -133.49 130.28 38.33 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.706 ' HB3' HG22 ' A' ' 4' ' ' THR . 37.2 ttm180 -138.32 144.08 40.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.178 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -109.83 143.15 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -92.63 129.3 38.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.516 0.674 . . . . 0.0 110.769 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -133.09 153.47 51.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.109 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.54 -178.56 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.718 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -55.7 -33.4 64.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.327 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 t -93.38 -25.89 0.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.78 139.18 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.746 1.631 . . . . 0.0 111.952 164.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.11 152.76 32.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.304 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.03 140.38 16.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.3 m -103.55 127.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 117.779 0.789 . . . . 0.0 110.113 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.737 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -126.17 140.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.737 ' N ' HD13 ' A' ' 40' ' ' ILE . . . -139.87 143.53 13.87 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -142.06 155.03 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.584 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -131.61 142.01 49.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.906 173.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.526 HG23 ' OD1' ' A' ' 25' ' ' ASN . 61.5 m -127.03 137.7 53.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.88 -175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -118.49 133.02 56.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.035 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 m -107.76 144.65 34.61 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 110.867 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 -178.345 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.949 0.404 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -132.61 131.7 41.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.592 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.16 146.34 18.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.052 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.14 127.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.662 HG22 ' HA3' ' A' ' 84' ' ' GLY . 60.9 p -123.2 154.88 38.13 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.139 0.274 . . . . 0.0 110.803 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.95 148.88 37.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.74 160.89 31.88 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 119.865 -1.159 . . . . 0.0 113.335 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -94.05 124.07 0.45 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.018 1.812 . . . . 0.0 112.061 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . . . -80.71 138.8 36.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.218 171.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 C--N 1.333 -0.146 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.482 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 CA--C 1.519 -0.231 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.38 129.96 70.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.087 0.47 . . . . 0.0 110.447 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 20.5 m-85 -120.01 134.03 55.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.99 137.58 11.21 Favored Glycine 0 N--CA 1.466 0.668 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.67 150.99 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.259 0.53 . . . . 0.0 111.822 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.09 140.77 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.27 175.01 26.85 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.459 -176.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.64 127.53 73.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.52 144.67 16.11 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -138.0 154.28 49.35 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.111 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.71 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -108.56 149.64 28.59 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.526 0.517 . . . . 0.0 111.593 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 164.03 26.94 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -104.24 128.13 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.99 0.395 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.3 m -114.37 141.01 48.18 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.677 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -140.52 144.09 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.11 176.59 35.9 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.227 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.05 150.6 30.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.661 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.12 28.04 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.274 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.19 149.93 35.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -121.6 138.67 54.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 112.128 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -125.99 109.95 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.73 124.34 27.14 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -105.51 176.06 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.373 2.716 . . . . 0.0 109.351 155.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.5 mtm -61.16 158.2 14.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.782 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 67.27 -165.95 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.537 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -58.43 -11.67 3.11 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 121' ' ' VAL . 9.9 t -78.41 17.77 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -167.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.43 138.02 41.44 Favored 'General case' 0 C--N 1.344 0.37 0 O-C-N 121.153 -0.967 . . . . 0.0 110.057 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.68 151.41 49.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.709 0.29 . . . . 0.0 111.269 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.96 139.66 41.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.364 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -122.22 129.12 51.95 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -140.21 154.02 46.77 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.313 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -124.52 142.7 51.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -128.78 146.84 50.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -128.5 135.51 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.046 0.45 . . . . 0.0 110.621 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.4 p -100.57 144.78 29.15 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -89.29 145.94 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -160.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -87.77 99.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.638 1.208 . . . . 0.0 112.924 -144.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -89.88 -176.99 5.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 112.528 -2.124 . . . . 0.0 107.499 156.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.2 t -52.17 -16.18 0.74 Allowed 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 112.078 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.32 130.69 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -114.92 139.04 50.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.375 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.37 135.97 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.597 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.64 5.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.06 134.18 51.48 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.652 0.726 . . . . 0.0 111.396 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -115.0 132.83 56.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 10' ' ' ALA . 67.3 mt -124.03 134.8 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -173.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.18 123.3 39.32 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.08 20.56 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.823 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.2 140.17 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 178.02 32.08 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.676 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.56 165.09 24.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.139 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -117.96 149.0 41.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.614 -178.756 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 CA--C 1.524 -0.036 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -136.01 155.18 50.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.921 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 p -129.98 132.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.187 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 m -128.08 140.12 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.32 140.74 12.27 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.78 30.58 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.355 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -117.16 136.31 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.683 -0.759 . . . . 0.0 109.11 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -117.31 138.07 52.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.384 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -126.15 132.04 51.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 p -115.57 141.31 48.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -78.94 127.02 31.46 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.063 0.852 . . . . 0.0 111.233 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.466 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 9.1 mtmp? . . . . . 0 C--O 1.232 0.133 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.32 159.74 35.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.285 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.23 151.4 18.36 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.08 143.22 11.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.784 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.11 132.98 52.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.551 ' OD1' HG22 ' A' ' 44' ' ' THR . 49.2 m-20 -126.7 135.91 51.76 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.459 -175.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.8 mt -122.25 139.3 53.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -135.07 142.5 46.31 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 111.538 -173.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.43 136.6 54.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.402 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -136.78 144.11 43.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -104.49 143.09 33.5 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.57 123.57 35.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.122 0.487 . . . . 0.0 110.112 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.04 153.47 41.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.975 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.32 -178.58 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.836 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -55.37 -41.53 72.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 m -82.29 -26.1 0.4 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -102.83 126.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.531 1.487 . . . . 0.0 112.04 160.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 156.59 32.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.97 140.28 19.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -101.62 124.93 55.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 117.292 0.546 . . . . 0.0 109.861 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.571 HD11 ' HB2' ' A' ' 70' ' ' ALA . 69.7 mt -117.44 134.93 59.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.9 133.26 7.53 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.1 t -132.84 140.51 47.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.041 0.421 . . . . 0.0 111.315 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.77 132.29 55.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 25' ' ' ASN . 68.9 p -128.75 142.57 50.96 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.94 -178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -125.48 135.51 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.168 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -109.51 144.83 37.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.785 0.326 . . . . 0.0 111.061 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.475 -178.822 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.899 0.38 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -123.27 129.36 51.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.38 134.81 7.98 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.44 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.23 123.75 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.661 HG22 ' HA3' ' A' ' 84' ' ' GLY . 63.5 p -123.24 153.44 40.16 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.154 0.284 . . . . 0.0 110.602 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.78 144.86 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.536 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.01 168.14 40.58 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 119.775 -1.202 . . . . 0.0 113.178 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -96.99 126.08 0.25 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.434 2.089 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.84 140.45 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.667 170.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.2 t80 . . . . . 0 C--N 1.332 -0.184 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.441 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 tt -128.95 133.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.789 -171.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -128.39 146.86 50.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.959 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.2 137.73 9.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.1 m -134.14 153.77 36.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.828 0.314 . . . . 0.0 110.97 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.24 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.03 26.73 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.305 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 87' ' ' TYR . 42.7 t -118.35 133.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 131.93 9.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CZ ' HG11 ' A' ' 85' ' ' VAL . 97.8 m-85 -120.85 142.02 50.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 0.0 110.405 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.634 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 175.156 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.7 t0 . . . . . 0 N--CA 1.46 0.036 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -123.85 150.79 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.057 0.456 . . . . 0.0 111.769 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.06 26.17 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -103.89 129.94 51.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.088 0.444 . . . . 0.0 110.449 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.4 m -112.39 141.73 45.77 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.661 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -131.93 139.06 48.6 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.44 155.02 26.3 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.792 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.23 148.89 30.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -151.81 162.26 29.62 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.893 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.96 150.31 27.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -135.03 139.65 44.99 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.576 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.511 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 46.2 p90 -137.95 120.69 16.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.1 124.4 26.49 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -105.19 175.99 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.087 2.525 . . . . 0.0 109.712 157.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.32 157.77 10.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.935 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 67.24 -167.61 0.2 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.694 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.41 -11.4 2.81 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' VAL . 7.2 t -78.23 17.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -169.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.1 136.45 43.7 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.511 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 71.3 mt -125.18 147.24 49.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.898 -167.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -132.53 136.74 46.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.151 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.26 130.44 52.74 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -139.91 154.07 47.14 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.996 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -124.83 143.13 50.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.965 0.412 . . . . 0.0 110.669 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -127.95 136.15 50.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.18 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.553 ' HB3' HG22 ' A' ' 137' ' ' VAL . 6.4 t -111.44 144.76 40.13 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 171.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -89.25 146.4 24.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.224 0.952 . . . . 0.0 109.667 -158.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 136' ' ' ASP . 58.2 mt -87.84 105.81 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 122.73 1.253 . . . . 0.0 112.879 -141.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -89.75 -176.74 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.314 156.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 t -52.16 -14.48 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.822 -0.549 . . . . 0.0 112.262 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.02 130.9 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.404 0.547 . . . . 0.0 110.337 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.477 ' HB2' HG23 ' A' ' 132' ' ' ILE . 29.4 t0 -115.02 139.19 50.06 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.553 HG22 ' HB3' ' A' ' 130' ' ' SER . 17.7 m -108.12 143.86 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.315 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.1 122.61 4.72 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 171.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.414 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 27.7 m -125.9 134.19 51.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.545 0.673 . . . . 0.0 111.352 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -109.29 132.23 54.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 10' ' ' ALA . 67.2 mt -122.5 133.5 68.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 123.209 0.318 . . . . 0.0 110.286 -175.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.85 126.17 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.53 153.02 20.85 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.137 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 123' ' ' LEU . 32.2 m -122.14 140.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 177.87 32.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.372 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -141.53 163.08 33.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.837 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -123.26 149.0 45.32 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.256 0.347 . . . . 0.0 110.54 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.63 -178.879 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.458 -0.041 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.4 p -125.17 155.4 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.378 . . . . 0.0 110.43 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.83 125.06 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.588 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -128.15 141.48 51.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 111.036 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.68 140.74 12.05 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.9 165.45 28.48 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.316 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -115.44 134.58 54.95 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -116.99 138.97 51.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.5 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -120.88 132.95 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -115.89 144.47 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -78.59 142.17 37.49 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.867 0.729 . . . . 0.0 111.13 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.313 -175.33 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.64 155.21 39.53 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.885 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 46' ' ' THR . . . -126.4 140.5 12.08 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.42 143.24 14.02 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.817 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.66 136.78 50.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -131.47 142.41 49.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.989 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.4 tp -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.137 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -127.23 141.96 51.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.009 0.433 . . . . 0.0 111.512 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.68 137.32 54.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.443 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -134.45 144.1 47.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 110.823 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -109.32 143.25 39.08 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.77 120.3 33.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.277 0.561 . . . . 0.0 111.157 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -133.86 153.63 51.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.962 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.51 -178.44 3.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.863 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -53.01 -33.87 53.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -91.4 -26.02 0.28 Allowed Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -102.79 133.0 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.683 1.589 . . . . 0.0 111.65 162.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.97 158.31 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.245 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.08 140.3 19.12 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.67 125.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 117.478 0.639 . . . . 0.0 109.784 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 70' ' ' ALA . 67.7 mt -120.54 137.77 53.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.15 137.38 9.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -135.91 140.97 44.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.085 0.442 . . . . 0.0 111.093 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.36 132.77 56.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.4 m -129.43 139.05 51.76 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.284 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -124.97 129.8 51.07 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' GLY . 5.9 m -124.75 145.95 49.45 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.978 0.353 . . . . 0.0 110.991 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.369 -178.956 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.7 t80 . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.932 0.396 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -134.82 127.78 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.607 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.01 140.32 11.09 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.649 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -122.08 122.57 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.564 HG23 ' C ' ' A' ' 83' ' ' VAL . 2.4 m -123.21 147.27 47.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.79 147.33 31.76 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.11 171.02 42.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.886 -1.15 . . . . 0.0 113.162 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -93.51 128.05 0.65 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.149 1.899 . . . . 0.0 112.905 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.5 138.57 36.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.188 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.8 t80 . . . . . 0 C--O 1.234 0.28 0 O-C-N 123.77 0.669 . . . . 0.0 109.228 173.525 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 CA--C 1.517 -0.324 0 CA-C-O 120.792 0.329 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.96 129.56 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.1 m-30 -122.6 135.35 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.03 137.65 11.24 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.544 ' HB ' HG22 ' A' ' 66' ' ' THR . 30.4 m -142.43 153.44 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 117.801 0.801 . . . . 0.0 112.021 -173.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.564 ' C ' HG23 ' A' ' 66' ' ' THR . 27.4 m -134.05 140.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 174.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 66' ' ' THR . . . -147.13 171.86 27.71 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.524 -176.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.62 125.82 74.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.6 146.43 16.19 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -139.1 155.13 48.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.861 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.656 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.222 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.45 0.167 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -109.59 149.7 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 124.024 0.827 . . . . 0.0 110.217 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.16 159.36 27.05 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -99.51 124.31 44.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -110.06 141.01 43.49 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.764 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -127.95 140.3 52.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.16 159.26 27.86 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.1 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.12 148.88 32.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.987 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.45 161.89 29.66 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.36 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.68 150.47 49.75 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -127.79 146.52 50.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.601 0.715 . . . . 0.0 112.582 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -124.07 112.56 17.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.43 124.21 29.76 Favored Pre-proline 0 N--CA 1.462 0.17 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -107.03 176.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.452 2.768 . . . . 0.0 109.342 155.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -62.88 156.06 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.763 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 67.84 -166.48 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.588 173.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -58.64 -11.42 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 121' ' ' VAL . 9.8 t -78.37 17.73 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.48 138.17 41.26 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.34 -0.85 . . . . 0.0 110.145 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 123' ' ' LEU . 5.4 mp -122.87 147.42 46.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.545 -170.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -132.61 136.41 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.385 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.36 130.7 54.51 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -140.18 154.03 46.81 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.321 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -128.15 145.29 51.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.521 ' OE2' HD12 ' A' ' 141' ' ' ILE . 47.1 mp0 -133.84 146.6 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.178 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -129.5 136.06 49.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.9 t -104.13 144.72 31.2 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -89.28 146.03 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -161.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.7 mt -87.9 106.71 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 122.76 1.266 . . . . 0.0 112.901 -142.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -89.68 -176.71 5.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 112.301 -2.227 . . . . 0.0 107.227 156.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.1 p -52.11 -13.32 0.3 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.611 . . . . 0.0 112.496 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.82 133.49 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.383 0.538 . . . . 0.0 109.83 167.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.87 139.37 45.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.342 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.06 132.5 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.615 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 124.11 5.2 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.07 134.28 51.43 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.337 0.569 . . . . 0.0 111.298 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.36 134.83 54.74 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.521 HD12 ' OE2' ' A' ' 128' ' ' GLU . 67.9 mt -125.34 135.73 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.429 -174.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 124.79 43.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.07 20.56 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.19 139.78 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.01 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.748 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.12 163.69 31.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.905 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -119.65 148.79 42.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.602 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.972 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.803 0.335 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 m -128.93 139.86 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.112 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 5' ' ' VAL . 35.7 m -128.71 128.93 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.135 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.5 m -128.15 142.29 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.53 140.8 12.07 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.19 -169.89 27.28 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.169 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -129.21 158.5 38.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.262 -0.469 . . . . 0.0 109.931 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.884 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -136.51 148.18 47.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.973 -177.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -126.35 132.8 51.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -118.52 142.03 48.0 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -79.04 125.07 28.91 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.872 0.732 . . . . 0.0 111.408 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.461 179.067 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 pttp . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.492 ' CE ' HG21 ' A' ' 46' ' ' THR . 86.0 mtp -115.17 143.31 45.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.07 140.15 16.03 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.45 143.28 14.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.823 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -111.3 137.81 48.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -125.92 133.88 51.74 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.193 0.308 . . . . 0.0 111.576 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.2 mt -118.01 141.86 48.0 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.779 0.674 . . . . 0.0 109.482 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -127.72 143.01 51.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.301 -174.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -132.15 132.54 43.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -138.55 144.2 39.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 -176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -108.37 142.45 38.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.59 131.03 38.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.274 0.559 . . . . 0.0 111.289 -174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -143.86 153.57 42.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.497 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.43 -178.4 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.136 -173.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -51.08 -37.78 47.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -89.13 -25.98 0.31 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -102.73 126.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.716 1.611 . . . . 0.0 111.869 161.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.536 HD22 ' CD1' ' A' ' 71' ' ' TYR . 73.4 mt -76.63 158.39 31.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.963 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.05 140.12 18.99 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.66 124.96 58.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.487 0.644 . . . . 0.0 109.28 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.492 HD11 ' CG1' ' A' ' 82' ' ' VAL . 41.3 pt -122.46 144.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.379 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.84 136.2 8.49 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -127.88 140.93 51.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.671 0.272 . . . . 0.0 110.811 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.74 131.2 56.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.1 m -126.44 134.8 50.88 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.247 0.342 . . . . 0.0 110.83 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -127.04 137.05 52.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.436 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.492 HG21 ' CE ' ' A' ' 21' ' ' MET . 7.2 m -108.5 148.28 30.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.017 0.436 . . . . 0.0 111.351 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.525 -177.793 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.9 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.715 0.293 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -138.02 132.98 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.993 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.97 19.58 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.519 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.449 ' C ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -127.27 127.37 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.656 HG22 ' HA3' ' A' ' 84' ' ' GLY . 31.2 p -123.21 154.99 38.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.655 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.62 148.28 34.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.09 170.92 42.25 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.968 -1.111 . . . . 0.0 113.337 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -99.15 122.65 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.628 2.219 . . . . 0.0 112.717 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.78 139.93 35.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.077 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CD1' HD22 ' A' ' 37' ' ' LEU . 65.8 m-85 . . . . . 0 C--N 1.332 -0.157 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.19 129.93 17.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -127.84 141.98 51.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.2 137.91 10.99 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.492 ' CG1' HD11 ' A' ' 40' ' ' ILE . 36.0 m -135.69 153.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.953 0.376 . . . . 0.0 111.182 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.68 140.84 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.656 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.21 175.21 26.69 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.339 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.62 129.66 75.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.08 145.47 16.66 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -138.68 160.02 40.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.1 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 . . . . . 0 N--CA 1.458 -0.074 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -139.42 158.99 43.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.009 0.433 . . . . 0.0 111.566 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.09 167.06 26.16 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.16 125.7 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -111.98 145.54 39.45 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.638 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -142.64 144.52 32.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.12 173.38 35.96 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.912 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.9 28.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.457 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.94 160.49 27.1 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.141 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.6 mp -113.13 151.06 31.3 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -121.98 133.62 54.82 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.802 -174.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -128.24 109.92 11.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.452 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 10.9 p-10 -140.53 124.64 10.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -167.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.29 176.11 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.629 2.219 . . . . 0.0 109.125 155.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -55.71 174.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.555 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -174.7 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.256 0.551 . . . . 0.0 112.126 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -62.95 -11.35 18.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.47 18.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.586 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.27 141.92 35.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.461 0.573 . . . . 0.0 110.162 -176.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 144' ' ' VAL . 4.5 mm? -124.02 148.99 46.58 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.84 -170.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -136.94 137.52 39.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.22 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -128.63 132.06 48.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.438 ' HB3' HD11 ' A' ' 141' ' ' ILE . 31.4 t -140.4 154.14 46.58 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.581 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.85 139.95 49.34 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -126.76 140.66 52.21 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 123.344 0.403 . . . . 0.0 110.453 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -124.23 136.03 53.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.284 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -109.1 144.84 36.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -89.19 145.94 25.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -160.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 pt -88.01 105.13 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 123.09 1.424 . . . . 0.0 114.689 -143.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -89.84 -176.97 5.11 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 112.703 -2.044 . . . . 0.0 106.845 157.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 t -52.06 -15.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.476 -0.765 . . . . 0.0 112.237 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.59 127.26 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 118.215 0.461 . . . . 0.0 109.808 168.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -103.9 139.19 39.41 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.13 131.16 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.32 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.19 118.48 3.29 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.2 m -126.2 134.2 51.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.347 0.573 . . . . 0.0 110.866 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -115.73 133.03 56.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.884 HG22 ' HB2' ' A' ' 10' ' ' ALA . 48.0 pt -121.98 145.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 123.247 0.342 . . . . 0.0 110.896 -177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -136.19 125.41 24.68 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.51 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -137.27 153.22 21.8 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.784 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.621 HG22 HD11 ' A' ' 123' ' ' LEU . 51.1 t -111.26 139.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.48 158.77 23.86 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.983 -172.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.32 152.86 46.9 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.136 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -117.81 140.37 49.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.8 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.702 179.682 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.622 HG22 ' CD ' ' A' ' 147' ' ' ARG . 29.2 p -122.3 156.22 34.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.416 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.01 115.99 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.555 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.6 m -128.3 142.91 51.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 0.0 110.769 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.37 140.92 11.92 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.58 -179.6 30.81 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.024 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -129.07 141.15 51.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -128.28 147.15 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -115.3 132.11 56.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -112.53 130.26 56.07 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.35 128.97 34.18 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.058 0.849 . . . . 0.0 110.86 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.866 -179.063 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt . . . . . 0 C--O 1.231 0.127 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.78 151.78 51.92 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.021 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.35 128.14 7.48 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -121.69 143.21 15.71 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.868 -173.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.1 133.77 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.556 ' C ' HD22 ' A' ' 26' ' ' LEU . 29.0 t30 -126.52 133.7 51.07 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.073 0.233 . . . . 0.0 111.574 -174.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 25' ' ' ASN . 4.5 mm? -118.93 136.25 54.17 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -136.7 139.08 41.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.428 . . . . 0.0 111.632 -172.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.18 137.88 54.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.484 ' HG2' HG22 ' A' ' 40' ' ' ILE . 36.7 mtm180 -133.16 144.14 49.68 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -107.11 142.18 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -92.78 127.65 38.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.214 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -137.03 153.46 50.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.883 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -74.77 -178.56 3.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.87 -36.62 65.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -91.6 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -170.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -102.81 135.06 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 111.891 164.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.03 156.76 29.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.119 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.48 140.15 16.48 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -101.58 125.17 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.415 0.608 . . . . 0.0 109.427 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.505 HD11 ' CG1' ' A' ' 82' ' ' VAL . 44.8 pt -125.8 144.87 34.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.248 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 140.58 9.26 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.44 ' OG ' ' ND2' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -142.05 146.03 35.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.395 -175.264 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.404 ' HD1' ' HH ' ' A' ' 63' ' ' TYR . 91.6 m-85 -119.61 132.69 55.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.445 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -126.97 133.84 50.5 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.126 0.266 . . . . 0.0 110.805 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -127.16 135.7 51.05 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.9 p -103.44 148.23 26.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.196 0.522 . . . . 0.0 111.294 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.578 -179.004 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.871 0.367 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' HH ' ' HD1' ' A' ' 43' ' ' PHE . 67.3 t80 -135.22 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.91 141.47 12.2 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.711 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.79 122.5 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.64 HG22 ' HA3' ' A' ' 84' ' ' GLY . 70.0 p -123.28 151.11 42.72 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.088 0.242 . . . . 0.0 111.14 -177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.05 146.29 30.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.435 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.04 171.14 42.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.071 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -97.33 124.0 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.314 2.009 . . . . 0.0 112.718 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.64 145.41 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.395 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 62.5 t80 . . . . . 0 C--O 1.233 0.202 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.304 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.521 -0.171 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.02 133.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.144 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -128.18 144.03 51.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.9 137.81 10.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.505 ' CG1' HD11 ' A' ' 40' ' ' ILE . 35.4 m -135.44 155.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.58 140.99 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.64 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.24 175.06 26.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.534 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.17 129.96 69.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.9 137.57 13.61 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.76 138.29 54.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.683 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.865 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -117.09 146.39 43.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 111.141 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.21 167.02 26.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.22 127.62 49.09 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -112.44 145.38 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 110.898 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -129.82 138.38 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.54 156.34 26.78 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.613 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.97 148.93 32.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.11 157.35 27.3 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.568 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.6 mp -109.87 148.96 30.58 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -121.86 139.19 53.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.806 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.61 109.94 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.456 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 7.4 p30 -133.5 124.31 17.98 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.48 ' HG2' HG13 ' A' ' 121' ' ' VAL . 3.8 Cg_endo -95.37 176.2 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.526 2.151 . . . . 0.0 109.534 156.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -65.72 150.48 48.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.779 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 78.35 -167.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -61.02 -11.99 10.07 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 121' ' ' VAL . 9.4 p -78.75 17.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -170.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.456 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.44 138.91 40.13 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.574 -0.704 . . . . 0.0 109.883 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HG ' HG12 ' A' ' 144' ' ' VAL . 4.3 mp -132.62 151.83 51.83 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.322 -170.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.06 147.35 46.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.316 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.54 134.62 50.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -140.17 154.04 46.82 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.036 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.84 140.88 50.12 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -128.6 140.09 51.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.787 0.327 . . . . 0.0 110.562 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -124.51 135.99 53.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.081 0.467 . . . . 0.0 111.042 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 t -116.19 144.69 43.85 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -89.35 146.15 24.88 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.805 0.691 . . . . 0.0 109.58 -161.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.79 101.1 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.817 1.294 . . . . 0.0 112.682 -144.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.71 -176.8 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 112.195 -2.275 . . . . 0.0 106.777 158.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 84.2 p -52.13 -13.1 0.28 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.25 133.54 65.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 118.295 0.498 . . . . 0.0 109.733 168.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -113.05 139.15 48.93 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.28 128.26 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.722 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.2 116.79 2.79 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.47 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 22.0 m -126.06 134.05 51.52 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.778 0.789 . . . . 0.0 111.355 -173.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.8 t90 -120.32 128.48 53.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 25' ' ' ASN . 17.1 tt -130.23 144.53 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.225 -173.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.17 132.17 45.94 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.78 153.16 23.02 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.545 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.481 HG12 ' HG ' ' A' ' 123' ' ' LEU . 34.5 m -125.18 144.67 34.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.19 178.13 32.02 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.195 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -132.52 173.21 11.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.695 -0.752 . . . . 0.0 109.927 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.622 ' CD ' HG22 ' A' ' 4' ' ' THR . 28.5 mmt85 -117.83 149.09 41.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.39 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.574 -178.943 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 C--O 1.231 0.101 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -123.17 156.15 35.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.389 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.91 131.44 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.162 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.0 m -128.19 143.0 51.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.838 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 140.9 12.23 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.71 -173.28 29.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.22 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -124.08 156.22 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.136 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.707 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -136.41 145.94 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.483 -176.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -128.18 131.97 48.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -114.77 131.74 56.69 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.376 0.422 . . . . 0.0 110.413 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.05 126.59 36.18 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.8 0.687 . . . . 0.0 110.923 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.801 -179.716 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.2 mttp . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.476 0.179 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -134.19 158.23 44.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.801 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.18 151.58 16.88 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.65 143.3 12.47 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.089 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.33 139.08 50.3 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -127.99 133.47 49.17 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.602 -174.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.07 137.84 54.47 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -135.97 147.11 47.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.094 0.473 . . . . 0.0 111.542 -173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -132.61 143.66 49.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.83 144.04 37.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.696 0.284 . . . . 0.0 111.018 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -105.89 143.17 34.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.56 125.8 37.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.5 0.667 . . . . 0.0 110.852 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -125.58 153.29 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.889 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.62 -178.32 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.305 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -53.07 -35.51 59.65 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.0 m -92.07 -25.94 0.28 Allowed Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -102.85 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.639 1.56 . . . . 0.0 112.39 162.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 71' ' ' TYR . 78.1 mt -78.12 164.25 25.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.073 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.27 140.13 15.55 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.73 125.02 55.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 117.649 0.724 . . . . 0.0 109.699 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 70' ' ' ALA . 71.8 mt -118.73 138.13 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.26 135.45 8.33 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -129.5 142.01 50.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.027 0.414 . . . . 0.0 111.068 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.37 128.25 55.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.7 m -120.82 131.26 54.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.577 0.227 . . . . 0.0 110.661 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.04 137.13 55.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.189 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -97.69 147.58 24.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.148 0.499 . . . . 0.0 111.067 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--O 1.236 0.378 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 -175.71 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 p90 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 121.442 0.639 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -117.66 134.74 54.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.149 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.84 132.08 7.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.9 mm -119.03 118.44 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.653 HG22 ' HA3' ' A' ' 84' ' ' GLY . 80.5 p -123.22 151.33 42.37 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.907 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.04 146.17 32.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.08 168.18 40.63 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.116 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.22 124.33 0.28 Allowed 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.394 2.063 . . . . 0.0 112.81 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.8 143.01 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.463 170.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.452 ' CD1' HD22 ' A' ' 37' ' ' LEU . 91.3 m-85 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 CA--C 1.522 -0.13 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.26 129.88 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.842 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -138.87 142.47 38.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.218 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.04 137.84 9.75 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.56 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.9 m -133.8 156.71 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 111.014 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.94 140.9 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.653 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.07 26.71 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.798 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.14 133.39 60.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.7 131.69 9.66 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -118.71 118.99 33.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -176.6 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 C--O 1.231 0.118 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.66 142.97 32.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.023 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.18 157.67 26.57 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.62 125.45 51.01 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.5 m -109.61 135.4 50.64 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.936 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -126.75 137.26 53.21 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.55 27.72 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.884 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.39 148.83 32.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.99 164.63 29.22 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.073 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -108.97 146.94 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -136.25 131.92 35.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.532 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -137.85 125.2 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -133.92 124.56 17.71 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -98.08 176.18 0.49 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.57 2.18 . . . . 0.0 109.615 158.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.3 ttm -56.12 145.87 24.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.114 0.483 . . . . 0.0 111.55 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 74.26 -157.12 0.06 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.383 0.673 . . . . 0.0 111.17 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.02 -11.32 13.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.5 t -78.54 17.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.563 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.15 135.96 44.67 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.309 -0.869 . . . . 0.0 110.212 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.623 HD11 HG12 ' A' ' 144' ' ' VAL . 4.4 mm? -125.49 146.21 49.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -171.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -137.14 138.32 40.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -128.31 133.92 48.82 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.2 m -140.05 154.14 46.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.599 -0.441 . . . . 0.0 112.015 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -123.81 141.89 51.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.67 149.85 46.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.981 0.419 . . . . 0.0 110.383 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -128.07 136.03 50.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.484 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -115.56 144.7 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -89.31 145.96 25.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -158.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 132' ' ' ILE . 12.5 tt -87.97 97.62 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 123.512 1.625 . . . . 0.0 113.655 -146.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.79 -176.77 5.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 112.144 -2.298 . . . . 0.0 107.476 157.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -52.22 -14.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.83 -0.544 . . . . 0.0 112.325 -175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.29 129.52 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.335 0.516 . . . . 0.0 109.897 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -115.05 139.18 50.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.18 132.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.816 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 117.76 3.06 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.0 m -126.15 134.26 51.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.798 0.799 . . . . 0.0 110.966 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -123.81 138.08 54.56 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.707 HG22 ' CB ' ' A' ' 10' ' ' ALA . 36.3 pt -132.52 151.14 34.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 O-C-N 123.141 0.276 . . . . 0.0 111.411 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.1 131.11 27.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.432 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -140.8 153.29 23.64 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.991 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.623 HG12 HD11 ' A' ' 123' ' ' LEU . 26.8 m -119.38 143.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.06 178.12 31.92 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -142.08 169.38 17.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.187 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -118.02 146.51 43.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.338 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 66.5 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.558 -179.163 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.6 p -125.24 156.07 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.125 0.488 . . . . 0.0 110.83 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.27 126.77 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.377 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.17 140.94 12.2 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.9 174.81 31.62 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.217 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -116.68 138.95 51.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.91 -0.645 . . . . 0.0 109.597 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -117.41 138.82 51.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.089 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -127.71 131.97 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -111.36 145.1 39.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.64 137.42 37.83 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.891 0.744 . . . . 0.0 111.562 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.0 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 64.7 mttp . . . . . 0 C--O 1.231 0.117 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.8 mtt -112.72 144.38 42.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.366 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 137.44 12.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.94 143.14 14.55 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.866 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -107.18 134.42 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -125.44 133.12 52.56 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.374 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.0 tp -121.55 134.76 55.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.253 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -128.48 148.79 50.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.316 0.579 . . . . 0.0 111.86 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -126.3 140.05 52.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.744 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.55 ' HG2' HG22 ' A' ' 40' ' ' ILE . 38.0 mtp180 -139.48 144.14 37.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.751 -173.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.93 143.1 44.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.67 128.27 38.46 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -129.86 153.49 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.402 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.69 -178.51 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.921 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -52.87 -36.27 58.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.429 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 m -93.71 -25.81 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 135.16 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.692 1.594 . . . . 0.0 112.219 165.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.97 160.69 28.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.82 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.12 140.3 22.08 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.48 124.97 56.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 117.482 0.641 . . . . 0.0 109.36 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.55 HG22 ' HG2' ' A' ' 29' ' ' ARG . 46.2 pt -128.27 143.45 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.391 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.35 145.31 16.1 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 t -137.71 141.19 41.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.167 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HD2' ' HH ' ' A' ' 63' ' ' TYR . 93.2 m-85 -113.53 131.58 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -125.84 135.77 52.33 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.678 0.275 . . . . 0.0 110.988 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -126.99 131.93 50.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.337 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 m -112.78 147.73 36.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.001 0.429 . . . . 0.0 111.41 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.181 179.508 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 121.014 0.435 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.467 ' HH ' ' HD2' ' A' ' 43' ' ' PHE . 71.7 t80 -138.39 130.52 28.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.468 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.09 148.67 20.04 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.941 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.5 123.4 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 t -123.5 155.07 38.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.25 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.51 152.92 41.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 171.14 42.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.93 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -96.58 125.61 0.27 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.232 1.955 . . . . 0.0 112.502 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.73 144.2 32.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.767 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.774 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' HD12 ' A' ' 113' ' ' LEU . 2.6 t . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.3 tt -154.59 133.82 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.298 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.72 150.03 44.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.444 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.03 137.87 9.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.11 152.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.264 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.53 141.18 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.11 175.14 26.64 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.9 129.29 73.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.94 143.94 17.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -134.84 146.98 49.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.862 0.331 . . . . 0.0 110.705 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 176.964 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.457 -0.114 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -107.34 147.1 30.74 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.146 0.279 . . . . 0.0 111.173 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 162.84 27.14 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.33 127.08 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.929 0.364 . . . . 0.0 110.189 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.4 t -115.6 138.11 51.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.255 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -141.34 149.39 41.1 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.16 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.14 174.44 36.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.99 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.86 33.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.71 155.98 26.09 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.424 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 78' ' ' SER . 6.9 tp -109.06 145.85 34.95 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -144.24 143.63 31.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.286 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -135.71 129.9 33.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 172.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.404 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 9.6 p-10 -141.2 124.62 9.97 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -170.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -102.32 176.19 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.572 2.182 . . . . 0.0 109.252 157.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.2 mtt -55.53 167.17 0.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.872 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 65.45 -173.79 0.18 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.866 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.69 -11.31 4.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.6 t -78.44 17.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -167.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.404 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.32 134.13 48.06 Favored 'General case' 0 C--N 1.341 0.232 0 O-C-N 121.535 -0.728 . . . . 0.0 109.882 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 123' ' ' LEU . 4.6 mp -133.42 148.42 51.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.637 -171.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.11 148.04 46.43 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.526 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.77 134.67 47.07 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -140.11 154.12 46.92 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.677 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -117.57 139.95 50.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.01 151.06 46.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.959 0.409 . . . . 0.0 110.611 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -127.48 136.1 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.283 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.9 t -113.95 144.75 42.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 146.16 24.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.131 0.491 . . . . 0.0 109.733 -159.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -87.94 102.64 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.728 1.251 . . . . 0.0 112.908 -144.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -89.68 -176.76 5.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 112.436 -2.166 . . . . 0.0 107.438 156.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.9 p -52.33 -14.21 0.44 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.797 -0.564 . . . . 0.0 112.338 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 135' ' ' VAL . 35.3 m -122.16 126.9 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.344 0.52 . . . . 0.0 110.147 168.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -103.54 139.17 39.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.149 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.14 134.01 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.594 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.08 122.14 4.55 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -125.99 134.2 51.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.496 0.648 . . . . 0.0 111.251 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -115.14 132.94 56.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' A' ' 10' ' ' ALA . 44.9 pt -128.56 145.02 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -176.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.81 131.63 37.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.278 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.89 153.1 23.04 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.752 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.35 144.82 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.15 177.95 32.09 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.437 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -140.06 166.24 25.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.52 -0.84 . . . . 0.0 110.005 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -117.97 149.08 41.53 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.324 0.39 . . . . 0.0 110.554 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.6 t80 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.65 -179.177 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.848 0.356 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.2 m -130.28 140.29 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.235 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.08 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.356 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.706 HG22 ' HA3' ' A' ' 145' ' ' GLY . 57.8 p -128.13 143.31 51.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.47 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.1 140.79 12.35 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.4 172.62 29.4 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.184 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.49 138.39 50.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.744 -0.728 . . . . 0.0 109.108 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -119.54 140.03 51.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.658 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.96 131.93 54.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -114.3 135.14 54.39 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.253 0.346 . . . . 0.0 110.375 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -84.31 123.16 29.87 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.995 0.809 . . . . 0.0 111.177 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.471 179.056 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.668 0.271 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -126.48 159.63 32.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.734 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.32 146.96 17.86 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.33 143.21 13.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.009 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -108.26 132.57 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -123.88 132.96 53.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.385 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 26' ' ' LEU . 8.2 tt -125.87 131.04 52.45 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HD3' HD11 ' A' ' 40' ' ' ILE . 60.5 mttp -128.07 146.54 50.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.129 0.49 . . . . 0.0 111.887 -174.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.35 132.78 55.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HD3' HD12 ' A' ' 40' ' ' ILE . 75.2 mtm180 -135.91 144.0 45.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.175 0.297 . . . . 0.0 111.357 -175.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -113.0 139.03 49.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.81 128.62 38.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.342 0.591 . . . . 0.0 110.657 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -134.76 153.4 52.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.789 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.46 -178.6 3.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.671 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -53.92 -33.47 56.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.39 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -94.27 -25.85 0.26 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 134.94 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.748 1.632 . . . . 0.0 111.904 164.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.17 156.0 30.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.191 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.07 140.26 15.08 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.58 127.27 56.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.47 0.635 . . . . 0.0 109.877 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.51 HD12 ' HD3' ' A' ' 29' ' ' ARG . 17.6 tt -124.4 135.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.58 134.48 7.7 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t -129.28 139.06 51.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.84 0.32 . . . . 0.0 111.202 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.11 131.45 56.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -127.95 136.94 52.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -124.85 136.17 53.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.285 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.8 m -112.42 146.95 37.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 -178.575 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.3 t80 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.946 0.403 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -137.1 117.89 14.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.355 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.43 138.43 10.15 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.666 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.1 126.92 73.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.672 HG22 ' HA3' ' A' ' 84' ' ' GLY . 68.0 p -123.26 152.03 41.75 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.255 0.347 . . . . 0.0 110.172 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.99 146.49 31.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.545 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -167.95 170.95 42.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.267 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -98.01 123.67 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.486 2.124 . . . . 0.0 112.667 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 145.56 31.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.886 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.504 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 CA--C 1.52 -0.174 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.25 129.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -133.55 145.23 49.92 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.9 137.69 9.71 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.545 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.1 m -134.75 154.56 37.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.722 0.296 . . . . 0.0 111.181 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.19 140.75 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.672 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.2 175.09 26.75 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.76 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.81 130.5 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.09 136.08 12.41 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.436 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 C--O 1.231 0.089 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -130.45 153.98 48.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.972 0.415 . . . . 0.0 111.405 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.11 26.16 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.86 126.99 53.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.6 m -106.38 137.2 44.77 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.897 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.44 132.23 48.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -143.16 157.14 26.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.874 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.52 148.86 32.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.85 162.4 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.504 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -108.97 149.42 29.24 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -134.94 137.01 42.71 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.488 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.03 127.81 16.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.451 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 10.1 p-10 -142.07 124.51 9.2 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -100.72 176.16 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.759 2.306 . . . . 0.0 109.385 156.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.455 ' O ' HG22 ' A' ' 121' ' ' VAL . 71.4 mtm -53.99 177.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 63.73 -175.06 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.236 0.541 . . . . 0.0 112.193 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -62.95 -11.39 18.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 118' ' ' MET . 26.8 m -78.11 17.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -165.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.451 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -103.92 138.38 40.57 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.454 0.57 . . . . 0.0 109.798 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.408 ' HG ' HG12 ' A' ' 144' ' ' VAL . 5.3 mp -132.69 153.83 50.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.009 0.433 . . . . 0.0 111.97 -168.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -137.16 140.4 41.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.032 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.74 132.24 53.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.8 p -140.13 154.17 46.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.88 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -123.79 141.02 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -120.33 138.6 53.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.539 0.524 . . . . 0.0 110.451 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -123.96 135.0 53.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.079 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -118.26 144.93 45.42 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -89.29 146.53 24.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -157.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.507 HG23 ' CG ' ' A' ' 136' ' ' ASP . 73.6 mt -87.7 97.07 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.906 1.336 . . . . 0.0 112.215 -144.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.79 -176.92 5.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.046 -2.343 . . . . 0.0 107.446 157.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.8 p -52.27 -13.46 0.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.04 132.11 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.386 0.539 . . . . 0.0 110.195 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.507 ' CG ' HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -108.72 139.2 43.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.23 -0.414 . . . . 0.0 109.991 -178.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.13 122.72 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.13 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.31 114.74 2.22 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -125.81 134.13 51.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.752 0.776 . . . . 0.0 111.244 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.61 131.23 56.77 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 10' ' ' ALA . 61.9 mt -123.06 134.81 65.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 O-C-N 123.182 0.301 . . . . 0.0 110.259 -175.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.4 125.1 40.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.0 153.2 21.66 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.855 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.408 HG12 ' HG ' ' A' ' 123' ' ' LEU . 35.8 m -122.26 146.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.706 ' HA3' HG22 ' A' ' 6' ' ' THR . . . -147.28 173.13 27.53 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.242 -174.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -128.88 154.64 46.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.465 -1.368 . . . . 0.0 109.376 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -118.0 149.11 41.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.966 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.5 t80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.033 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.795 0.331 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -128.02 140.66 51.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.772 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.68 136.99 58.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.036 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.95 140.61 11.94 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 173.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 168.4 30.1 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.365 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -121.94 135.87 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -127.59 149.03 50.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.19 134.39 54.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.18 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -112.86 142.59 45.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 142.1 37.66 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.649 0.593 . . . . 0.0 110.93 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.423 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 48.9 pttt . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.65 159.29 40.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.856 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.17 142.11 14.73 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.57 143.15 14.74 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.64 135.19 54.42 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.617 ' OD1' HG23 ' A' ' 44' ' ' THR . 92.9 m-20 -126.58 133.22 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 111.367 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.0 tp -120.03 134.95 55.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.019 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -130.22 145.77 51.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 112.066 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -120.34 137.82 54.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.042 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -135.26 144.28 46.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.834 0.35 . . . . 0.0 111.378 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -106.64 142.19 36.69 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -92.67 126.93 37.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.311 0.577 . . . . 0.0 110.373 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.99 153.62 41.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.735 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.38 -178.42 3.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.601 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -57.2 -35.42 69.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -87.04 -26.11 0.34 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -102.86 130.17 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.569 1.513 . . . . 0.0 112.105 160.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 69' ' ' PRO . 77.2 mt -77.74 155.24 31.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.996 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.64 140.06 18.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -99.79 124.93 53.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 117.397 0.599 . . . . 0.0 109.83 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.471 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.3 mt -120.27 132.88 68.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.77 134.17 8.61 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.3 p -127.36 141.98 51.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -113.01 128.08 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.769 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.617 HG23 ' OD1' ' A' ' 25' ' ' ASN . 55.0 m -124.45 132.7 53.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.12 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -127.09 136.03 51.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.487 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 m -117.81 145.21 44.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 110.955 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.006 179.564 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 121.115 0.483 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -128.8 119.15 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.221 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.19 135.18 8.19 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.272 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.02 117.29 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.575 HG22 ' HB ' ' A' ' 82' ' ' VAL . 2.0 m -123.28 148.65 45.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.768 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.82 31.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.13 168.93 41.14 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.114 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HB2' HD13 ' A' ' 37' ' ' LEU . 71.8 Cg_endo -98.41 122.9 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.555 2.17 . . . . 0.0 113.062 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.9 146.56 30.76 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.328 170.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.5 t80 . . . . . 0 C--N 1.333 -0.148 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.494 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 CA--C 1.519 -0.23 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.59 129.99 14.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.539 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -131.18 140.26 49.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.0 137.75 11.3 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 66' ' ' THR . 35.1 m -136.46 152.64 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.974 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 109' ' ' TYR . 35.9 m -134.17 140.95 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.455 ' N ' HG23 ' A' ' 66' ' ' THR . . . -147.17 174.95 26.78 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.57 -176.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.54 133.09 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.64 131.32 9.45 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -114.92 132.28 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.642 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.077 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.42 0.152 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.11 142.89 39.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.299 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.12 162.36 27.17 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -108.5 125.76 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.6 m -108.93 137.94 46.05 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.63 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.585 ' CD2' HG12 ' A' ' 83' ' ' VAL . 81.0 m-85 -125.92 138.89 53.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.73 157.64 27.33 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.841 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.8 148.78 32.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.82 160.37 28.47 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.102 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.5 mp -111.96 147.11 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.57 141.07 41.34 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.934 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -133.12 116.29 16.11 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -117.62 124.24 29.07 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.38 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -107.03 176.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.102 2.535 . . . . 0.0 109.423 157.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.33 170.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.182 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 65.39 -171.35 0.19 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.056 0.455 . . . . 0.0 111.956 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -61.51 -11.3 10.32 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 121' ' ' VAL . 6.3 t -78.38 18.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.13 0.572 . . . . 0.0 112.431 -164.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.91 137.61 41.66 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.233 -0.917 . . . . 0.0 109.662 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.77 148.77 50.88 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -168.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -137.13 142.04 42.26 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -126.32 132.14 51.69 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -140.15 154.08 46.86 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.863 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.14 140.6 52.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -121.56 141.67 50.84 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 123.372 0.42 . . . . 0.0 110.093 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -125.9 132.84 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.575 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.1 m -115.77 144.57 43.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -89.45 146.03 24.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -161.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 132' ' ' ILE . 10.5 tt -87.76 101.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 123.616 1.674 . . . . 0.0 113.697 -146.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -89.74 -176.7 5.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.244 157.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.14 -13.94 0.37 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.821 -0.549 . . . . 0.0 112.354 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.98 132.03 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.392 0.542 . . . . 0.0 109.747 166.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.08 139.22 50.07 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.15 127.68 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.767 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.41 116.1 2.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.525 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 40.1 m -126.1 134.14 51.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.477 0.639 . . . . 0.0 111.235 -175.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -122.64 133.78 54.51 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 17.7 tt -131.6 146.11 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.636 0.255 . . . . 0.0 111.269 -172.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.01 133.95 53.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.38 153.13 21.81 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.074 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.82 140.0 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -138.91 163.89 25.85 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.395 -173.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -134.15 152.33 51.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 113.485 -1.357 . . . . 0.0 108.801 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -136.76 149.0 47.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.531 -179.627 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.972 0.415 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.45 HG21 HH21 ' A' ' 29' ' ' ARG . 40.7 m -132.51 139.27 47.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.332 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.58 120.53 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.5 m -128.25 143.09 51.0 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.31 140.86 12.13 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.23 179.81 31.82 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.159 -175.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.6 144.57 46.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -0.622 . . . . 0.0 109.847 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.573 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -122.74 138.52 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.944 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -125.46 131.92 52.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -116.81 145.74 43.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 139.31 38.66 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.827 0.704 . . . . 0.0 111.253 -173.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.115 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 36.8 pttt . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.545 0.212 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.8 mtt -117.63 146.38 43.71 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.57 135.29 10.78 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.52 143.15 14.45 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.607 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.514 ' CE2' HD21 ' A' ' 26' ' ' LEU . 62.0 t80 -110.95 135.8 50.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.66 ' HB3' HG22 ' A' ' 44' ' ' THR . 23.0 p30 -131.63 144.57 51.14 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.945 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 24' ' ' PHE . 80.6 mt -124.41 140.51 52.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.239 173.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.16 141.89 51.04 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.043 0.449 . . . . 0.0 111.084 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -121.03 130.21 53.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HD3' HD12 ' A' ' 40' ' ' ILE . 40.0 mtm180 -134.39 144.08 47.99 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.265 0.353 . . . . 0.0 110.657 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -107.49 143.22 36.18 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.68 119.16 31.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.195 0.522 . . . . 0.0 109.981 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.45 153.4 46.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.991 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.7 -178.62 3.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.541 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -56.37 -32.96 65.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.315 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.2 m -93.38 -25.94 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -102.83 136.3 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.728 1.619 . . . . 0.0 111.848 164.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.6 mt -78.06 154.27 31.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.93 140.38 16.38 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.09 127.5 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.501 0.651 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.57 HD12 ' HD3' ' A' ' 29' ' ' ARG . 16.9 tt -123.36 138.39 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.28 139.77 10.58 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 p -135.41 144.93 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.067 0.434 . . . . 0.0 111.424 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -124.68 128.65 49.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.109 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 25' ' ' ASN . 36.8 p -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.855 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -127.28 137.12 52.77 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -111.54 150.73 29.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 111.202 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--O 1.235 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.141 -179.209 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 . . . . . 0 CA--C 1.523 -0.064 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.17 128.25 41.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.45 128.15 5.29 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 65' ' ' ILE . 7.6 tp -124.65 122.61 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.732 HG22 ' HA3' ' A' ' 84' ' ' GLY . 30.3 p -123.3 154.95 38.17 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.864 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.72 147.6 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.16 42.3 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.512 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -97.29 127.79 0.27 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.452 2.101 . . . . 0.0 112.818 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.66 138.55 36.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.652 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.0 t80 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.568 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.93 129.95 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.282 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -115.76 133.9 55.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.17 137.71 10.88 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 172.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.77 153.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 117.559 0.679 . . . . 0.0 111.976 -173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.466 HG13 ' CZ ' ' A' ' 107' ' ' PHE . 55.5 t -125.71 140.84 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.732 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.41 174.95 27.0 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.661 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.3 128.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.3 131.26 8.53 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -139.06 155.91 47.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.097 0.448 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.714 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.445 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.23 0.056 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -136.02 159.86 40.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 111.403 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.02 167.11 26.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.466 ' CZ ' HG13 ' A' ' 83' ' ' VAL . 61.0 t80 -93.2 124.86 37.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -113.07 140.55 47.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.039 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.2 139.38 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.5 161.9 28.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.152 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.34 148.94 31.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.368 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.448 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -148.04 162.0 28.68 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.61 -177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.448 HD22 ' C ' ' A' ' 112' ' ' GLY . 4.5 mm? -111.87 152.64 27.73 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -116.47 133.47 55.98 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 111.693 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.56 109.74 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.482 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 13.3 p-10 -140.59 124.71 10.58 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -165.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -101.23 176.14 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.381 2.054 . . . . 0.0 109.258 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.7 mtp -58.69 176.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 61.64 -174.45 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.901 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -60.63 -11.56 7.62 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.8 t -78.4 17.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -167.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.596 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.24 138.02 41.3 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.64 HD11 HG12 ' A' ' 144' ' ' VAL . 4.5 mm? -122.27 145.52 48.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -168.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.66 131.35 44.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.661 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -124.06 129.79 51.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -140.12 154.11 46.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.606 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -121.61 139.98 52.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.94 150.95 46.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.889 0.376 . . . . 0.0 110.742 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -131.84 136.02 47.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -113.32 144.57 42.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.194 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -89.21 146.24 24.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.782 0.676 . . . . 0.0 109.519 -160.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 pt -87.88 98.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 123.309 1.528 . . . . 0.0 114.032 -145.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -89.67 -176.74 5.08 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 112.2 -2.273 . . . . 0.0 106.903 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.3 p -52.32 -12.78 0.28 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.324 -0.86 . . . . 0.0 112.616 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.07 133.89 65.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.334 0.516 . . . . 0.0 109.837 168.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -115.0 139.1 50.13 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -108.18 129.77 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.743 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.23 117.18 2.9 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 169.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.6 m -126.14 134.26 51.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.862 0.831 . . . . 0.0 111.476 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -115.85 135.13 54.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.573 HG22 ' CB ' ' A' ' 10' ' ' ALA . 41.6 pt -130.84 144.71 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.286 -177.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.49 128.69 25.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.471 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.445 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -136.95 153.07 21.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.612 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.64 HG12 HD11 ' A' ' 123' ' ' LEU . 27.0 m -118.01 140.96 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.13 178.1 31.98 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.401 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -139.8 162.78 34.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.444 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -141.52 149.06 40.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.534 -179.675 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.461 0.08 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.4 m -126.0 139.74 53.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.918 0.389 . . . . 0.0 110.353 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.6 122.59 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.608 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.14 143.06 51.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.34 140.83 12.16 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.89 179.29 31.06 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.031 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -131.16 146.44 52.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.628 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -134.27 149.16 50.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.004 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.484 HE21 ' HZ2' ' A' ' 140' ' ' TRP . 13.9 tt0 -116.22 136.3 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -112.9 139.48 48.5 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.79 127.78 32.51 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.88 0.738 . . . . 0.0 111.02 -174.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.582 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 47.4 mtmt . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.671 0.272 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -129.04 160.95 31.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.666 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.83 148.22 17.58 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.14 14.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.755 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CE1' HD21 ' A' ' 26' ' ' LEU . 61.8 t80 -112.77 135.06 53.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.527 ' HB3' HD11 ' A' ' 141' ' ' ILE . 51.2 t30 -131.12 138.29 49.44 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.833 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 24' ' ' PHE . 82.4 mt -122.26 139.61 53.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.289 174.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -130.7 142.57 50.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.915 0.388 . . . . 0.0 111.427 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -122.26 133.15 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -137.08 144.09 42.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.079 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.09 143.2 33.59 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.59 125.83 37.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.277 0.561 . . . . 0.0 110.188 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.99 153.38 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.56 -178.6 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.715 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.04 -33.53 65.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.427 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -93.25 -26.06 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -102.77 135.28 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.756 1.637 . . . . 0.0 111.889 164.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 69' ' ' PRO . 4.2 pp -77.97 160.29 28.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.25 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.46 140.21 14.91 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.41 125.51 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.341 0.571 . . . . 0.0 109.935 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' A' ' 70' ' ' ALA . 72.3 mt -119.2 136.12 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.87 136.46 8.57 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.1 p -138.2 149.08 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.41 0.605 . . . . 0.0 111.59 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -122.2 135.56 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.969 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -130.13 140.04 50.83 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.144 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -125.64 136.99 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.59 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 m -101.27 145.31 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.344 -177.79 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.2 t80 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -130.11 133.12 46.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.83 135.51 7.87 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.89 123.57 67.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.662 HG22 ' HA3' ' A' ' 84' ' ' GLY . 69.5 p -123.23 153.4 40.18 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.052 0.22 . . . . 0.0 111.001 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 143.95 30.23 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.15 169.56 41.52 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.995 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.591 ' HB3' HD13 ' A' ' 37' ' ' LEU . 74.5 Cg_endo -97.27 124.92 0.22 Allowed 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 122.471 2.114 . . . . 0.0 112.914 176.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.611 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.81 147.02 30.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.719 169.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 t80 . . . . . 0 C--N 1.332 -0.157 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 172.827 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.47 HG22 HD23 ' A' ' 113' ' ' LEU . 48.0 pt -136.83 144.38 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.463 -167.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -137.1 147.34 46.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.847 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 137.87 9.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.518 HG12 ' HA3' ' A' ' 68' ' ' GLY . 32.9 m -134.67 156.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.76 0.314 . . . . 0.0 111.015 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.565 HG12 ' CD2' ' A' ' 109' ' ' TYR . 35.5 m -128.49 140.94 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.21 175.08 26.76 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.696 -176.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.75 129.72 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.56 137.88 11.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -139.05 151.8 47.06 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.558 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.623 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.94 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 C--O 1.23 0.046 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -132.06 153.17 50.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.227 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.29 167.07 26.22 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.99 125.91 47.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.1 m -110.24 142.2 42.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.15 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.565 ' CD2' HG12 ' A' ' 83' ' ' VAL . 87.7 m-85 -124.9 137.06 54.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.34 153.43 23.47 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.678 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.25 148.85 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.72 160.04 28.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.377 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.47 HD23 HG22 ' A' ' 79' ' ' ILE . 70.6 mt -108.86 146.04 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -125.75 140.59 52.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 111.805 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -139.97 110.0 6.48 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.458 ' CG ' ' HB1' ' A' ' 122' ' ' ALA . 53.9 m-20 -132.85 124.29 18.63 Favored Pre-proline 0 CA--C 1.529 0.136 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.472 -170.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -102.04 176.21 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.992 2.462 . . . . 0.0 109.255 156.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.439 ' O ' HG22 ' A' ' 121' ' ' VAL . 71.4 mtm -57.77 166.42 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.512 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 65.39 -174.47 0.18 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.16 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -58.74 -11.66 3.41 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 118' ' ' MET . 31.3 m -78.42 17.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -170.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.458 ' HB1' ' CG ' ' A' ' 116' ' ' ASN . . . -104.74 143.04 33.64 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -146.66 155.8 42.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.369 -174.348 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -137.09 148.09 46.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.602 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -126.15 127.53 45.88 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 64.9 p -140.23 154.21 46.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.444 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -120.87 150.13 41.53 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -124.72 137.95 54.31 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.487 0.492 . . . . 0.0 110.525 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -122.42 129.22 51.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.301 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.5 m -120.18 144.56 47.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -89.51 146.12 24.82 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.531 0.519 . . . . 0.0 109.602 -163.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 132' ' ' ILE . 9.8 tt -87.72 95.91 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 123.705 1.717 . . . . 0.0 113.422 -147.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -89.66 -176.84 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.434 157.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -52.01 -16.27 0.72 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.83 -0.544 . . . . 0.0 112.141 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.33 127.51 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 167.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -115.1 139.16 50.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.2 125.96 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.979 -171.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 108.83 1.12 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 167.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.487 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 30.4 m -126.08 134.26 51.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 117.633 0.716 . . . . 0.0 111.352 -174.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.484 ' HZ2' HE21 ' A' ' 11' ' ' GLN . 19.5 p90 -123.21 132.23 53.97 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.628 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 16.4 tt -130.28 143.77 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.188 0.305 . . . . 0.0 111.079 -171.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.2 53.53 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.82 153.11 20.95 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.709 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.3 141.18 47.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.28 178.05 32.14 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.78 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -139.77 171.8 13.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.691 -0.754 . . . . 0.0 110.277 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -117.88 148.95 41.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.503 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.0 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.618 -179.368 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.821 0.343 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 146' ' ' TYR . 19.2 m -129.71 143.11 50.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.511 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.98 127.0 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -128.41 143.17 50.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.899 0.381 . . . . 0.0 111.313 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.67 140.87 12.13 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.78 -175.91 30.23 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.32 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.52 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -127.85 148.92 50.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.508 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -121.85 135.25 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.618 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.93 143.77 44.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -78.46 138.63 38.56 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.674 0.609 . . . . 0.0 111.078 -173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.574 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 54.2 mtmt . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.6 mtm -119.55 153.42 35.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.551 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.18 140.64 13.68 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.11 143.19 14.58 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.813 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.12 132.18 54.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -127.12 139.02 53.27 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.165 0.291 . . . . 0.0 111.716 -173.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -127.99 132.81 49.15 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' N ' HD13 ' A' ' 26' ' ' LEU . 39.0 ttpt -136.18 147.65 47.77 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.02 0.438 . . . . 0.0 110.825 -176.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -132.69 151.18 52.04 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.584 ' CB ' HG22 ' A' ' 40' ' ' ILE . 49.6 ptt85 -150.98 144.45 24.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.144 -176.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -105.78 143.24 34.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -92.4 124.38 36.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.308 0.575 . . . . 0.0 110.091 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -121.37 153.32 37.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.871 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.64 -178.46 3.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.843 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -50.66 -42.33 56.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 p -90.26 -25.86 0.3 Allowed Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -102.83 131.95 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.497 1.465 . . . . 0.0 112.218 162.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.4 mt -78.07 162.04 26.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.672 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.19 140.22 23.55 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.32 124.79 54.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 117.821 0.811 . . . . 0.0 109.401 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 29' ' ' ARG . 43.8 pt -117.82 142.7 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -146.34 134.41 5.33 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -141.93 154.92 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.909 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -132.93 141.15 48.2 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -130.07 141.29 50.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.168 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -118.65 134.39 55.15 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.6 m -109.77 145.83 35.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.993 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.268 179.559 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.6 133.21 49.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.649 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.29 136.34 8.69 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 65' ' ' ILE . 16.6 tt -125.28 124.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.649 HG22 ' HA3' ' A' ' 84' ' ' GLY . 82.6 p -123.31 154.7 38.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.315 -175.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.81 147.98 41.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.27 171.02 36.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.42 -175.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -99.3 123.48 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.774 2.316 . . . . 0.0 111.945 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.6 143.56 33.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.4 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 t80 . . . . . 0 C--O 1.234 0.253 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.893 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -132.57 129.81 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.576 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -132.18 133.75 44.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.88 137.64 10.59 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.54 ' CG1' HD11 ' A' ' 40' ' ' ILE . 33.9 m -139.22 151.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 117.468 0.634 . . . . 0.0 112.382 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.78 140.93 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.649 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.17 175.14 26.69 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.361 -174.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.638 HG12 ' OH ' ' A' ' 105' ' ' TYR . 35.8 m -112.56 134.45 55.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.83 10.95 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -122.14 133.35 54.75 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 176.205 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.638 ' OH ' HG12 ' A' ' 85' ' ' VAL . 64.6 t80 -109.04 142.89 39.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.25 159.47 27.1 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -102.54 126.1 49.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 m -116.44 143.91 44.98 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.698 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -143.08 153.07 42.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.03 175.55 35.97 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.12 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.84 148.99 29.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.001 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.81 159.85 27.89 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.953 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.5 mp -121.53 147.63 45.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -134.42 141.04 46.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.273 0.559 . . . . 0.0 111.851 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -130.6 114.05 14.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.478 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 16.3 p-10 -134.51 124.69 17.19 Favored Pre-proline 0 N--CA 1.463 0.216 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -98.79 176.24 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.465 2.11 . . . . 0.0 109.146 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.445 ' O ' HG22 ' A' ' 121' ' ' VAL . 65.2 mtt -55.93 169.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.798 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -175.91 0.18 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.209 0.528 . . . . 0.0 112.298 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.87 -11.52 5.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 118' ' ' MET . 26.8 m -78.26 18.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -169.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.19 136.74 43.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.281 0.491 . . . . 0.0 109.863 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.406 ' CD2' HG12 ' A' ' 144' ' ' VAL . 74.5 mt -119.68 142.85 48.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.488 -168.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -135.69 136.21 40.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.288 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.33 134.62 52.15 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 m -140.09 154.0 46.91 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.419 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -120.77 141.6 50.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.76 140.91 50.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 110.239 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -125.06 136.15 53.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.213 0.53 . . . . 0.0 111.346 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.6 m -103.94 144.71 31.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -89.28 145.96 25.04 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -158.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.8 96.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 122.732 1.253 . . . . 0.0 112.533 -145.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -89.85 -176.84 5.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 112.174 -2.285 . . . . 0.0 106.871 157.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.32 -13.36 0.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.387 -0.821 . . . . 0.0 112.537 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -119.06 129.64 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.424 0.556 . . . . 0.0 110.092 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -115.15 139.12 50.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.617 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.11 134.66 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.525 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.22 121.58 4.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.4 m -126.13 134.18 51.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.529 0.665 . . . . 0.0 111.256 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -120.57 130.54 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 19.4 tt -131.25 144.62 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.136 -173.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.66 132.91 45.7 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.32 153.31 21.86 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.773 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.406 HG12 ' CD2' ' A' ' 123' ' ' LEU . 29.2 m -118.63 139.92 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.48 178.03 30.71 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.343 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 4' ' ' THR . 43.1 p90 -141.0 161.85 36.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.786 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -121.03 145.2 48.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.529 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.508 -179.403 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.741 0.305 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -121.76 140.06 52.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.507 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.52 128.51 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.2 m -128.14 142.11 51.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.408 . . . . 0.0 111.193 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.28 140.9 12.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.55 -179.9 31.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.374 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -122.27 140.23 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.65 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.39 138.87 54.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.504 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -125.75 131.78 52.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.5 p -115.92 143.59 45.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.42 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.82 129.42 34.58 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 124.116 0.885 . . . . 0.0 111.374 -173.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.643 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.994 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 40.9 mtmt . . . . . 0 C--O 1.231 0.095 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.4 mtt -129.74 154.01 47.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.614 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.5 147.9 16.73 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 143.33 12.28 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.46 133.46 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -127.38 136.63 52.14 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.433 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 tp -130.6 136.31 48.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -139.34 155.32 47.77 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.281 0.562 . . . . 0.0 112.197 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.92 140.37 52.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.097 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -132.62 144.35 50.3 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.212 0.32 . . . . 0.0 110.899 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.42 141.8 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -92.81 123.2 35.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.85 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.44 -178.5 3.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.882 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -54.77 -40.4 69.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 m -84.45 -26.19 0.38 Allowed Pre-proline 0 N--CA 1.467 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -169.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.62 126.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.531 1.487 . . . . 0.0 112.069 160.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 71' ' ' TYR . 77.6 mt -76.31 154.64 34.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.25 140.17 18.89 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.97 126.13 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 117.206 0.503 . . . . 0.0 109.647 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.455 ' C ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -124.57 134.99 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' N ' HD13 ' A' ' 40' ' ' ILE . . . -135.89 137.29 9.02 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -141.77 154.86 45.53 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.004 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.34 141.48 50.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.8 p -130.11 143.19 50.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.481 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.76 137.04 55.04 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -115.57 148.55 39.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.005 179.377 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.2 t80 . . . . . 0 CA--C 1.524 -0.044 0 CA-C-O 120.918 0.389 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -131.44 120.41 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.77 135.49 8.54 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 65' ' ' ILE . 15.8 tt -126.04 122.57 62.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.653 HG22 ' HA3' ' A' ' 84' ' ' GLY . 24.3 p -123.48 152.37 41.78 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.102 0.252 . . . . 0.0 110.602 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.563 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.0 146.39 30.97 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.51 41.46 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.287 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -99.02 122.3 0.13 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.734 2.289 . . . . 0.0 112.944 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.84 146.68 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.396 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.408 ' CD1' HD22 ' A' ' 37' ' ' LEU . 88.8 m-85 . . . . . 0 C--O 1.232 0.155 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.2 mt -141.55 129.85 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.898 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -134.15 142.77 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 66' ' ' THR . 9.2 p -139.82 143.91 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.045 0.423 . . . . 0.0 110.82 -172.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.573 HG12 ' CD1' ' A' ' 109' ' ' TYR . 35.9 m -130.36 140.91 47.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.653 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.15 26.67 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.431 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -115.49 130.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 134.91 11.59 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -122.12 136.2 54.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 176.046 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.4 t70 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -109.64 151.23 27.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.99 166.99 26.15 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.66 127.16 51.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.841 0.321 . . . . 0.0 110.349 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.4 t -105.52 132.07 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.566 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.573 ' CD1' HG12 ' A' ' 83' ' ' VAL . 84.7 m-85 -126.48 134.71 50.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.68 158.9 27.81 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.789 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.67 148.87 32.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.6 159.84 28.32 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.375 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.5 mp -112.1 148.52 33.76 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -137.5 137.24 38.46 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.279 -171.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -133.91 131.16 38.77 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -138.74 124.48 12.31 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -99.04 176.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.718 2.279 . . . . 0.0 109.746 159.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.5 ttm -54.51 138.27 40.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.138 0.494 . . . . 0.0 111.861 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 71.81 -153.73 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.457 171.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.97 -11.65 8.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -166.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' VAL . 7.3 t -78.68 17.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -166.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.39 143.02 33.55 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.062 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -146.37 153.81 40.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 111.403 -174.239 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p30 -137.29 148.1 46.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.885 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.485 ' CE2' HD12 ' A' ' 123' ' ' LEU . 98.2 m-85 -122.37 131.72 54.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 m -139.98 154.2 47.1 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.759 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -121.28 141.14 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.72 142.32 47.79 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.547 0.53 . . . . 0.0 110.314 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.46 131.54 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.584 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -110.7 144.73 39.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -89.23 146.1 24.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 123.79 0.681 . . . . 0.0 109.348 -158.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.508 HG23 ' CG ' ' A' ' 136' ' ' ASP . 68.6 mt -87.83 100.38 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.712 1.244 . . . . 0.0 112.636 -143.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -89.68 -177.0 5.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 112.392 -2.185 . . . . 0.0 107.555 156.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 t -52.25 -15.31 0.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.851 -0.531 . . . . 0.0 112.273 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.39 129.39 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.392 0.542 . . . . 0.0 110.079 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.508 ' CG ' HG23 ' A' ' 132' ' ' ILE . 0.7 OUTLIER -102.85 139.24 38.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 119.065 -0.493 . . . . 0.0 109.787 178.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.69 129.76 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.26 116.94 2.83 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.9 m -126.15 134.27 51.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.714 0.757 . . . . 0.0 111.19 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -109.34 134.14 52.18 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 141' ' ' ILE . 4.6 mp -124.26 136.34 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 O-C-N 123.131 0.269 . . . . 0.0 110.434 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.14 127.46 43.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.38 153.08 22.27 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.05 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.3 t -127.26 145.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.36 178.06 30.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.32 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -135.84 170.29 16.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.745 -0.728 . . . . 0.0 110.409 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.501 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 117.977 -1.011 . . . . 0.0 112.396 178.887 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.1 p -124.29 157.45 34.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.167 0.508 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.62 125.95 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.505 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 26' ' ' LEU . 31.6 m -128.19 143.11 51.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -177.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.54 140.73 12.0 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.61 176.49 33.14 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.394 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.03 149.84 41.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.941 -0.63 . . . . 0.0 109.667 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.566 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -130.36 141.71 50.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.187 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -128.0 131.91 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -116.1 145.93 42.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -78.72 142.05 37.4 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.782 0.676 . . . . 0.0 110.944 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.217 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 25.5 pttm . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.698 0.285 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.2 ttm -123.92 146.46 48.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.307 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 134.67 10.8 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.07 143.35 14.27 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -118.61 144.42 46.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.631 ' C ' HD22 ' A' ' 26' ' ' LEU . 27.3 p30 -143.96 153.23 42.05 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.752 -174.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.631 HD22 ' C ' ' A' ' 25' ' ' ASN . 4.5 mm? -123.2 142.91 50.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.521 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -136.22 138.42 41.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 111.016 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.93 140.45 49.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -133.66 144.21 49.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.975 0.417 . . . . 0.0 110.683 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -101.29 143.29 31.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -92.38 117.39 29.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.545 0.688 . . . . 0.0 110.407 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -126.2 153.55 44.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.631 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.59 -178.63 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.773 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -56.69 -33.42 66.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.29 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -102.78 140.98 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.714 1.61 . . . . 0.0 111.823 164.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.16 159.97 28.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.061 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.16 140.05 14.88 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.79 127.58 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.527 0.663 . . . . 0.0 109.948 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.27 144.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.388 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.99 137.87 8.73 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.3 t -136.53 141.35 43.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.019 0.41 . . . . 0.0 111.308 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.94 131.63 54.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -130.0 142.99 50.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.622 0.249 . . . . 0.0 111.554 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.18 136.38 51.99 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.8 p -121.17 152.32 38.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.946 0.403 . . . . 0.0 111.175 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.56 -178.859 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.78 133.62 54.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.57 128.64 5.42 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.8 mt -122.18 120.06 60.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.644 HG22 ' HA3' ' A' ' 84' ' ' GLY . 70.2 p -123.28 151.72 42.09 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.139 0.274 . . . . 0.0 111.047 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.97 145.27 30.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.15 170.09 41.81 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.882 -1.151 . . . . 0.0 113.085 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -98.72 126.03 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.379 2.053 . . . . 0.0 112.688 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.57 142.84 33.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.482 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 t80 . . . . . 0 C--N 1.332 -0.17 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.167 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 CA--C 1.52 -0.2 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 tt -131.92 136.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.28 -167.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -129.14 143.33 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.96 137.72 10.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.427 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -135.25 154.64 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.915 0.358 . . . . 0.0 111.296 -173.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.58 140.81 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.644 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.08 172.95 27.41 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.758 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.87 132.53 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 132.52 10.11 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -127.22 134.06 50.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.261 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.549 0.214 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -110.1 144.23 39.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.996 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.96 158.84 26.86 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.85 125.34 50.79 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -110.94 143.36 41.71 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.302 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -130.79 134.72 47.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.57 161.26 28.0 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.963 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.35 148.92 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.55 160.34 28.34 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.377 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.6 mt -108.89 151.21 26.59 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -123.69 132.11 53.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.759 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.21 111.44 15.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -130.74 124.42 20.82 Favored Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -169.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -96.41 176.05 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.739 2.293 . . . . 0.0 109.341 156.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -65.57 147.1 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 79.31 -164.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.761 0.825 . . . . 0.0 110.817 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.62 -11.88 8.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.67 17.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 134.67 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.525 0.602 . . . . 0.0 109.844 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.11 140.72 47.79 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.752 0.311 . . . . 0.0 111.184 -168.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -125.43 145.18 50.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.334 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -125.92 129.71 49.84 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.9 t -140.2 154.0 46.77 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.512 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -117.1 145.49 43.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -128.31 132.33 48.66 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.271 0.357 . . . . 0.0 110.043 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -118.75 134.6 55.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.856 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.0 m -115.65 144.75 43.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.52 146.02 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.64 0.587 . . . . 0.0 109.484 -160.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -87.74 95.95 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.708 1.242 . . . . 0.0 112.383 -146.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -89.91 -176.92 5.08 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.375 -2.193 . . . . 0.0 106.669 157.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.8 t -52.17 -16.02 0.71 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.303 -0.873 . . . . 0.0 112.179 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.63 129.38 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.251 0.478 . . . . 0.0 109.811 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -115.06 139.06 50.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.406 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.0 t -108.26 128.43 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.578 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.4 112.08 1.62 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 169.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -126.08 134.32 51.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.815 0.808 . . . . 0.0 111.176 -173.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -116.25 136.24 53.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.566 HG22 ' CB ' ' A' ' 10' ' ' ALA . 41.3 pt -130.13 147.22 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.169 -175.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.5 128.5 25.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.2 153.1 23.21 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.519 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -125.81 145.88 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.07 32.11 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.133 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.43 165.95 23.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.81 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -118.06 148.65 42.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.703 0.287 . . . . 0.0 110.45 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.618 -179.656 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.61 0.243 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.606 HG22 ' CB ' ' A' ' 147' ' ' ARG . 37.9 p -131.09 155.7 46.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.474 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.04 120.25 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.744 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.8 m -128.34 142.96 50.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.818 0.342 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.33 140.86 12.18 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.24 167.91 28.99 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.994 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.08 138.85 53.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.88 149.11 51.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.083 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -124.03 138.98 54.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -115.93 140.77 48.91 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.311 0.382 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.78 126.29 30.52 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.8 0.687 . . . . 0.0 111.381 -173.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.656 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.747 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.656 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 59.9 mttm . . . . . 0 C--O 1.231 0.084 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.6 mmm -125.3 155.12 40.71 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.251 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.37 148.35 16.76 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.04 143.03 14.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.717 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.587 ' CE1' HD21 ' A' ' 26' ' ' LEU . 58.2 t80 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.85 135.78 48.79 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.602 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.587 HD21 ' CE1' ' A' ' 24' ' ' PHE . 81.3 mt -120.31 140.25 51.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 40' ' ' ILE . 98.0 mttt -129.65 143.66 50.92 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.887 0.375 . . . . 0.0 111.37 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -125.32 132.29 52.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -139.93 144.15 36.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -98.47 143.44 28.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.75 136.05 33.57 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.241 0.543 . . . . 0.0 111.119 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -133.42 153.65 51.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.519 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.18 -178.3 3.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.334 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -51.14 -28.41 10.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -97.13 -25.82 0.24 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -102.82 148.08 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.817 1.678 . . . . 0.0 112.983 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.11 164.96 24.54 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.4 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.34 140.24 14.77 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 39' ' ' VAL . 11.5 p -111.04 125.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.415 HD11 ' HD3' ' A' ' 27' ' ' LYS . 17.7 tt -126.72 138.38 54.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.54 142.72 14.24 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.406 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 52.8 p -138.91 148.79 44.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.092 0.446 . . . . 0.0 111.668 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -121.42 133.71 55.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.218 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -128.95 137.19 51.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.65 0.262 . . . . 0.0 111.125 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -120.57 136.94 54.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.866 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.6 m -98.58 137.69 36.87 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.696 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.756 -175.375 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.135 0.493 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -123.08 124.82 43.95 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.88 139.49 11.14 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.639 -176.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 65' ' ' ILE . 16.8 tt -125.09 124.21 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.659 HG22 ' HA3' ' A' ' 84' ' ' GLY . 30.0 p -123.26 154.34 38.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.774 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.01 145.62 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.05 171.21 42.34 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.994 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -97.15 127.1 0.26 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.144 1.896 . . . . 0.0 112.821 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 143.39 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.177 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.637 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.4 mt -129.9 130.13 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -169.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.46 140.39 51.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.73 137.82 9.75 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -135.48 156.99 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 -175.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.03 140.83 47.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.659 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.19 175.2 26.68 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.067 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.01 134.86 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.92 133.64 10.79 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -122.54 141.26 51.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.874 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 . . . . . 0 CA--C 1.524 -0.024 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.512 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.2 166.02 26.49 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.98 127.98 53.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.948 0.374 . . . . 0.0 110.032 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.8 p -113.89 146.33 40.19 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -137.41 143.12 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.93 159.91 28.17 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.728 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.06 149.02 30.41 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.53 161.65 28.86 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.756 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.1 mt -108.92 147.48 32.14 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.04 132.62 54.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.649 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -125.32 109.93 13.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -120.13 124.29 27.88 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -100.14 176.24 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.353 2.702 . . . . 0.0 109.332 155.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 84.9 mtp -60.07 138.01 57.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.267 0.556 . . . . 0.0 112.245 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 68.15 -148.31 0.14 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.731 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -61.15 -12.08 11.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 121' ' ' VAL . 2.8 t -79.44 17.29 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.21 139.39 39.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.036 0.835 . . . . 0.0 110.282 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 143' ' ' GLY . 15.5 tp -132.62 141.46 48.67 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -168.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -133.7 146.43 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.792 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.456 ' CZ ' HD21 ' A' ' 123' ' ' LEU . 97.7 m-85 -121.34 134.11 55.13 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -140.16 154.02 46.82 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.351 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -120.47 145.62 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -127.12 140.0 52.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.383 . . . . 0.0 110.462 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -127.95 136.02 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.125 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.574 ' HB3' HG22 ' A' ' 137' ' ' VAL . 7.9 t -112.98 144.74 42.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -89.18 146.19 24.94 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 124.436 1.085 . . . . 0.0 109.384 -158.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.1 mt -87.56 104.03 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.947 1.356 . . . . 0.0 112.749 -142.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -89.76 -176.58 5.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 112.056 -2.338 . . . . 0.0 107.304 156.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.5 p -52.39 -12.69 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 p -123.24 131.51 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 110.296 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -115.08 139.17 50.11 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 130' ' ' SER . 16.8 m -108.23 140.59 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.242 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.17 119.49 3.6 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.415 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.3 m -126.0 134.17 51.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.637 0.718 . . . . 0.0 111.132 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -119.12 132.13 55.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 19.0 tt -131.79 144.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.569 0.223 . . . . 0.0 111.163 -174.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.53 132.5 48.3 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.57 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -139.6 153.16 22.92 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.811 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.5 144.51 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 176.95 32.58 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.814 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -135.38 170.25 16.23 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.59 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.606 ' CB ' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -143.08 149.05 37.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.686 0.279 . . . . 0.0 110.82 -178.081 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.884 -179.119 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.785 0.326 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 146' ' ' TYR . 21.6 m -125.11 141.24 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.09 128.52 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.39 140.85 11.68 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.69 -168.75 26.18 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.134 -1.032 . . . . 0.0 111.566 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -132.05 153.94 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.175 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -130.0 142.29 50.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.006 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -118.59 131.92 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 t -111.05 140.56 45.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.58 128.0 32.91 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.931 0.769 . . . . 0.0 111.298 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.152 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 52.1 mttp . . . . . 0 C--O 1.231 0.113 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.613 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.14 136.82 11.45 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.84 143.25 14.88 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.38 137.4 44.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.32 134.35 50.01 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.295 0.372 . . . . 0.0 111.66 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 26' ' ' LEU . 5.4 mp -122.54 138.69 54.49 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -134.9 143.06 46.74 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.089 0.471 . . . . 0.0 111.617 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -120.42 134.55 55.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.244 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttm105 -135.59 144.16 46.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 0.0 110.985 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.72 143.16 35.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.4 124.33 36.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 109.786 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.88 153.41 48.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.1 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.55 -178.62 3.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.566 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -57.73 -30.72 65.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 p -95.76 -25.74 0.25 Allowed Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -102.89 136.97 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.71 1.606 . . . . 0.0 111.956 165.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.13 155.13 30.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.1 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.28 15.54 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -101.99 125.93 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 117.346 0.573 . . . . 0.0 110.004 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.418 HD11 ' HB2' ' A' ' 70' ' ' ALA . 73.1 mt -118.44 132.08 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.62 132.55 8.0 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 t -133.54 140.59 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.112 0.456 . . . . 0.0 111.388 -173.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.416 ' HD2' ' HH ' ' A' ' 63' ' ' TYR . 95.8 m-85 -121.17 132.98 55.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.4 m -130.07 134.6 47.48 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.83 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.15 137.16 52.9 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -107.6 152.15 24.67 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 111.359 -172.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.878 -179.746 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.416 ' HH ' ' HD2' ' A' ' 43' ' ' PHE . 61.1 t80 -131.24 132.49 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.02 149.88 20.66 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.7 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 65' ' ' ILE . 16.7 tt -125.6 125.49 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.666 HG22 ' HA3' ' A' ' 84' ' ' GLY . 22.1 p -123.16 155.01 37.89 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.031 0.207 . . . . 0.0 110.52 -176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.547 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -145.56 143.97 30.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.16 159.17 31.66 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.881 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -95.15 124.09 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.969 1.78 . . . . 0.0 112.481 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.63 144.77 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.341 170.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.019 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.641 0.257 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.2 mt -128.93 132.71 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -130.77 146.79 52.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.621 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.464 0.525 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 66' ' ' THR . 8.9 p -140.15 144.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 117.121 0.46 . . . . 0.0 110.986 -170.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -131.99 140.83 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.666 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 175.09 26.82 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.14 -176.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 130.04 74.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.94 144.13 18.31 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -134.96 148.39 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.724 0.262 . . . . 0.0 110.692 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.749 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 . . . . . 0 C--O 1.231 0.119 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -117.21 147.61 42.35 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.304 0.377 . . . . 0.0 111.045 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 159.4 27.03 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -104.66 126.05 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.968 0.384 . . . . 0.0 110.062 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 94.0 p -108.22 137.29 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.969 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -127.75 140.73 51.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.28 169.2 32.67 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.465 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.67 148.98 30.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.789 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.86 158.95 27.84 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.615 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.9 tp -109.22 145.87 35.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -128.16 135.99 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.296 0.498 . . . . 0.0 111.471 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.39 129.73 25.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -140.99 124.67 10.17 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -96.09 176.16 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.533 2.156 . . . . 0.0 109.193 156.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -61.19 150.68 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.52 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 72.98 -160.48 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -61.43 -11.37 10.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.2 t -78.49 17.4 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.4 139.52 39.23 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.446 ' HG ' HG12 ' A' ' 144' ' ' VAL . 4.3 mp -135.88 153.64 51.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.934 0.397 . . . . 0.0 111.078 -171.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -137.06 143.84 42.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.046 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.98 132.61 53.24 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.1 t -140.04 153.92 46.94 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.582 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.27 140.11 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -127.84 146.98 50.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.285 0.366 . . . . 0.0 110.04 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -129.31 135.92 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -107.39 144.68 33.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -89.19 145.99 25.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -159.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 136' ' ' ASP . 68.3 mt -87.98 101.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.656 1.217 . . . . 0.0 112.779 -144.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -89.86 -176.89 5.08 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 112.405 -2.18 . . . . 0.0 107.418 156.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.3 p -52.04 -15.45 0.56 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.778 -0.577 . . . . 0.0 112.358 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.85 129.22 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.894 -0.504 . . . . 0.0 109.729 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 132' ' ' ILE . 2.6 p30 -111.2 139.15 46.82 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.19 133.96 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.879 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.22 3.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 170.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -126.36 134.24 51.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.795 0.798 . . . . 0.0 110.883 -176.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -119.05 136.09 54.31 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.511 HG12 ' HB2' ' A' ' 10' ' ' ALA . 61.7 mt -121.01 140.1 46.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.404 -172.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.1 123.34 25.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.76 153.31 22.57 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.787 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.446 HG12 ' HG ' ' A' ' 123' ' ' LEU . 34.6 m -125.13 147.1 29.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.17 32.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.216 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 4' ' ' THR . 47.0 p90 -138.88 167.18 22.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.714 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.605 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.495 -179.383 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.797 0.332 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 146' ' ' TYR . 34.4 m -125.3 140.66 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.58 126.33 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.073 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.454 HG23 ' C ' ' A' ' 144' ' ' VAL . 15.4 m -128.34 140.28 51.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.878 0.371 . . . . 0.0 110.67 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.77 140.82 12.1 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 108.446 -1.861 . . . . 0.0 108.446 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.38 -172.73 30.19 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.781 -1.199 . . . . 0.0 112.877 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -134.2 143.82 48.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.727 -0.736 . . . . 0.0 109.575 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.03 149.13 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.228 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -118.73 138.46 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.804 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -111.01 140.15 45.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.57 128.36 33.41 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.925 0.766 . . . . 0.0 111.322 -171.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.586 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.03 -177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.619 0.247 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.2 mtm -126.89 156.06 42.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.235 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.31 149.49 17.46 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.11 12.64 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' HE2' HD21 ' A' ' 26' ' ' LEU . 72.3 t80 -112.75 139.07 48.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.71 ' HB3' HG22 ' A' ' 44' ' ' THR . 28.9 p-10 -130.59 147.07 52.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 24' ' ' PHE . 77.2 mt -115.95 142.22 47.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.826 170.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -129.7 141.92 50.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.433 -170.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -133.98 147.39 51.01 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HG3' HG22 ' A' ' 40' ' ' ILE . 78.5 ttt180 -144.28 144.16 31.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.761 -175.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -110.39 140.95 44.11 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -92.96 125.58 37.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.227 0.536 . . . . 0.0 110.573 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -145.05 153.62 41.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.816 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.48 -178.49 3.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.038 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -53.48 -34.82 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.94 -26.05 0.3 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -102.8 127.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.673 1.582 . . . . 0.0 111.567 161.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.501 HD22 ' CD2' ' A' ' 71' ' ' TYR . 76.9 mt -75.77 153.4 37.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.169 -175.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.26 22.69 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.92 125.0 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 117.304 0.552 . . . . 0.0 109.695 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.445 HG22 ' HG3' ' A' ' 29' ' ' ARG . 37.0 pt -125.36 147.55 30.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.245 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.46 147.44 17.57 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 p -141.8 146.1 35.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.874 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -120.17 127.63 52.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.71 HG22 ' HB3' ' A' ' 25' ' ' ASN . 35.6 p -128.82 142.98 50.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.213 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -127.27 137.33 52.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.896 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -97.74 147.51 24.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.098 0.475 . . . . 0.0 111.28 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 C--O 1.235 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 -175.776 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.1 p90 . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.61 0.719 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -125.85 140.08 52.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.088 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.33 137.51 9.5 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.0 117.95 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.677 HG22 ' HA3' ' A' ' 84' ' ' GLY . 17.0 p -123.29 150.05 44.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.329 -175.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.539 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.15 149.08 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 171.0 41.32 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 119.855 -1.164 . . . . 0.0 113.067 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -97.74 126.92 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.563 2.175 . . . . 0.0 112.662 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.53 139.49 36.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.548 170.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.501 ' CD2' HD22 ' A' ' 37' ' ' LEU . 87.3 m-85 . . . . . 0 C--N 1.331 -0.235 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.515 0.198 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.5 tt -138.94 129.92 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -141.71 152.52 43.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.864 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.94 137.84 11.38 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 66' ' ' THR . 9.5 p -138.11 143.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 117.223 0.511 . . . . 0.0 111.01 -171.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.84 140.77 48.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.677 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.06 172.34 27.54 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.529 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t -115.03 130.71 69.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 131.71 9.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.35 140.06 50.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.602 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 40.2 p30 . . . . . 0 N--CA 1.458 -0.047 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -132.9 151.97 51.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.034 0.445 . . . . 0.0 111.545 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.03 165.98 26.45 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -106.13 125.79 51.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.886 0.343 . . . . 0.0 110.12 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.6 p -107.54 144.41 34.57 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -130.76 136.77 49.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.92 166.72 28.86 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.49 148.9 35.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.02 161.04 28.51 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.236 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 113' ' ' LEU . 4.6 mp -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.419 0.628 . . . . 0.0 111.971 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.75 109.95 12.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 168.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -121.04 124.58 27.35 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -166.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -97.51 176.12 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.658 2.239 . . . . 0.0 109.59 156.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.0 ttm -64.91 141.22 58.85 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.182 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 79.28 -162.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.696 0.799 . . . . 0.0 111.225 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -59.43 -11.54 4.6 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 m -78.63 17.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.14 134.32 47.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.54 0.609 . . . . 0.0 109.893 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' A' ' 144' ' ' VAL . 75.7 mt -114.96 144.17 44.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.916 -169.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -130.95 140.23 50.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.848 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.82 136.02 40.3 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 t -140.4 154.03 46.54 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.443 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.22 139.82 49.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -135.97 134.99 39.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.752 0.31 . . . . 0.0 110.229 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -124.74 134.84 52.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.124 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.3 p -96.79 144.78 26.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -89.16 145.9 25.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -162.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 132' ' ' ILE . 9.7 tt -87.87 102.33 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 123.364 1.554 . . . . 0.0 114.08 -144.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -89.66 -176.86 5.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 112.367 -2.197 . . . . 0.0 107.277 156.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -52.11 -15.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.785 -0.572 . . . . 0.0 112.271 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.4 129.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 168.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -113.71 139.15 49.32 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.58 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.9 t -108.21 134.7 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 124.71 5.39 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.431 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.5 m -126.21 134.14 51.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 117.459 0.63 . . . . 0.0 111.269 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -119.88 127.59 52.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.541 HD11 ' ND2' ' A' ' 25' ' ' ASN . 17.0 tt -130.5 143.44 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.385 -172.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.38 136.39 43.32 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.91 153.26 23.68 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.683 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.454 ' C ' HG23 ' A' ' 6' ' ' THR . 30.8 m -116.47 139.95 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -154.91 177.29 32.26 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.471 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.415 ' O ' HG23 ' A' ' 4' ' ' THR . 50.5 p90 -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.564 -0.818 . . . . 0.0 110.083 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -118.02 147.17 43.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.298 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.5 t80 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.58 -179.181 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.725 0.298 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 146' ' ' TYR . 25.4 m -124.92 140.21 53.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.154 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.44 119.99 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -128.22 141.81 51.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.33 140.69 12.47 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.1 165.11 28.21 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.037 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -121.62 145.86 47.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -134.58 149.03 50.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.903 0.382 . . . . 0.0 111.179 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -122.39 135.05 54.62 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 m -115.14 132.92 56.45 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.154 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.82 123.83 30.9 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.316 1.01 . . . . 0.0 110.93 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 179.509 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt . . . . . 0 N--CA 1.462 0.135 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.48 153.07 47.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.943 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.17 135.19 11.46 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.23 14.22 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -118.8 139.81 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -135.9 145.11 45.95 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.959 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -124.32 132.05 53.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.466 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.607 ' N ' HD13 ' A' ' 26' ' ' LEU . 7.7 mtpm? -125.56 143.06 51.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 111.377 -174.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.95 138.24 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -130.72 144.08 51.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.967 0.413 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.69 143.14 45.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.66 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.29 129.32 38.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.289 0.566 . . . . 0.0 110.543 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -131.03 153.49 49.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.763 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.6 -178.54 3.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -53.61 -34.35 58.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.605 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -94.56 -25.89 0.26 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -102.92 134.22 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.764 1.643 . . . . 0.0 111.877 163.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.1 160.59 27.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.83 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.43 140.17 24.1 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.12 124.88 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.319 0.56 . . . . 0.0 110.026 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.4 mt -120.49 135.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.51 140.1 11.35 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.449 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 46.3 p -142.13 150.08 40.65 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.323 0.562 . . . . 0.0 111.774 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.49 133.22 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.087 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -130.07 137.31 50.14 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.967 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.18 136.66 52.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -116.67 137.26 52.32 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.028 0.376 . . . . 0.0 110.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -175.619 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.002 0.429 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -122.33 123.0 40.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 132.29 7.93 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.8 mt -120.53 117.54 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.693 HG22 ' HA3' ' A' ' 84' ' ' GLY . 8.8 p -123.3 155.26 37.59 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.886 -173.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.19 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.5 157.34 28.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.632 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -95.6 122.39 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.992 1.795 . . . . 0.0 111.94 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.77 144.02 32.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.866 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.858 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.4 pt -133.06 146.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.643 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.21 155.03 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.452 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.81 137.95 11.5 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.2 t -131.9 139.03 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.854 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.39 140.73 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 174.89 26.91 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.647 -177.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.25 128.12 72.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.86 10.34 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -118.26 130.63 56.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.617 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 . . . . . 0 C--O 1.23 0.034 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -106.66 148.31 28.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.193 0.521 . . . . 0.0 112.385 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 162.49 27.16 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -103.15 126.99 50.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.195 0.497 . . . . 0.0 110.619 -178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -109.43 135.71 50.03 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.629 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -130.3 145.32 51.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.04 175.09 36.04 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.452 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.05 31.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.018 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.53 158.05 27.41 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.009 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.492 HD23 ' CE2' ' A' ' 115' ' ' PHE . 16.2 tp -117.8 145.81 44.27 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -123.95 132.26 53.69 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.569 0.622 . . . . 0.0 112.228 -174.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.492 ' CE2' HD23 ' A' ' 113' ' ' LEU . 96.8 m-85 -122.05 122.87 40.27 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 171.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -142.14 124.55 9.16 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -95.96 176.19 0.8 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.724 2.282 . . . . 0.0 109.364 155.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.1 mtp -55.17 138.59 44.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.289 0.566 . . . . 0.0 112.338 -174.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 71.46 -145.25 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.74 -11.85 29.86 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -166.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.0 t -78.8 17.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -168.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.49 137.8 41.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.607 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 143' ' ' GLY . 12.3 tp -130.17 140.98 50.7 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.297 -173.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -125.53 137.11 53.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -118.56 132.6 56.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -139.65 151.44 45.96 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.715 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -122.23 139.82 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -132.25 151.16 51.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -131.71 136.1 47.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.012 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 t -109.08 144.85 36.57 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.076 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -89.13 146.19 24.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.201 0.601 . . . . 0.0 109.406 -156.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.735 HG23 ' OD1' ' A' ' 136' ' ' ASP . 40.3 mm -87.66 96.0 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 122.841 1.305 . . . . 0.0 112.225 -142.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -91.9 -177.1 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.141 -2.299 . . . . 0.0 107.974 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.0 m -52.27 -17.61 1.21 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.022 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.33 131.0 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.735 ' OD1' HG23 ' A' ' 132' ' ' ILE . 20.5 m-20 -114.97 138.8 50.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.32 132.43 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.989 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.33 120.25 3.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 168.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.3 m -126.12 134.22 51.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.951 0.875 . . . . 0.0 111.543 -173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -112.94 131.39 55.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 10' ' ' ALA . 64.4 mt -123.53 139.02 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 123.118 0.261 . . . . 0.0 110.616 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.58 124.01 24.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.616 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -137.58 153.2 21.94 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.609 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 p -128.65 142.68 43.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 177.98 32.09 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.496 ' O ' HG23 ' A' ' 4' ' ' THR . 46.6 p90 -130.93 164.43 25.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.395 -0.903 . . . . 0.0 109.952 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -118.36 149.1 41.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.75 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 72.7 t80 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.957 -178.846 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--O 1.231 0.114 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.0 p -126.96 155.45 43.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.08 121.16 45.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.772 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.1 m -128.29 140.63 51.77 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.828 0.347 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.64 140.85 12.16 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.06 170.52 30.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.1 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.11 139.24 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.92 149.06 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.052 -176.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -118.16 138.59 52.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.265 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 t -111.97 137.3 50.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.68 142.01 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.973 0.795 . . . . 0.0 111.388 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.029 -177.352 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 C--O 1.231 0.084 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.39 159.75 38.35 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.807 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.07 144.42 15.41 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.89 142.96 14.14 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.864 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -113.65 133.91 55.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.694 ' CG ' HG22 ' A' ' 44' ' ' THR . 48.5 m-20 -129.14 138.83 52.01 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.28 -177.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 26' ' ' LEU . 8.5 tt -130.16 130.2 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.56 154.54 47.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.279 0.562 . . . . 0.0 112.235 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -123.21 141.89 51.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.806 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -132.76 144.03 49.99 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.561 0.538 . . . . 0.0 110.216 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.26 143.31 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -92.68 122.45 35.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 109.735 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -132.52 153.32 51.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.061 -172.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.7 -178.53 3.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.221 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.07 -25.92 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -170.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -102.85 135.71 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.802 1.668 . . . . 0.0 111.941 165.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.98 158.33 29.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.858 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.22 140.25 15.05 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.5 127.2 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 117.418 0.609 . . . . 0.0 110.06 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.9 mt -120.71 133.1 68.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.19 137.19 8.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 t -140.56 145.35 36.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.147 0.474 . . . . 0.0 111.44 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.92 135.08 54.32 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.694 HG22 ' CG ' ' A' ' 25' ' ' ASN . 42.4 p -126.81 141.09 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.634 0.254 . . . . 0.0 110.637 -177.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -127.02 134.6 50.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.8 m -115.29 141.76 47.59 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.688 0.28 . . . . 0.0 110.48 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.89 -177.792 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.044 0.45 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -122.9 132.97 54.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.226 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.27 135.27 8.05 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.71 124.43 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.563 HG22 ' HA3' ' A' ' 84' ' ' GLY . 72.2 p -123.18 149.41 44.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.126 0.266 . . . . 0.0 110.847 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.52 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.433 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.03 166.98 39.83 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.711 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.1 128.06 0.43 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 122.066 1.844 . . . . 0.0 112.769 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.61 142.17 34.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.061 169.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.6 t80 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.785 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.231 0.106 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 tt -140.51 129.87 26.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -142.74 154.08 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.441 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.51 137.79 9.81 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.433 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.6 m -134.3 155.04 38.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 117.143 0.471 . . . . 0.0 111.296 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.05 141.08 47.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.563 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.11 175.03 26.69 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.049 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.42 134.0 66.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 133.35 10.61 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -121.95 136.77 54.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.916 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 C--O 1.23 0.063 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -125.1 148.6 48.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 111.35 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.05 161.66 27.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.22 125.09 50.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 84.2 p -107.9 146.96 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.25 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -130.5 138.48 50.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.58 162.01 28.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.195 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.86 148.92 39.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.448 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -146.94 152.91 25.0 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.134 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 113' ' ' LEU . 2.8 mm? -122.06 145.87 47.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -137.93 136.74 37.3 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.438 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.63 122.13 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -116.06 124.22 30.0 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -106.24 176.17 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.68 2.92 . . . . 0.0 109.112 154.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -63.26 151.47 40.44 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.747 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 68.58 -165.31 0.19 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.495 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -57.88 -11.25 2.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 121' ' ' VAL . 10.2 t -78.21 17.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -167.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 138.61 40.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.174 -0.954 . . . . 0.0 110.162 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 123' ' ' LEU . 5.0 mp -127.91 144.46 51.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.615 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -134.8 144.06 47.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.385 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.38 137.97 52.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 t -140.15 152.1 45.8 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.523 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.26 139.69 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.12 141.23 50.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.743 0.306 . . . . 0.0 110.865 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -127.36 136.18 51.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.399 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.8 m -113.07 144.69 42.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -89.4 146.3 24.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.616 0.572 . . . . 0.0 109.678 -159.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.1 pt -87.8 95.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 123.229 1.49 . . . . 0.0 114.117 -145.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -89.78 -176.76 5.06 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 112.27 -2.241 . . . . 0.0 107.737 157.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.0 t -52.21 -16.03 0.72 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.73 132.56 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 118.187 0.449 . . . . 0.0 110.147 168.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -112.47 139.12 48.31 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.416 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.14 129.03 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.571 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.27 119.2 3.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.5 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.4 m -126.04 134.15 51.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.757 0.779 . . . . 0.0 111.054 -175.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -122.21 129.59 52.41 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 18.1 tt -129.89 144.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.631 0.253 . . . . 0.0 111.362 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -126.11 132.98 51.77 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.26 152.99 21.33 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.863 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.11 139.83 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.11 178.05 31.99 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.542 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.78 163.98 28.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.733 -0.734 . . . . 0.0 110.032 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -117.88 149.02 41.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.656 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.4 p90 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.492 179.422 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 64.5 p 48.74 33.62 4.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.965 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.6 p -143.85 148.18 35.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m -132.82 141.97 48.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.342 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.45 115.26 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.468 HG23 ' C ' ' A' ' 144' ' ' VAL . 6.1 m -128.17 139.69 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.83 140.85 12.23 Favored Glycine 0 N--CA 1.461 0.352 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.88 167.28 28.27 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.018 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -115.15 140.58 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.634 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -122.46 141.19 51.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.968 -178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -118.72 131.9 56.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 t -112.76 134.74 54.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.81 142.14 37.16 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.115 0.884 . . . . 0.0 110.844 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.84 143.17 31.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.494 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.7 153.5 20.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.55 143.34 10.23 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.043 -171.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 65.12 37.16 6.81 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.977 0.511 . . . . 0.0 111.225 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.8 mtt -149.66 173.97 13.08 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -115.81 164.82 13.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.954 0.407 . . . . 0.0 111.455 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -75.05 161.82 29.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.1 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -131.59 157.55 43.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.606 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.36 146.98 17.84 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.53 143.22 14.29 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.96 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -109.77 134.42 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -127.39 137.67 52.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.579 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD21 ' OH ' ' A' ' 28' ' ' TYR . 14.8 tp -122.6 134.3 54.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.117 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -128.35 143.82 51.06 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.07 0.462 . . . . 0.0 111.826 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.453 ' OH ' HD21 ' A' ' 26' ' ' LEU . 94.2 m-85 -123.65 138.61 54.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.405 174.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -131.4 144.06 50.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.86 0.362 . . . . 0.0 111.118 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -103.93 143.21 33.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.58 125.07 37.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -133.06 153.2 51.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.694 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.83 -178.4 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.177 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.46 -38.61 69.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -85.73 -25.99 0.35 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.81 142.38 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.58 1.52 . . . . 0.0 112.525 163.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.437 HD22 ' CD2' ' A' ' 71' ' ' TYR . 74.5 mt -78.06 165.04 24.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.005 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.09 140.12 14.92 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.18 125.47 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.364 0.582 . . . . 0.0 109.947 -174.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.17 135.5 62.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.66 138.02 10.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 t -131.71 137.33 48.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.813 0.307 . . . . 0.0 111.063 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -115.27 129.11 56.53 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 m -125.9 137.74 53.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.679 0.276 . . . . 0.0 110.731 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -126.06 132.58 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.771 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 m -101.49 146.01 28.22 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -142.72 146.44 34.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.533 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -137.0 136.86 38.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.637 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.7 p -65.43 156.31 32.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.574 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -56.8 148.53 20.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.655 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -112.21 176.55 4.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.225 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 146.99 30.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.297 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 p 62.98 132.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.581 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.6 m -81.04 12.93 3.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.78 -36.08 66.3 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.93 96.38 2.85 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.099 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -133.38 137.49 45.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.431 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.5 p30 35.12 31.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.73 -35.98 81.4 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -97.39 129.56 44.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.382 . . . . 0.0 111.482 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -126.13 148.06 49.48 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.28 138.26 54.67 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -127.1 135.73 51.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.43 135.38 7.57 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.569 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.58 119.35 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.698 HG22 ' HA3' ' A' ' 84' ' ' GLY . 20.1 p -123.23 153.67 39.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.036 0.21 . . . . 0.0 110.507 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.17 146.22 30.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.01 167.37 40.08 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.875 -1.155 . . . . 0.0 112.999 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.417 ' HB2' HD13 ' A' ' 37' ' ' LEU . 92.6 Cg_endo -97.18 124.21 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.276 1.984 . . . . 0.0 112.855 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.79 142.25 33.94 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.77 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.437 ' CD2' HD22 ' A' ' 37' ' ' LEU . 80.9 m-85 -115.59 123.89 49.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -95.82 108.71 21.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.352 0.596 . . . . 0.0 111.928 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.81 HD12 ' O ' ' A' ' 77' ' ' ALA . 68.6 mt -96.47 131.46 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.214 170.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -61.43 -34.34 75.23 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.188 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.44 -176.93 2.03 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -86.16 46.28 1.32 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.346 0.593 . . . . 0.0 110.507 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.81 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -122.14 22.43 10.21 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.247 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.2 t -68.95 149.69 48.57 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.276 0.489 . . . . 0.0 109.887 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.22 129.77 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -127.97 133.86 49.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.75 137.89 11.13 Favored Glycine 0 N--CA 1.465 0.62 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 66' ' ' THR . 8.2 p -142.79 145.95 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.557 0.679 . . . . 0.0 111.445 -172.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.441 HG12 ' HD1' ' A' ' 109' ' ' TYR . 27.7 m -129.35 140.93 47.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 175.07 26.83 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.444 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.42 127.22 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.69 137.56 11.32 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.19 157.91 45.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.098 0.449 . . . . 0.0 111.45 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.7 138.81 12.55 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -142.79 146.16 33.96 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.613 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -100.04 129.62 46.11 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -112.37 144.91 41.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.944 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 m -71.85 139.07 48.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.323 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.1 m -57.03 -49.8 74.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.914 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -175.78 -69.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.944 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.58 -53.4 0.21 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.86 -176.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.77 99.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.519 1.479 . . . . 0.0 112.897 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.2 m -86.26 131.3 34.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.726 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.2 165.15 37.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.428 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -121.92 65.77 0.91 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.626 0.727 . . . . 0.0 110.264 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -124.55 -3.58 7.82 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.71 145.78 55.59 Favored 'General case' 0 C--O 1.231 0.079 0 O-C-N 122.029 -0.419 . . . . 0.0 110.785 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -137.55 157.52 46.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.643 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 t -136.04 142.0 44.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -151.68 142.19 22.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.129 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.71 149.29 33.13 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.731 0.644 . . . . 0.0 110.817 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.0 161.62 27.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -101.67 127.17 48.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -113.66 145.47 41.26 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.034 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.441 ' HD1' HG12 ' A' ' 83' ' ' VAL . 77.4 t80 -131.16 139.47 49.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.41 161.32 27.96 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.732 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 148.91 35.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.95 164.52 29.2 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.857 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.501 HD11 ' HA ' ' A' ' 77' ' ' ALA . 7.6 tp -109.07 145.91 34.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -138.44 134.22 33.78 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.83 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -135.45 115.22 12.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.54 124.46 19.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -102.88 176.15 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.796 2.331 . . . . 0.0 109.294 157.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.2 mtm -55.38 164.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 66.48 -171.94 0.19 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.721 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.29 -11.42 4.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.1 t -78.32 17.91 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -166.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.614 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.43 130.61 52.31 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.331 -0.856 . . . . 0.0 110.231 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.614 HD22 ' C ' ' A' ' 122' ' ' ALA . 4.5 mm? -124.59 146.29 49.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.819 -171.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -137.15 139.54 41.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.411 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.98 131.17 47.41 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -140.24 154.09 46.76 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.663 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -118.32 140.37 49.93 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -126.81 136.62 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.193 0.308 . . . . 0.0 110.387 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -119.33 130.83 55.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.321 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.9 t -108.09 144.6 35.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -89.37 145.97 24.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -159.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 132' ' ' ILE . 13.0 tt -87.89 100.96 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 123.526 1.631 . . . . 0.0 113.678 -146.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -89.8 -176.7 5.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.18 -2.282 . . . . 0.0 106.597 157.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -52.16 -14.54 0.44 Allowed 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.339 -0.851 . . . . 0.0 112.206 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.02 132.59 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.362 0.528 . . . . 0.0 109.859 167.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -115.01 139.12 50.11 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.35 133.59 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.707 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.33 3.88 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.9 m -126.12 134.16 51.41 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.61 0.705 . . . . 0.0 111.12 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -117.29 130.92 56.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.634 HG22 ' HB2' ' A' ' 10' ' ' ALA . 2.6 pp -124.98 144.9 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.855 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.52 127.18 30.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.497 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -135.63 153.09 21.17 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.612 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.468 ' C ' HG23 ' A' ' 6' ' ' THR . 9.3 p -128.54 139.91 50.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.02 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.809 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -137.33 165.08 27.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.675 -0.763 . . . . 0.0 110.173 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -121.68 148.97 43.9 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.7 p90 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.075 -0.964 . . . . 0.0 112.453 -174.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.5 m -122.61 144.59 49.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.519 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p -155.35 169.23 24.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.664 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.706 HG22 ' HB3' ' A' ' 29' ' ' ARG . 14.9 t -135.1 151.83 51.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.947 0.404 . . . . 0.0 110.845 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.49 124.37 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.415 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 m -128.31 139.44 52.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 110.676 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.71 140.71 13.47 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.23 168.21 28.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.185 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -117.68 133.02 56.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -115.56 138.7 50.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.412 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -119.16 131.99 55.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.0 139.1 48.94 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.72 142.12 37.32 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.822 0.701 . . . . 0.0 111.218 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' HB2' ' C ' ' A' ' 19' ' ' ASN . . . -103.24 143.27 32.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.283 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -89.9 153.06 20.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.6 151.73 3.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.27 -0.49 . . . . 0.0 111.961 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 69.86 -0.58 2.65 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 91.7 mmm -129.4 171.79 12.17 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 121.456 -0.778 . . . . 0.0 110.149 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.426 ' C ' ' HB2' ' A' ' 14' ' ' ALA . 7.9 p30 -113.06 170.0 8.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.917 0.389 . . . . 0.0 111.242 -177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -82.79 171.05 14.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.597 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.3 mmm -128.8 155.79 44.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.294 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.48 143.35 14.98 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.54 143.17 14.22 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.909 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.38 131.38 54.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' HG23 ' A' ' 44' ' ' THR . 71.0 m-20 -119.66 135.19 54.92 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.296 0.373 . . . . 0.0 111.529 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tt -118.4 135.95 54.04 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -117.87 143.87 45.92 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.208 0.317 . . . . 0.0 111.32 -173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -133.49 130.28 38.33 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.706 ' HB3' HG22 ' A' ' 4' ' ' THR . 37.2 ttm180 -138.32 144.08 40.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.178 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -109.83 143.15 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -92.63 129.3 38.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.516 0.674 . . . . 0.0 110.769 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -133.09 153.47 51.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.109 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.54 -178.56 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.718 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -55.7 -33.4 64.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.327 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 t -93.38 -25.89 0.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.78 139.18 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.746 1.631 . . . . 0.0 111.952 164.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.11 152.76 32.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.304 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.03 140.38 16.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.3 m -103.55 127.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 117.779 0.789 . . . . 0.0 110.113 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.737 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -126.17 140.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.737 ' N ' HD13 ' A' ' 40' ' ' ILE . . . -139.87 143.53 13.87 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -142.06 155.03 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.584 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -131.61 142.01 49.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.906 173.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.526 HG23 ' OD1' ' A' ' 25' ' ' ASN . 61.5 m -127.03 137.7 53.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.88 -175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -118.49 133.02 56.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.035 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 m -107.76 144.65 34.61 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 110.867 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -142.29 157.96 44.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -133.58 136.89 45.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.776 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.4 m 62.36 -81.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.519 0.512 . . . . 0.0 111.128 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 64.98 55.54 1.14 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.642 0.734 . . . . 0.0 110.001 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.5 m -127.09 140.03 52.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.033 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.88 93.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.275 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.6 t -142.94 147.14 34.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -59.18 -27.55 65.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.026 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.82 -25.9 74.93 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.36 -0.447 . . . . 0.0 112.509 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 59.26 58.27 3.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.572 0.701 . . . . 0.0 110.282 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -53.79 -33.36 55.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.567 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -61.32 138.06 58.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 110.556 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.35 -68.01 0.46 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.282 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -98.27 142.04 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 111.184 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -125.98 148.99 49.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.639 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.18 140.15 53.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.949 0.404 . . . . 0.0 110.878 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -132.61 131.7 41.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.592 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.16 146.34 18.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.052 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.14 127.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.662 HG22 ' HA3' ' A' ' 84' ' ' GLY . 60.9 p -123.2 154.88 38.13 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.139 0.274 . . . . 0.0 110.803 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.95 148.88 37.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.74 160.89 31.88 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 119.865 -1.159 . . . . 0.0 113.335 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -94.05 124.07 0.45 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.018 1.812 . . . . 0.0 112.061 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . . . -80.71 138.8 36.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.218 171.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -116.53 129.67 56.32 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -95.86 110.57 22.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.258 0.551 . . . . 0.0 112.072 -169.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.704 HG21 ' HB3' ' A' ' 77' ' ' ALA . 44.7 mm -96.17 131.3 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.483 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -61.37 -34.81 75.94 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.12 -175.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -75.81 -172.51 1.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 34.7 p-90 -86.06 47.94 1.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.45 0.643 . . . . 0.0 110.179 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -122.2 22.77 10.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.222 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -68.73 147.56 51.64 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.38 129.96 70.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.087 0.47 . . . . 0.0 110.447 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 20.5 m-85 -120.01 134.03 55.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.99 137.58 11.21 Favored Glycine 0 N--CA 1.466 0.668 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.67 150.99 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.259 0.53 . . . . 0.0 111.822 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.09 140.77 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.27 175.01 26.85 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.459 -176.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.64 127.53 73.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.52 144.67 16.11 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -138.0 154.28 49.35 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.111 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.98 141.88 13.24 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -144.26 154.04 42.67 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.399 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -100.61 135.48 41.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.608 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -100.95 127.92 47.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.372 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 m -107.82 135.39 49.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.43 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.2 m -162.77 -66.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 110.908 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.14 -38.63 76.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -158.79 152.47 19.27 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.478 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -89.81 153.09 5.03 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.759 1.639 . . . . 0.0 112.009 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 99' ' ' LYS . 9.9 t -135.43 151.48 50.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -67.01 -38.38 85.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.183 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 97' ' ' THR . 28.5 mtpp -97.97 137.27 37.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.624 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -130.23 125.98 36.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.648 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 102' ' ' THR . 14.9 t70 -57.92 -32.58 67.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.621 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 101' ' ' ASP . 11.6 t 47.14 -169.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.119 0.568 . . . . 0.0 111.71 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.6 t -96.35 124.92 40.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.262 0.553 . . . . 0.0 111.679 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -136.73 142.03 43.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.854 173.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -108.56 149.64 28.59 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.526 0.517 . . . . 0.0 111.593 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 164.03 26.94 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -104.24 128.13 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.99 0.395 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.3 m -114.37 141.01 48.18 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.677 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -140.52 144.09 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.11 176.59 35.9 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.227 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.05 150.6 30.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.661 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.12 28.04 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.274 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.19 149.93 35.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -121.6 138.67 54.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 112.128 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -125.99 109.95 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.73 124.34 27.14 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -105.51 176.06 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.373 2.716 . . . . 0.0 109.351 155.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.5 mtm -61.16 158.2 14.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.782 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 67.27 -165.95 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.537 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -58.43 -11.67 3.11 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 121' ' ' VAL . 9.9 t -78.41 17.77 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -167.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.43 138.02 41.44 Favored 'General case' 0 C--N 1.344 0.37 0 O-C-N 121.153 -0.967 . . . . 0.0 110.057 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.68 151.41 49.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.709 0.29 . . . . 0.0 111.269 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.96 139.66 41.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.364 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -122.22 129.12 51.95 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -140.21 154.02 46.77 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.313 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -124.52 142.7 51.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -128.78 146.84 50.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -128.5 135.51 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.046 0.45 . . . . 0.0 110.621 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.4 p -100.57 144.78 29.15 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -89.29 145.94 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -160.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -87.77 99.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.638 1.208 . . . . 0.0 112.924 -144.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -89.88 -176.99 5.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 112.528 -2.124 . . . . 0.0 107.499 156.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.2 t -52.17 -16.18 0.74 Allowed 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 112.078 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.32 130.69 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -114.92 139.04 50.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.375 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.37 135.97 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.597 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.64 5.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.06 134.18 51.48 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.652 0.726 . . . . 0.0 111.396 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -115.0 132.83 56.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 10' ' ' ALA . 67.3 mt -124.03 134.8 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -173.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.18 123.3 39.32 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.08 20.56 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.823 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.2 140.17 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 178.02 32.08 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.676 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.56 165.09 24.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.139 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -117.96 149.0 41.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.614 -178.756 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.5 m -122.57 142.71 50.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.347 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -152.52 164.3 37.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.085 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -136.01 155.18 50.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.921 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 p -129.98 132.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.187 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 m -128.08 140.12 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.32 140.74 12.27 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.78 30.58 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.355 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -117.16 136.31 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.683 -0.759 . . . . 0.0 109.11 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -117.31 138.07 52.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.384 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -126.15 132.04 51.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 p -115.57 141.31 48.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -78.94 127.02 31.46 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.063 0.852 . . . . 0.0 111.233 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -102.72 143.16 32.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.466 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -89.8 153.19 20.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.5 109.79 1.02 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.885 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 155.58 -44.45 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.668 1.587 . . . . 0.0 109.1 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 87.1 mtp -127.57 168.28 15.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.184 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.01 162.17 14.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.96 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 9.1 mtmp? -58.15 170.66 0.64 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.281 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.32 159.74 35.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.285 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.23 151.4 18.36 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.08 143.22 11.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.784 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.11 132.98 52.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.551 ' OD1' HG22 ' A' ' 44' ' ' THR . 49.2 m-20 -126.7 135.91 51.76 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.459 -175.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.8 mt -122.25 139.3 53.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -135.07 142.5 46.31 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 111.538 -173.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.43 136.6 54.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.402 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -136.78 144.11 43.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -104.49 143.09 33.5 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.57 123.57 35.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.122 0.487 . . . . 0.0 110.112 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.04 153.47 41.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.975 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.32 -178.58 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.836 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -55.37 -41.53 72.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 m -82.29 -26.1 0.4 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -102.83 126.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.531 1.487 . . . . 0.0 112.04 160.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 156.59 32.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.97 140.28 19.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -101.62 124.93 55.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 117.292 0.546 . . . . 0.0 109.861 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.571 HD11 ' HB2' ' A' ' 70' ' ' ALA . 69.7 mt -117.44 134.93 59.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.9 133.26 7.53 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.1 t -132.84 140.51 47.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.041 0.421 . . . . 0.0 111.315 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.77 132.29 55.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 25' ' ' ASN . 68.9 p -128.75 142.57 50.96 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.94 -178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -125.48 135.51 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.168 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -109.51 144.83 37.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.785 0.326 . . . . 0.0 111.061 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -141.17 145.24 35.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.475 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -134.76 145.79 48.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.288 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.6 p -110.95 141.94 43.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.679 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -139.59 146.82 40.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.369 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.4 m -61.78 146.88 48.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.378 . . . . 0.0 109.996 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.0 130.19 45.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.945 0.403 . . . . 0.0 110.527 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -164.91 -176.59 4.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.53 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.0 p -60.15 -28.59 68.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.84 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.96 -15.79 74.33 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.042 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 61.93 -174.4 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.72 0.76 . . . . 0.0 110.863 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -54.54 -175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.376 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -52.14 133.7 33.37 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.456 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -60.78 -38.64 85.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.448 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -146.94 171.51 15.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.135 0.493 . . . . 0.0 111.723 -175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -126.1 157.99 36.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.547 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -118.45 135.97 54.06 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.899 0.38 . . . . 0.0 111.025 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -123.27 129.36 51.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.38 134.81 7.98 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.44 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.23 123.75 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.661 HG22 ' HA3' ' A' ' 84' ' ' GLY . 63.5 p -123.24 153.44 40.16 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.154 0.284 . . . . 0.0 110.602 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.78 144.86 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.536 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.01 168.14 40.58 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 119.775 -1.202 . . . . 0.0 113.178 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -96.99 126.08 0.25 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.434 2.089 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.84 140.45 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.667 170.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -116.04 131.76 56.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -95.88 115.65 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.539 . . . . 0.0 111.76 -169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 77' ' ' ALA . 81.5 mt -96.27 131.13 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.437 173.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -61.76 -30.81 71.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -86.44 38.46 0.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.836 0.35 . . . . 0.0 111.83 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 51.59 40.79 27.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.529 0.68 . . . . 0.0 111.362 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.785 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -122.0 22.76 10.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.138 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -68.58 145.43 53.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.037 -161.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 tt -128.95 133.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.789 -171.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -128.39 146.86 50.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.959 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.2 137.73 9.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.1 m -134.14 153.77 36.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.828 0.314 . . . . 0.0 110.97 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.24 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.03 26.73 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.305 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 87' ' ' TYR . 42.7 t -118.35 133.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 131.93 9.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CZ ' HG11 ' A' ' 85' ' ' VAL . 97.8 m-85 -120.85 142.02 50.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 0.0 110.405 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.98 131.15 10.51 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -126.57 133.27 51.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.683 0.278 . . . . 0.0 110.757 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -102.1 145.11 29.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.025 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -96.75 139.2 33.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.99 0.424 . . . . 0.0 110.429 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 m -76.2 144.3 40.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.145 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -74.56 -178.28 3.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 93' ' ' THR . 84.3 tt0 -51.8 -35.14 43.01 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -74.45 148.03 85.47 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -92.53 87.58 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.983 1.788 . . . . 0.0 112.553 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.2 m -125.71 129.99 50.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.402 . . . . 0.0 110.557 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.95 -33.85 70.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.682 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -57.18 -35.94 70.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.506 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -55.19 -37.64 67.33 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.232 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -69.64 132.41 46.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.748 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.1 m -129.43 141.33 51.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.181 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 t -128.94 135.05 48.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.119 0.485 . . . . 0.0 111.069 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -150.91 144.66 25.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.381 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -123.85 150.79 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.057 0.456 . . . . 0.0 111.769 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.06 26.17 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -103.89 129.94 51.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.088 0.444 . . . . 0.0 110.449 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.4 m -112.39 141.73 45.77 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.661 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -131.93 139.06 48.6 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.44 155.02 26.3 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.792 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.23 148.89 30.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -151.81 162.26 29.62 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.893 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.96 150.31 27.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -135.03 139.65 44.99 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.576 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.511 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 46.2 p90 -137.95 120.69 16.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.1 124.4 26.49 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -105.19 175.99 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.087 2.525 . . . . 0.0 109.712 157.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.32 157.77 10.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.935 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 67.24 -167.61 0.2 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.694 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.41 -11.4 2.81 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' VAL . 7.2 t -78.23 17.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -169.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.1 136.45 43.7 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.511 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 71.3 mt -125.18 147.24 49.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.898 -167.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -132.53 136.74 46.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.151 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.26 130.44 52.74 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -139.91 154.07 47.14 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.996 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -124.83 143.13 50.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.965 0.412 . . . . 0.0 110.669 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -127.95 136.15 50.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.18 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.553 ' HB3' HG22 ' A' ' 137' ' ' VAL . 6.4 t -111.44 144.76 40.13 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 171.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -89.25 146.4 24.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.224 0.952 . . . . 0.0 109.667 -158.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 136' ' ' ASP . 58.2 mt -87.84 105.81 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 122.73 1.253 . . . . 0.0 112.879 -141.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -89.75 -176.74 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.314 156.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 t -52.16 -14.48 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.822 -0.549 . . . . 0.0 112.262 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.02 130.9 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.404 0.547 . . . . 0.0 110.337 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.477 ' HB2' HG23 ' A' ' 132' ' ' ILE . 29.4 t0 -115.02 139.19 50.06 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.553 HG22 ' HB3' ' A' ' 130' ' ' SER . 17.7 m -108.12 143.86 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.315 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.1 122.61 4.72 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 171.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.414 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 27.7 m -125.9 134.19 51.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.545 0.673 . . . . 0.0 111.352 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -109.29 132.23 54.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 10' ' ' ALA . 67.2 mt -122.5 133.5 68.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 123.209 0.318 . . . . 0.0 110.286 -175.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.85 126.17 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.53 153.02 20.85 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.137 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 123' ' ' LEU . 32.2 m -122.14 140.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 177.87 32.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.372 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -141.53 163.08 33.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.837 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -123.26 149.0 45.32 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.256 0.347 . . . . 0.0 110.54 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.63 -178.879 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.482 ' HB1' ' HG3' ' A' ' 31' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.5 p -148.85 -58.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.535 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.7 p -158.62 157.64 32.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.244 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.4 p -125.17 155.4 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.378 . . . . 0.0 110.43 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.83 125.06 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.588 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -128.15 141.48 51.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 111.036 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.68 140.74 12.05 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.9 165.45 28.48 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.316 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -115.44 134.58 54.95 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -116.99 138.97 51.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.5 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -120.88 132.95 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -115.89 144.47 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -78.59 142.17 37.49 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.867 0.729 . . . . 0.0 111.13 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.62 143.19 30.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.313 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.73 153.37 20.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.777 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.69 142.57 11.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.028 -173.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 62.94 36.03 12.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.309 -0.445 . . . . 0.0 111.431 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.7 mtt -149.51 169.14 21.6 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -106.93 152.15 24.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.026 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.66 166.9 12.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.962 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.64 155.21 39.53 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.885 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 46' ' ' THR . . . -126.4 140.5 12.08 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.42 143.24 14.02 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.817 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.66 136.78 50.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -131.47 142.41 49.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.989 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.4 tp -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.137 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -127.23 141.96 51.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.009 0.433 . . . . 0.0 111.512 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.68 137.32 54.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.443 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -134.45 144.1 47.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 110.823 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -109.32 143.25 39.08 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.482 ' HG3' ' HB1' ' A' ' 1' ' ' ALA . 77.4 mm-40 -92.77 120.3 33.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.277 0.561 . . . . 0.0 111.157 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -133.86 153.63 51.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.962 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.51 -178.44 3.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.863 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -53.01 -33.87 53.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -91.4 -26.02 0.28 Allowed Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -102.79 133.0 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.683 1.589 . . . . 0.0 111.65 162.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.97 158.31 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.245 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.08 140.3 19.12 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.67 125.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 117.478 0.639 . . . . 0.0 109.784 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 70' ' ' ALA . 67.7 mt -120.54 137.77 53.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.15 137.38 9.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -135.91 140.97 44.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.085 0.442 . . . . 0.0 111.093 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.36 132.77 56.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.4 m -129.43 139.05 51.76 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.284 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -124.97 129.8 51.07 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' GLY . 5.9 m -124.75 145.95 49.45 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.978 0.353 . . . . 0.0 110.991 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -132.29 153.55 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.369 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -115.74 145.45 42.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.038 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 m -56.81 138.74 52.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.851 0.357 . . . . 0.0 110.878 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.01 -36.18 82.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.409 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.9 m -69.78 125.44 26.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.021 0.438 . . . . 0.0 111.153 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.18 149.33 51.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.778 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.0 t -60.38 -52.5 64.99 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.571 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m -99.07 -38.16 9.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.222 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.9 -27.03 72.92 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.705 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 66.66 -79.56 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.045 0.423 . . . . 0.0 110.948 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -113.63 126.7 55.56 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -135.08 151.58 50.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.877 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -137.03 120.9 17.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.274 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -129.62 128.52 42.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.252 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -111.7 132.83 54.35 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -124.19 136.07 53.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.932 0.396 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -134.82 127.78 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.607 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.01 140.32 11.09 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.649 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -122.08 122.57 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.564 HG23 ' C ' ' A' ' 83' ' ' VAL . 2.4 m -123.21 147.27 47.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.79 147.33 31.76 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.11 171.02 42.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.886 -1.15 . . . . 0.0 113.162 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -93.51 128.05 0.65 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.149 1.899 . . . . 0.0 112.905 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.5 138.57 36.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.188 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -100.13 149.62 23.34 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.77 0.669 . . . . 0.0 109.228 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -95.38 135.7 36.67 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.561 0.696 . . . . 0.0 112.028 -160.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.69 131.23 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.057 -170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -81.86 -43.72 17.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.352 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -165.31 85.57 0.38 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.051 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.0 m95 54.01 48.69 20.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.769 0.795 . . . . 0.0 110.298 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.07 22.93 10.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.27 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 t -68.48 145.1 54.36 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.656 -160.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.96 129.56 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.1 m-30 -122.6 135.35 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.03 137.65 11.24 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.544 ' HB ' HG22 ' A' ' 66' ' ' THR . 30.4 m -142.43 153.44 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 117.801 0.801 . . . . 0.0 112.021 -173.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.564 ' C ' HG23 ' A' ' 66' ' ' THR . 27.4 m -134.05 140.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 174.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 66' ' ' THR . . . -147.13 171.86 27.71 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.524 -176.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.62 125.82 74.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.6 146.43 16.19 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -139.1 155.13 48.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.861 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.05 144.95 15.45 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -141.96 142.69 32.99 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.732 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -96.23 128.73 43.4 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.187 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -115.88 147.99 40.47 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.037 0.446 . . . . 0.0 111.041 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.469 ' HB ' HG22 ' A' ' 97' ' ' THR . 72.5 p -85.47 159.15 20.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.413 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.563 HG23 ' HG3' ' A' ' 94' ' ' GLU . 4.3 t -122.17 -25.97 4.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.563 ' HG3' HG23 ' A' ' 93' ' ' THR . 95.8 mt-10 -123.37 156.89 34.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.817 0.342 . . . . 0.0 110.515 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -49.38 -45.06 76.73 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.227 -0.892 . . . . 0.0 112.971 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.97 99.57 1.0 Allowed 'Trans proline' 0 N--CA 1.496 1.672 0 CA-C-N 120.907 1.359 . . . . 0.0 110.958 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.469 HG22 ' HB ' ' A' ' 92' ' ' THR . 68.6 p -118.19 163.27 16.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.083 0.468 . . . . 0.0 110.939 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -117.72 150.89 38.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.315 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -54.66 -31.85 58.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.566 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -49.74 97.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 112.006 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -137.23 138.18 39.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.213 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.9 m -127.77 135.61 50.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.958 0.409 . . . . 0.0 111.26 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.1 p -139.65 138.91 36.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.874 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -162.97 151.77 14.6 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.973 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -109.59 149.7 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 124.024 0.827 . . . . 0.0 110.217 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.16 159.36 27.05 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -99.51 124.31 44.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -110.06 141.01 43.49 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.764 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -127.95 140.3 52.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.16 159.26 27.86 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.1 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.12 148.88 32.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.987 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.45 161.89 29.66 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.36 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.68 150.47 49.75 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -127.79 146.52 50.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.601 0.715 . . . . 0.0 112.582 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -124.07 112.56 17.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.43 124.21 29.76 Favored Pre-proline 0 N--CA 1.462 0.17 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -107.03 176.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.452 2.768 . . . . 0.0 109.342 155.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -62.88 156.06 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.763 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 67.84 -166.48 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.588 173.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -58.64 -11.42 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 121' ' ' VAL . 9.8 t -78.37 17.73 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.48 138.17 41.26 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.34 -0.85 . . . . 0.0 110.145 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 123' ' ' LEU . 5.4 mp -122.87 147.42 46.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.545 -170.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -132.61 136.41 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.385 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.36 130.7 54.51 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -140.18 154.03 46.81 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.321 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -128.15 145.29 51.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.521 ' OE2' HD12 ' A' ' 141' ' ' ILE . 47.1 mp0 -133.84 146.6 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.178 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -129.5 136.06 49.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.9 t -104.13 144.72 31.2 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -89.28 146.03 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -161.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.7 mt -87.9 106.71 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 122.76 1.266 . . . . 0.0 112.901 -142.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -89.68 -176.71 5.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 112.301 -2.227 . . . . 0.0 107.227 156.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.1 p -52.11 -13.32 0.3 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.611 . . . . 0.0 112.496 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.82 133.49 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.383 0.538 . . . . 0.0 109.83 167.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.87 139.37 45.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.342 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.06 132.5 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.615 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 124.11 5.2 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.07 134.28 51.43 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.337 0.569 . . . . 0.0 111.298 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.36 134.83 54.74 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.521 HD12 ' OE2' ' A' ' 128' ' ' GLU . 67.9 mt -125.34 135.73 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.429 -174.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 124.79 43.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.07 20.56 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.19 139.78 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.01 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.748 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.12 163.69 31.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.905 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -119.65 148.79 42.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.602 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.972 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.2 p -123.03 160.0 27.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -162.2 166.33 25.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.35 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 m -128.93 139.86 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.112 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 5' ' ' VAL . 35.7 m -128.71 128.93 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.135 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.5 m -128.15 142.29 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.53 140.8 12.07 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.19 -169.89 27.28 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.169 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -129.21 158.5 38.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.262 -0.469 . . . . 0.0 109.931 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.884 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -136.51 148.18 47.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.973 -177.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -126.35 132.8 51.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -118.52 142.03 48.0 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -79.04 125.07 28.91 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.872 0.732 . . . . 0.0 111.408 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.19 143.29 34.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.461 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -89.64 149.23 22.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.01 109.55 0.68 Allowed Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.272 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 170.5 -52.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.3 mtm -128.28 174.04 9.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.661 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -91.84 162.22 14.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.865 0.364 . . . . 0.0 110.738 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -49.5 163.78 0.1 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.9 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.633 ' HE1' HG21 ' A' ' 46' ' ' THR . 86.0 mtp -115.17 143.31 45.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.07 140.15 16.03 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.45 143.28 14.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.823 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -111.3 137.81 48.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -125.92 133.88 51.74 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.193 0.308 . . . . 0.0 111.576 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.2 mt -118.01 141.86 48.0 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.779 0.674 . . . . 0.0 109.482 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -127.72 143.01 51.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.301 -174.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -132.15 132.54 43.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -138.55 144.2 39.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 -176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -108.37 142.45 38.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.59 131.03 38.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.274 0.559 . . . . 0.0 111.289 -174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -143.86 153.57 42.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.497 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.43 -178.4 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.136 -173.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -51.08 -37.78 47.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -89.13 -25.98 0.31 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -102.73 126.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.716 1.611 . . . . 0.0 111.869 161.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.536 HD22 ' CD1' ' A' ' 71' ' ' TYR . 73.4 mt -76.63 158.39 31.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.963 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.05 140.12 18.99 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.66 124.96 58.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.487 0.644 . . . . 0.0 109.28 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.492 HD11 ' CG1' ' A' ' 82' ' ' VAL . 41.3 pt -122.46 144.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.379 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.84 136.2 8.49 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -127.88 140.93 51.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.671 0.272 . . . . 0.0 110.811 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.74 131.2 56.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.1 m -126.44 134.8 50.88 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.247 0.342 . . . . 0.0 110.83 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -127.04 137.05 52.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.436 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.633 HG21 ' HE1' ' A' ' 21' ' ' MET . 7.2 m -108.5 148.28 30.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.017 0.436 . . . . 0.0 111.351 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.38 140.8 47.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.525 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -133.08 142.4 48.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.226 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.8 t -140.59 133.06 28.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.445 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.521 ' HG2' HG23 ' A' ' 51' ' ' THR . 55.0 ttp180 -98.44 -68.9 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.228 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.521 HG23 ' HG2' ' A' ' 50' ' ' ARG . 66.0 p -127.59 163.63 23.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.125 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.25 113.49 19.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.272 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.7 m -124.84 148.48 48.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.529 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -59.0 -36.06 74.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.225 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.53 16.9 16.39 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.214 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 62.23 152.3 0.03 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.524 0.662 . . . . 0.0 111.381 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -60.62 156.79 15.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.59 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -173.58 111.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.988 0.423 . . . . 0.0 111.089 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -147.43 -74.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.555 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -135.3 146.78 48.83 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.682 0.277 . . . . 0.0 110.597 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -119.54 144.21 47.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -132.31 135.9 46.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.715 0.293 . . . . 0.0 110.414 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -138.02 132.98 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.993 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.97 19.58 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.519 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.449 ' C ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -127.27 127.37 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.656 HG22 ' HA3' ' A' ' 84' ' ' GLY . 31.2 p -123.21 154.99 38.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.655 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.62 148.28 34.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.09 170.92 42.25 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.968 -1.111 . . . . 0.0 113.337 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -99.15 122.65 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.628 2.219 . . . . 0.0 112.717 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.78 139.93 35.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.077 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CD1' HD22 ' A' ' 37' ' ' LEU . 65.8 m-85 -120.38 124.93 46.71 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -99.98 116.46 32.08 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.641 HD12 ' O ' ' A' ' 77' ' ' ALA . 82.4 mt -96.26 131.25 43.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.988 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -61.57 -30.52 70.72 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -171.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -87.52 54.1 3.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.138 0.494 . . . . 0.0 111.119 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 40.39 29.51 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.641 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -106.08 22.78 15.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.209 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.5 m -68.75 159.53 32.11 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.943 -166.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.19 129.93 17.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -127.84 141.98 51.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.2 137.91 10.99 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.492 ' CG1' HD11 ' A' ' 40' ' ' ILE . 36.0 m -135.69 153.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.953 0.376 . . . . 0.0 111.182 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.68 140.84 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.656 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.21 175.21 26.69 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.339 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.62 129.66 75.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.08 145.47 16.66 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -138.68 160.02 40.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.77 150.01 17.11 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -133.61 132.44 40.81 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -104.82 125.68 51.12 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -108.9 114.41 28.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.752 0.31 . . . . 0.0 110.818 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -108.13 140.32 41.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.495 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 m -80.91 130.45 35.04 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 54.09 63.57 2.13 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.544 0.688 . . . . 0.0 110.628 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -70.45 152.86 95.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.715 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.0 -56.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.621 1.547 . . . . 0.0 112.214 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -127.23 161.4 28.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.533 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -59.21 -38.18 79.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.164 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -54.89 -32.45 60.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.65 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -53.83 -38.54 64.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.669 0.271 . . . . 0.0 111.222 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.6 144.74 57.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.061 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -114.92 135.62 54.0 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -143.65 133.68 24.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -162.96 161.08 25.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.841 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -139.42 158.99 43.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.009 0.433 . . . . 0.0 111.566 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.09 167.06 26.16 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.16 125.7 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -111.98 145.54 39.45 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.638 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -142.64 144.52 32.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.12 173.38 35.96 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.912 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.9 28.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.457 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.94 160.49 27.1 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.141 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.6 mp -113.13 151.06 31.3 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -121.98 133.62 54.82 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.802 -174.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -128.24 109.92 11.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.452 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 10.9 p-10 -140.53 124.64 10.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -167.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.29 176.11 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.629 2.219 . . . . 0.0 109.125 155.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -55.71 174.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.555 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -174.7 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.256 0.551 . . . . 0.0 112.126 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -62.95 -11.35 18.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.47 18.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.586 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.27 141.92 35.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.461 0.573 . . . . 0.0 110.162 -176.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 144' ' ' VAL . 4.5 mm? -124.02 148.99 46.58 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.84 -170.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -136.94 137.52 39.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.22 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -128.63 132.06 48.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.438 ' HB3' HD11 ' A' ' 141' ' ' ILE . 31.4 t -140.4 154.14 46.58 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.581 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.85 139.95 49.34 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -126.76 140.66 52.21 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 123.344 0.403 . . . . 0.0 110.453 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -124.23 136.03 53.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.284 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -109.1 144.84 36.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -89.19 145.94 25.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -160.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 pt -88.01 105.13 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 123.09 1.424 . . . . 0.0 114.689 -143.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -89.84 -176.97 5.11 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 112.703 -2.044 . . . . 0.0 106.845 157.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 t -52.06 -15.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.476 -0.765 . . . . 0.0 112.237 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.59 127.26 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 118.215 0.461 . . . . 0.0 109.808 168.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -103.9 139.19 39.41 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.13 131.16 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.32 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.19 118.48 3.29 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.2 m -126.2 134.2 51.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.347 0.573 . . . . 0.0 110.866 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -115.73 133.03 56.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.884 HG22 ' HB2' ' A' ' 10' ' ' ALA . 48.0 pt -121.98 145.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 123.247 0.342 . . . . 0.0 110.896 -177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -136.19 125.41 24.68 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.51 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -137.27 153.22 21.8 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.784 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.621 HG22 HD11 ' A' ' 123' ' ' LEU . 51.1 t -111.26 139.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.48 158.77 23.86 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.983 -172.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.32 152.86 46.9 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.136 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -117.81 140.37 49.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.8 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.702 179.682 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.583 HG21 ' HG3' ' A' ' 31' ' ' GLU . 21.2 m -123.45 147.44 47.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.356 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -151.98 148.85 28.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.372 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.622 HG22 ' CD ' ' A' ' 147' ' ' ARG . 29.2 p -122.3 156.22 34.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.416 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.01 115.99 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.555 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.6 m -128.3 142.91 51.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 0.0 110.769 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.37 140.92 11.92 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.58 -179.6 30.81 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.024 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -129.07 141.15 51.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -128.28 147.15 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -115.3 132.11 56.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -112.53 130.26 56.07 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.35 128.97 34.18 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.058 0.849 . . . . 0.0 110.86 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.26 143.14 32.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.866 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -89.88 153.42 20.65 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.64 151.52 4.02 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.239 -171.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 66.03 29.81 9.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.192 -0.504 . . . . 0.0 111.804 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.583 ' CE ' HG23 ' A' ' 135' ' ' VAL . 69.1 mtm -151.05 174.03 13.65 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -111.44 147.78 34.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.484 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -77.88 164.17 25.39 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.78 151.78 51.92 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.021 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.35 128.14 7.48 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -121.69 143.21 15.71 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.868 -173.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.1 133.77 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.556 ' C ' HD22 ' A' ' 26' ' ' LEU . 29.0 t30 -126.52 133.7 51.07 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.073 0.233 . . . . 0.0 111.574 -174.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 25' ' ' ASN . 4.5 mm? -118.93 136.25 54.17 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -136.7 139.08 41.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.428 . . . . 0.0 111.632 -172.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.18 137.88 54.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.484 ' HG2' HG22 ' A' ' 40' ' ' ILE . 36.7 mtm180 -133.16 144.14 49.68 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -107.11 142.18 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.583 ' HG3' HG21 ' A' ' 2' ' ' THR . 77.6 mm-40 -92.78 127.65 38.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.214 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -137.03 153.46 50.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.883 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -74.77 -178.56 3.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.87 -36.62 65.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -91.6 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -170.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -102.81 135.06 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 111.891 164.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.03 156.76 29.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.119 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.48 140.15 16.48 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -101.58 125.17 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.415 0.608 . . . . 0.0 109.427 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.505 HD11 ' CG1' ' A' ' 82' ' ' VAL . 44.8 pt -125.8 144.87 34.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.248 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 140.58 9.26 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.44 ' OG ' ' ND2' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -142.05 146.03 35.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.395 -175.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.404 ' HD1' ' HH ' ' A' ' 63' ' ' TYR . 91.6 m-85 -119.61 132.69 55.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.445 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -126.97 133.84 50.5 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.126 0.266 . . . . 0.0 110.805 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -127.16 135.7 51.05 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.9 p -103.44 148.23 26.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.196 0.522 . . . . 0.0 111.294 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -143.08 152.73 42.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.578 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -133.08 136.92 46.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.176 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.5 p -166.22 34.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.242 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -60.25 -40.19 89.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.725 0.298 . . . . 0.0 110.586 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.3 m -128.48 139.03 52.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.283 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.91 94.12 9.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.518 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.0 t -141.05 136.85 32.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.522 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.0 p -62.43 -28.66 69.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.029 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.79 -38.4 66.14 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.775 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -147.87 88.83 1.7 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.404 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -135.72 125.42 25.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.9 t30 55.91 43.24 27.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.206 0.527 . . . . 0.0 110.776 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -91.37 152.63 20.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.504 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t30 61.79 109.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -115.32 145.03 42.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.008 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -134.22 135.95 43.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.871 0.367 . . . . 0.0 110.499 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' HH ' ' HD1' ' A' ' 43' ' ' PHE . 67.3 t80 -135.22 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.91 141.47 12.2 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.711 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.79 122.5 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.64 HG22 ' HA3' ' A' ' 84' ' ' GLY . 70.0 p -123.28 151.11 42.72 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.088 0.242 . . . . 0.0 111.14 -177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.05 146.29 30.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.435 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.04 171.14 42.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.071 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -97.33 124.0 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.314 2.009 . . . . 0.0 112.718 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.64 145.41 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.395 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -117.22 123.64 47.13 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -100.97 108.75 20.56 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.465 0.65 . . . . 0.0 112.244 -171.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 77' ' ' ALA . 22.8 pt -96.51 131.76 42.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.683 166.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -61.26 -14.98 30.31 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -71.78 175.22 5.92 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 170.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -87.47 40.77 0.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.212 0.53 . . . . 0.0 110.987 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.699 ' HB3' HD11 ' A' ' 73' ' ' ILE . . . -122.26 23.02 9.97 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.17 -174.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t -68.78 146.58 52.78 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -166.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.02 133.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.144 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -128.18 144.03 51.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.9 137.81 10.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.505 ' CG1' HD11 ' A' ' 40' ' ' ILE . 35.4 m -135.44 155.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.58 140.99 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.64 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.24 175.06 26.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.534 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.17 129.96 69.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.9 137.57 13.61 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.76 138.29 54.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.91 139.43 12.03 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -134.49 138.52 44.76 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.84 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -109.08 134.17 52.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.409 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -104.37 140.41 37.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 110.844 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 94' ' ' GLU . 25.1 m -107.99 137.91 45.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.233 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.4 p -112.3 30.11 7.35 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' H ' HG22 ' A' ' 92' ' ' THR . 84.2 tt0 54.79 88.13 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -132.29 166.91 25.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.979 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -45.42 -29.87 5.18 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.477 1.452 . . . . 0.0 112.691 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.1 m -81.69 140.27 34.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.197 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -93.25 112.39 24.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.956 0.407 . . . . 0.0 110.311 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -138.33 156.41 47.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.893 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -129.29 159.1 37.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.713 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.87 122.04 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.186 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 t -134.64 153.37 52.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.889 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -126.36 143.27 51.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -137.14 147.2 45.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.649 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -117.09 146.39 43.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 111.141 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.21 167.02 26.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.22 127.62 49.09 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -112.44 145.38 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 110.898 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -129.82 138.38 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.54 156.34 26.78 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.613 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.97 148.93 32.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.11 157.35 27.3 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.568 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.6 mp -109.87 148.96 30.58 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -121.86 139.19 53.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.806 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.61 109.94 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.456 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 7.4 p30 -133.5 124.31 17.98 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.48 ' HG2' HG13 ' A' ' 121' ' ' VAL . 3.8 Cg_endo -95.37 176.2 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.526 2.151 . . . . 0.0 109.534 156.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -65.72 150.48 48.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.779 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 78.35 -167.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -61.02 -11.99 10.07 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 121' ' ' VAL . 9.4 p -78.75 17.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -170.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.456 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.44 138.91 40.13 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.574 -0.704 . . . . 0.0 109.883 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HG ' HG12 ' A' ' 144' ' ' VAL . 4.3 mp -132.62 151.83 51.83 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.322 -170.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.06 147.35 46.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.316 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.54 134.62 50.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -140.17 154.04 46.82 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.036 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.84 140.88 50.12 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -128.6 140.09 51.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.787 0.327 . . . . 0.0 110.562 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -124.51 135.99 53.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.081 0.467 . . . . 0.0 111.042 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 t -116.19 144.69 43.85 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -89.35 146.15 24.88 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.805 0.691 . . . . 0.0 109.58 -161.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.79 101.1 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.817 1.294 . . . . 0.0 112.682 -144.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.71 -176.8 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 112.195 -2.275 . . . . 0.0 106.777 158.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 84.2 p -52.13 -13.1 0.28 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.583 HG23 ' CE ' ' A' ' 18' ' ' MET . 9.7 p -119.25 133.54 65.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 118.295 0.498 . . . . 0.0 109.733 168.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -113.05 139.15 48.93 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.28 128.26 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.722 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.2 116.79 2.79 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.47 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 22.0 m -126.06 134.05 51.52 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.778 0.789 . . . . 0.0 111.355 -173.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.8 t90 -120.32 128.48 53.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 25' ' ' ASN . 17.1 tt -130.23 144.53 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.225 -173.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.17 132.17 45.94 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.78 153.16 23.02 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.545 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.481 HG12 ' HG ' ' A' ' 123' ' ' LEU . 34.5 m -125.18 144.67 34.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.19 178.13 32.02 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.195 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -132.52 173.21 11.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.695 -0.752 . . . . 0.0 109.927 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.622 ' CD ' HG22 ' A' ' 4' ' ' THR . 28.5 mmt85 -117.83 149.09 41.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.39 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.574 -178.943 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.0 p -122.98 160.98 25.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.577 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p -162.28 162.73 28.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.071 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -123.17 156.15 35.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.389 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.91 131.44 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.162 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.0 m -128.19 143.0 51.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.838 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 140.9 12.23 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.71 -173.28 29.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.22 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -124.08 156.22 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.136 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.707 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -136.41 145.94 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.483 -176.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -128.18 131.97 48.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -114.77 131.74 56.69 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.376 0.422 . . . . 0.0 110.413 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.05 126.59 36.18 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.8 0.687 . . . . 0.0 110.923 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.4 143.2 33.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.801 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.77 153.06 20.98 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.0 109.49 0.66 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.126 -170.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 165.08 -54.55 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.6 mtt -128.24 171.99 11.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.79 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -100.23 165.09 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 111.154 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -60.73 167.12 2.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.693 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -134.19 158.23 44.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.801 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.18 151.58 16.88 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.65 143.3 12.47 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.089 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.33 139.08 50.3 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -127.99 133.47 49.17 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.602 -174.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.07 137.84 54.47 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -135.97 147.11 47.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.094 0.473 . . . . 0.0 111.542 -173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -132.61 143.66 49.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.83 144.04 37.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.696 0.284 . . . . 0.0 111.018 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -105.89 143.17 34.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.56 125.8 37.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.5 0.667 . . . . 0.0 110.852 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -125.58 153.29 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.889 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.62 -178.32 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.305 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -53.07 -35.51 59.65 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.0 m -92.07 -25.94 0.28 Allowed Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -102.85 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.639 1.56 . . . . 0.0 112.39 162.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 71' ' ' TYR . 78.1 mt -78.12 164.25 25.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.073 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.27 140.13 15.55 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.73 125.02 55.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 117.649 0.724 . . . . 0.0 109.699 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 70' ' ' ALA . 71.8 mt -118.73 138.13 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.26 135.45 8.33 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -129.5 142.01 50.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.027 0.414 . . . . 0.0 111.068 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.37 128.25 55.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.7 m -120.82 131.26 54.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.577 0.227 . . . . 0.0 110.661 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.04 137.13 55.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.189 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -97.69 147.58 24.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.148 0.499 . . . . 0.0 111.067 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -116.63 145.72 43.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -104.8 -177.33 3.33 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 124.295 0.997 . . . . 0.0 110.294 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.0 m -55.99 147.82 18.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.007 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -167.3 -68.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.01 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.2 m -134.57 83.91 2.07 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.23 158.1 44.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.432 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 m -57.6 159.62 4.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.113 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.4 p -58.93 -35.0 72.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.349 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.11 -36.86 64.03 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -88.45 118.16 27.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.952 0.406 . . . . 0.0 111.873 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -125.42 146.91 49.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.039 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -111.83 132.9 54.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 110.801 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -137.07 148.35 46.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.778 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 66.91 140.12 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -126.17 148.27 49.46 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -151.73 157.9 42.64 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.844 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -117.66 134.74 54.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.149 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.84 132.08 7.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.9 mm -119.03 118.44 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.653 HG22 ' HA3' ' A' ' 84' ' ' GLY . 80.5 p -123.22 151.33 42.37 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.907 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.04 146.17 32.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.08 168.18 40.63 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.116 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.22 124.33 0.28 Allowed 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.394 2.063 . . . . 0.0 112.81 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.8 143.01 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.463 170.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.452 ' CD1' HD22 ' A' ' 37' ' ' LEU . 91.3 m-85 -117.11 128.86 55.55 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -95.9 108.96 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.194 0.521 . . . . 0.0 112.346 -169.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.87 HG21 ' HB3' ' A' ' 77' ' ' ALA . 49.3 mm -96.39 131.39 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.475 171.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -61.63 -35.53 78.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.28 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -78.98 -168.61 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 44.3 p90 -85.49 45.05 1.15 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.356 0.598 . . . . 0.0 110.477 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.87 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -122.03 22.41 10.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.223 -175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -68.61 154.9 41.04 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -173.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.26 129.88 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.842 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -138.87 142.47 38.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.218 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.04 137.84 9.75 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.56 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.9 m -133.8 156.71 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 111.014 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.94 140.9 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.653 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.07 26.71 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.798 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.14 133.39 60.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.7 131.69 9.66 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -118.71 118.99 33.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.52 149.96 16.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -161.47 168.03 24.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.642 0.258 . . . . 0.0 110.947 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -104.56 127.55 52.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.451 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -116.42 136.72 52.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.389 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.566 HG21 ' O ' ' A' ' 95' ' ' TYR . 34.9 m -98.35 142.72 29.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.384 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.3 m -55.8 -41.91 74.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.893 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -104.35 -71.62 0.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.293 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.566 ' O ' HG21 ' A' ' 92' ' ' THR . 38.2 m-85 -156.62 154.42 26.8 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.486 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.96 112.99 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.291 1.327 . . . . 0.0 111.816 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.8 m -57.34 -42.69 82.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.543 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -174.1 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.449 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -98.58 137.39 37.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.534 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -137.02 134.71 36.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.896 0.379 . . . . 0.0 110.602 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -59.07 -34.32 71.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.419 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 103' ' ' SER . 1.2 m 67.18 169.94 0.25 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.72 0.295 . . . . 0.0 110.247 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 102' ' ' THR . 53.3 p -68.98 152.13 45.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.109 0.481 . . . . 0.0 111.239 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -152.8 142.75 22.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.553 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.66 142.97 32.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.023 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.18 157.67 26.57 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.62 125.45 51.01 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.5 m -109.61 135.4 50.64 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.936 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -126.75 137.26 53.21 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.55 27.72 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.884 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.39 148.83 32.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.99 164.63 29.22 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.073 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -108.97 146.94 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -136.25 131.92 35.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.532 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -137.85 125.2 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -133.92 124.56 17.71 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -98.08 176.18 0.49 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.57 2.18 . . . . 0.0 109.615 158.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.3 ttm -56.12 145.87 24.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.114 0.483 . . . . 0.0 111.55 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 74.26 -157.12 0.06 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.383 0.673 . . . . 0.0 111.17 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.02 -11.32 13.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.5 t -78.54 17.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.563 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.15 135.96 44.67 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.309 -0.869 . . . . 0.0 110.212 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.623 HD11 HG12 ' A' ' 144' ' ' VAL . 4.4 mm? -125.49 146.21 49.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -171.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -137.14 138.32 40.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -128.31 133.92 48.82 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.2 m -140.05 154.14 46.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.599 -0.441 . . . . 0.0 112.015 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -123.81 141.89 51.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.67 149.85 46.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.981 0.419 . . . . 0.0 110.383 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -128.07 136.03 50.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.484 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -115.56 144.7 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -89.31 145.96 25.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -158.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 132' ' ' ILE . 12.5 tt -87.97 97.62 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 123.512 1.625 . . . . 0.0 113.655 -146.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.79 -176.77 5.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 112.144 -2.298 . . . . 0.0 107.476 157.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -52.22 -14.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.83 -0.544 . . . . 0.0 112.325 -175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.29 129.52 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.335 0.516 . . . . 0.0 109.897 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -115.05 139.18 50.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.18 132.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.816 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 117.76 3.06 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.0 m -126.15 134.26 51.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.798 0.799 . . . . 0.0 110.966 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -123.81 138.08 54.56 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.707 HG22 ' CB ' ' A' ' 10' ' ' ALA . 36.3 pt -132.52 151.14 34.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 O-C-N 123.141 0.276 . . . . 0.0 111.411 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.1 131.11 27.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.432 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -140.8 153.29 23.64 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.991 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.623 HG12 HD11 ' A' ' 123' ' ' LEU . 26.8 m -119.38 143.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.06 178.12 31.92 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -142.08 169.38 17.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.187 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -118.02 146.51 43.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.338 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 66.5 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.558 -179.163 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.6 p -124.03 165.48 17.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.419 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p -152.31 160.65 43.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.992 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.6 p -125.24 156.07 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.125 0.488 . . . . 0.0 110.83 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.27 126.77 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.377 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.17 140.94 12.2 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.9 174.81 31.62 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.217 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -116.68 138.95 51.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.91 -0.645 . . . . 0.0 109.597 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -117.41 138.82 51.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.089 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -127.71 131.97 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -111.36 145.1 39.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.64 137.42 37.83 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.891 0.744 . . . . 0.0 111.562 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -109.82 143.44 39.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.0 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -89.7 153.48 20.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.64 146.8 7.11 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.259 -170.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 63.62 40.0 8.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.276 -0.462 . . . . 0.0 110.967 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.5 mtp -148.35 171.59 15.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -108.18 138.95 43.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 64.7 mttp -65.29 164.15 14.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.064 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.8 mtt -112.72 144.38 42.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.366 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 137.44 12.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.94 143.14 14.55 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.866 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -107.18 134.42 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -125.44 133.12 52.56 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.374 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.0 tp -121.55 134.76 55.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.253 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -128.48 148.79 50.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.316 0.579 . . . . 0.0 111.86 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -126.3 140.05 52.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.744 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.55 ' HG2' HG22 ' A' ' 40' ' ' ILE . 38.0 mtp180 -139.48 144.14 37.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.751 -173.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.93 143.1 44.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.67 128.27 38.46 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -129.86 153.49 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.402 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.69 -178.51 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.921 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -52.87 -36.27 58.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.429 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 m -93.71 -25.81 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 135.16 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.692 1.594 . . . . 0.0 112.219 165.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.97 160.69 28.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.82 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.12 140.3 22.08 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.48 124.97 56.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 117.482 0.641 . . . . 0.0 109.36 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.55 HG22 ' HG2' ' A' ' 29' ' ' ARG . 46.2 pt -128.27 143.45 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.391 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.35 145.31 16.1 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 t -137.71 141.19 41.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.167 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HD2' ' HH ' ' A' ' 63' ' ' TYR . 93.2 m-85 -113.53 131.58 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -125.84 135.77 52.33 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.678 0.275 . . . . 0.0 110.988 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -126.99 131.93 50.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.337 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 m -112.78 147.73 36.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.001 0.429 . . . . 0.0 111.41 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -134.35 141.32 46.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.181 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -133.94 150.81 51.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.252 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 t -141.62 129.14 21.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.728 0.299 . . . . 0.0 110.518 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -61.38 -42.07 98.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 110.529 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.2 p -133.37 164.14 27.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.93 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.52 93.84 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.327 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.6 t -166.6 140.53 4.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.651 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.2 m -60.03 -35.63 75.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.281 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.73 -29.04 69.91 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.382 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.33 115.31 19.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.149 0.474 . . . . 0.0 110.93 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -120.49 139.76 52.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.332 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -102.3 129.42 48.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 110.456 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -59.09 -33.57 70.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.022 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -60.88 109.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.58 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -116.37 133.42 56.04 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -123.58 138.64 54.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.014 0.435 . . . . 0.0 111.118 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.467 ' HH ' ' HD2' ' A' ' 43' ' ' PHE . 71.7 t80 -138.39 130.52 28.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.468 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.09 148.67 20.04 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.941 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.5 123.4 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 t -123.5 155.07 38.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.25 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.51 152.92 41.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 171.14 42.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.93 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -96.58 125.61 0.27 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.232 1.955 . . . . 0.0 112.502 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.73 144.2 32.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.767 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -112.67 159.23 19.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.4 mtm-85 -95.29 135.39 36.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.801 0.81 . . . . 0.0 112.242 -159.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.6 tt -73.73 130.95 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.042 -172.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -94.72 -43.6 8.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.849 170.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -173.75 96.49 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.073 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 53.27 26.98 5.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.627 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.22 22.4 10.16 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' HD12 ' A' ' 113' ' ' LEU . 2.6 t -68.73 152.5 45.24 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -172.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.3 tt -154.59 133.82 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.298 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.72 150.03 44.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.444 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.03 137.87 9.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.11 152.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.264 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.53 141.18 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.11 175.14 26.64 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.9 129.29 73.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.94 143.94 17.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -134.84 146.98 49.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.862 0.331 . . . . 0.0 110.705 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.8 149.64 17.3 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -135.43 139.21 43.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.582 0.23 . . . . 0.0 110.463 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.56 141.22 45.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.852 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -132.71 136.17 46.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.989 0.423 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 t -108.21 159.14 16.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.269 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.4 m -118.56 127.75 53.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.35 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 45.71 23.26 0.14 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -139.46 77.83 28.25 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -87.95 96.99 0.41 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.733 1.622 . . . . 0.0 112.062 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -137.76 158.19 44.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 111.301 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 51.3 -91.65 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.649 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -111.62 134.3 53.29 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 118.615 0.643 . . . . 0.0 110.879 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -61.92 -44.05 97.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.49 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -152.67 151.17 30.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.615 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 m -126.84 137.34 53.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.946 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.5 p -147.94 156.12 42.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.224 0.535 . . . . 0.0 111.84 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.06 144.17 29.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.28 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -107.34 147.1 30.74 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.146 0.279 . . . . 0.0 111.173 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 162.84 27.14 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.33 127.08 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.929 0.364 . . . . 0.0 110.189 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.4 t -115.6 138.11 51.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.255 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -141.34 149.39 41.1 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.16 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.14 174.44 36.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.99 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.86 33.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.71 155.98 26.09 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.424 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 78' ' ' SER . 6.9 tp -109.06 145.85 34.95 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -144.24 143.63 31.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.286 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -135.71 129.9 33.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 172.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.404 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 9.6 p-10 -141.2 124.62 9.97 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -170.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -102.32 176.19 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.572 2.182 . . . . 0.0 109.252 157.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.2 mtt -55.53 167.17 0.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.872 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 65.45 -173.79 0.18 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.866 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.69 -11.31 4.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.6 t -78.44 17.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -167.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.404 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.32 134.13 48.06 Favored 'General case' 0 C--N 1.341 0.232 0 O-C-N 121.535 -0.728 . . . . 0.0 109.882 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 123' ' ' LEU . 4.6 mp -133.42 148.42 51.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.637 -171.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.11 148.04 46.43 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.526 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.77 134.67 47.07 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -140.11 154.12 46.92 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.677 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -117.57 139.95 50.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.01 151.06 46.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.959 0.409 . . . . 0.0 110.611 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -127.48 136.1 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.283 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.9 t -113.95 144.75 42.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 146.16 24.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.131 0.491 . . . . 0.0 109.733 -159.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -87.94 102.64 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.728 1.251 . . . . 0.0 112.908 -144.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -89.68 -176.76 5.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 112.436 -2.166 . . . . 0.0 107.438 156.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.9 p -52.33 -14.21 0.44 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.797 -0.564 . . . . 0.0 112.338 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 135' ' ' VAL . 35.3 m -122.16 126.9 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.344 0.52 . . . . 0.0 110.147 168.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -103.54 139.17 39.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.149 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.14 134.01 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.594 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.08 122.14 4.55 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -125.99 134.2 51.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.496 0.648 . . . . 0.0 111.251 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -115.14 132.94 56.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' A' ' 10' ' ' ALA . 44.9 pt -128.56 145.02 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -176.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.81 131.63 37.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.278 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.89 153.1 23.04 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.752 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.35 144.82 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.15 177.95 32.09 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.437 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -140.06 166.24 25.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.52 -0.84 . . . . 0.0 110.005 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -117.97 149.08 41.53 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.324 0.39 . . . . 0.0 110.554 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.6 t80 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.65 -179.177 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.7 p -116.33 -36.77 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -150.88 134.29 16.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.571 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.2 m -130.28 140.29 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.235 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.08 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.356 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.706 HG22 ' HA3' ' A' ' 145' ' ' GLY . 57.8 p -128.13 143.31 51.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.47 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.1 140.79 12.35 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.4 172.62 29.4 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.184 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.49 138.39 50.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.744 -0.728 . . . . 0.0 109.108 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -119.54 140.03 51.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.658 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.96 131.93 54.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -114.3 135.14 54.39 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.253 0.346 . . . . 0.0 110.375 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -84.31 123.16 29.87 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.995 0.809 . . . . 0.0 111.177 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.12 143.15 33.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.471 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -89.69 153.2 20.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.07 109.59 0.69 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.103 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 169.58 -54.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.3 mtm -128.92 174.08 9.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.956 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -91.97 162.01 14.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.759 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -56.65 168.54 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.543 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -126.48 159.63 32.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.734 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.32 146.96 17.86 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.33 143.21 13.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.009 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -108.26 132.57 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -123.88 132.96 53.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.385 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 26' ' ' LEU . 8.2 tt -125.87 131.04 52.45 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HD3' HD11 ' A' ' 40' ' ' ILE . 60.5 mttp -128.07 146.54 50.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.129 0.49 . . . . 0.0 111.887 -174.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.35 132.78 55.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HD3' HD12 ' A' ' 40' ' ' ILE . 75.2 mtm180 -135.91 144.0 45.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.175 0.297 . . . . 0.0 111.357 -175.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -113.0 139.03 49.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.81 128.62 38.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.342 0.591 . . . . 0.0 110.657 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -134.76 153.4 52.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.789 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.46 -178.6 3.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.671 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -53.92 -33.47 56.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.39 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -94.27 -25.85 0.26 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 134.94 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.748 1.632 . . . . 0.0 111.904 164.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.17 156.0 30.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.191 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.07 140.26 15.08 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.58 127.27 56.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.47 0.635 . . . . 0.0 109.877 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.51 HD12 ' HD3' ' A' ' 29' ' ' ARG . 17.6 tt -124.4 135.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.58 134.48 7.7 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t -129.28 139.06 51.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.84 0.32 . . . . 0.0 111.202 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.11 131.45 56.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -127.95 136.94 52.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -124.85 136.17 53.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.285 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.8 m -112.42 146.95 37.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -138.49 146.5 42.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -129.82 136.84 50.04 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 p -119.26 -26.65 5.82 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -125.2 116.27 21.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.952 0.406 . . . . 0.0 111.034 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.4 m -132.4 141.88 49.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.183 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.58 93.92 7.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.349 . . . . 0.0 110.398 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.0 p -159.45 173.11 16.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.461 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -58.87 -36.89 75.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.987 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.83 -33.98 66.12 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.5 t0 80.53 -40.18 0.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.159 0.984 . . . . 0.0 111.948 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -117.15 127.14 53.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.782 0.325 . . . . 0.0 110.646 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -130.51 156.41 44.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.245 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -133.22 124.36 27.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.0 0.428 . . . . 0.0 110.794 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -115.97 144.76 43.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.594 176.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -109.02 125.96 52.63 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -125.8 135.92 52.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.455 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -137.1 117.89 14.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.355 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.43 138.43 10.15 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.666 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.1 126.92 73.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.672 HG22 ' HA3' ' A' ' 84' ' ' GLY . 68.0 p -123.26 152.03 41.75 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.255 0.347 . . . . 0.0 110.172 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.99 146.49 31.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.545 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -167.95 170.95 42.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.267 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -98.01 123.67 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.486 2.124 . . . . 0.0 112.667 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 145.56 31.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.886 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -122.98 132.51 54.18 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -95.83 112.4 24.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -168.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.918 HG21 ' HB3' ' A' ' 77' ' ' ALA . 43.4 mm -96.4 131.41 43.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.505 169.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -61.88 -29.81 70.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -118.55 86.62 2.57 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.3 t90 45.64 25.55 0.27 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 170.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.918 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -122.24 22.49 10.12 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m -68.51 151.99 46.02 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.25 129.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -133.55 145.23 49.92 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.9 137.69 9.71 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.545 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.1 m -134.75 154.56 37.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.722 0.296 . . . . 0.0 111.181 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.19 140.75 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.672 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.2 175.09 26.75 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.76 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.81 130.5 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.09 136.08 12.41 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.03 142.82 13.97 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -127.37 137.05 52.67 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -110.32 131.04 55.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.715 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.65 126.33 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.3 m -86.61 130.73 34.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.463 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.9 p -74.28 -35.99 63.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.394 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -70.61 -69.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.934 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -176.34 149.42 0.94 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.221 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.52 53.93 0.84 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.702 1.601 . . . . 0.0 111.928 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.8 m -56.77 -42.15 78.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.131 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.2 -58.26 3.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.021 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -135.24 146.52 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.874 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -56.01 -40.59 73.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -161.07 165.71 29.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.403 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.6 m -116.12 135.35 54.01 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.9 p -135.51 154.35 51.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.251 0.548 . . . . 0.0 111.651 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -159.86 159.69 32.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.304 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -130.45 153.98 48.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.972 0.415 . . . . 0.0 111.405 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.11 26.16 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.86 126.99 53.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.6 m -106.38 137.2 44.77 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.897 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.44 132.23 48.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -143.16 157.14 26.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.874 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.52 148.86 32.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.85 162.4 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.504 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -108.97 149.42 29.24 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -134.94 137.01 42.71 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.488 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.03 127.81 16.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.451 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 10.1 p-10 -142.07 124.51 9.2 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -100.72 176.16 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.759 2.306 . . . . 0.0 109.385 156.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.455 ' O ' HG22 ' A' ' 121' ' ' VAL . 71.4 mtm -53.99 177.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 63.73 -175.06 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.236 0.541 . . . . 0.0 112.193 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -62.95 -11.39 18.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 118' ' ' MET . 26.8 m -78.11 17.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -165.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.451 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -103.92 138.38 40.57 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.454 0.57 . . . . 0.0 109.798 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.408 ' HG ' HG12 ' A' ' 144' ' ' VAL . 5.3 mp -132.69 153.83 50.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.009 0.433 . . . . 0.0 111.97 -168.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -137.16 140.4 41.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.032 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.74 132.24 53.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.8 p -140.13 154.17 46.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.88 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -123.79 141.02 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -120.33 138.6 53.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.539 0.524 . . . . 0.0 110.451 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -123.96 135.0 53.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.079 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -118.26 144.93 45.42 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -89.29 146.53 24.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -157.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.507 HG23 ' CG ' ' A' ' 136' ' ' ASP . 73.6 mt -87.7 97.07 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.906 1.336 . . . . 0.0 112.215 -144.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.79 -176.92 5.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.046 -2.343 . . . . 0.0 107.446 157.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.8 p -52.27 -13.46 0.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.04 132.11 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.386 0.539 . . . . 0.0 110.195 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.507 ' CG ' HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -108.72 139.2 43.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.23 -0.414 . . . . 0.0 109.991 -178.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.13 122.72 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.13 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.31 114.74 2.22 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -125.81 134.13 51.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.752 0.776 . . . . 0.0 111.244 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.61 131.23 56.77 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 10' ' ' ALA . 61.9 mt -123.06 134.81 65.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 O-C-N 123.182 0.301 . . . . 0.0 110.259 -175.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.4 125.1 40.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.0 153.2 21.66 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.855 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.408 HG12 ' HG ' ' A' ' 123' ' ' LEU . 35.8 m -122.26 146.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.706 ' HA3' HG22 ' A' ' 6' ' ' THR . . . -147.28 173.13 27.53 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.242 -174.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -128.88 154.64 46.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.465 -1.368 . . . . 0.0 109.376 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -118.0 149.11 41.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.966 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.5 t80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.033 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.4 p -83.37 164.13 20.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.692 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t -157.62 155.07 29.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.658 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -128.02 140.66 51.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.772 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.68 136.99 58.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.036 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.95 140.61 11.94 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 173.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 168.4 30.1 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.365 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -121.94 135.87 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -127.59 149.03 50.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.19 134.39 54.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.18 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -112.86 142.59 45.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 142.1 37.66 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.649 0.593 . . . . 0.0 110.93 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -97.41 143.21 28.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.423 -174.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -89.7 153.13 20.95 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.68 142.47 11.93 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.092 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 62.47 35.31 14.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.691 0.396 . . . . 0.0 111.394 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.0 mtt -149.76 167.85 25.34 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -107.68 146.08 32.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.72 0.295 . . . . 0.0 110.921 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 48.9 pttt -56.42 172.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.564 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.65 159.29 40.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.856 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.17 142.11 14.73 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.57 143.15 14.74 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.64 135.19 54.42 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.617 ' OD1' HG23 ' A' ' 44' ' ' THR . 92.9 m-20 -126.58 133.22 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 111.367 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.0 tp -120.03 134.95 55.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.019 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -130.22 145.77 51.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 112.066 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -120.34 137.82 54.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.042 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -135.26 144.28 46.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.834 0.35 . . . . 0.0 111.378 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -106.64 142.19 36.69 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -92.67 126.93 37.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.311 0.577 . . . . 0.0 110.373 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.99 153.62 41.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.735 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.38 -178.42 3.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.601 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -57.2 -35.42 69.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -87.04 -26.11 0.34 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -102.86 130.17 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.569 1.513 . . . . 0.0 112.105 160.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 69' ' ' PRO . 77.2 mt -77.74 155.24 31.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.996 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.64 140.06 18.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -99.79 124.93 53.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 117.397 0.599 . . . . 0.0 109.83 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.471 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.3 mt -120.27 132.88 68.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.77 134.17 8.61 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.3 p -127.36 141.98 51.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -113.01 128.08 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.769 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.617 HG23 ' OD1' ' A' ' 25' ' ' ASN . 55.0 m -124.45 132.7 53.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.12 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -127.09 136.03 51.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.487 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 m -117.81 145.21 44.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 110.955 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -130.13 141.69 50.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.006 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -109.21 137.68 46.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.193 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.7 p -65.41 157.86 28.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.532 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -57.67 139.23 54.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.628 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.5 p -130.61 162.67 28.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.104 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.13 94.03 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.167 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 m -161.9 174.26 13.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.552 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.8 p -58.97 -31.23 68.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.58 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.84 -30.18 68.46 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.027 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 75.35 -75.18 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.308 0.643 . . . . 0.0 111.31 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -135.26 161.86 34.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.806 0.336 . . . . 0.0 110.962 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 56.93 54.02 7.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.54 0.686 . . . . 0.0 110.591 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -55.49 -39.34 70.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.034 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -144.83 158.85 43.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 111.18 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -125.97 147.85 49.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.082 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -123.99 135.96 53.98 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.115 0.483 . . . . 0.0 110.919 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -128.8 119.15 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.221 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.19 135.18 8.19 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.272 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.02 117.29 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.575 HG22 ' HB ' ' A' ' 82' ' ' VAL . 2.0 m -123.28 148.65 45.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.768 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.82 31.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.13 168.93 41.14 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.114 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HB2' HD13 ' A' ' 37' ' ' LEU . 71.8 Cg_endo -98.41 122.9 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.555 2.17 . . . . 0.0 113.062 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.9 146.56 30.76 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.328 170.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -121.02 128.93 53.14 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -95.84 108.91 21.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.385 0.612 . . . . 0.0 112.281 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 77' ' ' ALA . 79.8 mt -96.27 131.29 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.177 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -61.43 -35.0 76.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.162 -174.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -69.68 -178.2 1.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -87.4 40.84 0.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 110.778 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.65 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -122.19 22.51 10.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.26 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.2 p -68.68 165.07 20.19 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -171.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.59 129.99 14.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.539 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -131.18 140.26 49.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.0 137.75 11.3 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 66' ' ' THR . 35.1 m -136.46 152.64 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.974 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 109' ' ' TYR . 35.9 m -134.17 140.95 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.455 ' N ' HG23 ' A' ' 66' ' ' THR . . . -147.17 174.95 26.78 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.57 -176.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.54 133.09 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.64 131.32 9.45 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -114.92 132.28 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -115.95 127.85 7.73 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -126.43 145.27 50.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.595 0.236 . . . . 0.0 110.435 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -88.45 145.0 26.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.02 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -96.9 117.96 32.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.982 0.42 . . . . 0.0 110.398 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.8 m -108.12 149.07 28.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.365 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.9 m -58.4 151.12 20.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.066 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.92 -37.62 85.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.907 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -56.02 -55.59 39.82 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.114 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -42.13 126.95 3.84 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.932 1.755 . . . . 0.0 113.141 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.8 m -60.09 -37.56 80.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.335 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -90.63 135.91 33.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 111.225 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -113.35 156.06 24.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 61.2 71.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.394 0.616 . . . . 0.0 110.151 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.29 -41.36 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.452 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 66.0 p -131.21 153.8 49.1 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.005 0.431 . . . . 0.0 111.108 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.3 m -140.98 145.04 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.144 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -150.01 142.11 24.01 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.678 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.11 142.89 39.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.299 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.12 162.36 27.17 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -108.5 125.76 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.6 m -108.93 137.94 46.05 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.63 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.585 ' CD2' HG12 ' A' ' 83' ' ' VAL . 81.0 m-85 -125.92 138.89 53.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.73 157.64 27.33 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.841 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.8 148.78 32.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.82 160.37 28.47 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.102 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.5 mp -111.96 147.11 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.57 141.07 41.34 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.934 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -133.12 116.29 16.11 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -117.62 124.24 29.07 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.38 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -107.03 176.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.102 2.535 . . . . 0.0 109.423 157.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.33 170.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.182 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 65.39 -171.35 0.19 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.056 0.455 . . . . 0.0 111.956 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -61.51 -11.3 10.32 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 121' ' ' VAL . 6.3 t -78.38 18.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.13 0.572 . . . . 0.0 112.431 -164.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.91 137.61 41.66 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.233 -0.917 . . . . 0.0 109.662 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.77 148.77 50.88 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -168.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -137.13 142.04 42.26 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -126.32 132.14 51.69 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -140.15 154.08 46.86 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.863 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.14 140.6 52.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -121.56 141.67 50.84 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 123.372 0.42 . . . . 0.0 110.093 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -125.9 132.84 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.575 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.1 m -115.77 144.57 43.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -89.45 146.03 24.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -161.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 132' ' ' ILE . 10.5 tt -87.76 101.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 123.616 1.674 . . . . 0.0 113.697 -146.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -89.74 -176.7 5.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.244 157.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.14 -13.94 0.37 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.821 -0.549 . . . . 0.0 112.354 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.98 132.03 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.392 0.542 . . . . 0.0 109.747 166.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.08 139.22 50.07 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.15 127.68 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.767 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.41 116.1 2.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.525 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 40.1 m -126.1 134.14 51.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.477 0.639 . . . . 0.0 111.235 -175.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -122.64 133.78 54.51 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 17.7 tt -131.6 146.11 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.636 0.255 . . . . 0.0 111.269 -172.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.01 133.95 53.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.38 153.13 21.81 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.074 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.82 140.0 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -138.91 163.89 25.85 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.395 -173.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -134.15 152.33 51.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 113.485 -1.357 . . . . 0.0 108.801 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -136.76 149.0 47.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.531 -179.627 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -132.7 153.75 50.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.511 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 p -159.92 157.59 29.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.907 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.45 HG21 HH21 ' A' ' 29' ' ' ARG . 40.7 m -132.51 139.27 47.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.332 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.58 120.53 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.5 m -128.25 143.09 51.0 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.31 140.86 12.13 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.23 179.81 31.82 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.159 -175.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.6 144.57 46.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -0.622 . . . . 0.0 109.847 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.573 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -122.74 138.52 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.944 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -125.46 131.92 52.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -116.81 145.74 43.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 139.31 38.66 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.827 0.704 . . . . 0.0 111.253 -173.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -106.78 143.31 35.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.115 -177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -89.68 153.41 20.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.5 152.03 3.59 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.602 -0.333 . . . . 0.0 112.392 -168.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 63.75 31.35 14.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.896 -0.652 . . . . 0.0 111.787 -174.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 69.2 mtm -151.19 167.3 28.21 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -109.35 146.18 34.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.848 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 36.8 pttt -54.37 168.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.167 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.8 mtt -117.63 146.38 43.71 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.57 135.29 10.78 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.52 143.15 14.45 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.607 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.514 ' CE2' HD21 ' A' ' 26' ' ' LEU . 62.0 t80 -110.95 135.8 50.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.66 ' HB3' HG22 ' A' ' 44' ' ' THR . 23.0 p30 -131.63 144.57 51.14 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.945 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 24' ' ' PHE . 80.6 mt -124.41 140.51 52.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.239 173.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.16 141.89 51.04 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.043 0.449 . . . . 0.0 111.084 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -121.03 130.21 53.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HD3' HD12 ' A' ' 40' ' ' ILE . 40.0 mtm180 -134.39 144.08 47.99 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.265 0.353 . . . . 0.0 110.657 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -107.49 143.22 36.18 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.68 119.16 31.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.195 0.522 . . . . 0.0 109.981 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.45 153.4 46.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.991 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.7 -178.62 3.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.541 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -56.37 -32.96 65.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.315 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.2 m -93.38 -25.94 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -102.83 136.3 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.728 1.619 . . . . 0.0 111.848 164.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.6 mt -78.06 154.27 31.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.93 140.38 16.38 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.09 127.5 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.501 0.651 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.57 HD12 ' HD3' ' A' ' 29' ' ' ARG . 16.9 tt -123.36 138.39 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.28 139.77 10.58 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 p -135.41 144.93 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.067 0.434 . . . . 0.0 111.424 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -124.68 128.65 49.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.109 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 25' ' ' ASN . 36.8 p -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.855 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -127.28 137.12 52.77 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -111.54 150.73 29.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 111.202 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.24 151.55 50.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.141 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.05 147.0 31.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.116 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.3 p -123.31 138.29 54.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 0.0 110.17 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -150.88 151.24 31.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.612 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 p -75.53 166.97 22.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.06 178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.06 134.29 56.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.446 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 t -157.63 171.58 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.776 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.0 p -59.65 -25.27 64.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.137 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.78 -8.28 63.43 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 119.579 -0.567 . . . . 0.0 113.349 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 59.44 52.68 5.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.069 0.935 . . . . 0.0 110.563 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.7 t80 63.92 139.29 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.185 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -95.35 117.68 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.493 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.426 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 53.2 mttm -102.32 110.02 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.165 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 59' ' ' LYS . 9.4 m120 -133.82 150.24 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.741 175.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -126.13 142.83 51.36 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.689 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -129.9 138.04 50.71 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.17 128.25 41.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.45 128.15 5.29 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 65' ' ' ILE . 7.6 tp -124.65 122.61 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.732 HG22 ' HA3' ' A' ' 84' ' ' GLY . 30.3 p -123.3 154.95 38.17 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.864 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.72 147.6 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.16 42.3 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.512 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -97.29 127.79 0.27 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.452 2.101 . . . . 0.0 112.818 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.66 138.55 36.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.652 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -116.87 128.14 54.96 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -95.85 109.41 21.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.327 0.584 . . . . 0.0 111.852 -170.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 77' ' ' ALA . 79.7 mt -96.31 131.52 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.948 171.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -61.4 -29.22 69.79 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.705 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -73.97 -179.32 3.68 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -86.82 48.24 1.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.598 0.713 . . . . 0.0 110.076 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -122.2 22.62 10.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.003 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t -68.5 148.97 49.81 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -166.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.93 129.95 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.282 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -115.76 133.9 55.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.17 137.71 10.88 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 172.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.77 153.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 117.559 0.679 . . . . 0.0 111.976 -173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.466 HG13 ' CZ ' ' A' ' 107' ' ' PHE . 55.5 t -125.71 140.84 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.732 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.41 174.95 27.0 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.661 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.3 128.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.3 131.26 8.53 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -139.06 155.91 47.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.097 0.448 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.22 150.05 17.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -134.68 146.26 49.32 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -98.63 127.21 44.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.845 0.355 . . . . 0.0 110.424 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -105.42 118.61 36.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.475 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.9 m -108.16 140.52 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.209 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.1 m -121.16 135.45 55.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.592 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 62.17 55.46 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.583 0.706 . . . . 0.0 110.19 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -146.89 162.39 33.48 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.286 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.13 129.17 33.45 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.371 1.381 . . . . 0.0 111.933 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -66.56 -28.1 68.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.059 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -59.76 -31.51 69.72 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -55.89 -39.46 71.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.612 0.244 . . . . 0.0 110.823 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 63.69 144.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.996 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.29 178.41 7.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.803 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -124.62 141.15 52.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.927 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.2 p -140.41 155.89 46.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.182 0.515 . . . . 0.0 111.559 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.92 159.0 26.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.465 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -136.02 159.86 40.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 111.403 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.02 167.11 26.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.466 ' CZ ' HG13 ' A' ' 83' ' ' VAL . 61.0 t80 -93.2 124.86 37.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -113.07 140.55 47.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.039 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.2 139.38 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.5 161.9 28.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.152 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.34 148.94 31.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.368 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.448 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -148.04 162.0 28.68 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.61 -177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.448 HD22 ' C ' ' A' ' 112' ' ' GLY . 4.5 mm? -111.87 152.64 27.73 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -116.47 133.47 55.98 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 111.693 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.56 109.74 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.482 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 13.3 p-10 -140.59 124.71 10.58 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -165.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -101.23 176.14 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.381 2.054 . . . . 0.0 109.258 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.7 mtp -58.69 176.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 61.64 -174.45 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.901 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -60.63 -11.56 7.62 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.8 t -78.4 17.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -167.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.596 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.24 138.02 41.3 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.64 HD11 HG12 ' A' ' 144' ' ' VAL . 4.5 mm? -122.27 145.52 48.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -168.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.66 131.35 44.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.661 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -124.06 129.79 51.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -140.12 154.11 46.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.606 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -121.61 139.98 52.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.94 150.95 46.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.889 0.376 . . . . 0.0 110.742 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -131.84 136.02 47.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -113.32 144.57 42.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.194 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -89.21 146.24 24.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.782 0.676 . . . . 0.0 109.519 -160.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 pt -87.88 98.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 123.309 1.528 . . . . 0.0 114.032 -145.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -89.67 -176.74 5.08 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 112.2 -2.273 . . . . 0.0 106.903 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.3 p -52.32 -12.78 0.28 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.324 -0.86 . . . . 0.0 112.616 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.07 133.89 65.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.334 0.516 . . . . 0.0 109.837 168.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -115.0 139.1 50.13 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -108.18 129.77 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.743 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.23 117.18 2.9 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 169.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.6 m -126.14 134.26 51.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.862 0.831 . . . . 0.0 111.476 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -115.85 135.13 54.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.573 HG22 ' CB ' ' A' ' 10' ' ' ALA . 41.6 pt -130.84 144.71 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.286 -177.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.49 128.69 25.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.471 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.445 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -136.95 153.07 21.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.612 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.64 HG12 HD11 ' A' ' 123' ' ' LEU . 27.0 m -118.01 140.96 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.13 178.1 31.98 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.401 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -139.8 162.78 34.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.444 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -141.52 149.06 40.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.534 -179.675 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.7 m -124.85 -62.16 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.465 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -128.79 148.63 50.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.207 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.4 m -126.0 139.74 53.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.918 0.389 . . . . 0.0 110.353 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.6 122.59 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.608 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.14 143.06 51.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.34 140.83 12.16 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.89 179.29 31.06 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.031 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -131.16 146.44 52.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.628 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -134.27 149.16 50.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.004 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.484 HE21 ' HZ2' ' A' ' 140' ' ' TRP . 13.9 tt0 -116.22 136.3 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -112.9 139.48 48.5 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.79 127.78 32.51 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.88 0.738 . . . . 0.0 111.02 -174.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -85.0 143.31 29.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.582 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -89.74 153.34 20.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 146.89 6.87 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.107 -171.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 61.65 39.07 14.83 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.951 0.442 . . . . 0.0 110.687 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.4 ttm -158.04 153.42 25.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.979 176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -101.94 149.36 24.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 47.4 mtmt -55.71 166.17 0.74 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.741 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -129.04 160.95 31.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.666 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.83 148.22 17.58 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.14 14.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.755 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CE1' HD21 ' A' ' 26' ' ' LEU . 61.8 t80 -112.77 135.06 53.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.527 ' HB3' HD11 ' A' ' 141' ' ' ILE . 51.2 t30 -131.12 138.29 49.44 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.833 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 24' ' ' PHE . 82.4 mt -122.26 139.61 53.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.289 174.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -130.7 142.57 50.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.915 0.388 . . . . 0.0 111.427 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -122.26 133.15 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -137.08 144.09 42.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.079 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.09 143.2 33.59 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.59 125.83 37.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.277 0.561 . . . . 0.0 110.188 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.99 153.38 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.56 -178.6 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.715 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.04 -33.53 65.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.427 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -93.25 -26.06 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -102.77 135.28 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.756 1.637 . . . . 0.0 111.889 164.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 69' ' ' PRO . 4.2 pp -77.97 160.29 28.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.25 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.46 140.21 14.91 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.41 125.51 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.341 0.571 . . . . 0.0 109.935 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' A' ' 70' ' ' ALA . 72.3 mt -119.2 136.12 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.87 136.46 8.57 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.1 p -138.2 149.08 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.41 0.605 . . . . 0.0 111.59 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -122.2 135.56 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.969 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -130.13 140.04 50.83 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.144 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -125.64 136.99 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.59 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 m -101.27 145.31 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -130.95 147.07 52.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.344 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -134.43 136.94 43.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.72 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -105.55 135.85 46.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 111.017 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -134.33 169.1 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.355 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 p -70.24 168.0 16.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.087 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.01 117.78 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.908 0.385 . . . . 0.0 110.447 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.3 p -159.58 178.94 9.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.579 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.2 p -59.48 -24.82 63.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.241 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.76 -14.12 72.51 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.148 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 59.51 48.32 9.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.934 0.867 . . . . 0.0 110.721 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 59.31 30.61 20.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.846 178.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -128.46 117.58 21.59 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.766 0.317 . . . . 0.0 110.745 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -95.08 -68.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.161 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -139.87 172.81 12.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.141 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -125.97 143.09 51.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -135.29 135.97 41.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -130.11 133.12 46.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.83 135.51 7.87 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.89 123.57 67.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.662 HG22 ' HA3' ' A' ' 84' ' ' GLY . 69.5 p -123.23 153.4 40.18 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.052 0.22 . . . . 0.0 111.001 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 143.95 30.23 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.15 169.56 41.52 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.995 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.591 ' HB3' HD13 ' A' ' 37' ' ' LEU . 74.5 Cg_endo -97.27 124.92 0.22 Allowed 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 122.471 2.114 . . . . 0.0 112.914 176.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.611 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.81 147.02 30.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.719 169.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -121.58 129.31 52.77 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 172.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -95.85 108.84 21.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.384 0.612 . . . . 0.0 111.661 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.26 131.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.242 172.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -61.59 -34.72 76.1 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.956 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -65.71 -179.25 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -88.05 37.47 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 111.19 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.482 ' O ' HG23 ' A' ' 79' ' ' ILE . . . -122.07 22.47 10.25 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m -68.92 150.58 47.58 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 77' ' ' ALA . 48.0 pt -136.83 144.38 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.463 -167.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -137.1 147.34 46.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.847 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 137.87 9.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.518 HG12 ' HA3' ' A' ' 68' ' ' GLY . 32.9 m -134.67 156.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.76 0.314 . . . . 0.0 111.015 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.565 HG12 ' CD2' ' A' ' 109' ' ' TYR . 35.5 m -128.49 140.94 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.21 175.08 26.76 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.696 -176.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.75 129.72 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.56 137.88 11.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -139.05 151.8 47.06 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.558 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.07 150.18 17.54 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -125.93 133.08 51.97 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -106.88 131.76 53.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -109.77 139.08 45.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.089 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.6 p -108.02 151.9 25.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 0.0 110.783 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.8 p -72.96 -34.88 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -98.59 143.71 28.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.804 0.335 . . . . 0.0 110.423 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -121.79 80.25 40.83 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.527 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.59 -31.52 5.43 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.395 1.397 . . . . 0.0 112.183 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.2 m -112.58 146.02 39.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.015 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -56.63 -38.72 72.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.847 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -128.9 120.66 26.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.696 0.284 . . . . 0.0 110.461 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -150.5 126.27 10.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.727 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -164.96 158.56 17.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.699 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.5 m -128.82 137.57 51.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.109 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.1 t -139.62 133.09 30.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.932 0.396 . . . . 0.0 111.114 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -140.07 155.14 47.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.5 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -132.06 153.17 50.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.227 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.29 167.07 26.22 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.99 125.91 47.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.1 m -110.24 142.2 42.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.15 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.565 ' CD2' HG12 ' A' ' 83' ' ' VAL . 87.7 m-85 -124.9 137.06 54.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.34 153.43 23.47 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.678 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.25 148.85 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.72 160.04 28.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.377 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.47 HD23 HG22 ' A' ' 79' ' ' ILE . 70.6 mt -108.86 146.04 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -125.75 140.59 52.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 111.805 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -139.97 110.0 6.48 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.458 ' CG ' ' HB1' ' A' ' 122' ' ' ALA . 53.9 m-20 -132.85 124.29 18.63 Favored Pre-proline 0 CA--C 1.529 0.136 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.472 -170.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -102.04 176.21 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.992 2.462 . . . . 0.0 109.255 156.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.439 ' O ' HG22 ' A' ' 121' ' ' VAL . 71.4 mtm -57.77 166.42 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.512 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 65.39 -174.47 0.18 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.16 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -58.74 -11.66 3.41 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 118' ' ' MET . 31.3 m -78.42 17.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -170.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.458 ' HB1' ' CG ' ' A' ' 116' ' ' ASN . . . -104.74 143.04 33.64 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -146.66 155.8 42.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.369 -174.348 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -137.09 148.09 46.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.602 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -126.15 127.53 45.88 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 64.9 p -140.23 154.21 46.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.444 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -120.87 150.13 41.53 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -124.72 137.95 54.31 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.487 0.492 . . . . 0.0 110.525 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -122.42 129.22 51.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.301 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.5 m -120.18 144.56 47.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -89.51 146.12 24.82 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.531 0.519 . . . . 0.0 109.602 -163.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 132' ' ' ILE . 9.8 tt -87.72 95.91 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 123.705 1.717 . . . . 0.0 113.422 -147.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -89.66 -176.84 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.434 157.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -52.01 -16.27 0.72 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.83 -0.544 . . . . 0.0 112.141 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.33 127.51 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 167.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -115.1 139.16 50.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.2 125.96 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.979 -171.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 108.83 1.12 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 167.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.487 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 30.4 m -126.08 134.26 51.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 117.633 0.716 . . . . 0.0 111.352 -174.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.484 ' HZ2' HE21 ' A' ' 11' ' ' GLN . 19.5 p90 -123.21 132.23 53.97 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.628 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 16.4 tt -130.28 143.77 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.188 0.305 . . . . 0.0 111.079 -171.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.2 53.53 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.82 153.11 20.95 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.709 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.3 141.18 47.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.28 178.05 32.14 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.78 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -139.77 171.8 13.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.691 -0.754 . . . . 0.0 110.277 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -117.88 148.95 41.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.503 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.0 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.618 -179.368 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.5 p -122.96 163.85 19.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.407 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -153.99 163.1 40.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 146' ' ' TYR . 19.2 m -129.71 143.11 50.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.511 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.98 127.0 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -128.41 143.17 50.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.899 0.381 . . . . 0.0 111.313 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.67 140.87 12.13 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.78 -175.91 30.23 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.32 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.52 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -127.85 148.92 50.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.508 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -121.85 135.25 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.618 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.93 143.77 44.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -78.46 138.63 38.56 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.674 0.609 . . . . 0.0 111.078 -173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -105.76 143.36 34.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -89.61 153.29 20.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.014 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.76 151.98 3.9 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.168 -171.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 68.57 21.35 8.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.462 -0.369 . . . . 0.0 111.984 -172.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -150.09 166.03 31.0 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -108.59 156.96 18.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.76 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.574 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 54.2 mtmt -62.52 164.68 7.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.206 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.6 mtm -119.55 153.42 35.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.551 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.18 140.64 13.68 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.11 143.19 14.58 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.813 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.12 132.18 54.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -127.12 139.02 53.27 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.165 0.291 . . . . 0.0 111.716 -173.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -127.99 132.81 49.15 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' N ' HD13 ' A' ' 26' ' ' LEU . 39.0 ttpt -136.18 147.65 47.77 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.02 0.438 . . . . 0.0 110.825 -176.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -132.69 151.18 52.04 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.584 ' CB ' HG22 ' A' ' 40' ' ' ILE . 49.6 ptt85 -150.98 144.45 24.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.144 -176.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -105.78 143.24 34.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -92.4 124.38 36.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.308 0.575 . . . . 0.0 110.091 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -121.37 153.32 37.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.871 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.64 -178.46 3.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.843 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -50.66 -42.33 56.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 p -90.26 -25.86 0.3 Allowed Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -102.83 131.95 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.497 1.465 . . . . 0.0 112.218 162.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.4 mt -78.07 162.04 26.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.672 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.19 140.22 23.55 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.32 124.79 54.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 117.821 0.811 . . . . 0.0 109.401 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 29' ' ' ARG . 43.8 pt -117.82 142.7 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -146.34 134.41 5.33 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -141.93 154.92 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.909 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -132.93 141.15 48.2 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -130.07 141.29 50.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.168 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -118.65 134.39 55.15 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.6 m -109.77 145.83 35.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.993 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -133.81 140.19 46.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.268 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -145.23 136.8 25.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.749 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t -141.05 137.38 32.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.788 0.327 . . . . 0.0 110.806 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -93.37 -59.87 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.277 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.5 p -127.84 160.36 32.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.159 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.26 102.75 15.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.428 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -124.46 141.67 51.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.587 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -62.56 -36.2 81.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.396 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.51 -45.93 5.65 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.895 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -97.8 116.3 29.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.928 0.394 . . . . 0.0 111.594 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -129.92 126.87 38.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.267 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 55.22 89.05 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 111.045 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -58.68 -38.97 79.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.223 -176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -141.7 151.54 43.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.802 0.334 . . . . 0.0 110.935 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -126.16 149.12 49.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.229 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -130.51 136.47 48.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.423 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.6 133.21 49.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.649 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.29 136.34 8.69 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 65' ' ' ILE . 16.6 tt -125.28 124.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.649 HG22 ' HA3' ' A' ' 84' ' ' GLY . 82.6 p -123.31 154.7 38.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.315 -175.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.81 147.98 41.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.27 171.02 36.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.42 -175.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -99.3 123.48 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.774 2.316 . . . . 0.0 111.945 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.6 143.56 33.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.4 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -124.02 159.89 28.87 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -95.16 135.64 36.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.951 0.881 . . . . 0.0 112.873 -162.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 114' ' ' GLN . 16.5 tt -73.92 131.02 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.041 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -94.82 -66.52 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.423 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.29 93.52 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.678 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 t90 52.68 34.85 16.89 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 111.246 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.97 22.53 10.31 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.67 146.46 52.97 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -132.57 129.81 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.576 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -132.18 133.75 44.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.88 137.64 10.59 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.54 ' CG1' HD11 ' A' ' 40' ' ' ILE . 33.9 m -139.22 151.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 117.468 0.634 . . . . 0.0 112.382 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.78 140.93 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.649 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.17 175.14 26.69 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.361 -174.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.638 HG12 ' OH ' ' A' ' 105' ' ' TYR . 35.8 m -112.56 134.45 55.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.83 10.95 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -122.14 133.35 54.75 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.79 138.96 15.27 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -128.79 135.25 48.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.757 0.278 . . . . 0.0 110.356 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -106.94 130.61 54.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.601 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -105.65 128.55 53.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.388 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.7 p -82.73 157.44 23.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.478 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.9 p -68.59 -37.08 79.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.16 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -115.99 130.52 56.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 110.726 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 51.2 68.78 3.02 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.489 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.76 88.97 1.34 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.365 1.377 . . . . 0.0 111.738 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.5 p -122.41 165.29 16.55 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.035 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -57.4 -35.03 69.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.41 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -53.74 -37.58 63.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.576 0.226 . . . . 0.0 111.254 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -129.05 114.64 16.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.871 0.367 . . . . 0.0 110.396 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -170.88 173.06 5.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.4 m -121.09 136.41 54.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.131 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -138.14 141.1 40.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.896 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -142.22 141.84 32.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.466 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.638 ' OH ' HG12 ' A' ' 85' ' ' VAL . 64.6 t80 -109.04 142.89 39.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.25 159.47 27.1 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -102.54 126.1 49.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 m -116.44 143.91 44.98 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.698 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -143.08 153.07 42.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.03 175.55 35.97 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.12 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.84 148.99 29.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.001 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.81 159.85 27.89 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.953 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.5 mp -121.53 147.63 45.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.6 ' O ' HD12 ' A' ' 73' ' ' ILE . 61.2 tt0 -134.42 141.04 46.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.273 0.559 . . . . 0.0 111.851 -174.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -130.6 114.05 14.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.478 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 16.3 p-10 -134.51 124.69 17.19 Favored Pre-proline 0 N--CA 1.463 0.216 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -98.79 176.24 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.465 2.11 . . . . 0.0 109.146 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.445 ' O ' HG22 ' A' ' 121' ' ' VAL . 65.2 mtt -55.93 169.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.798 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -175.91 0.18 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.209 0.528 . . . . 0.0 112.298 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.87 -11.52 5.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 118' ' ' MET . 26.8 m -78.26 18.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -169.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.19 136.74 43.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.281 0.491 . . . . 0.0 109.863 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.406 ' CD2' HG12 ' A' ' 144' ' ' VAL . 74.5 mt -119.68 142.85 48.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.488 -168.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -135.69 136.21 40.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.288 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.33 134.62 52.15 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 m -140.09 154.0 46.91 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.419 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -120.77 141.6 50.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.76 140.91 50.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 110.239 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -125.06 136.15 53.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.213 0.53 . . . . 0.0 111.346 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.6 m -103.94 144.71 31.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -89.28 145.96 25.04 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -158.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.8 96.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 122.732 1.253 . . . . 0.0 112.533 -145.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -89.85 -176.84 5.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 112.174 -2.285 . . . . 0.0 106.871 157.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.32 -13.36 0.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.387 -0.821 . . . . 0.0 112.537 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -119.06 129.64 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.424 0.556 . . . . 0.0 110.092 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -115.15 139.12 50.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.617 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.11 134.66 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.525 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.22 121.58 4.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.4 m -126.13 134.18 51.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.529 0.665 . . . . 0.0 111.256 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -120.57 130.54 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 19.4 tt -131.25 144.62 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.136 -173.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.66 132.91 45.7 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.32 153.31 21.86 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.773 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.406 HG12 ' CD2' ' A' ' 123' ' ' LEU . 29.2 m -118.63 139.92 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.48 178.03 30.71 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.343 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 4' ' ' THR . 43.1 p90 -141.0 161.85 36.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.786 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -121.03 145.2 48.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.529 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.508 -179.403 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.537 HG21 ' NH2' ' A' ' 147' ' ' ARG . 36.3 m -82.02 142.01 32.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.57 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -140.78 155.59 46.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.46 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -121.76 140.06 52.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.507 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.52 128.51 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.2 m -128.14 142.11 51.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.408 . . . . 0.0 111.193 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.28 140.9 12.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.55 -179.9 31.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.374 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -122.27 140.23 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.65 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.39 138.87 54.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.504 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -125.75 131.78 52.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.5 p -115.92 143.59 45.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.42 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.82 129.42 34.58 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 124.116 0.885 . . . . 0.0 111.374 -173.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.643 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -104.74 143.31 33.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.994 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -89.8 153.4 20.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.217 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.65 152.16 3.69 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.992 -0.443 . . . . 0.0 111.992 -172.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 83.49 -28.09 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.529 1.132 . . . . 0.0 111.724 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 86.2 mtp -112.83 162.9 15.26 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -106.98 159.98 15.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.914 0.388 . . . . 0.0 111.081 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 40.9 mtmt -64.62 167.97 6.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.353 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.4 mtt -129.74 154.01 47.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.614 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.5 147.9 16.73 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 143.33 12.28 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.46 133.46 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -127.38 136.63 52.14 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.433 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 tp -130.6 136.31 48.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -139.34 155.32 47.77 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.281 0.562 . . . . 0.0 112.197 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.92 140.37 52.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.097 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -132.62 144.35 50.3 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.212 0.32 . . . . 0.0 110.899 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.42 141.8 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -92.81 123.2 35.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.85 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.44 -178.5 3.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.882 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -54.77 -40.4 69.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 m -84.45 -26.19 0.38 Allowed Pre-proline 0 N--CA 1.467 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -169.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.62 126.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.531 1.487 . . . . 0.0 112.069 160.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 71' ' ' TYR . 77.6 mt -76.31 154.64 34.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.25 140.17 18.89 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.97 126.13 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 117.206 0.503 . . . . 0.0 109.647 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.455 ' C ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -124.57 134.99 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' N ' HD13 ' A' ' 40' ' ' ILE . . . -135.89 137.29 9.02 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -141.77 154.86 45.53 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.004 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.34 141.48 50.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.8 p -130.11 143.19 50.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.481 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.76 137.04 55.04 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -115.57 148.55 39.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -132.81 149.29 52.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.005 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -116.11 155.55 28.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.322 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.9 t -97.66 126.44 42.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 110.175 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -149.74 148.03 28.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.487 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.4 m -58.23 148.15 28.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.271 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.671 ' HB2' ' OH ' ' A' ' 57' ' ' TYR . . . -57.84 138.16 55.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 110.596 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.2 p -152.94 167.44 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -59.0 -33.92 71.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.563 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.01 3.11 14.29 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.508 -0.607 . . . . 0.0 113.608 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 64.52 144.23 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 117.987 0.894 . . . . 0.0 111.044 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.671 ' OH ' ' HB2' ' A' ' 52' ' ' ALA . 91.1 m-85 -58.1 165.75 1.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.772 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.63 43.97 15.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.096 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -57.75 -37.62 73.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.777 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -99.83 143.17 30.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -125.46 146.42 49.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.429 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -123.5 135.91 54.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.384 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -131.44 120.41 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.77 135.49 8.54 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 65' ' ' ILE . 15.8 tt -126.04 122.57 62.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.653 HG22 ' HA3' ' A' ' 84' ' ' GLY . 24.3 p -123.48 152.37 41.78 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.102 0.252 . . . . 0.0 110.602 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.563 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.0 146.39 30.97 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.51 41.46 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.287 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -99.02 122.3 0.13 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.734 2.289 . . . . 0.0 112.944 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.84 146.68 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.396 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.408 ' CD1' HD22 ' A' ' 37' ' ' LEU . 88.8 m-85 -117.47 126.54 52.79 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -95.88 108.69 21.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.624 0.726 . . . . 0.0 112.008 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.5 131.46 43.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.95 167.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -61.34 -31.01 70.87 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.289 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -86.71 -177.16 6.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.886 0.374 . . . . 0.0 110.41 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.6 ' CZ3' HD22 ' A' ' 113' ' ' LEU . 86.5 t90 -62.98 -7.02 4.44 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.85 22.26 0.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.7 p -68.76 158.31 34.57 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.2 mt -141.55 129.85 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.898 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -134.15 142.77 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 66' ' ' THR . 9.2 p -139.82 143.91 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.045 0.423 . . . . 0.0 110.82 -172.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.573 HG12 ' CD1' ' A' ' 109' ' ' TYR . 35.9 m -130.36 140.91 47.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.653 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.15 26.67 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.431 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -115.49 130.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 134.91 11.59 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -122.12 136.2 54.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.0 127.62 7.06 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -133.63 157.76 44.93 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 117.075 0.438 . . . . 0.0 111.598 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -98.47 133.57 42.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.43 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -97.74 132.04 43.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.498 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.8 t -86.19 159.16 19.57 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.541 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 p -81.96 164.3 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.49 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.46 -35.36 73.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.265 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -61.97 140.66 95.75 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.941 -0.552 . . . . 0.0 109.73 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.78 112.2 1.57 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.262 1.308 . . . . 0.0 111.877 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 99' ' ' LYS . 31.0 m -123.02 138.92 54.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.42 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -62.31 -34.99 77.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.495 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.481 ' H ' HG22 ' A' ' 97' ' ' THR . 17.7 ttmm -56.93 143.25 38.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.472 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -117.81 174.4 6.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.646 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -78.36 125.2 29.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.974 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.5 m -125.97 138.85 53.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.656 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.6 p -146.92 166.18 27.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.279 0.561 . . . . 0.0 111.938 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -142.09 153.03 43.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.667 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -109.64 151.23 27.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.99 166.99 26.15 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.66 127.16 51.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.841 0.321 . . . . 0.0 110.349 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.4 t -105.52 132.07 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.566 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.573 ' CD1' HG12 ' A' ' 83' ' ' VAL . 84.7 m-85 -126.48 134.71 50.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.68 158.9 27.81 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.789 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.67 148.87 32.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.6 159.84 28.32 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.375 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.6 HD22 ' CZ3' ' A' ' 76' ' ' TRP . 5.5 mp -112.1 148.52 33.76 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -137.5 137.24 38.46 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.279 -171.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -133.91 131.16 38.77 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -138.74 124.48 12.31 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -99.04 176.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.718 2.279 . . . . 0.0 109.746 159.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.5 ttm -54.51 138.27 40.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.138 0.494 . . . . 0.0 111.861 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 71.81 -153.73 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.457 171.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.97 -11.65 8.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -166.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' VAL . 7.3 t -78.68 17.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -166.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.39 143.02 33.55 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.062 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 123' ' ' LEU . 0.9 OUTLIER -146.37 153.81 40.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 111.403 -174.239 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p30 -137.29 148.1 46.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.885 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.485 ' CE2' HD12 ' A' ' 123' ' ' LEU . 98.2 m-85 -122.37 131.72 54.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 m -139.98 154.2 47.1 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.759 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -121.28 141.14 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.72 142.32 47.79 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.547 0.53 . . . . 0.0 110.314 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.46 131.54 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.584 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -110.7 144.73 39.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -89.23 146.1 24.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 123.79 0.681 . . . . 0.0 109.348 -158.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.508 HG23 ' CG ' ' A' ' 136' ' ' ASP . 68.6 mt -87.83 100.38 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.712 1.244 . . . . 0.0 112.636 -143.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -89.68 -177.0 5.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 112.392 -2.185 . . . . 0.0 107.555 156.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 t -52.25 -15.31 0.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.851 -0.531 . . . . 0.0 112.273 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.39 129.39 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.392 0.542 . . . . 0.0 110.079 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.508 ' CG ' HG23 ' A' ' 132' ' ' ILE . 0.7 OUTLIER -102.85 139.24 38.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 119.065 -0.493 . . . . 0.0 109.787 178.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.69 129.76 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.26 116.94 2.83 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.9 m -126.15 134.27 51.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.714 0.757 . . . . 0.0 111.19 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -109.34 134.14 52.18 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 141' ' ' ILE . 4.6 mp -124.26 136.34 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 O-C-N 123.131 0.269 . . . . 0.0 110.434 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.14 127.46 43.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.38 153.08 22.27 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.05 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.3 t -127.26 145.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.36 178.06 30.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.32 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -135.84 170.29 16.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.745 -0.728 . . . . 0.0 110.409 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.537 ' NH2' HG21 ' A' ' 2' ' ' THR . 21.0 mtp-105 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.501 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 117.977 -1.011 . . . . 0.0 112.396 178.887 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.1 p -85.93 163.26 18.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.941 0.401 . . . . 0.0 110.779 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p -161.52 170.84 19.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.044 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.1 p -124.29 157.45 34.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.167 0.508 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.62 125.95 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.505 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 26' ' ' LEU . 31.6 m -128.19 143.11 51.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -177.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.54 140.73 12.0 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.61 176.49 33.14 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.394 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.03 149.84 41.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.941 -0.63 . . . . 0.0 109.667 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.566 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -130.36 141.71 50.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.187 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -128.0 131.91 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -116.1 145.93 42.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -78.72 142.05 37.4 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.782 0.676 . . . . 0.0 110.944 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -98.04 143.23 28.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.217 -176.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -89.9 153.3 20.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.49 147.67 6.27 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.321 -171.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 68.05 23.08 8.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.739 0.415 . . . . 0.0 111.572 -175.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 69.0 mtm -149.36 166.2 29.73 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.757 -0.589 . . . . 0.0 110.487 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -109.6 155.31 21.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.04 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 25.5 pttm -58.05 168.96 0.87 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.151 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.2 ttm -123.92 146.46 48.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.307 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 134.67 10.8 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.07 143.35 14.27 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -118.61 144.42 46.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.631 ' C ' HD22 ' A' ' 26' ' ' LEU . 27.3 p30 -143.96 153.23 42.05 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.752 -174.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.631 HD22 ' C ' ' A' ' 25' ' ' ASN . 4.5 mm? -123.2 142.91 50.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.521 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -136.22 138.42 41.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 111.016 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.93 140.45 49.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -133.66 144.21 49.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.975 0.417 . . . . 0.0 110.683 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -101.29 143.29 31.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -92.38 117.39 29.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.545 0.688 . . . . 0.0 110.407 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -126.2 153.55 44.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.631 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.59 -178.63 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.773 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -56.69 -33.42 66.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.29 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -102.78 140.98 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.714 1.61 . . . . 0.0 111.823 164.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.16 159.97 28.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.061 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.16 140.05 14.88 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.79 127.58 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.527 0.663 . . . . 0.0 109.948 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.27 144.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.388 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.99 137.87 8.73 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.3 t -136.53 141.35 43.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.019 0.41 . . . . 0.0 111.308 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.94 131.63 54.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -130.0 142.99 50.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.622 0.249 . . . . 0.0 111.554 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.18 136.38 51.99 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.8 p -121.17 152.32 38.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.946 0.403 . . . . 0.0 111.175 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -138.94 157.94 45.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.56 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -119.0 147.84 43.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.81 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -141.61 84.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 0.0 110.361 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -58.54 -43.84 89.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.475 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.1 m -138.17 142.63 40.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.486 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.2 94.08 4.05 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.9 m -136.02 161.91 34.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.9 m -58.94 -28.05 65.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.904 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.72 -15.25 73.38 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 121.281 -0.485 . . . . 0.0 113.107 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 60.96 62.54 1.42 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 117.822 0.811 . . . . 0.0 110.929 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -55.05 145.27 21.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.862 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -159.13 -73.84 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.24 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 52.55 33.42 13.43 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -175.16 120.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.569 0.223 . . . . 0.0 110.946 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -126.08 142.02 51.7 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -136.81 136.1 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 110.355 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.78 133.62 54.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.57 128.64 5.42 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.8 mt -122.18 120.06 60.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.644 HG22 ' HA3' ' A' ' 84' ' ' GLY . 70.2 p -123.28 151.72 42.09 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.139 0.274 . . . . 0.0 111.047 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.97 145.27 30.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.15 170.09 41.81 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.882 -1.151 . . . . 0.0 113.085 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -98.72 126.03 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.379 2.053 . . . . 0.0 112.688 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.57 142.84 33.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.482 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -119.99 137.61 53.97 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -95.84 115.79 27.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.518 0.675 . . . . 0.0 112.602 -170.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 77' ' ' ALA . 48.6 mm -96.23 131.6 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.937 170.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -61.27 -35.34 77.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.761 -174.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.5 -178.47 1.43 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 171.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -86.09 48.7 1.65 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.599 0.714 . . . . 0.0 110.026 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -121.9 22.56 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.251 -174.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 m -68.56 145.86 53.6 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -167.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 tt -131.92 136.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.28 -167.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -129.14 143.33 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.96 137.72 10.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.427 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -135.25 154.64 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.915 0.358 . . . . 0.0 111.296 -173.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.58 140.81 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.644 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.08 172.95 27.41 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.758 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.87 132.53 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 132.52 10.11 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -127.22 134.06 50.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.13 142.76 14.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -138.58 139.97 38.82 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.68 139.69 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 110.741 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -106.6 144.43 33.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 94' ' ' GLU . 23.4 m -108.05 137.97 45.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.443 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.6 m -57.25 -39.23 75.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.861 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 92' ' ' THR . 48.3 mp0 -86.0 -173.97 4.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.362 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -53.32 154.54 5.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.134 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.51 121.47 8.57 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.348 1.365 . . . . 0.0 112.252 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -137.41 162.23 34.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.488 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -59.38 -36.97 76.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.987 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -73.68 139.64 45.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.676 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 t60 80.75 -42.7 0.2 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.392 1.058 . . . . 0.0 111.72 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.58 112.18 22.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.851 0.358 . . . . 0.0 110.53 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.0 p -131.17 161.79 31.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.609 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.2 p -132.67 149.07 52.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.293 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -153.72 143.97 22.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.915 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -110.1 144.23 39.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.996 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.96 158.84 26.86 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.85 125.34 50.79 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -110.94 143.36 41.71 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.302 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -130.79 134.72 47.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.57 161.26 28.0 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.963 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.35 148.92 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.55 160.34 28.34 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.377 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.6 mt -108.89 151.21 26.59 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -123.69 132.11 53.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.759 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.21 111.44 15.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -130.74 124.42 20.82 Favored Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -169.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -96.41 176.05 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.739 2.293 . . . . 0.0 109.341 156.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -65.57 147.1 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 79.31 -164.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.761 0.825 . . . . 0.0 110.817 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.62 -11.88 8.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.67 17.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 134.67 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.525 0.602 . . . . 0.0 109.844 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.11 140.72 47.79 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.752 0.311 . . . . 0.0 111.184 -168.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -125.43 145.18 50.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.334 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -125.92 129.71 49.84 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.9 t -140.2 154.0 46.77 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.512 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -117.1 145.49 43.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -128.31 132.33 48.66 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.271 0.357 . . . . 0.0 110.043 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -118.75 134.6 55.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.856 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.0 m -115.65 144.75 43.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.52 146.02 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.64 0.587 . . . . 0.0 109.484 -160.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -87.74 95.95 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.708 1.242 . . . . 0.0 112.383 -146.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -89.91 -176.92 5.08 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.375 -2.193 . . . . 0.0 106.669 157.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.8 t -52.17 -16.02 0.71 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.303 -0.873 . . . . 0.0 112.179 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.63 129.38 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.251 0.478 . . . . 0.0 109.811 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -115.06 139.06 50.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.406 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.0 t -108.26 128.43 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.578 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.4 112.08 1.62 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 169.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -126.08 134.32 51.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.815 0.808 . . . . 0.0 111.176 -173.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -116.25 136.24 53.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.566 HG22 ' CB ' ' A' ' 10' ' ' ALA . 41.3 pt -130.13 147.22 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.169 -175.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.5 128.5 25.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.2 153.1 23.21 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.519 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -125.81 145.88 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.07 32.11 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.133 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.43 165.95 23.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.81 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -118.06 148.65 42.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.703 0.287 . . . . 0.0 110.45 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.618 -179.656 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.9 p 48.96 43.12 21.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.15 0.5 . . . . 0.0 111.635 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.3 p -147.06 150.86 35.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.435 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.606 HG22 ' CB ' ' A' ' 147' ' ' ARG . 37.9 p -131.09 155.7 46.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.474 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.04 120.25 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.744 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.8 m -128.34 142.96 50.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.818 0.342 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.33 140.86 12.18 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.24 167.91 28.99 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.994 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.08 138.85 53.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.88 149.11 51.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.083 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -124.03 138.98 54.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -115.93 140.77 48.91 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.311 0.382 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.78 126.29 30.52 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.8 0.687 . . . . 0.0 111.381 -173.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.656 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -101.63 143.33 31.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.747 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -89.58 153.53 20.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.761 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.53 152.19 3.55 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.49 -167.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 68.54 22.72 7.58 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.491 -0.855 . . . . 0.0 112.652 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.5 mtm -149.88 166.52 29.32 Favored 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -100.91 148.77 24.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 111.397 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.656 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 59.9 mttm -63.32 169.56 3.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.145 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.6 mmm -125.3 155.12 40.71 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.251 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.37 148.35 16.76 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.04 143.03 14.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.717 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.587 ' CE1' HD21 ' A' ' 26' ' ' LEU . 58.2 t80 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.85 135.78 48.79 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.602 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.587 HD21 ' CE1' ' A' ' 24' ' ' PHE . 81.3 mt -120.31 140.25 51.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 40' ' ' ILE . 98.0 mttt -129.65 143.66 50.92 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.887 0.375 . . . . 0.0 111.37 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -125.32 132.29 52.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -139.93 144.15 36.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -98.47 143.44 28.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.75 136.05 33.57 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.241 0.543 . . . . 0.0 111.119 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -133.42 153.65 51.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.519 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.18 -178.3 3.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.334 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -51.14 -28.41 10.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -97.13 -25.82 0.24 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -102.82 148.08 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.817 1.678 . . . . 0.0 112.983 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.11 164.96 24.54 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.4 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.34 140.24 14.77 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 39' ' ' VAL . 11.5 p -111.04 125.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.415 HD11 ' HD3' ' A' ' 27' ' ' LYS . 17.7 tt -126.72 138.38 54.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.54 142.72 14.24 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.407 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 52.8 p -138.91 148.79 44.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.092 0.446 . . . . 0.0 111.668 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -121.42 133.71 55.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.218 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -128.95 137.19 51.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.65 0.262 . . . . 0.0 111.125 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -120.57 136.94 54.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.866 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.6 m -98.58 137.69 36.87 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.696 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -143.2 149.11 37.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.756 -175.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -110.25 141.91 42.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -84.03 4.59 29.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 47.99 93.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.426 0.557 . . . . 0.0 112.206 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.1 p -120.7 162.0 20.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.336 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.53 93.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.553 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.5 t -178.34 -175.34 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.807 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.7 p -58.93 -32.94 70.04 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.126 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.19 22.34 10.25 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 121.673 -0.299 . . . . 0.0 112.418 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -53.49 -34.19 57.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.59 0.695 . . . . 0.0 111.565 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -106.14 133.72 50.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -55.67 170.16 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -134.65 -155.18 0.64 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.252 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -48.73 140.56 8.31 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.236 -0.29 . . . . 0.0 111.489 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -112.53 152.61 28.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.047 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -120.81 137.4 54.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.135 0.493 . . . . 0.0 111.147 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -123.08 124.82 43.95 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.88 139.49 11.14 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.639 -176.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 65' ' ' ILE . 16.8 tt -125.09 124.21 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.659 HG22 ' HA3' ' A' ' 84' ' ' GLY . 30.0 p -123.26 154.34 38.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.774 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.01 145.62 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.05 171.21 42.34 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.994 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -97.15 127.1 0.26 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.144 1.896 . . . . 0.0 112.821 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 143.39 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.177 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -112.55 132.41 55.13 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -95.87 109.03 21.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.409 0.623 . . . . 0.0 111.537 -169.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.6 mm -96.22 131.48 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.343 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -61.41 -34.93 76.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.729 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.77 174.98 5.35 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -85.72 49.79 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.617 0.722 . . . . 0.0 110.346 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.07 22.76 10.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.151 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m -68.62 150.56 47.84 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.835 -163.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.4 mt -129.9 130.13 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -169.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.46 140.39 51.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.73 137.82 9.75 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -135.48 156.99 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 -175.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.03 140.83 47.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.659 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.19 175.2 26.68 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.067 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.01 134.86 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.92 133.64 10.79 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -122.54 141.26 51.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.89 146.08 16.27 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.26 142.71 41.99 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -101.26 129.45 47.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.914 0.387 . . . . 0.0 111.052 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -127.8 148.15 50.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.297 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.8 p -108.08 150.4 27.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.937 0.398 . . . . 0.0 110.628 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -81.16 -27.35 35.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.181 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.13 -36.57 75.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.587 0.232 . . . . 0.0 111.379 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -142.71 157.13 62.42 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.742 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.29 -44.38 0.43 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.335 1.357 . . . . 0.0 111.534 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.5 m -83.66 138.98 33.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.126 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -113.88 129.82 56.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 110.811 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -64.87 -40.85 95.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.722 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -139.61 164.21 30.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.957 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -159.6 171.35 19.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.669 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.9 m -125.24 136.08 53.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.004 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -127.69 139.84 52.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.176 0.512 . . . . 0.0 111.511 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -140.76 155.5 46.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.846 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.512 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.2 166.02 26.49 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.98 127.98 53.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.948 0.374 . . . . 0.0 110.032 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.8 p -113.89 146.33 40.19 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -137.41 143.12 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.93 159.91 28.17 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.728 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.06 149.02 30.41 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.53 161.65 28.86 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.756 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.1 mt -108.92 147.48 32.14 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.04 132.62 54.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.649 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -125.32 109.93 13.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -120.13 124.29 27.88 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -100.14 176.24 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.353 2.702 . . . . 0.0 109.332 155.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 84.9 mtp -60.07 138.01 57.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.267 0.556 . . . . 0.0 112.245 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 68.15 -148.31 0.14 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.731 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -61.15 -12.08 11.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 121' ' ' VAL . 2.8 t -79.44 17.29 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.21 139.39 39.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.036 0.835 . . . . 0.0 110.282 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 143' ' ' GLY . 15.5 tp -132.62 141.46 48.67 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -168.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -133.7 146.43 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.792 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.456 ' CZ ' HD21 ' A' ' 123' ' ' LEU . 97.7 m-85 -121.34 134.11 55.13 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -140.16 154.02 46.82 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.351 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -120.47 145.62 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -127.12 140.0 52.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.383 . . . . 0.0 110.462 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -127.95 136.02 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.125 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.574 ' HB3' HG22 ' A' ' 137' ' ' VAL . 7.9 t -112.98 144.74 42.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -89.18 146.19 24.94 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 124.436 1.085 . . . . 0.0 109.384 -158.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.1 mt -87.56 104.03 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.947 1.356 . . . . 0.0 112.749 -142.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -89.76 -176.58 5.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 112.056 -2.338 . . . . 0.0 107.304 156.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.5 p -52.39 -12.69 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 p -123.24 131.51 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 110.296 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -115.08 139.17 50.11 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 130' ' ' SER . 16.8 m -108.23 140.59 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.242 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.17 119.49 3.6 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.415 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.3 m -126.0 134.17 51.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.637 0.718 . . . . 0.0 111.132 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -119.12 132.13 55.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 19.0 tt -131.79 144.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.569 0.223 . . . . 0.0 111.163 -174.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.53 132.5 48.3 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.57 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -139.6 153.16 22.92 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.811 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.5 144.51 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 176.95 32.58 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.814 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -135.38 170.25 16.23 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.59 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.606 ' CB ' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -143.08 149.05 37.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.686 0.279 . . . . 0.0 110.82 -178.081 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.884 -179.119 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.5 p -122.97 160.12 26.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.406 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -166.39 147.21 6.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.538 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 146' ' ' TYR . 21.6 m -125.11 141.24 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.09 128.52 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.39 140.85 11.68 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.69 -168.75 26.18 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.134 -1.032 . . . . 0.0 111.566 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -132.05 153.94 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.175 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -130.0 142.29 50.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.006 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -118.59 131.92 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 t -111.05 140.56 45.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.58 128.0 32.91 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.931 0.769 . . . . 0.0 111.298 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -95.88 143.33 27.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.152 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -89.63 153.44 20.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.41 151.93 3.54 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.487 -0.387 . . . . 0.0 112.345 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 62.79 33.0 15.66 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.632 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.3 mtt -151.12 170.41 19.48 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -110.19 152.92 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.33 . . . . 0.0 110.826 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 52.1 mttp -65.28 165.01 12.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.14 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.613 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.14 136.82 11.45 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.84 143.25 14.88 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.38 137.4 44.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.32 134.35 50.01 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.295 0.372 . . . . 0.0 111.66 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 26' ' ' LEU . 5.4 mp -122.54 138.69 54.49 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -134.9 143.06 46.74 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.089 0.471 . . . . 0.0 111.617 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -120.42 134.55 55.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.244 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttm105 -135.59 144.16 46.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 0.0 110.985 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.72 143.16 35.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.4 124.33 36.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 109.786 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.88 153.41 48.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.1 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.55 -178.62 3.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.566 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -57.73 -30.72 65.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 p -95.76 -25.74 0.25 Allowed Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -102.89 136.97 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.71 1.606 . . . . 0.0 111.956 165.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.13 155.13 30.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.1 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.28 15.54 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -101.99 125.93 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 117.346 0.573 . . . . 0.0 110.004 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.418 HD11 ' HB2' ' A' ' 70' ' ' ALA . 73.1 mt -118.44 132.08 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.62 132.55 8.0 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 t -133.54 140.59 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.112 0.456 . . . . 0.0 111.388 -173.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.416 ' HD2' ' HH ' ' A' ' 63' ' ' TYR . 95.8 m-85 -121.17 132.98 55.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.4 m -130.07 134.6 47.48 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.83 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.15 137.16 52.9 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -107.6 152.15 24.67 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 111.359 -172.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -138.29 158.4 44.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.878 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.85 165.65 10.93 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.7 p -59.9 -24.73 64.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.6 mtm-85 58.18 39.53 25.83 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.089 0.471 . . . . 0.0 110.825 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.6 m -123.95 145.16 49.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.951 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.85 124.41 19.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.889 0.376 . . . . 0.0 110.534 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -154.3 151.95 29.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.528 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.6 p -62.29 -32.08 72.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.73 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.13 -45.98 1.12 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -84.51 112.73 20.66 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.821 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.459 ' CE2' ' ND2' ' A' ' 58' ' ' ASN . 73.1 t80 -156.59 100.12 1.92 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.828 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.459 ' ND2' ' CE2' ' A' ' 57' ' ' TYR . 77.3 m-20 56.52 48.57 16.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.316 0.579 . . . . 0.0 110.846 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -68.51 162.62 25.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.621 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -67.16 173.96 3.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.984 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -121.1 150.89 40.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.722 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -119.74 136.0 54.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.001 0.429 . . . . 0.0 110.996 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.416 ' HH ' ' HD2' ' A' ' 43' ' ' PHE . 61.1 t80 -131.24 132.49 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.02 149.88 20.66 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.7 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 65' ' ' ILE . 16.7 tt -125.6 125.49 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.666 HG22 ' HA3' ' A' ' 84' ' ' GLY . 22.1 p -123.16 155.01 37.89 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.031 0.207 . . . . 0.0 110.52 -176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.547 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -145.56 143.97 30.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.16 159.17 31.66 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.881 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -95.15 124.09 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.969 1.78 . . . . 0.0 112.481 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.63 144.77 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.341 170.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -111.77 132.95 54.31 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -95.77 108.93 21.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.522 0.677 . . . . 0.0 111.668 -168.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 77' ' ' ALA . 76.9 mt -96.23 131.42 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.042 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.29 -35.07 76.32 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.752 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -67.88 174.71 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -86.77 48.55 1.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.54 0.685 . . . . 0.0 110.205 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -121.96 22.69 10.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.363 -174.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -68.6 147.54 51.78 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 118.416 0.553 . . . . 0.0 110.382 -163.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.2 mt -128.93 132.71 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -130.77 146.79 52.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.621 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.464 0.525 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 66' ' ' THR . 8.9 p -140.15 144.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 117.121 0.46 . . . . 0.0 110.986 -170.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -131.99 140.83 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.666 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 175.09 26.82 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.14 -176.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 130.04 74.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.94 144.13 18.31 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -134.96 148.39 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.724 0.262 . . . . 0.0 110.692 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.19 138.38 14.44 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -137.58 147.01 44.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -98.73 127.54 44.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.954 0.407 . . . . 0.0 110.587 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -127.22 148.14 50.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.45 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.1 m -103.8 142.98 33.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 m -95.79 152.59 18.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.778 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 63.94 -83.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.129 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -124.17 152.34 67.18 Favored Pre-proline 0 N--CA 1.464 0.262 0 O-C-N 122.176 -0.327 . . . . 0.0 110.303 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -90.78 122.5 0.84 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.749 1.632 . . . . 0.0 112.711 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.8 p -125.3 145.46 50.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.372 -0.376 . . . . 0.0 109.992 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 46.44 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -75.48 129.79 37.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.57 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -173.27 43.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.352 0.596 . . . . 0.0 110.549 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.64 142.84 58.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.338 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.1 p -125.28 156.16 39.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.425 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.9 m -131.58 142.09 49.83 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -154.52 141.83 19.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.58 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -117.21 147.61 42.35 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.304 0.377 . . . . 0.0 111.045 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 159.4 27.03 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -104.66 126.05 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.968 0.384 . . . . 0.0 110.062 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 94.0 p -108.22 137.29 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.969 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -127.75 140.73 51.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.28 169.2 32.67 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.465 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.67 148.98 30.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.789 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.86 158.95 27.84 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.615 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.9 tp -109.22 145.87 35.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -128.16 135.99 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.296 0.498 . . . . 0.0 111.471 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.39 129.73 25.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -140.99 124.67 10.17 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -96.09 176.16 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.533 2.156 . . . . 0.0 109.193 156.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -61.19 150.68 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.52 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 72.98 -160.48 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -61.43 -11.37 10.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.2 t -78.49 17.4 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.4 139.52 39.23 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.446 ' HG ' HG12 ' A' ' 144' ' ' VAL . 4.3 mp -135.88 153.64 51.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.934 0.397 . . . . 0.0 111.078 -171.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -137.06 143.84 42.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.046 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.98 132.61 53.24 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.1 t -140.04 153.92 46.94 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.582 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.27 140.11 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -127.84 146.98 50.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.285 0.366 . . . . 0.0 110.04 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -129.31 135.92 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -107.39 144.68 33.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -89.19 145.99 25.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -159.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 136' ' ' ASP . 68.3 mt -87.98 101.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.656 1.217 . . . . 0.0 112.779 -144.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -89.86 -176.89 5.08 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 112.405 -2.18 . . . . 0.0 107.418 156.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.3 p -52.04 -15.45 0.56 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.778 -0.577 . . . . 0.0 112.358 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.85 129.22 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.894 -0.504 . . . . 0.0 109.729 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 132' ' ' ILE . 2.6 p30 -111.2 139.15 46.82 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.19 133.96 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.879 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.22 3.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 170.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -126.36 134.24 51.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.795 0.798 . . . . 0.0 110.883 -176.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -119.05 136.09 54.31 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.511 HG12 ' HB2' ' A' ' 10' ' ' ALA . 61.7 mt -121.01 140.1 46.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.404 -172.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.1 123.34 25.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.76 153.31 22.57 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.787 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.446 HG12 ' HG ' ' A' ' 123' ' ' LEU . 34.6 m -125.13 147.1 29.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.17 32.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.216 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 4' ' ' THR . 47.0 p90 -138.88 167.18 22.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.714 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.605 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.495 -179.383 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.524 ' HB3' ' C ' ' A' ' 148' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 m -159.14 -50.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.659 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t -150.71 147.45 27.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 146' ' ' TYR . 34.4 m -125.3 140.66 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.58 126.33 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.073 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.454 HG23 ' C ' ' A' ' 144' ' ' VAL . 15.4 m -128.34 140.28 51.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.878 0.371 . . . . 0.0 110.67 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.77 140.82 12.1 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 108.446 -1.861 . . . . 0.0 108.446 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.38 -172.73 30.19 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.781 -1.199 . . . . 0.0 112.877 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -134.2 143.82 48.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.727 -0.736 . . . . 0.0 109.575 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.03 149.13 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.228 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -118.73 138.46 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.804 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -111.01 140.15 45.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.57 128.36 33.41 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.925 0.766 . . . . 0.0 111.322 -171.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.586 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -95.53 143.31 26.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.03 -177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -89.48 153.34 20.88 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 148.58 5.73 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.302 -170.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 63.43 36.24 11.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.256 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.2 mtt -150.08 174.04 13.19 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -115.85 137.8 51.75 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 110.919 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -53.37 167.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.2 mtm -126.89 156.06 42.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.235 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.31 149.49 17.46 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.11 12.64 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.407 ' HE2' HD21 ' A' ' 26' ' ' LEU . 72.3 t80 -112.75 139.07 48.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.71 ' HB3' HG22 ' A' ' 44' ' ' THR . 28.9 p-10 -130.59 147.07 52.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 24' ' ' PHE . 77.2 mt -115.95 142.22 47.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.826 170.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -129.7 141.92 50.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.433 -170.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -133.98 147.39 51.01 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HG3' HG22 ' A' ' 40' ' ' ILE . 78.5 ttt180 -144.28 144.16 31.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.761 -175.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -110.39 140.95 44.11 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -92.96 125.58 37.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.227 0.536 . . . . 0.0 110.573 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -145.05 153.62 41.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.816 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.48 -178.49 3.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.038 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -53.48 -34.82 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.94 -26.05 0.3 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -102.8 127.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.673 1.582 . . . . 0.0 111.567 161.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.501 HD22 ' CD2' ' A' ' 71' ' ' TYR . 76.9 mt -75.77 153.4 37.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.169 -175.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.26 22.69 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.92 125.0 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 117.304 0.552 . . . . 0.0 109.695 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.445 HG22 ' HG3' ' A' ' 29' ' ' ARG . 37.0 pt -125.36 147.55 30.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.245 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.46 147.44 17.57 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 p -141.8 146.1 35.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.874 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -120.17 127.63 52.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.71 HG22 ' HB3' ' A' ' 25' ' ' ASN . 35.6 p -128.82 142.98 50.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.213 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -127.27 137.33 52.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.896 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -97.74 147.51 24.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.098 0.475 . . . . 0.0 111.28 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -129.93 148.39 51.79 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -129.34 164.03 24.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.86 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -139.95 106.42 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.485 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -133.17 154.22 50.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.694 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.7 p -119.43 164.91 15.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.677 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.08 95.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 110.592 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -125.25 145.26 50.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.628 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.4 p -66.29 -27.98 68.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.178 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.9 -45.98 48.09 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -171.16 155.55 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.349 . . . . 0.0 111.054 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -149.24 144.66 26.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 59.28 83.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.586 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -74.4 -179.99 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.47 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -84.13 155.99 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.495 . . . . 0.0 111.52 -173.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -126.13 158.12 36.33 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -149.1 155.23 40.41 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 121.61 0.719 . . . . 0.0 112.214 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -125.85 140.08 52.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.088 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.33 137.51 9.5 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.0 117.95 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.677 HG22 ' HA3' ' A' ' 84' ' ' GLY . 17.0 p -123.29 150.05 44.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.329 -175.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.539 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.15 149.08 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 171.0 41.32 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 119.855 -1.164 . . . . 0.0 113.067 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -97.74 126.92 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.563 2.175 . . . . 0.0 112.662 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.53 139.49 36.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.548 170.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.501 ' CD2' HD22 ' A' ' 37' ' ' LEU . 87.3 m-85 -131.21 160.06 35.94 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.8 mmt-85 -104.42 108.66 20.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.154 0.502 . . . . 0.0 111.03 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.0 tt -96.39 131.33 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.512 171.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -61.6 -31.98 72.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.642 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.03 -37.83 75.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.649 0.261 . . . . 0.0 111.414 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -126.45 -169.67 2.06 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.26 -18.68 14.78 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t -149.48 137.48 20.47 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 118.148 0.431 . . . . 0.0 111.188 172.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.5 tt -138.94 129.92 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -141.71 152.52 43.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.864 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.94 137.84 11.38 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 66' ' ' THR . 9.5 p -138.11 143.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 117.223 0.511 . . . . 0.0 111.01 -171.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.84 140.77 48.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.677 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.06 172.34 27.54 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.529 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t -115.03 130.71 69.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 131.71 9.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.35 140.06 50.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.17 150.07 17.52 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -132.92 134.93 45.2 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -103.23 137.49 41.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.62 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -102.66 146.14 28.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.342 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 94' ' ' GLU . 13.9 m -89.89 137.5 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.497 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.2 p -103.95 26.59 8.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.097 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.477 ' H ' HG22 ' A' ' 92' ' ' THR . 77.5 mm-40 49.66 26.46 1.81 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.2 -54.48 0.1 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-O 119.284 -0.389 . . . . 0.0 111.102 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.51 -68.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.357 1.371 . . . . 0.0 112.48 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p -125.49 162.83 24.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 110.376 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -58.25 -41.52 84.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.643 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -136.19 128.05 29.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.568 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -135.12 133.56 39.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.263 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -155.59 122.2 5.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.81 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.4 m -126.29 141.0 52.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.041 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.1 m -123.13 143.81 49.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.961 0.41 . . . . 0.0 110.949 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -157.34 157.38 34.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.639 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -132.9 151.97 51.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.034 0.445 . . . . 0.0 111.545 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.03 165.98 26.45 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -106.13 125.79 51.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.886 0.343 . . . . 0.0 110.12 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.6 p -107.54 144.41 34.57 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -130.76 136.77 49.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.92 166.72 28.86 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.49 148.9 35.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.02 161.04 28.51 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.236 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 113' ' ' LEU . 4.6 mp -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.419 0.628 . . . . 0.0 111.971 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.75 109.95 12.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 168.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -121.04 124.58 27.35 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -166.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -97.51 176.12 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.658 2.239 . . . . 0.0 109.59 156.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.0 ttm -64.91 141.22 58.85 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.182 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 79.28 -162.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.696 0.799 . . . . 0.0 111.225 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -59.43 -11.54 4.6 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 m -78.63 17.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.14 134.32 47.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.54 0.609 . . . . 0.0 109.893 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' A' ' 144' ' ' VAL . 75.7 mt -114.96 144.17 44.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.916 -169.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -130.95 140.23 50.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.848 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.82 136.02 40.3 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 t -140.4 154.03 46.54 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.443 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.22 139.82 49.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -135.97 134.99 39.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.752 0.31 . . . . 0.0 110.229 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -124.74 134.84 52.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.124 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.3 p -96.79 144.78 26.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -89.16 145.9 25.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -162.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 132' ' ' ILE . 9.7 tt -87.87 102.33 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 123.364 1.554 . . . . 0.0 114.08 -144.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -89.66 -176.86 5.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 112.367 -2.197 . . . . 0.0 107.277 156.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -52.11 -15.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.785 -0.572 . . . . 0.0 112.271 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.4 129.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 168.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -113.71 139.15 49.32 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.58 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.9 t -108.21 134.7 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 124.71 5.39 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.431 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.5 m -126.21 134.14 51.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 117.459 0.63 . . . . 0.0 111.269 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -119.88 127.59 52.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.541 HD11 ' ND2' ' A' ' 25' ' ' ASN . 17.0 tt -130.5 143.44 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.385 -172.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.38 136.39 43.32 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.91 153.26 23.68 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.683 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.454 ' C ' HG23 ' A' ' 6' ' ' THR . 30.8 m -116.47 139.95 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -154.91 177.29 32.26 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.471 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.415 ' O ' HG23 ' A' ' 4' ' ' THR . 50.5 p90 -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.564 -0.818 . . . . 0.0 110.083 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -118.02 147.17 43.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.298 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.524 ' C ' ' HB3' ' A' ' 1' ' ' ALA . 67.5 t80 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.58 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.8 m -52.46 -36.91 55.79 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.696 0.284 . . . . 0.0 111.517 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t -148.3 133.15 18.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.533 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 146' ' ' TYR . 25.4 m -124.92 140.21 53.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.154 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.44 119.99 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -128.22 141.81 51.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.33 140.69 12.47 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.1 165.11 28.21 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.037 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -121.62 145.86 47.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -134.58 149.03 50.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.903 0.382 . . . . 0.0 111.179 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -122.39 135.05 54.62 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 m -115.14 132.92 56.45 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.154 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.82 123.83 30.9 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.316 1.01 . . . . 0.0 110.93 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.48 143.2 33.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -89.71 153.12 20.96 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.44 109.39 0.68 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.138 -171.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 167.65 -52.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.2 mtm -128.48 173.95 9.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.186 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -91.97 170.07 10.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.305 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -65.63 165.12 12.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.754 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.48 153.07 47.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.943 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.17 135.19 11.46 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.23 14.22 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -118.8 139.81 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -135.9 145.11 45.95 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.959 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -124.32 132.05 53.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.466 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.607 ' N ' HD13 ' A' ' 26' ' ' LEU . 7.7 mtpm? -125.56 143.06 51.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 111.377 -174.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.95 138.24 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -130.72 144.08 51.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.967 0.413 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.69 143.14 45.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.66 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.29 129.32 38.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.289 0.566 . . . . 0.0 110.543 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -131.03 153.49 49.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.763 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.6 -178.54 3.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -53.61 -34.35 58.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.605 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -94.56 -25.89 0.26 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -102.92 134.22 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.764 1.643 . . . . 0.0 111.877 163.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.1 160.59 27.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.83 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.43 140.17 24.1 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.12 124.88 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.319 0.56 . . . . 0.0 110.026 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.4 mt -120.49 135.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.51 140.1 11.35 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.449 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 46.3 p -142.13 150.08 40.65 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.323 0.562 . . . . 0.0 111.774 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.49 133.22 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.087 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -130.07 137.31 50.14 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.967 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.18 136.66 52.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -116.67 137.26 52.32 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.028 0.376 . . . . 0.0 110.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -143.36 172.69 12.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -136.62 138.27 40.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.118 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 t -93.63 130.16 39.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.091 0.472 . . . . 0.0 110.917 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -107.35 -174.76 2.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.872 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.9 p -59.42 156.85 12.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.014 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.4 117.23 6.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.621 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.4 p -150.97 149.82 30.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.434 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.9 m -64.27 -36.22 83.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.88 -38.29 65.26 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 -175.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 56.68 101.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.754 0.311 . . . . 0.0 110.48 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -55.93 -74.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.29 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 53.89 44.22 29.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.349 0.595 . . . . 0.0 110.861 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -57.35 -43.97 83.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.997 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -108.93 123.87 49.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.622 0.249 . . . . 0.0 110.865 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -126.14 143.34 51.16 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -125.65 135.97 52.73 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.002 0.429 . . . . 0.0 110.768 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -122.33 123.0 40.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 132.29 7.93 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.8 mt -120.53 117.54 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.693 HG22 ' HA3' ' A' ' 84' ' ' GLY . 8.8 p -123.3 155.26 37.59 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.886 -173.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.19 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.5 157.34 28.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.632 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -95.6 122.39 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.992 1.795 . . . . 0.0 111.94 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.77 144.02 32.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.866 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -117.87 130.09 56.04 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -96.03 108.95 21.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.463 0.649 . . . . 0.0 111.863 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.435 HD12 ' O ' ' A' ' 77' ' ' ALA . 69.6 mt -96.26 131.5 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.083 171.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -61.37 -34.42 75.29 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.823 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.28 174.64 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 171.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -85.61 48.05 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.573 0.701 . . . . 0.0 110.437 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 79' ' ' ILE . . . -122.05 22.63 10.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.17 -175.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.2 m -68.58 147.39 52.01 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -164.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 77' ' ' ALA . 47.4 pt -133.06 146.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.643 -168.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.21 155.03 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.452 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.81 137.95 11.5 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.2 t -131.9 139.03 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.854 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.39 140.73 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 174.89 26.91 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.647 -177.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.25 128.12 72.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.86 10.34 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -118.26 130.63 56.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.74 134.89 12.47 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -141.32 140.41 33.79 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.004 -176.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -106.94 134.37 50.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.081 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -98.03 146.86 25.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.72 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 m -108.08 141.25 40.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.672 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.603 HG23 ' HD1' ' A' ' 95' ' ' TYR . 5.6 t -100.32 175.82 5.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.135 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -64.53 86.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.796 0.331 . . . . 0.0 110.636 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.603 ' HD1' HG23 ' A' ' 93' ' ' THR . 7.9 m-85 -154.97 168.45 12.03 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.742 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -47.9 172.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.422 1.414 . . . . 0.0 112.109 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.4 m -70.74 131.75 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 110.694 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -139.03 142.64 38.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.402 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -80.99 130.53 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.765 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.547 ' CD2' HG22 ' A' ' 102' ' ' THR . 7.6 p-80 -134.93 156.64 48.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.842 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -60.91 -28.16 68.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.49 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.547 HG22 ' CD2' ' A' ' 100' ' ' HIS . 64.1 p 53.34 -173.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.628 0.251 . . . . 0.0 110.775 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -62.98 134.77 56.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.257 0.551 . . . . 0.0 111.685 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -153.63 141.8 20.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.903 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -106.66 148.31 28.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.193 0.521 . . . . 0.0 112.385 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 162.49 27.16 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -103.15 126.99 50.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.195 0.497 . . . . 0.0 110.619 -178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -109.43 135.71 50.03 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.629 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -130.3 145.32 51.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.04 175.09 36.04 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.452 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.05 31.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.018 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.53 158.05 27.41 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.009 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.492 HD23 ' CE2' ' A' ' 115' ' ' PHE . 16.2 tp -117.8 145.81 44.27 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -123.95 132.26 53.69 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.569 0.622 . . . . 0.0 112.228 -174.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.492 ' CE2' HD23 ' A' ' 113' ' ' LEU . 96.8 m-85 -122.05 122.87 40.27 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 171.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -142.14 124.55 9.16 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -95.96 176.19 0.8 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.724 2.282 . . . . 0.0 109.364 155.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.1 mtp -55.17 138.59 44.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.289 0.566 . . . . 0.0 112.338 -174.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 71.46 -145.25 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.74 -11.85 29.86 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -166.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.0 t -78.8 17.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -168.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.49 137.8 41.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.607 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 143' ' ' GLY . 12.3 tp -130.17 140.98 50.7 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.297 -173.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -125.53 137.11 53.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -118.56 132.6 56.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -139.65 151.44 45.96 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.715 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -122.23 139.82 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -132.25 151.16 51.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -131.71 136.1 47.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.012 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 t -109.08 144.85 36.57 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.076 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -89.13 146.19 24.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.201 0.601 . . . . 0.0 109.406 -156.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.735 HG23 ' OD1' ' A' ' 136' ' ' ASP . 40.3 mm -87.66 96.0 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 122.841 1.305 . . . . 0.0 112.225 -142.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -91.9 -177.1 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.141 -2.299 . . . . 0.0 107.974 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.0 m -52.27 -17.61 1.21 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.022 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.33 131.0 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.735 ' OD1' HG23 ' A' ' 132' ' ' ILE . 20.5 m-20 -114.97 138.8 50.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.32 132.43 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.989 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.33 120.25 3.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 168.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.3 m -126.12 134.22 51.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.951 0.875 . . . . 0.0 111.543 -173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -112.94 131.39 55.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 10' ' ' ALA . 64.4 mt -123.53 139.02 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 123.118 0.261 . . . . 0.0 110.616 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.58 124.01 24.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.616 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -137.58 153.2 21.94 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.609 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 p -128.65 142.68 43.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 177.98 32.09 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.496 ' O ' HG23 ' A' ' 4' ' ' THR . 46.6 p90 -130.93 164.43 25.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.395 -0.903 . . . . 0.0 109.952 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -118.36 149.1 41.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.75 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 72.7 t80 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.957 -178.846 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.2 p -123.06 160.55 26.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.514 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 m -158.66 150.52 21.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.27 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.0 p -126.96 155.45 43.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.08 121.16 45.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.772 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.1 m -128.29 140.63 51.77 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.828 0.347 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.64 140.85 12.16 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.06 170.52 30.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.1 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.11 139.24 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.92 149.06 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.052 -176.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -118.16 138.59 52.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.265 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 t -111.97 137.3 50.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.68 142.01 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.973 0.795 . . . . 0.0 111.388 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.84 143.25 33.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.029 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -89.83 153.27 20.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.62 139.46 16.67 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.283 -0.484 . . . . 0.0 111.996 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 66.08 37.17 5.34 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.398 -0.401 . . . . 0.0 111.166 -175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 80.1 mtp -149.55 173.92 13.09 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 173.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -109.43 160.19 16.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.871 0.367 . . . . 0.0 111.249 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -86.21 171.69 11.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.921 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.39 159.75 38.35 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.807 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.07 144.42 15.41 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.89 142.96 14.14 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.864 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -113.65 133.91 55.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.694 ' CG ' HG22 ' A' ' 44' ' ' THR . 48.5 m-20 -129.14 138.83 52.01 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.28 -177.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 26' ' ' LEU . 8.5 tt -130.16 130.2 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.56 154.54 47.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.279 0.562 . . . . 0.0 112.235 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -123.21 141.89 51.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.806 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -132.76 144.03 49.99 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.561 0.538 . . . . 0.0 110.216 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.26 143.31 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -92.68 122.45 35.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 109.735 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -132.52 153.32 51.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.061 -172.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.7 -178.53 3.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.221 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.07 -25.92 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -170.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -102.85 135.71 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.802 1.668 . . . . 0.0 111.941 165.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.98 158.33 29.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.858 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.22 140.25 15.05 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.5 127.2 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 117.418 0.609 . . . . 0.0 110.06 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.9 mt -120.71 133.1 68.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.19 137.19 8.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 t -140.56 145.35 36.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.147 0.474 . . . . 0.0 111.44 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.92 135.08 54.32 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.694 HG22 ' CG ' ' A' ' 25' ' ' ASN . 42.4 p -126.81 141.09 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.634 0.254 . . . . 0.0 110.637 -177.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -127.02 134.6 50.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.8 m -115.29 141.76 47.59 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.688 0.28 . . . . 0.0 110.48 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -142.97 147.81 35.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.89 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -172.31 136.67 0.83 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.477 172.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.1 p -177.92 -176.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.005 0.431 . . . . 0.0 110.487 -176.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -79.56 154.37 28.83 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 51' ' ' THR . 5.8 t -47.19 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 112.307 -176.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.31 158.14 44.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.584 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 p -59.0 171.76 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.0 m -58.78 -36.0 73.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.306 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.81 -16.29 31.43 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.173 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.07 132.82 37.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.71 0.755 . . . . 0.0 111.448 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 59.12 -94.8 0.05 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.166 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.1 m120 58.39 48.06 12.87 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.9 0.773 . . . . 0.0 109.953 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -58.69 139.1 56.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.338 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.1 m120 60.43 103.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.221 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -119.3 134.93 54.95 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.76 141.57 51.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.044 0.45 . . . . 0.0 111.333 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -122.9 132.97 54.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.226 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.27 135.27 8.05 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.71 124.43 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.563 HG22 ' HA3' ' A' ' 84' ' ' GLY . 72.2 p -123.18 149.41 44.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.126 0.266 . . . . 0.0 110.847 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.52 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.433 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.03 166.98 39.83 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.711 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.1 128.06 0.43 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 122.066 1.844 . . . . 0.0 112.769 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.61 142.17 34.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.061 169.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -140.91 160.18 40.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -112.06 108.63 17.99 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.32 0.581 . . . . 0.0 111.473 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.728 HD12 HD13 ' A' ' 79' ' ' ILE . 83.8 mt -96.68 131.49 43.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 165.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -61.21 -25.11 66.82 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.174 -168.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -59.44 -40.71 87.67 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.767 0.258 . . . . 0.0 111.648 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -119.24 158.3 26.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.73 -18.93 42.57 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.608 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 t -149.75 138.1 20.63 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.151 0.432 . . . . 0.0 110.509 169.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.728 HD13 HD12 ' A' ' 73' ' ' ILE . 17.2 tt -140.51 129.87 26.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -142.74 154.08 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.441 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.51 137.79 9.81 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.433 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.6 m -134.3 155.04 38.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 117.143 0.471 . . . . 0.0 111.296 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.05 141.08 47.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.563 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.11 175.03 26.69 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.049 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.42 134.0 66.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 133.35 10.61 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -121.95 136.77 54.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.2 145.58 17.14 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -132.86 134.31 44.45 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.585 0.231 . . . . 0.0 110.437 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -109.99 130.27 55.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -121.31 132.65 54.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.79 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.8 m -108.07 133.43 52.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.213 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.5 p -139.95 21.54 2.46 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.53 -53.82 42.02 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.572 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.27 -55.11 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.45 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -85.43 166.66 10.58 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.555 1.504 . . . . 0.0 112.224 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.9 p -125.01 154.3 41.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.411 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -175.01 -67.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.077 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -58.78 -34.43 71.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.377 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 64.07 -84.1 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.172 0.295 . . . . 0.0 110.935 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -144.45 140.37 28.92 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.891 0.377 . . . . 0.0 110.872 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.4 m -122.97 134.14 54.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.847 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -125.91 142.52 51.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.041 0.448 . . . . 0.0 111.286 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -150.26 141.96 23.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.271 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -125.1 148.6 48.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 111.35 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.05 161.66 27.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.22 125.09 50.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 84.2 p -107.9 146.96 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.25 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -130.5 138.48 50.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.58 162.01 28.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.195 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.86 148.92 39.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.448 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -146.94 152.91 25.0 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.134 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 113' ' ' LEU . 2.8 mm? -122.06 145.87 47.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -137.93 136.74 37.3 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.438 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.63 122.13 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -116.06 124.22 30.0 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -106.24 176.17 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.68 2.92 . . . . 0.0 109.112 154.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -63.26 151.47 40.44 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.747 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 68.58 -165.31 0.19 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.495 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -57.88 -11.25 2.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 121' ' ' VAL . 10.2 t -78.21 17.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -167.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 138.61 40.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.174 -0.954 . . . . 0.0 110.162 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 123' ' ' LEU . 5.0 mp -127.91 144.46 51.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.615 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -134.8 144.06 47.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.385 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.38 137.97 52.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 t -140.15 152.1 45.8 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.523 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.26 139.69 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.12 141.23 50.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.743 0.306 . . . . 0.0 110.865 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -127.36 136.18 51.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.399 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.8 m -113.07 144.69 42.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -89.4 146.3 24.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.616 0.572 . . . . 0.0 109.678 -159.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.1 pt -87.8 95.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 123.229 1.49 . . . . 0.0 114.117 -145.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -89.78 -176.76 5.06 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 112.27 -2.241 . . . . 0.0 107.737 157.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.0 t -52.21 -16.03 0.72 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.73 132.56 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 118.187 0.449 . . . . 0.0 110.147 168.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -112.47 139.12 48.31 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.416 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.14 129.03 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.571 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.27 119.2 3.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.5 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.4 m -126.04 134.15 51.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.757 0.779 . . . . 0.0 111.054 -175.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -122.21 129.59 52.41 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 18.1 tt -129.89 144.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.631 0.253 . . . . 0.0 111.362 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -126.11 132.98 51.77 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.26 152.99 21.33 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.863 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.11 139.83 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.11 178.05 31.99 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.542 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.78 163.98 28.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.733 -0.734 . . . . 0.0 110.032 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -117.88 149.02 41.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.656 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.4 p90 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.492 179.422 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.6 p . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m -132.82 141.97 48.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.342 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.45 115.26 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.468 HG23 ' C ' ' A' ' 144' ' ' VAL . 6.1 m -128.17 139.69 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.83 140.85 12.23 Favored Glycine 0 N--CA 1.461 0.352 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.88 167.28 28.27 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.018 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -115.15 140.58 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.634 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -122.46 141.19 51.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.968 -178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -118.72 131.9 56.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 t -112.76 134.74 54.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.81 142.14 37.16 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.115 0.884 . . . . 0.0 110.844 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.494 -176.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -131.59 157.55 43.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.606 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.36 146.98 17.84 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.53 143.22 14.29 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.96 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -109.77 134.42 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -127.39 137.67 52.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.579 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD21 ' OH ' ' A' ' 28' ' ' TYR . 14.8 tp -122.6 134.3 54.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.117 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -128.35 143.82 51.06 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.07 0.462 . . . . 0.0 111.826 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.453 ' OH ' HD21 ' A' ' 26' ' ' LEU . 94.2 m-85 -123.65 138.61 54.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.405 174.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -131.4 144.06 50.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.86 0.362 . . . . 0.0 111.118 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -103.93 143.21 33.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.58 125.07 37.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -133.06 153.2 51.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.694 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.83 -178.4 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.177 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.46 -38.61 69.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -85.73 -25.99 0.35 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.81 142.38 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.58 1.52 . . . . 0.0 112.525 163.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.437 HD22 ' CD2' ' A' ' 71' ' ' TYR . 74.5 mt -78.06 165.04 24.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.005 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.09 140.12 14.92 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.18 125.47 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.364 0.582 . . . . 0.0 109.947 -174.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.17 135.5 62.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.66 138.02 10.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 t -131.71 137.33 48.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.813 0.307 . . . . 0.0 111.063 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -115.27 129.11 56.53 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 m -125.9 137.74 53.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.679 0.276 . . . . 0.0 110.731 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -126.06 132.58 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.771 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 m -101.49 146.01 28.22 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.533 -177.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -127.1 135.73 51.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.43 135.38 7.57 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.569 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.58 119.35 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.698 HG22 ' HA3' ' A' ' 84' ' ' GLY . 20.1 p -123.23 153.67 39.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.036 0.21 . . . . 0.0 110.507 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.17 146.22 30.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.01 167.37 40.08 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.875 -1.155 . . . . 0.0 112.999 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.417 ' HB2' HD13 ' A' ' 37' ' ' LEU . 92.6 Cg_endo -97.18 124.21 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.276 1.984 . . . . 0.0 112.855 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.79 142.25 33.94 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.77 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.437 ' CD2' HD22 ' A' ' 37' ' ' LEU . 80.9 m-85 . . . . . 0 C--N 1.331 -0.215 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 CA--C 1.522 -0.113 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.22 129.77 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -127.97 133.86 49.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.75 137.89 11.13 Favored Glycine 0 N--CA 1.465 0.62 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 66' ' ' THR . 8.2 p -142.79 145.95 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.557 0.679 . . . . 0.0 111.445 -172.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.441 HG12 ' HD1' ' A' ' 109' ' ' TYR . 27.7 m -129.35 140.93 47.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 175.07 26.83 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.444 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.42 127.22 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.69 137.56 11.32 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.19 157.91 45.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.098 0.449 . . . . 0.0 111.45 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.668 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.71 149.29 33.13 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.731 0.644 . . . . 0.0 110.817 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.0 161.62 27.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -101.67 127.17 48.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -113.66 145.47 41.26 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.034 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.441 ' HD1' HG12 ' A' ' 83' ' ' VAL . 77.4 t80 -131.16 139.47 49.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.41 161.32 27.96 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.732 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 148.91 35.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.95 164.52 29.2 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.857 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.6 tp -109.07 145.91 34.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -138.44 134.22 33.78 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.83 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -135.45 115.22 12.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.54 124.46 19.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -102.88 176.15 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.796 2.331 . . . . 0.0 109.294 157.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.2 mtm -55.38 164.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 66.48 -171.94 0.19 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.721 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.29 -11.42 4.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.1 t -78.32 17.91 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -166.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.614 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.43 130.61 52.31 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.331 -0.856 . . . . 0.0 110.231 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.614 HD22 ' C ' ' A' ' 122' ' ' ALA . 4.5 mm? -124.59 146.29 49.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.819 -171.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -137.15 139.54 41.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.411 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.98 131.17 47.41 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -140.24 154.09 46.76 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.663 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -118.32 140.37 49.93 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -126.81 136.62 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.193 0.308 . . . . 0.0 110.387 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -119.33 130.83 55.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.321 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.9 t -108.09 144.6 35.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -89.37 145.97 24.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -159.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 132' ' ' ILE . 13.0 tt -87.89 100.96 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 123.526 1.631 . . . . 0.0 113.678 -146.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -89.8 -176.7 5.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.18 -2.282 . . . . 0.0 106.597 157.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -52.16 -14.54 0.44 Allowed 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.339 -0.851 . . . . 0.0 112.206 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.02 132.59 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.362 0.528 . . . . 0.0 109.859 167.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -115.01 139.12 50.11 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.35 133.59 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.707 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.33 3.88 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.9 m -126.12 134.16 51.41 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.61 0.705 . . . . 0.0 111.12 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -117.29 130.92 56.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.634 HG22 ' HB2' ' A' ' 10' ' ' ALA . 2.6 pp -124.98 144.9 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.855 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.52 127.18 30.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.497 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -135.63 153.09 21.17 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.612 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.468 ' C ' HG23 ' A' ' 6' ' ' THR . 9.3 p -128.54 139.91 50.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.02 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.809 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -137.33 165.08 27.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.675 -0.763 . . . . 0.0 110.173 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -121.68 148.97 43.9 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.7 p90 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.075 -0.964 . . . . 0.0 112.453 -174.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.523 -0.068 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.706 HG22 ' HB3' ' A' ' 29' ' ' ARG . 14.9 t -135.1 151.83 51.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.947 0.404 . . . . 0.0 110.845 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.49 124.37 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.415 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 m -128.31 139.44 52.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 110.676 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.71 140.71 13.47 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.23 168.21 28.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.185 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -117.68 133.02 56.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -115.56 138.7 50.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.412 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -119.16 131.99 55.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.0 139.1 48.94 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.72 142.12 37.32 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.822 0.701 . . . . 0.0 111.218 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.283 -176.531 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.7 mttt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.642 0.258 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.3 mmm -128.8 155.79 44.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.294 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.48 143.35 14.98 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.54 143.17 14.22 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.909 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.38 131.38 54.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' HG23 ' A' ' 44' ' ' THR . 71.0 m-20 -119.66 135.19 54.92 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.296 0.373 . . . . 0.0 111.529 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tt -118.4 135.95 54.04 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -117.87 143.87 45.92 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.208 0.317 . . . . 0.0 111.32 -173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -133.49 130.28 38.33 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.706 ' HB3' HG22 ' A' ' 4' ' ' THR . 37.2 ttm180 -138.32 144.08 40.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.178 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -109.83 143.15 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -92.63 129.3 38.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.516 0.674 . . . . 0.0 110.769 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -133.09 153.47 51.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.109 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.54 -178.56 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.718 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -55.7 -33.4 64.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.327 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 t -93.38 -25.89 0.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.78 139.18 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.746 1.631 . . . . 0.0 111.952 164.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.11 152.76 32.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.304 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.03 140.38 16.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.3 m -103.55 127.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 117.779 0.789 . . . . 0.0 110.113 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.737 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -126.17 140.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.737 ' N ' HD13 ' A' ' 40' ' ' ILE . . . -139.87 143.53 13.87 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -142.06 155.03 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.584 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -131.61 142.01 49.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.906 173.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.526 HG23 ' OD1' ' A' ' 25' ' ' ASN . 61.5 m -127.03 137.7 53.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.88 -175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -118.49 133.02 56.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.035 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 m -107.76 144.65 34.61 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 110.867 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 -178.345 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.949 0.404 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -132.61 131.7 41.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.592 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.16 146.34 18.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.052 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.14 127.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.662 HG22 ' HA3' ' A' ' 84' ' ' GLY . 60.9 p -123.2 154.88 38.13 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.139 0.274 . . . . 0.0 110.803 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.95 148.88 37.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.74 160.89 31.88 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 119.865 -1.159 . . . . 0.0 113.335 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -94.05 124.07 0.45 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.018 1.812 . . . . 0.0 112.061 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . . . -80.71 138.8 36.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.218 171.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 C--N 1.333 -0.146 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.482 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 CA--C 1.519 -0.231 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.38 129.96 70.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.087 0.47 . . . . 0.0 110.447 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 20.5 m-85 -120.01 134.03 55.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.99 137.58 11.21 Favored Glycine 0 N--CA 1.466 0.668 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.67 150.99 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.259 0.53 . . . . 0.0 111.822 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.09 140.77 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.27 175.01 26.85 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.459 -176.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.64 127.53 73.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.52 144.67 16.11 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -138.0 154.28 49.35 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.111 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.71 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 . . . . . 0 C--O 1.232 0.138 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -108.56 149.64 28.59 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.526 0.517 . . . . 0.0 111.593 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 164.03 26.94 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -104.24 128.13 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.99 0.395 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.3 m -114.37 141.01 48.18 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.677 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -140.52 144.09 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.11 176.59 35.9 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.227 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.05 150.6 30.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.661 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.12 28.04 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.274 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.19 149.93 35.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -121.6 138.67 54.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 112.128 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -125.99 109.95 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.73 124.34 27.14 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -105.51 176.06 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.373 2.716 . . . . 0.0 109.351 155.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.5 mtm -61.16 158.2 14.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.782 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 67.27 -165.95 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.537 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -58.43 -11.67 3.11 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 121' ' ' VAL . 9.9 t -78.41 17.77 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -167.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.43 138.02 41.44 Favored 'General case' 0 C--N 1.344 0.37 0 O-C-N 121.153 -0.967 . . . . 0.0 110.057 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.68 151.41 49.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.709 0.29 . . . . 0.0 111.269 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.96 139.66 41.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.364 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -122.22 129.12 51.95 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -140.21 154.02 46.77 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.313 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -124.52 142.7 51.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -128.78 146.84 50.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -128.5 135.51 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.046 0.45 . . . . 0.0 110.621 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.4 p -100.57 144.78 29.15 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -89.29 145.94 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -160.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -87.77 99.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.638 1.208 . . . . 0.0 112.924 -144.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -89.88 -176.99 5.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 112.528 -2.124 . . . . 0.0 107.499 156.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.2 t -52.17 -16.18 0.74 Allowed 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 112.078 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.32 130.69 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -114.92 139.04 50.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.375 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.37 135.97 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.597 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.64 5.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.06 134.18 51.48 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.652 0.726 . . . . 0.0 111.396 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -115.0 132.83 56.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 10' ' ' ALA . 67.3 mt -124.03 134.8 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -173.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.18 123.3 39.32 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.08 20.56 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.823 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.2 140.17 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 178.02 32.08 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.676 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.56 165.09 24.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.139 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -117.96 149.0 41.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.614 -178.756 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 CA--C 1.524 -0.036 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -136.01 155.18 50.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.921 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 p -129.98 132.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.187 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 m -128.08 140.12 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.32 140.74 12.27 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.78 30.58 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.355 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -117.16 136.31 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.683 -0.759 . . . . 0.0 109.11 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -117.31 138.07 52.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.384 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -126.15 132.04 51.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 p -115.57 141.31 48.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -78.94 127.02 31.46 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.063 0.852 . . . . 0.0 111.233 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.466 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 9.1 mtmp? . . . . . 0 C--O 1.232 0.133 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.32 159.74 35.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.285 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.23 151.4 18.36 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.08 143.22 11.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.784 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.11 132.98 52.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.551 ' OD1' HG22 ' A' ' 44' ' ' THR . 49.2 m-20 -126.7 135.91 51.76 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.459 -175.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.8 mt -122.25 139.3 53.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -135.07 142.5 46.31 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 111.538 -173.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.43 136.6 54.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.402 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -136.78 144.11 43.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -104.49 143.09 33.5 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.57 123.57 35.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.122 0.487 . . . . 0.0 110.112 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.04 153.47 41.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.975 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.32 -178.58 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.836 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -55.37 -41.53 72.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 m -82.29 -26.1 0.4 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -102.83 126.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.531 1.487 . . . . 0.0 112.04 160.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 156.59 32.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.97 140.28 19.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -101.62 124.93 55.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 117.292 0.546 . . . . 0.0 109.861 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.571 HD11 ' HB2' ' A' ' 70' ' ' ALA . 69.7 mt -117.44 134.93 59.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.9 133.26 7.53 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.1 t -132.84 140.51 47.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.041 0.421 . . . . 0.0 111.315 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.77 132.29 55.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 25' ' ' ASN . 68.9 p -128.75 142.57 50.96 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.94 -178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -125.48 135.51 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.168 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -109.51 144.83 37.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.785 0.326 . . . . 0.0 111.061 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.475 -178.822 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.899 0.38 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -123.27 129.36 51.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.38 134.81 7.98 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.44 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.23 123.75 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.661 HG22 ' HA3' ' A' ' 84' ' ' GLY . 63.5 p -123.24 153.44 40.16 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.154 0.284 . . . . 0.0 110.602 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.78 144.86 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.536 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.01 168.14 40.58 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 119.775 -1.202 . . . . 0.0 113.178 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -96.99 126.08 0.25 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.434 2.089 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.84 140.45 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.667 170.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.2 t80 . . . . . 0 C--N 1.332 -0.184 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.441 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 tt -128.95 133.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.789 -171.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -128.39 146.86 50.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.959 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.2 137.73 9.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.1 m -134.14 153.77 36.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.828 0.314 . . . . 0.0 110.97 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.24 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.03 26.73 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.305 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 87' ' ' TYR . 42.7 t -118.35 133.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 131.93 9.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CZ ' HG11 ' A' ' 85' ' ' VAL . 97.8 m-85 -120.85 142.02 50.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 0.0 110.405 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.634 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 175.156 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.7 t0 . . . . . 0 N--CA 1.46 0.036 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -123.85 150.79 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.057 0.456 . . . . 0.0 111.769 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.06 26.17 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -103.89 129.94 51.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.088 0.444 . . . . 0.0 110.449 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.4 m -112.39 141.73 45.77 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.661 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -131.93 139.06 48.6 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.44 155.02 26.3 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.792 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.23 148.89 30.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -151.81 162.26 29.62 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.893 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.96 150.31 27.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -135.03 139.65 44.99 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.576 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.511 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 46.2 p90 -137.95 120.69 16.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.1 124.4 26.49 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -105.19 175.99 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.087 2.525 . . . . 0.0 109.712 157.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.32 157.77 10.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.935 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 67.24 -167.61 0.2 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.694 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.41 -11.4 2.81 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' VAL . 7.2 t -78.23 17.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -169.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.1 136.45 43.7 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.511 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 71.3 mt -125.18 147.24 49.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.898 -167.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -132.53 136.74 46.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.151 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.26 130.44 52.74 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -139.91 154.07 47.14 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.996 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -124.83 143.13 50.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.965 0.412 . . . . 0.0 110.669 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -127.95 136.15 50.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.18 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.553 ' HB3' HG22 ' A' ' 137' ' ' VAL . 6.4 t -111.44 144.76 40.13 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 171.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -89.25 146.4 24.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.224 0.952 . . . . 0.0 109.667 -158.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 136' ' ' ASP . 58.2 mt -87.84 105.81 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 122.73 1.253 . . . . 0.0 112.879 -141.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -89.75 -176.74 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.314 156.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 t -52.16 -14.48 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.822 -0.549 . . . . 0.0 112.262 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.02 130.9 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.404 0.547 . . . . 0.0 110.337 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.477 ' HB2' HG23 ' A' ' 132' ' ' ILE . 29.4 t0 -115.02 139.19 50.06 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.553 HG22 ' HB3' ' A' ' 130' ' ' SER . 17.7 m -108.12 143.86 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.315 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.1 122.61 4.72 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 171.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.414 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 27.7 m -125.9 134.19 51.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.545 0.673 . . . . 0.0 111.352 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -109.29 132.23 54.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 10' ' ' ALA . 67.2 mt -122.5 133.5 68.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 123.209 0.318 . . . . 0.0 110.286 -175.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.85 126.17 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.53 153.02 20.85 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.137 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 123' ' ' LEU . 32.2 m -122.14 140.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 177.87 32.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.372 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -141.53 163.08 33.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.837 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -123.26 149.0 45.32 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.256 0.347 . . . . 0.0 110.54 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.63 -178.879 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.458 -0.041 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.4 p -125.17 155.4 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.378 . . . . 0.0 110.43 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.83 125.06 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.588 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -128.15 141.48 51.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 111.036 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.68 140.74 12.05 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.9 165.45 28.48 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.316 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -115.44 134.58 54.95 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -116.99 138.97 51.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.5 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -120.88 132.95 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -115.89 144.47 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -78.59 142.17 37.49 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.867 0.729 . . . . 0.0 111.13 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.313 -175.33 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.64 155.21 39.53 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.885 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 46' ' ' THR . . . -126.4 140.5 12.08 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.42 143.24 14.02 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.817 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.66 136.78 50.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -131.47 142.41 49.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.989 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.4 tp -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.137 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -127.23 141.96 51.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.009 0.433 . . . . 0.0 111.512 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.68 137.32 54.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.443 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -134.45 144.1 47.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 110.823 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -109.32 143.25 39.08 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.77 120.3 33.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.277 0.561 . . . . 0.0 111.157 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -133.86 153.63 51.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.962 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.51 -178.44 3.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.863 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -53.01 -33.87 53.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -91.4 -26.02 0.28 Allowed Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -102.79 133.0 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.683 1.589 . . . . 0.0 111.65 162.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.97 158.31 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.245 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.08 140.3 19.12 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.67 125.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 117.478 0.639 . . . . 0.0 109.784 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 70' ' ' ALA . 67.7 mt -120.54 137.77 53.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.15 137.38 9.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -135.91 140.97 44.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.085 0.442 . . . . 0.0 111.093 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.36 132.77 56.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.4 m -129.43 139.05 51.76 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.284 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -124.97 129.8 51.07 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' GLY . 5.9 m -124.75 145.95 49.45 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.978 0.353 . . . . 0.0 110.991 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.369 -178.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.7 t80 . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.932 0.396 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -134.82 127.78 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.607 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.01 140.32 11.09 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.649 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -122.08 122.57 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.564 HG23 ' C ' ' A' ' 83' ' ' VAL . 2.4 m -123.21 147.27 47.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.79 147.33 31.76 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.11 171.02 42.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.886 -1.15 . . . . 0.0 113.162 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -93.51 128.05 0.65 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.149 1.899 . . . . 0.0 112.905 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.5 138.57 36.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.188 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.8 t80 . . . . . 0 C--O 1.234 0.28 0 O-C-N 123.77 0.669 . . . . 0.0 109.228 173.525 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 CA--C 1.517 -0.324 0 CA-C-O 120.792 0.329 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.96 129.56 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.1 m-30 -122.6 135.35 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.03 137.65 11.24 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.544 ' HB ' HG22 ' A' ' 66' ' ' THR . 30.4 m -142.43 153.44 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 117.801 0.801 . . . . 0.0 112.021 -173.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.564 ' C ' HG23 ' A' ' 66' ' ' THR . 27.4 m -134.05 140.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 174.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 66' ' ' THR . . . -147.13 171.86 27.71 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.524 -176.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.62 125.82 74.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.6 146.43 16.19 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -139.1 155.13 48.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.861 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.656 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.222 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.45 0.167 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -109.59 149.7 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 124.024 0.827 . . . . 0.0 110.217 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.16 159.36 27.05 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -99.51 124.31 44.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -110.06 141.01 43.49 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.764 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -127.95 140.3 52.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.16 159.26 27.86 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.1 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.12 148.88 32.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.987 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.45 161.89 29.66 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.36 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.68 150.47 49.75 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -127.79 146.52 50.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.601 0.715 . . . . 0.0 112.582 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -124.07 112.56 17.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.43 124.21 29.76 Favored Pre-proline 0 N--CA 1.462 0.17 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -107.03 176.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.452 2.768 . . . . 0.0 109.342 155.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -62.88 156.06 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.763 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 67.84 -166.48 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.588 173.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -58.64 -11.42 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 121' ' ' VAL . 9.8 t -78.37 17.73 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.48 138.17 41.26 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.34 -0.85 . . . . 0.0 110.145 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 123' ' ' LEU . 5.4 mp -122.87 147.42 46.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.545 -170.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -132.61 136.41 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.385 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.36 130.7 54.51 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -140.18 154.03 46.81 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.321 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -128.15 145.29 51.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.521 ' OE2' HD12 ' A' ' 141' ' ' ILE . 47.1 mp0 -133.84 146.6 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.178 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -129.5 136.06 49.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.9 t -104.13 144.72 31.2 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -89.28 146.03 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -161.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.7 mt -87.9 106.71 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 122.76 1.266 . . . . 0.0 112.901 -142.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -89.68 -176.71 5.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 112.301 -2.227 . . . . 0.0 107.227 156.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.1 p -52.11 -13.32 0.3 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.611 . . . . 0.0 112.496 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.82 133.49 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.383 0.538 . . . . 0.0 109.83 167.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.87 139.37 45.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.342 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.06 132.5 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.615 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 124.11 5.2 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.07 134.28 51.43 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.337 0.569 . . . . 0.0 111.298 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.36 134.83 54.74 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.521 HD12 ' OE2' ' A' ' 128' ' ' GLU . 67.9 mt -125.34 135.73 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.429 -174.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 124.79 43.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.07 20.56 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.19 139.78 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.01 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.748 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.12 163.69 31.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.905 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -119.65 148.79 42.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.602 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.972 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.803 0.335 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 m -128.93 139.86 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.112 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 5' ' ' VAL . 35.7 m -128.71 128.93 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.135 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.5 m -128.15 142.29 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.53 140.8 12.07 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.19 -169.89 27.28 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.169 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -129.21 158.5 38.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.262 -0.469 . . . . 0.0 109.931 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.884 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -136.51 148.18 47.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.973 -177.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -126.35 132.8 51.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -118.52 142.03 48.0 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -79.04 125.07 28.91 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.872 0.732 . . . . 0.0 111.408 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.461 179.067 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 pttp . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.492 ' CE ' HG21 ' A' ' 46' ' ' THR . 86.0 mtp -115.17 143.31 45.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.07 140.15 16.03 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.45 143.28 14.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.823 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -111.3 137.81 48.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.539 ' ND2' HG23 ' A' ' 44' ' ' THR . 23.8 m120 -125.92 133.88 51.74 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.193 0.308 . . . . 0.0 111.576 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.2 mt -118.01 141.86 48.0 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.779 0.674 . . . . 0.0 109.482 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -127.72 143.01 51.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.301 -174.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -132.15 132.54 43.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -138.55 144.2 39.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 -176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -108.37 142.45 38.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.59 131.03 38.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.274 0.559 . . . . 0.0 111.289 -174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -143.86 153.57 42.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.497 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.43 -178.4 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.136 -173.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -51.08 -37.78 47.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -89.13 -25.98 0.31 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -102.73 126.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.716 1.611 . . . . 0.0 111.869 161.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.536 HD22 ' CD1' ' A' ' 71' ' ' TYR . 73.4 mt -76.63 158.39 31.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.963 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.05 140.12 18.99 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.66 124.96 58.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.487 0.644 . . . . 0.0 109.28 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.492 HD11 ' CG1' ' A' ' 82' ' ' VAL . 41.3 pt -122.46 144.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.379 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.84 136.2 8.49 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -127.88 140.93 51.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.671 0.272 . . . . 0.0 110.811 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.74 131.2 56.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.539 HG23 ' ND2' ' A' ' 25' ' ' ASN . 41.1 m -126.44 134.8 50.88 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.247 0.342 . . . . 0.0 110.83 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -127.04 137.05 52.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.436 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.492 HG21 ' CE ' ' A' ' 21' ' ' MET . 7.2 m -108.5 148.28 30.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.017 0.436 . . . . 0.0 111.351 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.525 -177.793 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.9 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.715 0.293 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -138.02 132.98 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.993 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.97 19.58 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.519 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.449 ' C ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -127.27 127.37 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.656 HG22 ' HA3' ' A' ' 84' ' ' GLY . 31.2 p -123.21 154.99 38.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.655 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.62 148.28 34.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.09 170.92 42.25 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.968 -1.111 . . . . 0.0 113.337 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -99.15 122.65 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.628 2.219 . . . . 0.0 112.717 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.78 139.93 35.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.077 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CD1' HD22 ' A' ' 37' ' ' LEU . 65.8 m-85 . . . . . 0 C--N 1.332 -0.157 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.19 129.93 17.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -127.84 141.98 51.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.2 137.91 10.99 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.492 ' CG1' HD11 ' A' ' 40' ' ' ILE . 36.0 m -135.69 153.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.953 0.376 . . . . 0.0 111.182 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.68 140.84 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.656 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.21 175.21 26.69 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.339 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.62 129.66 75.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.08 145.47 16.66 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -138.68 160.02 40.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.1 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 . . . . . 0 N--CA 1.458 -0.074 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -139.42 158.99 43.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.009 0.433 . . . . 0.0 111.566 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.09 167.06 26.16 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.16 125.7 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -111.98 145.54 39.45 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.638 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -142.64 144.52 32.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.12 173.38 35.96 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.912 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.9 28.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.457 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.94 160.49 27.1 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.141 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.6 mp -113.13 151.06 31.3 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -121.98 133.62 54.82 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.802 -174.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -128.24 109.92 11.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.452 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 1.6 p30 -140.53 124.64 10.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -167.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.29 176.11 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.629 2.219 . . . . 0.0 109.125 155.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -55.71 174.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.555 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -174.7 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.256 0.551 . . . . 0.0 112.126 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -62.95 -11.35 18.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.47 18.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.586 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.27 141.92 35.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.461 0.573 . . . . 0.0 110.162 -176.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 144' ' ' VAL . 4.5 mm? -124.02 148.99 46.58 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.84 -170.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -136.94 137.52 39.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.22 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -128.63 132.06 48.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.438 ' HB3' HD11 ' A' ' 141' ' ' ILE . 31.4 t -140.4 154.14 46.58 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.581 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.85 139.95 49.34 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -126.76 140.66 52.21 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 123.344 0.403 . . . . 0.0 110.453 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -124.23 136.03 53.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.284 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -109.1 144.84 36.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -89.19 145.94 25.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -160.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 pt -88.01 105.13 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 123.09 1.424 . . . . 0.0 114.689 -143.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -89.84 -176.97 5.11 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 112.703 -2.044 . . . . 0.0 106.845 157.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 t -52.06 -15.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.476 -0.765 . . . . 0.0 112.237 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.59 127.26 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 118.215 0.461 . . . . 0.0 109.808 168.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -103.9 139.19 39.41 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.13 131.16 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.32 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.19 118.48 3.29 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.2 m -126.2 134.2 51.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.347 0.573 . . . . 0.0 110.866 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -115.73 133.03 56.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.884 HG22 ' HB2' ' A' ' 10' ' ' ALA . 48.0 pt -121.98 145.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 123.247 0.342 . . . . 0.0 110.896 -177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -136.19 125.41 24.68 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.51 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -137.27 153.22 21.8 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.784 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.621 HG22 HD11 ' A' ' 123' ' ' LEU . 51.1 t -111.26 139.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.48 158.77 23.86 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.983 -172.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.32 152.86 46.9 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.136 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -117.81 140.37 49.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.8 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.702 179.682 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.622 HG22 ' CD ' ' A' ' 147' ' ' ARG . 29.2 p -122.3 156.22 34.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.416 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.01 115.99 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.555 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.6 m -128.3 142.91 51.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 0.0 110.769 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.37 140.92 11.92 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.58 -179.6 30.81 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.024 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -129.07 141.15 51.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -128.28 147.15 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -115.3 132.11 56.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -112.53 130.26 56.07 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.35 128.97 34.18 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.058 0.849 . . . . 0.0 110.86 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.866 -179.063 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt . . . . . 0 C--O 1.231 0.127 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.78 151.78 51.92 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.021 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.35 128.14 7.48 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -121.69 143.21 15.71 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.868 -173.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.1 133.77 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.556 ' C ' HD22 ' A' ' 26' ' ' LEU . 22.5 t-20 -126.52 133.7 51.07 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.073 0.233 . . . . 0.0 111.574 -174.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 25' ' ' ASN . 4.5 mm? -118.93 136.25 54.17 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -136.7 139.08 41.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.428 . . . . 0.0 111.632 -172.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.18 137.88 54.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.484 ' HG2' HG22 ' A' ' 40' ' ' ILE . 36.7 mtm180 -133.16 144.14 49.68 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -107.11 142.18 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -92.78 127.65 38.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.214 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -137.03 153.46 50.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.883 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -74.77 -178.56 3.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.87 -36.62 65.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -91.6 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -170.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -102.81 135.06 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 111.891 164.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.03 156.76 29.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.119 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.48 140.15 16.48 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -101.58 125.17 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.415 0.608 . . . . 0.0 109.427 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.505 HD11 ' CG1' ' A' ' 82' ' ' VAL . 44.8 pt -125.8 144.87 34.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.248 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 140.58 9.26 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.05 146.03 35.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.395 -175.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.404 ' HD1' ' HH ' ' A' ' 63' ' ' TYR . 91.6 m-85 -119.61 132.69 55.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.445 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -126.97 133.84 50.5 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.126 0.266 . . . . 0.0 110.805 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -127.16 135.7 51.05 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.9 p -103.44 148.23 26.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.196 0.522 . . . . 0.0 111.294 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.578 -179.004 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 79.5 t80 . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.871 0.367 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' HH ' ' HD1' ' A' ' 43' ' ' PHE . 67.3 t80 -135.22 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.91 141.47 12.2 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.711 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.79 122.5 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.64 HG22 ' HA3' ' A' ' 84' ' ' GLY . 70.0 p -123.28 151.11 42.72 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.088 0.242 . . . . 0.0 111.14 -177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.05 146.29 30.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.435 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.04 171.14 42.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.071 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -97.33 124.0 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.314 2.009 . . . . 0.0 112.718 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.64 145.41 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.395 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 62.5 t80 . . . . . 0 C--O 1.233 0.202 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.304 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.521 -0.171 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.02 133.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.144 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -128.18 144.03 51.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.9 137.81 10.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.505 ' CG1' HD11 ' A' ' 40' ' ' ILE . 35.4 m -135.44 155.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.58 140.99 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.64 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.24 175.06 26.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.534 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.17 129.96 69.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.9 137.57 13.61 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.76 138.29 54.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.683 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.865 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -117.09 146.39 43.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 111.141 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.21 167.02 26.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.22 127.62 49.09 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -112.44 145.38 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 110.898 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -129.82 138.38 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.54 156.34 26.78 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.613 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.97 148.93 32.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.11 157.35 27.3 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.568 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.6 mp -109.87 148.96 30.58 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -121.86 139.19 53.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.806 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.61 109.94 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.456 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 7.4 p30 -133.5 124.31 17.98 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.48 ' HG2' HG13 ' A' ' 121' ' ' VAL . 3.8 Cg_endo -95.37 176.2 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.526 2.151 . . . . 0.0 109.534 156.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -65.72 150.48 48.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.779 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 78.35 -167.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -61.02 -11.99 10.07 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 121' ' ' VAL . 9.4 p -78.75 17.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -170.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.456 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.44 138.91 40.13 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.574 -0.704 . . . . 0.0 109.883 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HG ' HG12 ' A' ' 144' ' ' VAL . 4.3 mp -132.62 151.83 51.83 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.322 -170.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.06 147.35 46.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.316 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.54 134.62 50.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -140.17 154.04 46.82 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.036 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.84 140.88 50.12 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -128.6 140.09 51.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.787 0.327 . . . . 0.0 110.562 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -124.51 135.99 53.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.081 0.467 . . . . 0.0 111.042 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 t -116.19 144.69 43.85 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -89.35 146.15 24.88 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.805 0.691 . . . . 0.0 109.58 -161.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.79 101.1 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.817 1.294 . . . . 0.0 112.682 -144.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.71 -176.8 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 112.195 -2.275 . . . . 0.0 106.777 158.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 84.2 p -52.13 -13.1 0.28 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.25 133.54 65.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 118.295 0.498 . . . . 0.0 109.733 168.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -113.05 139.15 48.93 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.28 128.26 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.722 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.2 116.79 2.79 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.47 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 22.0 m -126.06 134.05 51.52 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.778 0.789 . . . . 0.0 111.355 -173.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.8 t90 -120.32 128.48 53.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 25' ' ' ASN . 17.1 tt -130.23 144.53 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.225 -173.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.17 132.17 45.94 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.78 153.16 23.02 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.545 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.481 HG12 ' HG ' ' A' ' 123' ' ' LEU . 34.5 m -125.18 144.67 34.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.19 178.13 32.02 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.195 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -132.52 173.21 11.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.695 -0.752 . . . . 0.0 109.927 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.622 ' CD ' HG22 ' A' ' 4' ' ' THR . 28.5 mmt85 -117.83 149.09 41.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.39 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.574 -178.943 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 C--O 1.231 0.101 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -123.17 156.15 35.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.389 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.91 131.44 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.162 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.0 m -128.19 143.0 51.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.838 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 140.9 12.23 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.71 -173.28 29.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.22 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -124.08 156.22 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.136 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.707 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -136.41 145.94 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.483 -176.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -128.18 131.97 48.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -114.77 131.74 56.69 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.376 0.422 . . . . 0.0 110.413 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.05 126.59 36.18 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.8 0.687 . . . . 0.0 110.923 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.801 -179.716 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.2 mttp . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.476 0.179 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -134.19 158.23 44.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.801 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.18 151.58 16.88 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.65 143.3 12.47 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.089 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.33 139.08 50.3 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -127.99 133.47 49.17 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.602 -174.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.07 137.84 54.47 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -135.97 147.11 47.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.094 0.473 . . . . 0.0 111.542 -173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -132.61 143.66 49.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.83 144.04 37.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.696 0.284 . . . . 0.0 111.018 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -105.89 143.17 34.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.56 125.8 37.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.5 0.667 . . . . 0.0 110.852 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -125.58 153.29 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.889 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.62 -178.32 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.305 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -53.07 -35.51 59.65 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.0 m -92.07 -25.94 0.28 Allowed Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -102.85 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.639 1.56 . . . . 0.0 112.39 162.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 71' ' ' TYR . 78.1 mt -78.12 164.25 25.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.073 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.27 140.13 15.55 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.73 125.02 55.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 117.649 0.724 . . . . 0.0 109.699 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 70' ' ' ALA . 71.8 mt -118.73 138.13 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.26 135.45 8.33 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -129.5 142.01 50.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.027 0.414 . . . . 0.0 111.068 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.37 128.25 55.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.7 m -120.82 131.26 54.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.577 0.227 . . . . 0.0 110.661 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.04 137.13 55.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.189 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -97.69 147.58 24.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.148 0.499 . . . . 0.0 111.067 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--O 1.236 0.378 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 -175.71 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 p90 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 121.442 0.639 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -117.66 134.74 54.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.149 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.84 132.08 7.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.9 mm -119.03 118.44 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.653 HG22 ' HA3' ' A' ' 84' ' ' GLY . 80.5 p -123.22 151.33 42.37 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.907 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.04 146.17 32.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.08 168.18 40.63 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.116 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.22 124.33 0.28 Allowed 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.394 2.063 . . . . 0.0 112.81 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.8 143.01 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.463 170.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.452 ' CD1' HD22 ' A' ' 37' ' ' LEU . 91.3 m-85 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 CA--C 1.522 -0.13 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.26 129.88 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.842 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -138.87 142.47 38.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.218 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.04 137.84 9.75 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.56 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.9 m -133.8 156.71 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 111.014 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.94 140.9 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.653 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.07 26.71 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.798 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.14 133.39 60.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.7 131.69 9.66 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -118.71 118.99 33.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -176.6 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 C--O 1.231 0.118 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.66 142.97 32.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.023 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.18 157.67 26.57 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.62 125.45 51.01 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.5 m -109.61 135.4 50.64 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.936 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -126.75 137.26 53.21 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.55 27.72 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.884 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.39 148.83 32.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.99 164.63 29.22 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.073 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -108.97 146.94 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -136.25 131.92 35.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.532 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -137.85 125.2 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -133.92 124.56 17.71 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -98.08 176.18 0.49 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.57 2.18 . . . . 0.0 109.615 158.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.3 ttm -56.12 145.87 24.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.114 0.483 . . . . 0.0 111.55 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 74.26 -157.12 0.06 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.383 0.673 . . . . 0.0 111.17 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.02 -11.32 13.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.5 t -78.54 17.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.563 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.15 135.96 44.67 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.309 -0.869 . . . . 0.0 110.212 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.623 HD11 HG12 ' A' ' 144' ' ' VAL . 4.4 mm? -125.49 146.21 49.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -171.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -137.14 138.32 40.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -128.31 133.92 48.82 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.2 m -140.05 154.14 46.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.599 -0.441 . . . . 0.0 112.015 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -123.81 141.89 51.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.67 149.85 46.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.981 0.419 . . . . 0.0 110.383 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -128.07 136.03 50.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.484 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -115.56 144.7 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -89.31 145.96 25.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -158.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 132' ' ' ILE . 12.5 tt -87.97 97.62 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 123.512 1.625 . . . . 0.0 113.655 -146.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.79 -176.77 5.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 112.144 -2.298 . . . . 0.0 107.476 157.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -52.22 -14.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.83 -0.544 . . . . 0.0 112.325 -175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.29 129.52 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.335 0.516 . . . . 0.0 109.897 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -115.05 139.18 50.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.18 132.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.816 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 117.76 3.06 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.0 m -126.15 134.26 51.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.798 0.799 . . . . 0.0 110.966 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -123.81 138.08 54.56 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.707 HG22 ' CB ' ' A' ' 10' ' ' ALA . 36.3 pt -132.52 151.14 34.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 O-C-N 123.141 0.276 . . . . 0.0 111.411 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.1 131.11 27.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.432 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -140.8 153.29 23.64 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.991 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.623 HG12 HD11 ' A' ' 123' ' ' LEU . 26.8 m -119.38 143.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.06 178.12 31.92 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -142.08 169.38 17.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.187 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -118.02 146.51 43.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.338 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 66.5 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.558 -179.163 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.6 p -125.24 156.07 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.125 0.488 . . . . 0.0 110.83 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.27 126.77 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.377 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.17 140.94 12.2 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.9 174.81 31.62 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.217 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -116.68 138.95 51.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.91 -0.645 . . . . 0.0 109.597 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -117.41 138.82 51.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.089 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -127.71 131.97 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -111.36 145.1 39.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.64 137.42 37.83 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.891 0.744 . . . . 0.0 111.562 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.0 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 64.7 mttp . . . . . 0 C--O 1.231 0.117 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.8 mtt -112.72 144.38 42.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.366 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 137.44 12.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.94 143.14 14.55 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.866 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -107.18 134.42 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -125.44 133.12 52.56 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.374 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.0 tp -121.55 134.76 55.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.253 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -128.48 148.79 50.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.316 0.579 . . . . 0.0 111.86 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -126.3 140.05 52.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.744 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.55 ' HG2' HG22 ' A' ' 40' ' ' ILE . 38.0 mtp180 -139.48 144.14 37.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.751 -173.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.93 143.1 44.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.67 128.27 38.46 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -129.86 153.49 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.402 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.69 -178.51 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.921 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -52.87 -36.27 58.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.429 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 m -93.71 -25.81 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 135.16 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.692 1.594 . . . . 0.0 112.219 165.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.97 160.69 28.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.82 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.12 140.3 22.08 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.48 124.97 56.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 117.482 0.641 . . . . 0.0 109.36 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.55 HG22 ' HG2' ' A' ' 29' ' ' ARG . 46.2 pt -128.27 143.45 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.391 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.35 145.31 16.1 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 t -137.71 141.19 41.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.167 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HD2' ' HH ' ' A' ' 63' ' ' TYR . 93.2 m-85 -113.53 131.58 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -125.84 135.77 52.33 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.678 0.275 . . . . 0.0 110.988 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -126.99 131.93 50.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.337 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 m -112.78 147.73 36.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.001 0.429 . . . . 0.0 111.41 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.181 179.508 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 121.014 0.435 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.467 ' HH ' ' HD2' ' A' ' 43' ' ' PHE . 71.7 t80 -138.39 130.52 28.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.468 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.09 148.67 20.04 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.941 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.5 123.4 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 t -123.5 155.07 38.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.25 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.51 152.92 41.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 171.14 42.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.93 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -96.58 125.61 0.27 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.232 1.955 . . . . 0.0 112.502 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.73 144.2 32.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.767 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.774 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' HD12 ' A' ' 113' ' ' LEU . 2.6 t . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.3 tt -154.59 133.82 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.298 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.72 150.03 44.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.444 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.03 137.87 9.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.11 152.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.264 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.53 141.18 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.11 175.14 26.64 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.9 129.29 73.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.94 143.94 17.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -134.84 146.98 49.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.862 0.331 . . . . 0.0 110.705 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 176.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.457 -0.114 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -107.34 147.1 30.74 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.146 0.279 . . . . 0.0 111.173 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 162.84 27.14 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.33 127.08 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.929 0.364 . . . . 0.0 110.189 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.4 t -115.6 138.11 51.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.255 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -141.34 149.39 41.1 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.16 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.14 174.44 36.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.99 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.86 33.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.71 155.98 26.09 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.424 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 78' ' ' SER . 6.9 tp -109.06 145.85 34.95 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -144.24 143.63 31.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.286 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -135.71 129.9 33.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 172.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.404 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 2.1 p30 -141.2 124.62 9.97 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -170.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -102.32 176.19 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.572 2.182 . . . . 0.0 109.252 157.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.2 mtt -55.53 167.17 0.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.872 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 65.45 -173.79 0.18 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.866 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.69 -11.31 4.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.6 t -78.44 17.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -167.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.404 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.32 134.13 48.06 Favored 'General case' 0 C--N 1.341 0.232 0 O-C-N 121.535 -0.728 . . . . 0.0 109.882 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 123' ' ' LEU . 4.6 mp -133.42 148.42 51.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.637 -171.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.11 148.04 46.43 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.526 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.77 134.67 47.07 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -140.11 154.12 46.92 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.677 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -117.57 139.95 50.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.01 151.06 46.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.959 0.409 . . . . 0.0 110.611 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -127.48 136.1 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.283 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.9 t -113.95 144.75 42.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 146.16 24.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.131 0.491 . . . . 0.0 109.733 -159.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -87.94 102.64 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.728 1.251 . . . . 0.0 112.908 -144.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -89.68 -176.76 5.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 112.436 -2.166 . . . . 0.0 107.438 156.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.9 p -52.33 -14.21 0.44 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.797 -0.564 . . . . 0.0 112.338 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 135' ' ' VAL . 35.3 m -122.16 126.9 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.344 0.52 . . . . 0.0 110.147 168.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -103.54 139.17 39.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.149 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.14 134.01 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.594 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.08 122.14 4.55 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -125.99 134.2 51.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.496 0.648 . . . . 0.0 111.251 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -115.14 132.94 56.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' A' ' 10' ' ' ALA . 44.9 pt -128.56 145.02 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -176.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.81 131.63 37.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.278 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.89 153.1 23.04 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.752 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.35 144.82 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.15 177.95 32.09 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.437 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -140.06 166.24 25.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.52 -0.84 . . . . 0.0 110.005 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -117.97 149.08 41.53 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.324 0.39 . . . . 0.0 110.554 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.6 t80 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.65 -179.177 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.848 0.356 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.2 m -130.28 140.29 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.235 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.08 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.356 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.706 HG22 ' HA3' ' A' ' 145' ' ' GLY . 57.8 p -128.13 143.31 51.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.47 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.1 140.79 12.35 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.4 172.62 29.4 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.184 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.49 138.39 50.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.744 -0.728 . . . . 0.0 109.108 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -119.54 140.03 51.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.658 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.96 131.93 54.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -114.3 135.14 54.39 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.253 0.346 . . . . 0.0 110.375 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -84.31 123.16 29.87 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.995 0.809 . . . . 0.0 111.177 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.471 179.056 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.668 0.271 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -126.48 159.63 32.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.734 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.32 146.96 17.86 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.33 143.21 13.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.009 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -108.26 132.57 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -123.88 132.96 53.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.385 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' C ' HD23 ' A' ' 26' ' ' LEU . 8.2 tt -125.87 131.04 52.45 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HD3' HD11 ' A' ' 40' ' ' ILE . 60.5 mttp -128.07 146.54 50.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.129 0.49 . . . . 0.0 111.887 -174.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.35 132.78 55.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HD3' HD12 ' A' ' 40' ' ' ILE . 75.2 mtm180 -135.91 144.0 45.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.175 0.297 . . . . 0.0 111.357 -175.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -113.0 139.03 49.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.81 128.62 38.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.342 0.591 . . . . 0.0 110.657 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -134.76 153.4 52.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.789 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.46 -178.6 3.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.671 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -53.92 -33.47 56.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.39 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -94.27 -25.85 0.26 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 134.94 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.748 1.632 . . . . 0.0 111.904 164.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.17 156.0 30.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.191 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.07 140.26 15.08 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.58 127.27 56.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.47 0.635 . . . . 0.0 109.877 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.51 HD12 ' HD3' ' A' ' 29' ' ' ARG . 17.6 tt -124.4 135.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.58 134.48 7.7 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t -129.28 139.06 51.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.84 0.32 . . . . 0.0 111.202 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.11 131.45 56.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -127.95 136.94 52.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -124.85 136.17 53.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.285 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.8 m -112.42 146.95 37.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 -178.575 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.3 t80 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.946 0.403 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -137.1 117.89 14.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.355 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.43 138.43 10.15 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.666 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.1 126.92 73.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.672 HG22 ' HA3' ' A' ' 84' ' ' GLY . 68.0 p -123.26 152.03 41.75 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.255 0.347 . . . . 0.0 110.172 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.99 146.49 31.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.545 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -167.95 170.95 42.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.267 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -98.01 123.67 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.486 2.124 . . . . 0.0 112.667 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 145.56 31.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.886 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.504 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 CA--C 1.52 -0.174 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.25 129.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -133.55 145.23 49.92 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.9 137.69 9.71 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.545 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.1 m -134.75 154.56 37.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.722 0.296 . . . . 0.0 111.181 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.19 140.75 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.672 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.2 175.09 26.75 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.76 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.81 130.5 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.09 136.08 12.41 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.436 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 C--O 1.231 0.089 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -130.45 153.98 48.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.972 0.415 . . . . 0.0 111.405 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.11 26.16 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.86 126.99 53.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.6 m -106.38 137.2 44.77 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.897 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.44 132.23 48.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -143.16 157.14 26.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.874 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.52 148.86 32.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.85 162.4 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.504 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -108.97 149.42 29.24 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -134.94 137.01 42.71 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.488 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.03 127.81 16.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.451 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 10.1 p-10 -142.07 124.51 9.2 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -100.72 176.16 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.759 2.306 . . . . 0.0 109.385 156.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.455 ' O ' HG22 ' A' ' 121' ' ' VAL . 71.4 mtm -53.99 177.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 63.73 -175.06 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.236 0.541 . . . . 0.0 112.193 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -62.95 -11.39 18.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 118' ' ' MET . 26.8 m -78.11 17.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -165.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.451 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -103.92 138.38 40.57 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.454 0.57 . . . . 0.0 109.798 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.408 ' HG ' HG12 ' A' ' 144' ' ' VAL . 5.3 mp -132.69 153.83 50.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.009 0.433 . . . . 0.0 111.97 -168.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -137.16 140.4 41.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.032 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.74 132.24 53.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.8 p -140.13 154.17 46.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.88 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -123.79 141.02 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -120.33 138.6 53.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.539 0.524 . . . . 0.0 110.451 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -123.96 135.0 53.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.079 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -118.26 144.93 45.42 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -89.29 146.53 24.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -157.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.507 HG23 ' CG ' ' A' ' 136' ' ' ASP . 73.6 mt -87.7 97.07 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.906 1.336 . . . . 0.0 112.215 -144.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.79 -176.92 5.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.046 -2.343 . . . . 0.0 107.446 157.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.8 p -52.27 -13.46 0.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.04 132.11 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.386 0.539 . . . . 0.0 110.195 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.507 ' CG ' HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -108.72 139.2 43.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.23 -0.414 . . . . 0.0 109.991 -178.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.13 122.72 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.13 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.31 114.74 2.22 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -125.81 134.13 51.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.752 0.776 . . . . 0.0 111.244 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.61 131.23 56.77 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 10' ' ' ALA . 61.9 mt -123.06 134.81 65.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 O-C-N 123.182 0.301 . . . . 0.0 110.259 -175.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.4 125.1 40.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.0 153.2 21.66 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.855 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.408 HG12 ' HG ' ' A' ' 123' ' ' LEU . 35.8 m -122.26 146.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.706 ' HA3' HG22 ' A' ' 6' ' ' THR . . . -147.28 173.13 27.53 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.242 -174.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -128.88 154.64 46.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.465 -1.368 . . . . 0.0 109.376 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -118.0 149.11 41.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.966 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.5 t80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.033 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.795 0.331 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -128.02 140.66 51.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.772 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.68 136.99 58.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.036 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.95 140.61 11.94 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 173.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 168.4 30.1 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.365 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -121.94 135.87 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -127.59 149.03 50.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.19 134.39 54.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.18 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -112.86 142.59 45.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 142.1 37.66 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.649 0.593 . . . . 0.0 110.93 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.423 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 48.9 pttt . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.65 159.29 40.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.856 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.17 142.11 14.73 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.57 143.15 14.74 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.64 135.19 54.42 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.617 ' OD1' HG23 ' A' ' 44' ' ' THR . 92.9 m-20 -126.58 133.22 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 111.367 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.0 tp -120.03 134.95 55.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.019 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -130.22 145.77 51.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 112.066 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -120.34 137.82 54.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.042 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -135.26 144.28 46.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.834 0.35 . . . . 0.0 111.378 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -106.64 142.19 36.69 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -92.67 126.93 37.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.311 0.577 . . . . 0.0 110.373 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.99 153.62 41.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.735 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.38 -178.42 3.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.601 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -57.2 -35.42 69.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -87.04 -26.11 0.34 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -102.86 130.17 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.569 1.513 . . . . 0.0 112.105 160.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 69' ' ' PRO . 77.2 mt -77.74 155.24 31.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.996 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.64 140.06 18.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -99.79 124.93 53.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 117.397 0.599 . . . . 0.0 109.83 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.471 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.3 mt -120.27 132.88 68.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.77 134.17 8.61 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.3 p -127.36 141.98 51.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -113.01 128.08 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.769 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.617 HG23 ' OD1' ' A' ' 25' ' ' ASN . 55.0 m -124.45 132.7 53.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.12 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -127.09 136.03 51.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.487 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 m -117.81 145.21 44.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 110.955 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.006 179.564 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 121.115 0.483 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -128.8 119.15 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.221 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.19 135.18 8.19 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.272 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.02 117.29 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.575 HG22 ' HB ' ' A' ' 82' ' ' VAL . 2.0 m -123.28 148.65 45.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.768 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.82 31.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.13 168.93 41.14 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.114 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HB2' HD13 ' A' ' 37' ' ' LEU . 71.8 Cg_endo -98.41 122.9 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.555 2.17 . . . . 0.0 113.062 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.9 146.56 30.76 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.328 170.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.5 t80 . . . . . 0 C--N 1.333 -0.148 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.494 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 CA--C 1.519 -0.23 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.59 129.99 14.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.539 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -131.18 140.26 49.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.0 137.75 11.3 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 66' ' ' THR . 35.1 m -136.46 152.64 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.974 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 109' ' ' TYR . 35.9 m -134.17 140.95 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.455 ' N ' HG23 ' A' ' 66' ' ' THR . . . -147.17 174.95 26.78 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.57 -176.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.54 133.09 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.64 131.32 9.45 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -114.92 132.28 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.642 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.077 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.42 0.152 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.11 142.89 39.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.299 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.12 162.36 27.17 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -108.5 125.76 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.6 m -108.93 137.94 46.05 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.63 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.585 ' CD2' HG12 ' A' ' 83' ' ' VAL . 81.0 m-85 -125.92 138.89 53.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.73 157.64 27.33 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.841 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.8 148.78 32.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.82 160.37 28.47 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.102 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.5 mp -111.96 147.11 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.57 141.07 41.34 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.934 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -133.12 116.29 16.11 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -117.62 124.24 29.07 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.38 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -107.03 176.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.102 2.535 . . . . 0.0 109.423 157.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.33 170.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.182 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 65.39 -171.35 0.19 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.056 0.455 . . . . 0.0 111.956 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -61.51 -11.3 10.32 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 121' ' ' VAL . 6.3 t -78.38 18.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.13 0.572 . . . . 0.0 112.431 -164.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.91 137.61 41.66 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.233 -0.917 . . . . 0.0 109.662 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.77 148.77 50.88 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -168.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -137.13 142.04 42.26 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -126.32 132.14 51.69 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -140.15 154.08 46.86 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.863 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.14 140.6 52.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -121.56 141.67 50.84 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 123.372 0.42 . . . . 0.0 110.093 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -125.9 132.84 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.575 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.1 m -115.77 144.57 43.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -89.45 146.03 24.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -161.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 132' ' ' ILE . 10.5 tt -87.76 101.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 123.616 1.674 . . . . 0.0 113.697 -146.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -89.74 -176.7 5.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.244 157.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.14 -13.94 0.37 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.821 -0.549 . . . . 0.0 112.354 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.98 132.03 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.392 0.542 . . . . 0.0 109.747 166.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.08 139.22 50.07 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.15 127.68 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.767 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.41 116.1 2.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.525 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 40.1 m -126.1 134.14 51.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.477 0.639 . . . . 0.0 111.235 -175.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -122.64 133.78 54.51 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 17.7 tt -131.6 146.11 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.636 0.255 . . . . 0.0 111.269 -172.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.01 133.95 53.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.38 153.13 21.81 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.074 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.82 140.0 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -138.91 163.89 25.85 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.395 -173.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -134.15 152.33 51.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 113.485 -1.357 . . . . 0.0 108.801 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -136.76 149.0 47.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.531 -179.627 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.972 0.415 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.45 HG21 HH21 ' A' ' 29' ' ' ARG . 40.7 m -132.51 139.27 47.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.332 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.58 120.53 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.5 m -128.25 143.09 51.0 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.31 140.86 12.13 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.23 179.81 31.82 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.159 -175.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.6 144.57 46.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -0.622 . . . . 0.0 109.847 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.573 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -122.74 138.52 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.944 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -125.46 131.92 52.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -116.81 145.74 43.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 139.31 38.66 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.827 0.704 . . . . 0.0 111.253 -173.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.115 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 36.8 pttt . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.545 0.212 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.8 mtt -117.63 146.38 43.71 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.57 135.29 10.78 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.52 143.15 14.45 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.607 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.514 ' CE2' HD21 ' A' ' 26' ' ' LEU . 62.0 t80 -110.95 135.8 50.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.66 ' HB3' HG22 ' A' ' 44' ' ' THR . 23.0 p30 -131.63 144.57 51.14 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.945 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 24' ' ' PHE . 80.6 mt -124.41 140.51 52.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.239 173.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.16 141.89 51.04 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.043 0.449 . . . . 0.0 111.084 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -121.03 130.21 53.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HD3' HD12 ' A' ' 40' ' ' ILE . 40.0 mtm180 -134.39 144.08 47.99 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.265 0.353 . . . . 0.0 110.657 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -107.49 143.22 36.18 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.68 119.16 31.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.195 0.522 . . . . 0.0 109.981 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.45 153.4 46.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.991 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.7 -178.62 3.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.541 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -56.37 -32.96 65.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.315 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.2 m -93.38 -25.94 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -102.83 136.3 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.728 1.619 . . . . 0.0 111.848 164.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.6 mt -78.06 154.27 31.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.93 140.38 16.38 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.09 127.5 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.501 0.651 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.57 HD12 ' HD3' ' A' ' 29' ' ' ARG . 16.9 tt -123.36 138.39 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.28 139.77 10.58 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 p -135.41 144.93 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.067 0.434 . . . . 0.0 111.424 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -124.68 128.65 49.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.109 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 25' ' ' ASN . 36.8 p -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.855 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -127.28 137.12 52.77 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -111.54 150.73 29.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 111.202 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--O 1.235 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.141 -179.209 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 . . . . . 0 CA--C 1.523 -0.064 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.17 128.25 41.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.45 128.15 5.29 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 65' ' ' ILE . 7.6 tp -124.65 122.61 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.732 HG22 ' HA3' ' A' ' 84' ' ' GLY . 30.3 p -123.3 154.95 38.17 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.864 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.72 147.6 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.16 42.3 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.512 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -97.29 127.79 0.27 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.452 2.101 . . . . 0.0 112.818 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.66 138.55 36.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.652 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.0 t80 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.568 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.93 129.95 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.282 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -115.76 133.9 55.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.17 137.71 10.88 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 172.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.77 153.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 117.559 0.679 . . . . 0.0 111.976 -173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.466 HG13 ' CZ ' ' A' ' 107' ' ' PHE . 55.5 t -125.71 140.84 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.732 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.41 174.95 27.0 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.661 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.3 128.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.3 131.26 8.53 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -139.06 155.91 47.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.097 0.448 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.714 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.445 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 C--O 1.23 0.056 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -136.02 159.86 40.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 111.403 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.02 167.11 26.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.466 ' CZ ' HG13 ' A' ' 83' ' ' VAL . 61.0 t80 -93.2 124.86 37.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -113.07 140.55 47.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.039 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.2 139.38 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.5 161.9 28.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.152 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.34 148.94 31.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.368 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.448 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -148.04 162.0 28.68 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.61 -177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.448 HD22 ' C ' ' A' ' 112' ' ' GLY . 4.5 mm? -111.87 152.64 27.73 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -116.47 133.47 55.98 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 111.693 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.56 109.74 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.482 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 13.3 p-10 -140.59 124.71 10.58 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -165.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -101.23 176.14 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.381 2.054 . . . . 0.0 109.258 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.7 mtp -58.69 176.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 61.64 -174.45 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.901 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -60.63 -11.56 7.62 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.8 t -78.4 17.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -167.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.596 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.24 138.02 41.3 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.64 HD11 HG12 ' A' ' 144' ' ' VAL . 4.5 mm? -122.27 145.52 48.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -168.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.66 131.35 44.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.661 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -124.06 129.79 51.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -140.12 154.11 46.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.606 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -121.61 139.98 52.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.94 150.95 46.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.889 0.376 . . . . 0.0 110.742 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -131.84 136.02 47.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -113.32 144.57 42.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.194 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -89.21 146.24 24.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.782 0.676 . . . . 0.0 109.519 -160.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 pt -87.88 98.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 123.309 1.528 . . . . 0.0 114.032 -145.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -89.67 -176.74 5.08 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 112.2 -2.273 . . . . 0.0 106.903 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.3 p -52.32 -12.78 0.28 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.324 -0.86 . . . . 0.0 112.616 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.07 133.89 65.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.334 0.516 . . . . 0.0 109.837 168.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -115.0 139.1 50.13 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -108.18 129.77 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.743 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.23 117.18 2.9 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 169.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.6 m -126.14 134.26 51.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.862 0.831 . . . . 0.0 111.476 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -115.85 135.13 54.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.573 HG22 ' CB ' ' A' ' 10' ' ' ALA . 41.6 pt -130.84 144.71 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.286 -177.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.49 128.69 25.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.471 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.445 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -136.95 153.07 21.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.612 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.64 HG12 HD11 ' A' ' 123' ' ' LEU . 27.0 m -118.01 140.96 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.13 178.1 31.98 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.401 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -139.8 162.78 34.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.444 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -141.52 149.06 40.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.534 -179.675 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.461 0.08 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.4 m -126.0 139.74 53.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.918 0.389 . . . . 0.0 110.353 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.6 122.59 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.608 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.14 143.06 51.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.34 140.83 12.16 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.89 179.29 31.06 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.031 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -131.16 146.44 52.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.628 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -134.27 149.16 50.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.004 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -116.22 136.3 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -112.9 139.48 48.5 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.79 127.78 32.51 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.88 0.738 . . . . 0.0 111.02 -174.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.582 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 47.4 mtmt . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.671 0.272 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -129.04 160.95 31.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.666 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.83 148.22 17.58 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.14 14.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.755 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CE1' HD21 ' A' ' 26' ' ' LEU . 61.8 t80 -112.77 135.06 53.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.527 ' HB3' HD11 ' A' ' 141' ' ' ILE . 51.2 t30 -131.12 138.29 49.44 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.833 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 24' ' ' PHE . 82.4 mt -122.26 139.61 53.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.289 174.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -130.7 142.57 50.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.915 0.388 . . . . 0.0 111.427 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -122.26 133.15 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -137.08 144.09 42.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.079 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.09 143.2 33.59 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.59 125.83 37.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.277 0.561 . . . . 0.0 110.188 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.99 153.38 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.56 -178.6 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.715 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.04 -33.53 65.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.427 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -93.25 -26.06 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -102.77 135.28 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.756 1.637 . . . . 0.0 111.889 164.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 69' ' ' PRO . 4.2 pp -77.97 160.29 28.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.25 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.46 140.21 14.91 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.41 125.51 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.341 0.571 . . . . 0.0 109.935 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' A' ' 70' ' ' ALA . 72.3 mt -119.2 136.12 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.87 136.46 8.57 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.1 p -138.2 149.08 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.41 0.605 . . . . 0.0 111.59 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -122.2 135.56 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.969 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -130.13 140.04 50.83 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.144 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -125.64 136.99 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.59 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 m -101.27 145.31 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.344 -177.79 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.2 t80 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -130.11 133.12 46.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.83 135.51 7.87 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.89 123.57 67.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.662 HG22 ' HA3' ' A' ' 84' ' ' GLY . 69.5 p -123.23 153.4 40.18 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.052 0.22 . . . . 0.0 111.001 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 143.95 30.23 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.15 169.56 41.52 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.995 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.591 ' HB3' HD13 ' A' ' 37' ' ' LEU . 74.5 Cg_endo -97.27 124.92 0.22 Allowed 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 122.471 2.114 . . . . 0.0 112.914 176.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.611 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.81 147.02 30.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.719 169.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 t80 . . . . . 0 C--N 1.332 -0.157 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 172.827 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.47 HG22 HD23 ' A' ' 113' ' ' LEU . 48.0 pt -136.83 144.38 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.463 -167.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -137.1 147.34 46.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.847 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 137.87 9.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.518 HG12 ' HA3' ' A' ' 68' ' ' GLY . 32.9 m -134.67 156.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.76 0.314 . . . . 0.0 111.015 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.565 HG12 ' CD2' ' A' ' 109' ' ' TYR . 35.5 m -128.49 140.94 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.21 175.08 26.76 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.696 -176.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.75 129.72 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.56 137.88 11.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -139.05 151.8 47.06 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.558 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.623 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.94 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 C--O 1.23 0.046 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -132.06 153.17 50.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.227 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.29 167.07 26.22 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.99 125.91 47.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.1 m -110.24 142.2 42.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.15 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.565 ' CD2' HG12 ' A' ' 83' ' ' VAL . 87.7 m-85 -124.9 137.06 54.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.34 153.43 23.47 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.678 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.25 148.85 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.72 160.04 28.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.377 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.47 HD23 HG22 ' A' ' 79' ' ' ILE . 70.6 mt -108.86 146.04 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -125.75 140.59 52.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 111.805 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -139.97 110.0 6.48 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.458 ' CG ' ' HB1' ' A' ' 122' ' ' ALA . 53.9 m-20 -132.85 124.29 18.63 Favored Pre-proline 0 CA--C 1.529 0.136 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.472 -170.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -102.04 176.21 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.992 2.462 . . . . 0.0 109.255 156.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.439 ' O ' HG22 ' A' ' 121' ' ' VAL . 71.4 mtm -57.77 166.42 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.512 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 65.39 -174.47 0.18 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.16 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -58.74 -11.66 3.41 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 118' ' ' MET . 31.3 m -78.42 17.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -170.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.458 ' HB1' ' CG ' ' A' ' 116' ' ' ASN . . . -104.74 143.04 33.64 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.524 ' N ' HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -146.66 155.8 42.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.369 -174.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -137.09 148.09 46.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.602 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -126.15 127.53 45.88 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 64.9 p -140.23 154.21 46.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.444 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -120.87 150.13 41.53 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -124.72 137.95 54.31 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.487 0.492 . . . . 0.0 110.525 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -122.42 129.22 51.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.301 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.5 m -120.18 144.56 47.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -89.51 146.12 24.82 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.531 0.519 . . . . 0.0 109.602 -163.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 132' ' ' ILE . 9.8 tt -87.72 95.91 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 123.705 1.717 . . . . 0.0 113.422 -147.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -89.66 -176.84 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.434 157.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -52.01 -16.27 0.72 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.83 -0.544 . . . . 0.0 112.141 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.33 127.51 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 167.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -115.1 139.16 50.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.2 125.96 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.979 -171.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 108.83 1.12 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 167.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.487 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 30.4 m -126.08 134.26 51.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 117.633 0.716 . . . . 0.0 111.352 -174.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -123.21 132.23 53.97 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.628 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 16.4 tt -130.28 143.77 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.188 0.305 . . . . 0.0 111.079 -171.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.2 53.53 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.82 153.11 20.95 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.709 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.3 141.18 47.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.28 178.05 32.14 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.78 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -139.77 171.8 13.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.691 -0.754 . . . . 0.0 110.277 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -117.88 148.95 41.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.503 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.0 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.618 -179.368 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.821 0.343 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 146' ' ' TYR . 19.2 m -129.71 143.11 50.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.511 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.98 127.0 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -128.41 143.17 50.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.899 0.381 . . . . 0.0 111.313 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.67 140.87 12.13 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.78 -175.91 30.23 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.32 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.52 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -127.85 148.92 50.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.508 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -121.85 135.25 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.618 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.93 143.77 44.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -78.46 138.63 38.56 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.674 0.609 . . . . 0.0 111.078 -173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.574 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 54.2 mtmt . . . . . 0 C--O 1.231 0.094 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.6 mtm -119.55 153.42 35.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.551 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.18 140.64 13.68 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.11 143.19 14.58 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.813 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.12 132.18 54.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -127.12 139.02 53.27 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.165 0.291 . . . . 0.0 111.716 -173.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -127.99 132.81 49.15 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' N ' HD13 ' A' ' 26' ' ' LEU . 39.0 ttpt -136.18 147.65 47.77 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.02 0.438 . . . . 0.0 110.825 -176.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -132.69 151.18 52.04 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.584 ' CB ' HG22 ' A' ' 40' ' ' ILE . 49.6 ptt85 -150.98 144.45 24.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.144 -176.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -105.78 143.24 34.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -92.4 124.38 36.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.308 0.575 . . . . 0.0 110.091 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -121.37 153.32 37.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.871 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.64 -178.46 3.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.843 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -50.66 -42.33 56.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 p -90.26 -25.86 0.3 Allowed Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -102.83 131.95 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.497 1.465 . . . . 0.0 112.218 162.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.4 mt -78.07 162.04 26.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.672 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.19 140.22 23.55 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.32 124.79 54.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 117.821 0.811 . . . . 0.0 109.401 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 29' ' ' ARG . 43.8 pt -117.82 142.7 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -146.34 134.41 5.33 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -141.93 154.92 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.909 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -132.93 141.15 48.2 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -130.07 141.29 50.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.168 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -118.65 134.39 55.15 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.6 m -109.77 145.83 35.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.993 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.268 179.559 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.6 133.21 49.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.649 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.29 136.34 8.69 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 65' ' ' ILE . 16.6 tt -125.28 124.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.649 HG22 ' HA3' ' A' ' 84' ' ' GLY . 82.6 p -123.31 154.7 38.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.315 -175.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.81 147.98 41.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.27 171.02 36.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.42 -175.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -99.3 123.48 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.774 2.316 . . . . 0.0 111.945 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.6 143.56 33.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.4 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 t80 . . . . . 0 C--O 1.234 0.253 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.893 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -132.57 129.81 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.576 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -132.18 133.75 44.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.88 137.64 10.59 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.54 ' CG1' HD11 ' A' ' 40' ' ' ILE . 33.9 m -139.22 151.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 117.468 0.634 . . . . 0.0 112.382 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.78 140.93 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.649 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.17 175.14 26.69 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.361 -174.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.638 HG12 ' OH ' ' A' ' 105' ' ' TYR . 35.8 m -112.56 134.45 55.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.83 10.95 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -122.14 133.35 54.75 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 176.205 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.638 ' OH ' HG12 ' A' ' 85' ' ' VAL . 64.6 t80 -109.04 142.89 39.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.25 159.47 27.1 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -102.54 126.1 49.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 m -116.44 143.91 44.98 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.698 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -143.08 153.07 42.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.03 175.55 35.97 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.12 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.84 148.99 29.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.001 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.81 159.85 27.89 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.953 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.5 mp -121.53 147.63 45.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -134.42 141.04 46.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.273 0.559 . . . . 0.0 111.851 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -130.6 114.05 14.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.478 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 16.3 p-10 -134.51 124.69 17.19 Favored Pre-proline 0 N--CA 1.463 0.216 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -98.79 176.24 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.465 2.11 . . . . 0.0 109.146 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.445 ' O ' HG22 ' A' ' 121' ' ' VAL . 65.2 mtt -55.93 169.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.798 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -175.91 0.18 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.209 0.528 . . . . 0.0 112.298 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.87 -11.52 5.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 118' ' ' MET . 26.8 m -78.26 18.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -169.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.19 136.74 43.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.281 0.491 . . . . 0.0 109.863 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.406 ' CD2' HG12 ' A' ' 144' ' ' VAL . 74.5 mt -119.68 142.85 48.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.488 -168.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -135.69 136.21 40.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.288 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.33 134.62 52.15 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 m -140.09 154.0 46.91 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.419 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -120.77 141.6 50.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.76 140.91 50.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 110.239 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -125.06 136.15 53.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.213 0.53 . . . . 0.0 111.346 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.6 m -103.94 144.71 31.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -89.28 145.96 25.04 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -158.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.8 96.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 122.732 1.253 . . . . 0.0 112.533 -145.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -89.85 -176.84 5.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 112.174 -2.285 . . . . 0.0 106.871 157.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.32 -13.36 0.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.387 -0.821 . . . . 0.0 112.537 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -119.06 129.64 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.424 0.556 . . . . 0.0 110.092 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -115.15 139.12 50.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.617 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.11 134.66 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.525 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.22 121.58 4.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.4 m -126.13 134.18 51.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.529 0.665 . . . . 0.0 111.256 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -120.57 130.54 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 19.4 tt -131.25 144.62 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.136 -173.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.66 132.91 45.7 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.32 153.31 21.86 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.773 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.406 HG12 ' CD2' ' A' ' 123' ' ' LEU . 29.2 m -118.63 139.92 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.48 178.03 30.71 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.343 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 4' ' ' THR . 43.1 p90 -141.0 161.85 36.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.786 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -121.03 145.2 48.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.529 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.508 -179.403 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.741 0.305 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -121.76 140.06 52.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.507 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.52 128.51 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.2 m -128.14 142.11 51.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.408 . . . . 0.0 111.193 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.28 140.9 12.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.55 -179.9 31.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.374 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -122.27 140.23 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.65 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.39 138.87 54.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.504 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -125.75 131.78 52.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.5 p -115.92 143.59 45.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.42 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.82 129.42 34.58 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 124.116 0.885 . . . . 0.0 111.374 -173.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.643 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.994 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 40.9 mtmt . . . . . 0 C--O 1.231 0.095 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.4 mtt -129.74 154.01 47.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.614 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.5 147.9 16.73 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 143.33 12.28 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.46 133.46 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -127.38 136.63 52.14 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.433 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 tp -130.6 136.31 48.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -139.34 155.32 47.77 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.281 0.562 . . . . 0.0 112.197 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.92 140.37 52.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.097 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -132.62 144.35 50.3 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.212 0.32 . . . . 0.0 110.899 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.42 141.8 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -92.81 123.2 35.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.85 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.44 -178.5 3.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.882 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -54.77 -40.4 69.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 m -84.45 -26.19 0.38 Allowed Pre-proline 0 N--CA 1.467 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -169.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.62 126.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.531 1.487 . . . . 0.0 112.069 160.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 71' ' ' TYR . 77.6 mt -76.31 154.64 34.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.25 140.17 18.89 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.97 126.13 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 117.206 0.503 . . . . 0.0 109.647 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.455 ' C ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -124.57 134.99 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' N ' HD13 ' A' ' 40' ' ' ILE . . . -135.89 137.29 9.02 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -141.77 154.86 45.53 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.004 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.34 141.48 50.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.8 p -130.11 143.19 50.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.481 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.76 137.04 55.04 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -115.57 148.55 39.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.005 179.377 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.2 t80 . . . . . 0 CA--C 1.524 -0.044 0 CA-C-O 120.918 0.389 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -131.44 120.41 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.77 135.49 8.54 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 65' ' ' ILE . 15.8 tt -126.04 122.57 62.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.653 HG22 ' HA3' ' A' ' 84' ' ' GLY . 24.3 p -123.48 152.37 41.78 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.102 0.252 . . . . 0.0 110.602 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.563 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.0 146.39 30.97 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.51 41.46 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.287 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -99.02 122.3 0.13 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.734 2.289 . . . . 0.0 112.944 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.84 146.68 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.396 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.408 ' CD1' HD22 ' A' ' 37' ' ' LEU . 88.8 m-85 . . . . . 0 C--O 1.232 0.155 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.461 0.11 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.2 mt -141.55 129.85 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.898 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -134.15 142.77 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 66' ' ' THR . 9.2 p -139.82 143.91 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.045 0.423 . . . . 0.0 110.82 -172.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.573 HG12 ' CD1' ' A' ' 109' ' ' TYR . 35.9 m -130.36 140.91 47.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.653 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.15 26.67 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.431 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -115.49 130.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 134.91 11.59 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -122.12 136.2 54.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 176.046 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.4 t70 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -109.64 151.23 27.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.99 166.99 26.15 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.66 127.16 51.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.841 0.321 . . . . 0.0 110.349 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.4 t -105.52 132.07 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.566 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.573 ' CD1' HG12 ' A' ' 83' ' ' VAL . 84.7 m-85 -126.48 134.71 50.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.68 158.9 27.81 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.789 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.67 148.87 32.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.6 159.84 28.32 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.375 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.5 mp -112.1 148.52 33.76 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -137.5 137.24 38.46 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.279 -171.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -133.91 131.16 38.77 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -138.74 124.48 12.31 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -99.04 176.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.718 2.279 . . . . 0.0 109.746 159.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.5 ttm -54.51 138.27 40.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.138 0.494 . . . . 0.0 111.861 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 71.81 -153.73 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.457 171.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.97 -11.65 8.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -166.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' VAL . 7.3 t -78.68 17.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -166.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.39 143.02 33.55 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.062 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -146.37 153.81 40.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 111.403 -174.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p30 -137.29 148.1 46.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.885 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.485 ' CE2' HD12 ' A' ' 123' ' ' LEU . 98.2 m-85 -122.37 131.72 54.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 m -139.98 154.2 47.1 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.759 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -121.28 141.14 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.72 142.32 47.79 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.547 0.53 . . . . 0.0 110.314 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.46 131.54 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.584 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -110.7 144.73 39.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -89.23 146.1 24.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 123.79 0.681 . . . . 0.0 109.348 -158.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.508 HG23 ' CG ' ' A' ' 136' ' ' ASP . 68.6 mt -87.83 100.38 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.712 1.244 . . . . 0.0 112.636 -143.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -89.68 -177.0 5.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 112.392 -2.185 . . . . 0.0 107.555 156.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 t -52.25 -15.31 0.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.851 -0.531 . . . . 0.0 112.273 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.39 129.39 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.392 0.542 . . . . 0.0 110.079 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.508 ' CG ' HG23 ' A' ' 132' ' ' ILE . 0.7 OUTLIER -102.85 139.24 38.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 119.065 -0.493 . . . . 0.0 109.787 178.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.69 129.76 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.26 116.94 2.83 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.9 m -126.15 134.27 51.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.714 0.757 . . . . 0.0 111.19 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -109.34 134.14 52.18 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 141' ' ' ILE . 4.6 mp -124.26 136.34 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 O-C-N 123.131 0.269 . . . . 0.0 110.434 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.14 127.46 43.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.38 153.08 22.27 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.05 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.3 t -127.26 145.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.36 178.06 30.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.32 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -135.84 170.29 16.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.745 -0.728 . . . . 0.0 110.409 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.501 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 117.977 -1.011 . . . . 0.0 112.396 178.887 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.1 p -124.29 157.45 34.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.167 0.508 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.62 125.95 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.505 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 26' ' ' LEU . 31.6 m -128.19 143.11 51.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -177.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.54 140.73 12.0 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.61 176.49 33.14 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.394 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.03 149.84 41.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.941 -0.63 . . . . 0.0 109.667 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.566 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -130.36 141.71 50.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.187 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -128.0 131.91 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -116.1 145.93 42.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -78.72 142.05 37.4 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.782 0.676 . . . . 0.0 110.944 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.217 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 25.5 pttm . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.698 0.285 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.2 ttm -123.92 146.46 48.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.307 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 134.67 10.8 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.07 143.35 14.27 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -118.61 144.42 46.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.631 ' C ' HD22 ' A' ' 26' ' ' LEU . 27.3 p30 -143.96 153.23 42.05 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.752 -174.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.631 HD22 ' C ' ' A' ' 25' ' ' ASN . 4.5 mm? -123.2 142.91 50.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.521 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -136.22 138.42 41.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 111.016 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.93 140.45 49.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -133.66 144.21 49.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.975 0.417 . . . . 0.0 110.683 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -101.29 143.29 31.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -92.38 117.39 29.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.545 0.688 . . . . 0.0 110.407 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -126.2 153.55 44.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.631 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.59 -178.63 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.773 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -56.69 -33.42 66.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.29 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -102.78 140.98 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.714 1.61 . . . . 0.0 111.823 164.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.16 159.97 28.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.061 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.16 140.05 14.88 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.79 127.58 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.527 0.663 . . . . 0.0 109.948 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.27 144.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.388 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.99 137.87 8.73 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.3 t -136.53 141.35 43.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.019 0.41 . . . . 0.0 111.308 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.94 131.63 54.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -130.0 142.99 50.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.622 0.249 . . . . 0.0 111.554 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.18 136.38 51.99 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.8 p -121.17 152.32 38.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.946 0.403 . . . . 0.0 111.175 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.56 -178.859 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.78 133.62 54.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.57 128.64 5.42 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.8 mt -122.18 120.06 60.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.644 HG22 ' HA3' ' A' ' 84' ' ' GLY . 70.2 p -123.28 151.72 42.09 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.139 0.274 . . . . 0.0 111.047 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.97 145.27 30.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.15 170.09 41.81 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.882 -1.151 . . . . 0.0 113.085 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -98.72 126.03 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.379 2.053 . . . . 0.0 112.688 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.57 142.84 33.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.482 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 t80 . . . . . 0 C--N 1.332 -0.17 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.167 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 CA--C 1.52 -0.2 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 tt -131.92 136.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.28 -167.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -129.14 143.33 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.96 137.72 10.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.427 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -135.25 154.64 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.915 0.358 . . . . 0.0 111.296 -173.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.58 140.81 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.644 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.08 172.95 27.41 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.758 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.87 132.53 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 132.52 10.11 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -127.22 134.06 50.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.261 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.549 0.214 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -110.1 144.23 39.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.996 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.96 158.84 26.86 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.85 125.34 50.79 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -110.94 143.36 41.71 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.302 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -130.79 134.72 47.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.57 161.26 28.0 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.963 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.35 148.92 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.55 160.34 28.34 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.377 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.6 mt -108.89 151.21 26.59 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -123.69 132.11 53.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.759 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.21 111.44 15.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -130.74 124.42 20.82 Favored Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -169.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -96.41 176.05 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.739 2.293 . . . . 0.0 109.341 156.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -65.57 147.1 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 79.31 -164.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.761 0.825 . . . . 0.0 110.817 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.62 -11.88 8.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.67 17.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 134.67 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.525 0.602 . . . . 0.0 109.844 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.11 140.72 47.79 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.752 0.311 . . . . 0.0 111.184 -168.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -125.43 145.18 50.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.334 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -125.92 129.71 49.84 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.9 t -140.2 154.0 46.77 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.512 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -117.1 145.49 43.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -128.31 132.33 48.66 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.271 0.357 . . . . 0.0 110.043 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -118.75 134.6 55.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.856 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.0 m -115.65 144.75 43.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.52 146.02 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.64 0.587 . . . . 0.0 109.484 -160.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -87.74 95.95 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.708 1.242 . . . . 0.0 112.383 -146.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -89.91 -176.92 5.08 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.375 -2.193 . . . . 0.0 106.669 157.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.8 t -52.17 -16.02 0.71 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.303 -0.873 . . . . 0.0 112.179 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.63 129.38 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.251 0.478 . . . . 0.0 109.811 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -115.06 139.06 50.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.406 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.0 t -108.26 128.43 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.578 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.4 112.08 1.62 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 169.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -126.08 134.32 51.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.815 0.808 . . . . 0.0 111.176 -173.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -116.25 136.24 53.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.566 HG22 ' CB ' ' A' ' 10' ' ' ALA . 41.3 pt -130.13 147.22 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.169 -175.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.5 128.5 25.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.2 153.1 23.21 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.519 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -125.81 145.88 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.07 32.11 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.133 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.43 165.95 23.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.81 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -118.06 148.65 42.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.703 0.287 . . . . 0.0 110.45 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.618 -179.656 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.61 0.243 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.606 HG22 ' CB ' ' A' ' 147' ' ' ARG . 37.9 p -131.09 155.7 46.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.474 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.04 120.25 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.744 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.8 m -128.34 142.96 50.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.818 0.342 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.33 140.86 12.18 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.24 167.91 28.99 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.994 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.08 138.85 53.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.88 149.11 51.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.083 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -124.03 138.98 54.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -115.93 140.77 48.91 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.311 0.382 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.78 126.29 30.52 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.8 0.687 . . . . 0.0 111.381 -173.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.656 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.747 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.656 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 59.9 mttm . . . . . 0 C--O 1.231 0.084 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.6 mmm -125.3 155.12 40.71 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.251 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.37 148.35 16.76 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.04 143.03 14.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.717 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.587 ' CE1' HD21 ' A' ' 26' ' ' LEU . 58.2 t80 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.85 135.78 48.79 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.602 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.587 HD21 ' CE1' ' A' ' 24' ' ' PHE . 81.3 mt -120.31 140.25 51.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 40' ' ' ILE . 98.0 mttt -129.65 143.66 50.92 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.887 0.375 . . . . 0.0 111.37 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -125.32 132.29 52.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -139.93 144.15 36.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -98.47 143.44 28.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.75 136.05 33.57 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.241 0.543 . . . . 0.0 111.119 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -133.42 153.65 51.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.519 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.18 -178.3 3.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.334 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -51.14 -28.41 10.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -97.13 -25.82 0.24 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -102.82 148.08 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.817 1.678 . . . . 0.0 112.983 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.11 164.96 24.54 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.4 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.34 140.24 14.77 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 39' ' ' VAL . 11.5 p -111.04 125.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.415 HD11 ' HD3' ' A' ' 27' ' ' LYS . 17.7 tt -126.72 138.38 54.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.54 142.72 14.24 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.406 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 52.8 p -138.91 148.79 44.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.092 0.446 . . . . 0.0 111.668 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -121.42 133.71 55.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.218 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -128.95 137.19 51.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.65 0.262 . . . . 0.0 111.125 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -120.57 136.94 54.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.866 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.6 m -98.58 137.69 36.87 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.696 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.756 -175.375 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.135 0.493 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -123.08 124.82 43.95 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.88 139.49 11.14 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.639 -176.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 65' ' ' ILE . 16.8 tt -125.09 124.21 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.659 HG22 ' HA3' ' A' ' 84' ' ' GLY . 30.0 p -123.26 154.34 38.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.774 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.01 145.62 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.05 171.21 42.34 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.994 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -97.15 127.1 0.26 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.144 1.896 . . . . 0.0 112.821 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 143.39 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.177 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.637 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.4 mt -129.9 130.13 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -169.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.46 140.39 51.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.73 137.82 9.75 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -135.48 156.99 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 -175.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.03 140.83 47.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.659 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.19 175.2 26.68 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.067 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.01 134.86 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.92 133.64 10.79 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -122.54 141.26 51.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.874 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 . . . . . 0 CA--C 1.524 -0.024 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.512 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.2 166.02 26.49 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.98 127.98 53.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.948 0.374 . . . . 0.0 110.032 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.8 p -113.89 146.33 40.19 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -137.41 143.12 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.93 159.91 28.17 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.728 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.06 149.02 30.41 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.53 161.65 28.86 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.756 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.1 mt -108.92 147.48 32.14 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.04 132.62 54.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.649 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -125.32 109.93 13.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -120.13 124.29 27.88 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -100.14 176.24 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.353 2.702 . . . . 0.0 109.332 155.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 84.9 mtp -60.07 138.01 57.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.267 0.556 . . . . 0.0 112.245 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 68.15 -148.31 0.14 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.731 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -61.15 -12.08 11.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 121' ' ' VAL . 2.8 t -79.44 17.29 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.21 139.39 39.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.036 0.835 . . . . 0.0 110.282 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 143' ' ' GLY . 15.5 tp -132.62 141.46 48.67 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -168.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -133.7 146.43 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.792 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.456 ' CZ ' HD21 ' A' ' 123' ' ' LEU . 97.7 m-85 -121.34 134.11 55.13 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -140.16 154.02 46.82 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.351 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -120.47 145.62 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -127.12 140.0 52.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.383 . . . . 0.0 110.462 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -127.95 136.02 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.125 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.574 ' HB3' HG22 ' A' ' 137' ' ' VAL . 7.9 t -112.98 144.74 42.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -89.18 146.19 24.94 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 124.436 1.085 . . . . 0.0 109.384 -158.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.1 mt -87.56 104.03 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.947 1.356 . . . . 0.0 112.749 -142.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -89.76 -176.58 5.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 112.056 -2.338 . . . . 0.0 107.304 156.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.5 p -52.39 -12.69 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 p -123.24 131.51 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 110.296 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -115.08 139.17 50.11 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 130' ' ' SER . 16.8 m -108.23 140.59 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.242 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.17 119.49 3.6 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.415 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.3 m -126.0 134.17 51.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.637 0.718 . . . . 0.0 111.132 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -119.12 132.13 55.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 19.0 tt -131.79 144.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.569 0.223 . . . . 0.0 111.163 -174.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.53 132.5 48.3 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.57 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -139.6 153.16 22.92 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.811 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.5 144.51 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 176.95 32.58 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.814 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -135.38 170.25 16.23 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.59 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.606 ' CB ' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -143.08 149.05 37.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.686 0.279 . . . . 0.0 110.82 -178.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.884 -179.119 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.785 0.326 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 146' ' ' TYR . 21.6 m -125.11 141.24 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.09 128.52 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.39 140.85 11.68 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.69 -168.75 26.18 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.134 -1.032 . . . . 0.0 111.566 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -132.05 153.94 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.175 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -130.0 142.29 50.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.006 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -118.59 131.92 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 t -111.05 140.56 45.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.58 128.0 32.91 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.931 0.769 . . . . 0.0 111.298 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.152 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 52.1 mttp . . . . . 0 C--O 1.231 0.113 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.613 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.14 136.82 11.45 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.84 143.25 14.88 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.38 137.4 44.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.32 134.35 50.01 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.295 0.372 . . . . 0.0 111.66 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 26' ' ' LEU . 5.4 mp -122.54 138.69 54.49 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -134.9 143.06 46.74 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.089 0.471 . . . . 0.0 111.617 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -120.42 134.55 55.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.244 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttm105 -135.59 144.16 46.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 0.0 110.985 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.72 143.16 35.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.4 124.33 36.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 109.786 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.88 153.41 48.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.1 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.55 -178.62 3.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.566 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -57.73 -30.72 65.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 p -95.76 -25.74 0.25 Allowed Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -102.89 136.97 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.71 1.606 . . . . 0.0 111.956 165.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.13 155.13 30.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.1 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.28 15.54 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -101.99 125.93 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 117.346 0.573 . . . . 0.0 110.004 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.418 HD11 ' HB2' ' A' ' 70' ' ' ALA . 73.1 mt -118.44 132.08 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.62 132.55 8.0 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 t -133.54 140.59 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.112 0.456 . . . . 0.0 111.388 -173.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.416 ' HD2' ' HH ' ' A' ' 63' ' ' TYR . 95.8 m-85 -121.17 132.98 55.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.4 m -130.07 134.6 47.48 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.83 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.15 137.16 52.9 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -107.6 152.15 24.67 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 111.359 -172.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.878 -179.746 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 121.001 0.429 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.416 ' HH ' ' HD2' ' A' ' 43' ' ' PHE . 61.1 t80 -131.24 132.49 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.02 149.88 20.66 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.7 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 65' ' ' ILE . 16.7 tt -125.6 125.49 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.666 HG22 ' HA3' ' A' ' 84' ' ' GLY . 22.1 p -123.16 155.01 37.89 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.031 0.207 . . . . 0.0 110.52 -176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.547 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -145.56 143.97 30.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.16 159.17 31.66 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.881 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -95.15 124.09 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.969 1.78 . . . . 0.0 112.481 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.63 144.77 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.341 170.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.019 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.641 0.257 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.2 mt -128.93 132.71 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -130.77 146.79 52.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.621 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.464 0.525 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 66' ' ' THR . 8.9 p -140.15 144.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 117.121 0.46 . . . . 0.0 110.986 -170.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -131.99 140.83 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.666 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 175.09 26.82 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.14 -176.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 130.04 74.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.94 144.13 18.31 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -134.96 148.39 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.724 0.262 . . . . 0.0 110.692 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.749 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 . . . . . 0 C--O 1.231 0.119 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -117.21 147.61 42.35 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.304 0.377 . . . . 0.0 111.045 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 159.4 27.03 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -104.66 126.05 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.968 0.384 . . . . 0.0 110.062 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 94.0 p -108.22 137.29 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.969 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -127.75 140.73 51.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.28 169.2 32.67 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.465 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.67 148.98 30.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.789 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.86 158.95 27.84 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.615 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.9 tp -109.22 145.87 35.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -128.16 135.99 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.296 0.498 . . . . 0.0 111.471 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.39 129.73 25.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -140.99 124.67 10.17 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -96.09 176.16 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.533 2.156 . . . . 0.0 109.193 156.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -61.19 150.68 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.52 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 72.98 -160.48 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -61.43 -11.37 10.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.2 t -78.49 17.4 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.4 139.52 39.23 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.446 ' HG ' HG12 ' A' ' 144' ' ' VAL . 4.3 mp -135.88 153.64 51.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.934 0.397 . . . . 0.0 111.078 -171.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -137.06 143.84 42.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.046 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.98 132.61 53.24 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.1 t -140.04 153.92 46.94 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.582 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.27 140.11 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -127.84 146.98 50.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.285 0.366 . . . . 0.0 110.04 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -129.31 135.92 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -107.39 144.68 33.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -89.19 145.99 25.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -159.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 136' ' ' ASP . 68.3 mt -87.98 101.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.656 1.217 . . . . 0.0 112.779 -144.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -89.86 -176.89 5.08 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 112.405 -2.18 . . . . 0.0 107.418 156.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.3 p -52.04 -15.45 0.56 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.778 -0.577 . . . . 0.0 112.358 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.85 129.22 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.894 -0.504 . . . . 0.0 109.729 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 132' ' ' ILE . 2.6 p30 -111.2 139.15 46.82 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.19 133.96 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.879 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.22 3.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 170.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -126.36 134.24 51.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.795 0.798 . . . . 0.0 110.883 -176.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -119.05 136.09 54.31 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.511 HG12 ' HB2' ' A' ' 10' ' ' ALA . 61.7 mt -121.01 140.1 46.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.404 -172.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.1 123.34 25.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.76 153.31 22.57 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.787 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.446 HG12 ' HG ' ' A' ' 123' ' ' LEU . 34.6 m -125.13 147.1 29.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.17 32.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.216 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 4' ' ' THR . 47.0 p90 -138.88 167.18 22.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.714 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.605 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.495 -179.383 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.797 0.332 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 146' ' ' TYR . 34.4 m -125.3 140.66 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.58 126.33 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.073 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.454 HG23 ' C ' ' A' ' 144' ' ' VAL . 15.4 m -128.34 140.28 51.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.878 0.371 . . . . 0.0 110.67 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.77 140.82 12.1 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 108.446 -1.861 . . . . 0.0 108.446 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.38 -172.73 30.19 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.781 -1.199 . . . . 0.0 112.877 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -134.2 143.82 48.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.727 -0.736 . . . . 0.0 109.575 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.03 149.13 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.228 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -118.73 138.46 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.804 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -111.01 140.15 45.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.57 128.36 33.41 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.925 0.766 . . . . 0.0 111.322 -171.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.586 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.03 -177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.619 0.247 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.2 mtm -126.89 156.06 42.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.235 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.31 149.49 17.46 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.11 12.64 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' HE2' HD21 ' A' ' 26' ' ' LEU . 72.3 t80 -112.75 139.07 48.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.71 ' HB3' HG22 ' A' ' 44' ' ' THR . 28.9 p-10 -130.59 147.07 52.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 24' ' ' PHE . 77.2 mt -115.95 142.22 47.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.826 170.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -129.7 141.92 50.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.433 -170.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -133.98 147.39 51.01 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HG3' HG22 ' A' ' 40' ' ' ILE . 78.5 ttt180 -144.28 144.16 31.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.761 -175.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -110.39 140.95 44.11 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -92.96 125.58 37.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.227 0.536 . . . . 0.0 110.573 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -145.05 153.62 41.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.816 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.48 -178.49 3.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.038 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -53.48 -34.82 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.94 -26.05 0.3 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -102.8 127.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.673 1.582 . . . . 0.0 111.567 161.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.501 HD22 ' CD2' ' A' ' 71' ' ' TYR . 76.9 mt -75.77 153.4 37.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.169 -175.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.26 22.69 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.92 125.0 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 117.304 0.552 . . . . 0.0 109.695 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.445 HG22 ' HG3' ' A' ' 29' ' ' ARG . 37.0 pt -125.36 147.55 30.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.245 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.46 147.44 17.57 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 p -141.8 146.1 35.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.874 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -120.17 127.63 52.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.71 HG22 ' HB3' ' A' ' 25' ' ' ASN . 35.6 p -128.82 142.98 50.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.213 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -127.27 137.33 52.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.896 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -97.74 147.51 24.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.098 0.475 . . . . 0.0 111.28 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 C--O 1.235 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 -175.776 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.1 p90 . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.61 0.719 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -125.85 140.08 52.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.088 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.33 137.51 9.5 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.0 117.95 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.677 HG22 ' HA3' ' A' ' 84' ' ' GLY . 17.0 p -123.29 150.05 44.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.329 -175.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.539 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.15 149.08 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 171.0 41.32 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 119.855 -1.164 . . . . 0.0 113.067 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -97.74 126.92 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.563 2.175 . . . . 0.0 112.662 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.53 139.49 36.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.548 170.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.501 ' CD2' HD22 ' A' ' 37' ' ' LEU . 87.3 m-85 . . . . . 0 C--N 1.331 -0.235 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.515 0.198 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.5 tt -138.94 129.92 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -141.71 152.52 43.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.864 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.94 137.84 11.38 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 66' ' ' THR . 9.5 p -138.11 143.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 117.223 0.511 . . . . 0.0 111.01 -171.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.84 140.77 48.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.677 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.06 172.34 27.54 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.529 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t -115.03 130.71 69.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 131.71 9.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.35 140.06 50.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.602 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 40.2 p30 . . . . . 0 N--CA 1.458 -0.047 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -132.9 151.97 51.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.034 0.445 . . . . 0.0 111.545 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.03 165.98 26.45 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -106.13 125.79 51.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.886 0.343 . . . . 0.0 110.12 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.6 p -107.54 144.41 34.57 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -130.76 136.77 49.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.92 166.72 28.86 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.49 148.9 35.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.02 161.04 28.51 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.236 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 113' ' ' LEU . 4.6 mp -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.419 0.628 . . . . 0.0 111.971 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.75 109.95 12.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 168.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -121.04 124.58 27.35 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -166.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -97.51 176.12 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.658 2.239 . . . . 0.0 109.59 156.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.0 ttm -64.91 141.22 58.85 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.182 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 79.28 -162.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.696 0.799 . . . . 0.0 111.225 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -59.43 -11.54 4.6 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 m -78.63 17.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.14 134.32 47.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.54 0.609 . . . . 0.0 109.893 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' A' ' 144' ' ' VAL . 75.7 mt -114.96 144.17 44.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.916 -169.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -130.95 140.23 50.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.848 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.82 136.02 40.3 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 t -140.4 154.03 46.54 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.443 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.22 139.82 49.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -135.97 134.99 39.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.752 0.31 . . . . 0.0 110.229 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -124.74 134.84 52.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.124 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.3 p -96.79 144.78 26.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -89.16 145.9 25.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -162.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 132' ' ' ILE . 9.7 tt -87.87 102.33 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 123.364 1.554 . . . . 0.0 114.08 -144.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -89.66 -176.86 5.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 112.367 -2.197 . . . . 0.0 107.277 156.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -52.11 -15.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.785 -0.572 . . . . 0.0 112.271 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.4 129.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 168.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -113.71 139.15 49.32 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.58 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.9 t -108.21 134.7 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 124.71 5.39 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.431 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.5 m -126.21 134.14 51.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 117.459 0.63 . . . . 0.0 111.269 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -119.88 127.59 52.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.541 HD11 ' ND2' ' A' ' 25' ' ' ASN . 17.0 tt -130.5 143.44 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.385 -172.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.38 136.39 43.32 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.91 153.26 23.68 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.683 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.454 ' C ' HG23 ' A' ' 6' ' ' THR . 30.8 m -116.47 139.95 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -154.91 177.29 32.26 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.471 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.415 ' O ' HG23 ' A' ' 4' ' ' THR . 50.5 p90 -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.564 -0.818 . . . . 0.0 110.083 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -118.02 147.17 43.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.298 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.5 t80 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.58 -179.181 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.725 0.298 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 146' ' ' TYR . 25.4 m -124.92 140.21 53.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.154 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.44 119.99 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -128.22 141.81 51.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.33 140.69 12.47 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.1 165.11 28.21 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.037 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -121.62 145.86 47.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -134.58 149.03 50.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.903 0.382 . . . . 0.0 111.179 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -122.39 135.05 54.62 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 m -115.14 132.92 56.45 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.154 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.82 123.83 30.9 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.316 1.01 . . . . 0.0 110.93 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 179.509 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt . . . . . 0 N--CA 1.462 0.135 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.48 153.07 47.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.943 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.17 135.19 11.46 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.23 14.22 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -118.8 139.81 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.9 145.11 45.95 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.959 -176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -124.32 132.05 53.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.607 ' N ' HD13 ' A' ' 26' ' ' LEU . 7.7 mtpm? -125.56 143.06 51.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 111.377 -174.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.95 138.24 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -130.72 144.08 51.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.967 0.413 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.69 143.14 45.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.66 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.29 129.32 38.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.289 0.566 . . . . 0.0 110.543 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -131.03 153.49 49.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.763 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.6 -178.54 3.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -53.61 -34.35 58.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.605 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -94.56 -25.89 0.26 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -102.92 134.22 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.764 1.643 . . . . 0.0 111.877 163.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.1 160.59 27.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.83 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.43 140.17 24.1 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.12 124.88 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.319 0.56 . . . . 0.0 110.026 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.4 mt -120.49 135.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.51 140.1 11.35 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.449 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 46.3 p -142.13 150.08 40.65 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.323 0.562 . . . . 0.0 111.774 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.49 133.22 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.087 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -130.07 137.31 50.14 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.967 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.18 136.66 52.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -116.67 137.26 52.32 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.028 0.376 . . . . 0.0 110.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -175.619 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.002 0.429 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -122.33 123.0 40.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 132.29 7.93 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.8 mt -120.53 117.54 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.693 HG22 ' HA3' ' A' ' 84' ' ' GLY . 8.8 p -123.3 155.26 37.59 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.886 -173.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.19 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.5 157.34 28.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.632 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -95.6 122.39 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.992 1.795 . . . . 0.0 111.94 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.77 144.02 32.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.866 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.858 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 CA--C 1.52 -0.196 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.4 pt -133.06 146.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.643 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.21 155.03 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.452 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.81 137.95 11.5 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.2 t -131.9 139.03 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.854 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.39 140.73 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 174.89 26.91 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.647 -177.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.25 128.12 72.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.86 10.34 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -118.26 130.63 56.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.617 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 . . . . . 0 C--O 1.23 0.034 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -106.66 148.31 28.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.193 0.521 . . . . 0.0 112.385 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 162.49 27.16 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -103.15 126.99 50.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.195 0.497 . . . . 0.0 110.619 -178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -109.43 135.71 50.03 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.629 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -130.3 145.32 51.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.04 175.09 36.04 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.452 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.05 31.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.018 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.53 158.05 27.41 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.009 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.492 HD23 ' CE2' ' A' ' 115' ' ' PHE . 16.2 tp -117.8 145.81 44.27 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -123.95 132.26 53.69 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.569 0.622 . . . . 0.0 112.228 -174.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.492 ' CE2' HD23 ' A' ' 113' ' ' LEU . 96.8 m-85 -122.05 122.87 40.27 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 171.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -142.14 124.55 9.16 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -95.96 176.19 0.8 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.724 2.282 . . . . 0.0 109.364 155.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.1 mtp -55.17 138.59 44.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.289 0.566 . . . . 0.0 112.338 -174.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 71.46 -145.25 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.74 -11.85 29.86 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -166.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.0 t -78.8 17.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -168.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.49 137.8 41.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.607 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 143' ' ' GLY . 12.3 tp -130.17 140.98 50.7 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.297 -173.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -125.53 137.11 53.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -118.56 132.6 56.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -139.65 151.44 45.96 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.715 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -122.23 139.82 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -132.25 151.16 51.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -131.71 136.1 47.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.012 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 t -109.08 144.85 36.57 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.076 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -89.13 146.19 24.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.201 0.601 . . . . 0.0 109.406 -156.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.735 HG23 ' OD1' ' A' ' 136' ' ' ASP . 40.3 mm -87.66 96.0 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 122.841 1.305 . . . . 0.0 112.225 -142.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -91.9 -177.1 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.141 -2.299 . . . . 0.0 107.974 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.0 m -52.27 -17.61 1.21 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.022 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.33 131.0 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.735 ' OD1' HG23 ' A' ' 132' ' ' ILE . 20.5 m-20 -114.97 138.8 50.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.32 132.43 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.989 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.33 120.25 3.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 168.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.3 m -126.12 134.22 51.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.951 0.875 . . . . 0.0 111.543 -173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -112.94 131.39 55.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 10' ' ' ALA . 64.4 mt -123.53 139.02 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 123.118 0.261 . . . . 0.0 110.616 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.58 124.01 24.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.616 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -137.58 153.2 21.94 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.609 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 p -128.65 142.68 43.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 177.98 32.09 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.496 ' O ' HG23 ' A' ' 4' ' ' THR . 46.6 p90 -130.93 164.43 25.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.395 -0.903 . . . . 0.0 109.952 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -118.36 149.1 41.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.75 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 72.7 t80 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.957 -178.846 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--O 1.231 0.114 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.0 p -126.96 155.45 43.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.08 121.16 45.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.772 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.1 m -128.29 140.63 51.77 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.828 0.347 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.64 140.85 12.16 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.06 170.52 30.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.1 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.11 139.24 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.92 149.06 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.052 -176.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -118.16 138.59 52.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.265 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 t -111.97 137.3 50.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.68 142.01 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.973 0.795 . . . . 0.0 111.388 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.029 -177.352 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 C--O 1.231 0.084 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.39 159.75 38.35 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.807 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.07 144.42 15.41 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.89 142.96 14.14 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.864 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -113.65 133.91 55.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.694 ' CG ' HG22 ' A' ' 44' ' ' THR . 48.5 m-20 -129.14 138.83 52.01 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.28 -177.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.43 ' C ' HD23 ' A' ' 26' ' ' LEU . 8.5 tt -130.16 130.2 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.56 154.54 47.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.279 0.562 . . . . 0.0 112.235 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -123.21 141.89 51.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.806 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -132.76 144.03 49.99 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.561 0.538 . . . . 0.0 110.216 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.26 143.31 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -92.68 122.45 35.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 109.735 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -132.52 153.32 51.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.061 -172.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.7 -178.53 3.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.221 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.07 -25.92 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -170.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -102.85 135.71 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.802 1.668 . . . . 0.0 111.941 165.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.98 158.33 29.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.858 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.22 140.25 15.05 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.5 127.2 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 117.418 0.609 . . . . 0.0 110.06 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.9 mt -120.71 133.1 68.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.19 137.19 8.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 t -140.56 145.35 36.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.147 0.474 . . . . 0.0 111.44 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.92 135.08 54.32 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.694 HG22 ' CG ' ' A' ' 25' ' ' ASN . 42.4 p -126.81 141.09 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.634 0.254 . . . . 0.0 110.637 -177.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -127.02 134.6 50.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.8 m -115.29 141.76 47.59 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.688 0.28 . . . . 0.0 110.48 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.89 -177.792 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.044 0.45 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -122.9 132.97 54.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.226 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.27 135.27 8.05 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.71 124.43 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.563 HG22 ' HA3' ' A' ' 84' ' ' GLY . 72.2 p -123.18 149.41 44.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.126 0.266 . . . . 0.0 110.847 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.52 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.433 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.03 166.98 39.83 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.711 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.1 128.06 0.43 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 122.066 1.844 . . . . 0.0 112.769 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.61 142.17 34.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.061 169.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.6 t80 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.785 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.231 0.106 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 tt -140.51 129.87 26.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -142.74 154.08 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.441 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.51 137.79 9.81 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.433 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.6 m -134.3 155.04 38.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 117.143 0.471 . . . . 0.0 111.296 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.05 141.08 47.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.563 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.11 175.03 26.69 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.049 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.42 134.0 66.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 133.35 10.61 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -121.95 136.77 54.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 C--O 1.23 0.063 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -125.1 148.6 48.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 111.35 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.05 161.66 27.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.22 125.09 50.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 84.2 p -107.9 146.96 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.25 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -130.5 138.48 50.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.58 162.01 28.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.195 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.86 148.92 39.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.448 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -146.94 152.91 25.0 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.134 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.8 mm? -122.06 145.87 47.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -137.93 136.74 37.3 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.438 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.63 122.13 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -116.06 124.22 30.0 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -106.24 176.17 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.68 2.92 . . . . 0.0 109.112 154.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -63.26 151.47 40.44 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.747 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 68.58 -165.31 0.19 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.495 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -57.88 -11.25 2.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 121' ' ' VAL . 10.2 t -78.21 17.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -167.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 138.61 40.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.174 -0.954 . . . . 0.0 110.162 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 123' ' ' LEU . 5.0 mp -127.91 144.46 51.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.615 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -134.8 144.06 47.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.385 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.38 137.97 52.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 t -140.15 152.1 45.8 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.523 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.26 139.69 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.12 141.23 50.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.743 0.306 . . . . 0.0 110.865 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -127.36 136.18 51.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.399 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.8 m -113.07 144.69 42.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -89.4 146.3 24.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.616 0.572 . . . . 0.0 109.678 -159.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.1 pt -87.8 95.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 123.229 1.49 . . . . 0.0 114.117 -145.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -89.78 -176.76 5.06 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 112.27 -2.241 . . . . 0.0 107.737 157.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.0 t -52.21 -16.03 0.72 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.73 132.56 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 118.187 0.449 . . . . 0.0 110.147 168.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -112.47 139.12 48.31 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.416 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.14 129.03 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.571 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.27 119.2 3.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.5 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.4 m -126.04 134.15 51.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.757 0.779 . . . . 0.0 111.054 -175.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -122.21 129.59 52.41 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 18.1 tt -129.89 144.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.631 0.253 . . . . 0.0 111.362 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -126.11 132.98 51.77 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.26 152.99 21.33 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.863 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.11 139.83 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.11 178.05 31.99 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.542 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.78 163.98 28.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.733 -0.734 . . . . 0.0 110.032 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -117.88 149.02 41.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.656 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.4 p90 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.492 179.422 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 64.5 p 48.74 33.62 4.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.965 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.6 p -143.85 148.18 35.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m -132.82 141.97 48.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.342 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.45 115.26 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.468 HG23 ' C ' ' A' ' 144' ' ' VAL . 6.1 m -128.17 139.69 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.83 140.85 12.23 Favored Glycine 0 N--CA 1.461 0.352 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.88 167.28 28.27 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.018 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -115.15 140.58 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.634 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -122.46 141.19 51.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.968 -178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -118.72 131.9 56.15 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 t -112.76 134.74 54.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.81 142.14 37.16 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.115 0.884 . . . . 0.0 110.844 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.84 143.17 31.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.494 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.7 153.5 20.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.55 143.34 10.23 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.043 -171.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 65.12 37.16 6.81 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.977 0.511 . . . . 0.0 111.225 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.8 mtt -149.66 173.97 13.08 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -115.81 164.82 13.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.954 0.407 . . . . 0.0 111.455 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -75.05 161.82 29.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.1 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -131.59 157.55 43.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.606 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.36 146.98 17.84 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.53 143.22 14.29 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.96 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -109.77 134.42 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -127.39 137.67 52.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.579 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD21 ' OH ' ' A' ' 28' ' ' TYR . 14.8 tp -122.6 134.3 54.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.117 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -128.35 143.82 51.06 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.07 0.462 . . . . 0.0 111.826 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.453 ' OH ' HD21 ' A' ' 26' ' ' LEU . 94.2 m-85 -123.65 138.61 54.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.405 174.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -131.4 144.06 50.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.86 0.362 . . . . 0.0 111.118 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -103.93 143.21 33.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.58 125.07 37.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.294 0.569 . . . . 0.0 110.327 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -133.06 153.2 51.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.694 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -74.83 -178.4 3.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.177 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.46 -38.61 69.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -85.73 -25.99 0.35 Allowed Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.81 142.38 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.58 1.52 . . . . 0.0 112.525 163.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.437 HD22 ' CD2' ' A' ' 71' ' ' TYR . 74.5 mt -78.06 165.04 24.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.005 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.09 140.12 14.92 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.18 125.47 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.364 0.582 . . . . 0.0 109.947 -174.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.17 135.5 62.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.66 138.02 10.38 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.0 t -131.71 137.33 48.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.813 0.307 . . . . 0.0 111.063 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -115.27 129.11 56.53 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.9 m -125.9 137.74 53.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.679 0.276 . . . . 0.0 110.731 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -126.06 132.58 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.771 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.8 m -101.49 146.01 28.22 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -142.72 146.44 34.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.533 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -137.0 136.86 38.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.637 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.7 p -65.43 156.31 32.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.574 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -56.8 148.53 20.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.655 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -112.21 176.55 4.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.225 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 146.99 30.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.297 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 p 62.98 132.12 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.581 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.6 m -81.04 12.93 3.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.78 -36.08 66.3 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.93 96.38 2.85 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.099 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -133.38 137.49 45.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.431 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.5 p30 35.12 31.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.73 -35.98 81.4 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -97.39 129.56 44.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.382 . . . . 0.0 111.482 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -126.13 148.06 49.48 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.28 138.26 54.67 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -127.1 135.73 51.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.43 135.38 7.57 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.569 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.58 119.35 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.698 HG22 ' HA3' ' A' ' 84' ' ' GLY . 20.1 p -123.23 153.67 39.82 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.036 0.21 . . . . 0.0 110.507 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.17 146.22 30.75 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.01 167.37 40.08 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.875 -1.155 . . . . 0.0 112.999 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.417 ' HB2' HD13 ' A' ' 37' ' ' LEU . 92.6 Cg_endo -97.18 124.21 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.276 1.984 . . . . 0.0 112.855 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.79 142.25 33.94 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.77 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.437 ' CD2' HD22 ' A' ' 37' ' ' LEU . 80.9 m-85 -115.59 123.89 49.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -95.82 108.71 21.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.352 0.596 . . . . 0.0 111.928 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.81 HD12 ' O ' ' A' ' 77' ' ' ALA . 68.6 mt -96.47 131.46 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.214 170.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -61.43 -34.34 75.23 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.188 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.44 -176.93 2.03 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -86.16 46.28 1.32 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.346 0.593 . . . . 0.0 110.507 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.81 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -122.14 22.43 10.21 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.247 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.2 t -68.95 149.69 48.57 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.276 0.489 . . . . 0.0 109.887 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.22 129.77 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -127.97 133.86 49.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.75 137.89 11.13 Favored Glycine 0 N--CA 1.465 0.62 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 66' ' ' THR . 8.2 p -142.79 145.95 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.557 0.679 . . . . 0.0 111.445 -172.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.441 HG12 ' HD1' ' A' ' 109' ' ' TYR . 27.7 m -129.35 140.93 47.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 175.07 26.83 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.444 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.42 127.22 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.69 137.56 11.32 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -139.19 157.91 45.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.098 0.449 . . . . 0.0 111.45 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.7 138.81 12.55 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -142.79 146.16 33.96 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.613 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -100.04 129.62 46.11 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -112.37 144.91 41.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.944 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 m -71.85 139.07 48.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.323 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.1 m -57.03 -49.8 74.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.914 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -175.78 -69.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.944 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.58 -53.4 0.21 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.86 -176.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.77 99.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.519 1.479 . . . . 0.0 112.897 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.2 m -86.26 131.3 34.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.726 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -155.2 165.15 37.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.428 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -121.92 65.77 0.91 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.626 0.727 . . . . 0.0 110.264 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -124.55 -3.58 7.82 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.71 145.78 55.59 Favored 'General case' 0 C--O 1.231 0.079 0 O-C-N 122.029 -0.419 . . . . 0.0 110.785 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -137.55 157.52 46.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.643 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 t -136.04 142.0 44.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -151.68 142.19 22.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.129 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.71 149.29 33.13 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.731 0.644 . . . . 0.0 110.817 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.0 161.62 27.16 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -101.67 127.17 48.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -113.66 145.47 41.26 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.034 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.441 ' HD1' HG12 ' A' ' 83' ' ' VAL . 77.4 t80 -131.16 139.47 49.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.286 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.41 161.32 27.96 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.732 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.1 148.91 35.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.95 164.52 29.2 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.857 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.501 HD11 ' HA ' ' A' ' 77' ' ' ALA . 7.6 tp -109.07 145.91 34.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -138.44 134.22 33.78 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.83 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -135.45 115.22 12.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.54 124.46 19.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -102.88 176.15 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.796 2.331 . . . . 0.0 109.294 157.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.2 mtm -55.38 164.49 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.791 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 66.48 -171.94 0.19 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.721 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -59.29 -11.42 4.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.1 t -78.32 17.91 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -166.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.614 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.43 130.61 52.31 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.331 -0.856 . . . . 0.0 110.231 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.614 HD22 ' C ' ' A' ' 122' ' ' ALA . 4.5 mm? -124.59 146.29 49.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.819 -171.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -137.15 139.54 41.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.411 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.98 131.17 47.41 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.4 m -140.24 154.09 46.76 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.663 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -118.32 140.37 49.93 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -126.81 136.62 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.193 0.308 . . . . 0.0 110.387 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -119.33 130.83 55.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.321 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.9 t -108.09 144.6 35.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -89.37 145.97 24.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -159.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 132' ' ' ILE . 13.0 tt -87.89 100.96 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 123.526 1.631 . . . . 0.0 113.678 -146.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -89.8 -176.7 5.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 112.18 -2.282 . . . . 0.0 106.597 157.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -52.16 -14.54 0.44 Allowed 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.339 -0.851 . . . . 0.0 112.206 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.02 132.59 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.362 0.528 . . . . 0.0 109.859 167.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -115.01 139.12 50.11 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.35 133.59 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.707 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.33 3.88 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.9 m -126.12 134.16 51.41 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 117.61 0.705 . . . . 0.0 111.12 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -117.29 130.92 56.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.634 HG22 ' HB2' ' A' ' 10' ' ' ALA . 2.6 pp -124.98 144.9 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.855 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.52 127.18 30.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.497 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -135.63 153.09 21.17 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.612 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.468 ' C ' HG23 ' A' ' 6' ' ' THR . 9.3 p -128.54 139.91 50.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.02 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.809 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -137.33 165.08 27.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.675 -0.763 . . . . 0.0 110.173 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -121.68 148.97 43.9 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.005 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 30.7 p90 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.075 -0.964 . . . . 0.0 112.453 -174.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.5 m -122.61 144.59 49.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.519 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p -155.35 169.23 24.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.664 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.706 HG22 ' HB3' ' A' ' 29' ' ' ARG . 14.9 t -135.1 151.83 51.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.947 0.404 . . . . 0.0 110.845 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.49 124.37 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.415 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 m -128.31 139.44 52.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.938 0.399 . . . . 0.0 110.676 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.71 140.71 13.47 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.23 168.21 28.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.185 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -117.68 133.02 56.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -115.56 138.7 50.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.412 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -119.16 131.99 55.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.0 139.1 48.94 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.72 142.12 37.32 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.822 0.701 . . . . 0.0 111.218 -172.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' HB2' ' C ' ' A' ' 19' ' ' ASN . . . -103.24 143.27 32.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.283 -176.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -89.9 153.06 20.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.6 151.73 3.86 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.27 -0.49 . . . . 0.0 111.961 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 69.86 -0.58 2.65 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 91.7 mmm -129.4 171.79 12.17 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 121.456 -0.778 . . . . 0.0 110.149 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.426 ' C ' ' HB2' ' A' ' 14' ' ' ALA . 7.9 p30 -113.06 170.0 8.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.917 0.389 . . . . 0.0 111.242 -177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -82.79 171.05 14.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.597 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 94.3 mmm -128.8 155.79 44.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.294 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.48 143.35 14.98 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.54 143.17 14.22 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.909 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.38 131.38 54.32 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' HG23 ' A' ' 44' ' ' THR . 71.0 m-20 -119.66 135.19 54.92 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.296 0.373 . . . . 0.0 111.529 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tt -118.4 135.95 54.04 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -117.87 143.87 45.92 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.208 0.317 . . . . 0.0 111.32 -173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -133.49 130.28 38.33 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.706 ' HB3' HG22 ' A' ' 4' ' ' THR . 37.2 ttm180 -138.32 144.08 40.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.178 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -109.83 143.15 40.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -92.63 129.3 38.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.516 0.674 . . . . 0.0 110.769 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -133.09 153.47 51.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.109 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.54 -178.56 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.718 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -55.7 -33.4 64.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.327 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 t -93.38 -25.89 0.27 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.78 139.18 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.746 1.631 . . . . 0.0 111.952 164.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.11 152.76 32.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.304 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.03 140.38 16.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.3 m -103.55 127.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 117.779 0.789 . . . . 0.0 110.113 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.737 HD13 ' N ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -126.17 140.1 49.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.737 ' N ' HD13 ' A' ' 40' ' ' ILE . . . -139.87 143.53 13.87 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -142.06 155.03 45.37 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.584 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -131.61 142.01 49.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.906 173.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.526 HG23 ' OD1' ' A' ' 25' ' ' ASN . 61.5 m -127.03 137.7 53.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.88 -175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -118.49 133.02 56.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.035 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.1 m -107.76 144.65 34.61 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.856 0.36 . . . . 0.0 110.867 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -142.29 157.96 44.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -133.58 136.89 45.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.776 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.4 m 62.36 -81.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.519 0.512 . . . . 0.0 111.128 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 64.98 55.54 1.14 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.642 0.734 . . . . 0.0 110.001 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.5 m -127.09 140.03 52.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.033 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.88 93.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.275 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.6 t -142.94 147.14 34.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -59.18 -27.55 65.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.026 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.82 -25.9 74.93 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.36 -0.447 . . . . 0.0 112.509 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 59.26 58.27 3.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.572 0.701 . . . . 0.0 110.282 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -53.79 -33.36 55.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.567 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -61.32 138.06 58.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 110.556 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -138.35 -68.01 0.46 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.282 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -98.27 142.04 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 111.184 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -125.98 148.99 49.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.639 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -125.18 140.15 53.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.949 0.404 . . . . 0.0 110.878 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -132.61 131.7 41.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.592 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.16 146.34 18.1 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.052 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.14 127.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.662 HG22 ' HA3' ' A' ' 84' ' ' GLY . 60.9 p -123.2 154.88 38.13 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.139 0.274 . . . . 0.0 110.803 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.95 148.88 37.59 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.74 160.89 31.88 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 119.865 -1.159 . . . . 0.0 113.335 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -94.05 124.07 0.45 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.018 1.812 . . . . 0.0 112.061 171.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB2' ' CE2' ' A' ' 80' ' ' TYR . . . -80.71 138.8 36.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.218 171.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -116.53 129.67 56.32 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -95.86 110.57 22.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.258 0.551 . . . . 0.0 112.072 -169.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.704 HG21 ' HB3' ' A' ' 77' ' ' ALA . 44.7 mm -96.17 131.3 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.483 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -61.37 -34.81 75.94 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.12 -175.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -75.81 -172.51 1.94 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 34.7 p-90 -86.06 47.94 1.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.45 0.643 . . . . 0.0 110.179 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -122.2 22.77 10.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.222 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -68.73 147.56 51.64 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -170.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.38 129.96 70.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.087 0.47 . . . . 0.0 110.447 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 20.5 m-85 -120.01 134.03 55.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.99 137.58 11.21 Favored Glycine 0 N--CA 1.466 0.668 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 173.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.67 150.99 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.259 0.53 . . . . 0.0 111.822 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.09 140.77 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.27 175.01 26.85 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.459 -176.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.6 t -115.64 127.53 73.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.52 144.67 16.11 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -138.0 154.28 49.35 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.111 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.98 141.88 13.24 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -144.26 154.04 42.67 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.399 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -100.61 135.48 41.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.608 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -100.95 127.92 47.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.372 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 m -107.82 135.39 49.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.43 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.2 m -162.77 -66.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 110.908 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.14 -38.63 76.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -158.79 152.47 19.27 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.478 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -89.81 153.09 5.03 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.759 1.639 . . . . 0.0 112.009 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 99' ' ' LYS . 9.9 t -135.43 151.48 50.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -67.01 -38.38 85.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.183 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 97' ' ' THR . 28.5 mtpp -97.97 137.27 37.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.624 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -130.23 125.98 36.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.648 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 102' ' ' THR . 14.9 t70 -57.92 -32.58 67.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.621 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 101' ' ' ASP . 11.6 t 47.14 -169.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.119 0.568 . . . . 0.0 111.71 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.6 t -96.35 124.92 40.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.262 0.553 . . . . 0.0 111.679 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -136.73 142.03 43.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.854 173.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -108.56 149.64 28.59 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.526 0.517 . . . . 0.0 111.593 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 164.03 26.94 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -104.24 128.13 51.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.99 0.395 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.3 m -114.37 141.01 48.18 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.677 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -140.52 144.09 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.11 176.59 35.9 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.227 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.05 150.6 30.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.661 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.55 160.12 28.04 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.274 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.19 149.93 35.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -121.6 138.67 54.22 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 112.128 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -125.99 109.95 13.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.73 124.34 27.14 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -169.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -105.51 176.06 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.373 2.716 . . . . 0.0 109.351 155.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.5 mtm -61.16 158.2 14.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.782 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 67.27 -165.95 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.537 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -58.43 -11.67 3.11 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 121' ' ' VAL . 9.9 t -78.41 17.77 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -167.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.43 138.02 41.44 Favored 'General case' 0 C--N 1.344 0.37 0 O-C-N 121.153 -0.967 . . . . 0.0 110.057 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.68 151.41 49.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.709 0.29 . . . . 0.0 111.269 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.96 139.66 41.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.364 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -122.22 129.12 51.95 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -140.21 154.02 46.77 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.313 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -124.52 142.7 51.14 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -128.78 146.84 50.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -128.5 135.51 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.046 0.45 . . . . 0.0 110.621 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.4 p -100.57 144.78 29.15 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -89.29 145.94 25.05 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -160.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -87.77 99.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 122.638 1.208 . . . . 0.0 112.924 -144.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -89.88 -176.99 5.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 112.528 -2.124 . . . . 0.0 107.499 156.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.2 t -52.17 -16.18 0.74 Allowed 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 112.078 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.32 130.69 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -114.92 139.04 50.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.375 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.37 135.97 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.597 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.64 5.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.06 134.18 51.48 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.652 0.726 . . . . 0.0 111.396 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -115.0 132.83 56.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 10' ' ' ALA . 67.3 mt -124.03 134.8 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -173.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.18 123.3 39.32 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.08 20.56 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.823 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.2 140.17 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 178.02 32.08 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.676 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.56 165.09 24.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.139 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -117.96 149.0 41.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.614 -178.756 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.5 m -122.57 142.71 50.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.347 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -152.52 164.3 37.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.085 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -136.01 155.18 50.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.921 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 p -129.98 132.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.187 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.3 m -128.08 140.12 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.32 140.74 12.27 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.78 30.58 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.355 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -117.16 136.31 53.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.683 -0.759 . . . . 0.0 109.11 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -117.31 138.07 52.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.384 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -126.15 132.04 51.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 p -115.57 141.31 48.24 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -78.94 127.02 31.46 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.063 0.852 . . . . 0.0 111.233 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -102.72 143.16 32.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.466 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -89.8 153.19 20.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.5 109.79 1.02 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.885 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 155.58 -44.45 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.668 1.587 . . . . 0.0 109.1 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 87.1 mtp -127.57 168.28 15.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.184 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.01 162.17 14.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.96 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 9.1 mtmp? -58.15 170.66 0.64 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.281 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.32 159.74 35.22 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.285 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.23 151.4 18.36 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.08 143.22 11.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.784 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.11 132.98 52.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.551 ' OD1' HG22 ' A' ' 44' ' ' THR . 49.2 m-20 -126.7 135.91 51.76 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.459 -175.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.8 mt -122.25 139.3 53.95 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -135.07 142.5 46.31 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.016 0.436 . . . . 0.0 111.538 -173.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.43 136.6 54.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.402 173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -136.78 144.11 43.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -104.49 143.09 33.5 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.57 123.57 35.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.122 0.487 . . . . 0.0 110.112 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.04 153.47 41.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.975 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.32 -178.58 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.836 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -55.37 -41.53 72.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 m -82.29 -26.1 0.4 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -102.83 126.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.531 1.487 . . . . 0.0 112.04 160.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 156.59 32.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.126 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.97 140.28 19.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -101.62 124.93 55.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 117.292 0.546 . . . . 0.0 109.861 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.571 HD11 ' HB2' ' A' ' 70' ' ' ALA . 69.7 mt -117.44 134.93 59.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.9 133.26 7.53 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.1 t -132.84 140.51 47.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.041 0.421 . . . . 0.0 111.315 -175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.77 132.29 55.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 25' ' ' ASN . 68.9 p -128.75 142.57 50.96 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.94 -178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -125.48 135.51 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.168 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -109.51 144.83 37.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.785 0.326 . . . . 0.0 111.061 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -141.17 145.24 35.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.475 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -134.76 145.79 48.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.288 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.6 p -110.95 141.94 43.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.679 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -139.59 146.82 40.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.369 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.4 m -61.78 146.88 48.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.367 -0.378 . . . . 0.0 109.996 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.0 130.19 45.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.945 0.403 . . . . 0.0 110.527 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.6 t -164.91 -176.59 4.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.53 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.0 p -60.15 -28.59 68.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.84 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.96 -15.79 74.33 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.042 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 61.93 -174.4 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.72 0.76 . . . . 0.0 110.863 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -54.54 -175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.376 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -52.14 133.7 33.37 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.456 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -60.78 -38.64 85.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.448 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -146.94 171.51 15.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.135 0.493 . . . . 0.0 111.723 -175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -126.1 157.99 36.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.547 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -118.45 135.97 54.06 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.899 0.38 . . . . 0.0 111.025 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -123.27 129.36 51.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.38 134.81 7.98 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.44 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.23 123.75 68.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.661 HG22 ' HA3' ' A' ' 84' ' ' GLY . 63.5 p -123.24 153.44 40.16 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.154 0.284 . . . . 0.0 110.602 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.78 144.86 31.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.536 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.01 168.14 40.58 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 119.775 -1.202 . . . . 0.0 113.178 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -96.99 126.08 0.25 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 122.434 2.089 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.84 140.45 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.667 170.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -116.04 131.76 56.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -95.88 115.65 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.231 0.539 . . . . 0.0 111.76 -169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 77' ' ' ALA . 81.5 mt -96.27 131.13 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.437 173.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -61.76 -30.81 71.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -86.44 38.46 0.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.836 0.35 . . . . 0.0 111.83 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 51.59 40.79 27.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.529 0.68 . . . . 0.0 111.362 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.785 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -122.0 22.76 10.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.138 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -68.58 145.43 53.98 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.037 -161.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 tt -128.95 133.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.789 -171.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -128.39 146.86 50.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.959 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.2 137.73 9.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.1 m -134.14 153.77 36.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.828 0.314 . . . . 0.0 110.97 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.24 140.83 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.03 26.73 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.305 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 87' ' ' TYR . 42.7 t -118.35 133.79 64.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 131.93 9.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CZ ' HG11 ' A' ' 85' ' ' VAL . 97.8 m-85 -120.85 142.02 50.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 0.0 110.405 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.98 131.15 10.51 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -126.57 133.27 51.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.683 0.278 . . . . 0.0 110.757 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -102.1 145.11 29.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.025 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -96.75 139.2 33.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.99 0.424 . . . . 0.0 110.429 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.9 m -76.2 144.3 40.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.145 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -74.56 -178.28 3.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 93' ' ' THR . 84.3 tt0 -51.8 -35.14 43.01 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -74.45 148.03 85.47 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -92.53 87.58 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.983 1.788 . . . . 0.0 112.553 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.2 m -125.71 129.99 50.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.402 . . . . 0.0 110.557 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -70.95 -33.85 70.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.682 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -57.18 -35.94 70.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.506 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -55.19 -37.64 67.33 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.232 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -69.64 132.41 46.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.838 0.351 . . . . 0.0 110.748 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.1 m -129.43 141.33 51.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.181 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 t -128.94 135.05 48.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.119 0.485 . . . . 0.0 111.069 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -150.91 144.66 25.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.381 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -123.85 150.79 44.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.057 0.456 . . . . 0.0 111.769 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.06 26.17 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -103.89 129.94 51.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.088 0.444 . . . . 0.0 110.449 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.4 m -112.39 141.73 45.77 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.661 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -131.93 139.06 48.6 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.44 155.02 26.3 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.792 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.23 148.89 30.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -151.81 162.26 29.62 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.893 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.96 150.31 27.92 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -135.03 139.65 44.99 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.269 -0.573 . . . . 0.0 111.576 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.511 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 46.2 p90 -137.95 120.69 16.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.1 124.4 26.49 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -105.19 175.99 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.087 2.525 . . . . 0.0 109.712 157.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.32 157.77 10.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.935 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 67.24 -167.61 0.2 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.694 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.41 -11.4 2.81 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' VAL . 7.2 t -78.23 17.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -169.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.1 136.45 43.7 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.243 -0.911 . . . . 0.0 109.682 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.511 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 71.3 mt -125.18 147.24 49.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 111.898 -167.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -132.53 136.74 46.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.151 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.26 130.44 52.74 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -139.91 154.07 47.14 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.996 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -124.83 143.13 50.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.965 0.412 . . . . 0.0 110.669 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -127.95 136.15 50.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.18 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.553 ' HB3' HG22 ' A' ' 137' ' ' VAL . 6.4 t -111.44 144.76 40.13 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 171.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -89.25 146.4 24.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.224 0.952 . . . . 0.0 109.667 -158.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 136' ' ' ASP . 58.2 mt -87.84 105.81 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 122.73 1.253 . . . . 0.0 112.879 -141.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -89.75 -176.74 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 112.332 -2.213 . . . . 0.0 107.314 156.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.3 t -52.16 -14.48 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.822 -0.549 . . . . 0.0 112.262 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.02 130.9 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.404 0.547 . . . . 0.0 110.337 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.477 ' HB2' HG23 ' A' ' 132' ' ' ILE . 29.4 t0 -115.02 139.19 50.06 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.553 HG22 ' HB3' ' A' ' 130' ' ' SER . 17.7 m -108.12 143.86 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.315 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.1 122.61 4.72 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 171.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.414 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 27.7 m -125.9 134.19 51.66 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.545 0.673 . . . . 0.0 111.352 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -109.29 132.23 54.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.432 HG12 ' HB2' ' A' ' 10' ' ' ALA . 67.2 mt -122.5 133.5 68.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 123.209 0.318 . . . . 0.0 110.286 -175.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.85 126.17 41.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 174.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.53 153.02 20.85 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.137 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 123' ' ' LEU . 32.2 m -122.14 140.76 45.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 177.87 32.08 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.372 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -141.53 163.08 33.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.837 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -123.26 149.0 45.32 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.256 0.347 . . . . 0.0 110.54 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.63 -178.879 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.482 ' HB1' ' HG3' ' A' ' 31' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.5 p -148.85 -58.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.535 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.7 p -158.62 157.64 32.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.244 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.4 p -125.17 155.4 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.378 . . . . 0.0 110.43 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.83 125.06 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.588 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -128.15 141.48 51.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 111.036 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.68 140.74 12.05 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.9 165.45 28.48 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.316 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -115.44 134.58 54.95 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -116.99 138.97 51.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.5 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -120.88 132.95 55.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.0 m -115.89 144.47 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -78.59 142.17 37.49 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.867 0.729 . . . . 0.0 111.13 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.62 143.19 30.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.313 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.73 153.37 20.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.777 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.69 142.57 11.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.028 -173.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 62.94 36.03 12.95 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.309 -0.445 . . . . 0.0 111.431 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.7 mtt -149.51 169.14 21.6 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -106.93 152.15 24.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.026 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -66.66 166.9 12.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.962 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.64 155.21 39.53 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.885 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 46' ' ' THR . . . -126.4 140.5 12.08 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.42 143.24 14.02 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.817 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.66 136.78 50.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -131.47 142.41 49.98 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.989 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.4 tp -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.137 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -127.23 141.96 51.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.009 0.433 . . . . 0.0 111.512 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.68 137.32 54.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.443 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -134.45 144.1 47.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.0 110.823 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -109.32 143.25 39.08 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.482 ' HG3' ' HB1' ' A' ' 1' ' ' ALA . 77.4 mm-40 -92.77 120.3 33.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.277 0.561 . . . . 0.0 111.157 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -133.86 153.63 51.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.962 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.51 -178.44 3.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.863 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -53.01 -33.87 53.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -91.4 -26.02 0.28 Allowed Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -102.79 133.0 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.683 1.589 . . . . 0.0 111.65 162.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.97 158.31 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.245 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.08 140.3 19.12 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.67 125.37 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 117.478 0.639 . . . . 0.0 109.784 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 70' ' ' ALA . 67.7 mt -120.54 137.77 53.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.15 137.38 9.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -135.91 140.97 44.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.085 0.442 . . . . 0.0 111.093 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.36 132.77 56.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.4 m -129.43 139.05 51.76 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.284 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -124.97 129.8 51.07 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' GLY . 5.9 m -124.75 145.95 49.45 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.978 0.353 . . . . 0.0 110.991 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -132.29 153.55 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.369 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -115.74 145.45 42.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.038 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 m -56.81 138.74 52.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.851 0.357 . . . . 0.0 110.878 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -63.01 -36.18 82.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.409 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.9 m -69.78 125.44 26.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.021 0.438 . . . . 0.0 111.153 -175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.18 149.33 51.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.778 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.0 t -60.38 -52.5 64.99 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.571 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m -99.07 -38.16 9.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.222 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.9 -27.03 72.92 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.705 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 66.66 -79.56 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.045 0.423 . . . . 0.0 110.948 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -113.63 126.7 55.56 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -135.08 151.58 50.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.877 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -137.03 120.9 17.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.274 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -129.62 128.52 42.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.252 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -111.7 132.83 54.35 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -124.19 136.07 53.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.932 0.396 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -134.82 127.78 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.607 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.01 140.32 11.09 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.649 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.3 mt -122.08 122.57 66.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.564 HG23 ' C ' ' A' ' 83' ' ' VAL . 2.4 m -123.21 147.27 47.07 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.79 147.33 31.76 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.11 171.02 42.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 119.886 -1.15 . . . . 0.0 113.162 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -93.51 128.05 0.65 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.149 1.899 . . . . 0.0 112.905 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.5 138.57 36.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.188 171.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -100.13 149.62 23.34 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.77 0.669 . . . . 0.0 109.228 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -95.38 135.7 36.67 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.561 0.696 . . . . 0.0 112.028 -160.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.69 131.23 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.057 -170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -81.86 -43.72 17.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.352 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -165.31 85.57 0.38 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.051 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.0 m95 54.01 48.69 20.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.769 0.795 . . . . 0.0 110.298 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.07 22.93 10.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.27 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 t -68.48 145.1 54.36 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.656 -160.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 73.4 mt -130.96 129.56 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.1 m-30 -122.6 135.35 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.03 137.65 11.24 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 108.704 -1.759 . . . . 0.0 108.704 168.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.544 ' HB ' HG22 ' A' ' 66' ' ' THR . 30.4 m -142.43 153.44 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-N 117.801 0.801 . . . . 0.0 112.021 -173.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.564 ' C ' HG23 ' A' ' 66' ' ' THR . 27.4 m -134.05 140.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 174.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 66' ' ' THR . . . -147.13 171.86 27.71 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.524 -176.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.62 125.82 74.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.6 146.43 16.19 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -139.1 155.13 48.13 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.861 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.05 144.95 15.45 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -141.96 142.69 32.99 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.732 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -96.23 128.73 43.4 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.187 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -115.88 147.99 40.47 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.037 0.446 . . . . 0.0 111.041 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.469 ' HB ' HG22 ' A' ' 97' ' ' THR . 72.5 p -85.47 159.15 20.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.413 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.563 HG23 ' HG3' ' A' ' 94' ' ' GLU . 4.3 t -122.17 -25.97 4.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.563 ' HG3' HG23 ' A' ' 93' ' ' THR . 95.8 mt-10 -123.37 156.89 34.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.817 0.342 . . . . 0.0 110.515 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -49.38 -45.06 76.73 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.227 -0.892 . . . . 0.0 112.971 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.97 99.57 1.0 Allowed 'Trans proline' 0 N--CA 1.496 1.672 0 CA-C-N 120.907 1.359 . . . . 0.0 110.958 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.469 HG22 ' HB ' ' A' ' 92' ' ' THR . 68.6 p -118.19 163.27 16.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.083 0.468 . . . . 0.0 110.939 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -117.72 150.89 38.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.315 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -54.66 -31.85 58.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.566 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -49.74 97.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 112.006 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -137.23 138.18 39.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.213 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.9 m -127.77 135.61 50.36 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.958 0.409 . . . . 0.0 111.26 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.1 p -139.65 138.91 36.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.874 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -162.97 151.77 14.6 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.973 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -109.59 149.7 29.29 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 124.024 0.827 . . . . 0.0 110.217 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.16 159.36 27.05 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -99.51 124.31 44.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -110.06 141.01 43.49 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.764 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -127.95 140.3 52.07 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.16 159.26 27.86 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.1 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.12 148.88 32.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.987 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.45 161.89 29.66 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.36 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.68 150.47 49.75 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -127.79 146.52 50.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.601 0.715 . . . . 0.0 112.582 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -124.07 112.56 17.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -116.43 124.21 29.76 Favored Pre-proline 0 N--CA 1.462 0.17 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -107.03 176.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.452 2.768 . . . . 0.0 109.342 155.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -62.88 156.06 25.3 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.763 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 67.84 -166.48 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.588 173.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -58.64 -11.42 3.05 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 121' ' ' VAL . 9.8 t -78.37 17.73 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.48 138.17 41.26 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.34 -0.85 . . . . 0.0 110.145 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 123' ' ' LEU . 5.4 mp -122.87 147.42 46.59 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.545 -170.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -132.61 136.41 46.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.385 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.36 130.7 54.51 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.8 m -140.18 154.03 46.81 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.321 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -128.15 145.29 51.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.521 ' OE2' HD12 ' A' ' 141' ' ' ILE . 47.1 mp0 -133.84 146.6 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.178 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -129.5 136.06 49.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.9 t -104.13 144.72 31.2 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -89.28 146.03 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -161.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.7 mt -87.9 106.71 16.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 122.76 1.266 . . . . 0.0 112.901 -142.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -89.68 -176.71 5.07 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 112.301 -2.227 . . . . 0.0 107.227 156.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.1 p -52.11 -13.32 0.3 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.722 -0.611 . . . . 0.0 112.496 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.82 133.49 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.383 0.538 . . . . 0.0 109.83 167.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -109.87 139.37 45.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.342 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.06 132.5 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.615 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 124.11 5.2 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.9 m -126.07 134.28 51.43 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.337 0.569 . . . . 0.0 111.298 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -115.36 134.83 54.74 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.521 HD12 ' OE2' ' A' ' 128' ' ' GLU . 67.9 mt -125.34 135.73 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.429 -174.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 124.79 43.33 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.02 153.07 20.56 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.903 -175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.19 139.78 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.17 178.11 32.01 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.748 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.12 163.69 31.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.905 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -119.65 148.79 42.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.602 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.972 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.2 p -123.03 160.0 27.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -162.2 166.33 25.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.35 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 m -128.93 139.86 51.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.112 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 5' ' ' VAL . 35.7 m -128.71 128.93 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.135 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.5 m -128.15 142.29 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.788 0.328 . . . . 0.0 110.582 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.53 140.8 12.07 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.19 -169.89 27.28 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.169 -175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -129.21 158.5 38.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.262 -0.469 . . . . 0.0 109.931 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.884 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -136.51 148.18 47.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.973 -177.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -126.35 132.8 51.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -118.52 142.03 48.0 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -79.04 125.07 28.91 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 123.872 0.732 . . . . 0.0 111.408 -174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.19 143.29 34.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.461 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -89.64 149.23 22.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.01 109.55 0.68 Allowed Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.272 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 170.5 -52.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.3 mtm -128.28 174.04 9.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.661 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -91.84 162.22 14.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.865 0.364 . . . . 0.0 110.738 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -49.5 163.78 0.1 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.9 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.633 ' HE1' HG21 ' A' ' 46' ' ' THR . 86.0 mtp -115.17 143.31 45.42 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.07 140.15 16.03 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.45 143.28 14.9 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.823 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -111.3 137.81 48.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.539 ' ND2' HG23 ' A' ' 44' ' ' THR . 23.8 m120 -125.92 133.88 51.74 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.193 0.308 . . . . 0.0 111.576 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.2 mt -118.01 141.86 48.0 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.779 0.674 . . . . 0.0 109.482 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -127.72 143.01 51.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.301 -174.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -132.15 132.54 43.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -138.55 144.2 39.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.666 0.27 . . . . 0.0 111.303 -176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -108.37 142.45 38.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.59 131.03 38.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.274 0.559 . . . . 0.0 111.289 -174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -143.86 153.57 42.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.497 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.43 -178.4 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.136 -173.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -51.08 -37.78 47.75 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -89.13 -25.98 0.31 Allowed Pre-proline 0 N--CA 1.466 0.339 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -102.73 126.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.716 1.611 . . . . 0.0 111.869 161.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.536 HD22 ' CD1' ' A' ' 71' ' ' TYR . 73.4 mt -76.63 158.39 31.12 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.963 -175.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.05 140.12 18.99 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.66 124.96 58.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.487 0.644 . . . . 0.0 109.28 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.492 HD11 ' CG1' ' A' ' 82' ' ' VAL . 41.3 pt -122.46 144.5 31.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.78 0.324 . . . . 0.0 110.379 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.84 136.2 8.49 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -127.88 140.93 51.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.671 0.272 . . . . 0.0 110.811 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.74 131.2 56.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.539 HG23 ' ND2' ' A' ' 25' ' ' ASN . 41.1 m -126.44 134.8 50.88 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.247 0.342 . . . . 0.0 110.83 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -127.04 137.05 52.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.436 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.633 HG21 ' HE1' ' A' ' 21' ' ' MET . 7.2 m -108.5 148.28 30.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.017 0.436 . . . . 0.0 111.351 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.38 140.8 47.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.525 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -133.08 142.4 48.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.226 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.8 t -140.59 133.06 28.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.445 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.521 ' HG2' HG23 ' A' ' 51' ' ' THR . 55.0 ttp180 -98.44 -68.9 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.228 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.521 HG23 ' HG2' ' A' ' 50' ' ' ARG . 66.0 p -127.59 163.63 23.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.125 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.25 113.49 19.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 0.0 110.272 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.7 m -124.84 148.48 48.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.529 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.4 m -59.0 -36.06 74.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.225 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.53 16.9 16.39 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.085 -0.578 . . . . 0.0 113.214 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 62.23 152.3 0.03 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.524 0.662 . . . . 0.0 111.381 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -60.62 156.79 15.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.59 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -173.58 111.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.988 0.423 . . . . 0.0 111.089 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -147.43 -74.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.555 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -135.3 146.78 48.83 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.682 0.277 . . . . 0.0 110.597 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -119.54 144.21 47.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -132.31 135.9 46.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.715 0.293 . . . . 0.0 110.414 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -138.02 132.98 33.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.993 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.97 19.58 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.519 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.449 ' C ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -127.27 127.37 69.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.656 HG22 ' HA3' ' A' ' 84' ' ' GLY . 31.2 p -123.21 154.99 38.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.655 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.62 148.28 34.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.09 170.92 42.25 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.968 -1.111 . . . . 0.0 113.337 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -99.15 122.65 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 122.628 2.219 . . . . 0.0 112.717 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.78 139.93 35.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.077 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CD1' HD22 ' A' ' 37' ' ' LEU . 65.8 m-85 -120.38 124.93 46.71 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -99.98 116.46 32.08 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.641 HD12 ' O ' ' A' ' 77' ' ' ALA . 82.4 mt -96.26 131.25 43.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.988 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -61.57 -30.52 70.72 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -171.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -87.52 54.1 3.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.138 0.494 . . . . 0.0 111.119 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 40.39 29.51 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.641 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -106.08 22.78 15.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.209 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.5 m -68.75 159.53 32.11 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.943 -166.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 tt -143.19 129.93 17.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -127.84 141.98 51.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.2 137.91 10.99 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.492 ' CG1' HD11 ' A' ' 40' ' ' ILE . 36.0 m -135.69 153.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.953 0.376 . . . . 0.0 111.182 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.68 140.84 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.656 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.21 175.21 26.69 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.339 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.62 129.66 75.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.08 145.47 16.66 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -138.68 160.02 40.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.77 150.01 17.11 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -133.61 132.44 40.81 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -104.82 125.68 51.12 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -108.9 114.41 28.15 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.752 0.31 . . . . 0.0 110.818 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -108.13 140.32 41.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.495 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 m -80.91 130.45 35.04 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 54.09 63.57 2.13 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.544 0.688 . . . . 0.0 110.628 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -70.45 152.86 95.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.715 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.0 -56.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.621 1.547 . . . . 0.0 112.214 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -127.23 161.4 28.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.533 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -59.21 -38.18 79.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.164 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -54.89 -32.45 60.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.65 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -53.83 -38.54 64.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.669 0.271 . . . . 0.0 111.222 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.6 144.74 57.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.061 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -114.92 135.62 54.0 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -143.65 133.68 24.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.698 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -162.96 161.08 25.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.841 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -139.42 158.99 43.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.009 0.433 . . . . 0.0 111.566 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.09 167.06 26.16 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.16 125.7 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -111.98 145.54 39.45 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.638 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -142.64 144.52 32.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.12 173.38 35.96 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.912 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.9 28.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.457 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.94 160.49 27.1 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.141 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.6 mp -113.13 151.06 31.3 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -121.98 133.62 54.82 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.802 -174.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -128.24 109.92 11.93 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.452 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 1.6 p30 -140.53 124.64 10.61 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -167.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.29 176.11 0.47 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.629 2.219 . . . . 0.0 109.125 155.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -55.71 174.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.555 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -174.7 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.256 0.551 . . . . 0.0 112.126 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -62.95 -11.35 18.05 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.47 18.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -165.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.586 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.27 141.92 35.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.461 0.573 . . . . 0.0 110.162 -176.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 144' ' ' VAL . 4.5 mm? -124.02 148.99 46.58 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.84 -170.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -136.94 137.52 39.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.22 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -128.63 132.06 48.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.438 ' HB3' HD11 ' A' ' 141' ' ' ILE . 31.4 t -140.4 154.14 46.58 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.581 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.85 139.95 49.34 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -126.76 140.66 52.21 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 123.344 0.403 . . . . 0.0 110.453 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -124.23 136.03 53.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.284 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.9 m -109.1 144.84 36.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -89.19 145.94 25.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -160.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.1 pt -88.01 105.13 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 123.09 1.424 . . . . 0.0 114.689 -143.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.6 ttp85 -89.84 -176.97 5.11 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 112.703 -2.044 . . . . 0.0 106.845 157.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.7 t -52.06 -15.71 0.62 Allowed 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.476 -0.765 . . . . 0.0 112.237 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.59 127.26 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 118.215 0.461 . . . . 0.0 109.808 168.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -103.9 139.19 39.41 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.13 131.16 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.32 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.19 118.48 3.29 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 172.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.2 m -126.2 134.2 51.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.347 0.573 . . . . 0.0 110.866 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -115.73 133.03 56.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.884 HG22 ' HB2' ' A' ' 10' ' ' ALA . 48.0 pt -121.98 145.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 O-C-N 123.247 0.342 . . . . 0.0 110.896 -177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -136.19 125.41 24.68 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.51 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -137.27 153.22 21.8 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.784 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.621 HG22 HD11 ' A' ' 123' ' ' LEU . 51.1 t -111.26 139.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.48 158.77 23.86 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.983 -172.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.32 152.86 46.9 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.136 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -117.81 140.37 49.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.8 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.702 179.682 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.583 HG21 ' HG3' ' A' ' 31' ' ' GLU . 21.2 m -123.45 147.44 47.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.356 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -151.98 148.85 28.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.372 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.622 HG22 ' CD ' ' A' ' 147' ' ' ARG . 29.2 p -122.3 156.22 34.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.432 . . . . 0.0 110.416 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.01 115.99 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.555 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.6 m -128.3 142.91 51.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.005 0.431 . . . . 0.0 110.769 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.37 140.92 11.92 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.58 -179.6 30.81 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.024 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -129.07 141.15 51.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -128.28 147.15 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -115.3 132.11 56.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.4 t -112.53 130.26 56.07 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -80.35 128.97 34.18 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.058 0.849 . . . . 0.0 110.86 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.26 143.14 32.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.866 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -89.88 153.42 20.65 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.64 151.52 4.02 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.239 -171.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 66.03 29.81 9.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.192 -0.504 . . . . 0.0 111.804 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.583 ' CE ' HG23 ' A' ' 135' ' ' VAL . 69.1 mtm -151.05 174.03 13.65 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -111.44 147.78 34.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.484 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -77.88 164.17 25.39 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.78 151.78 51.92 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.021 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.35 128.14 7.48 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -121.69 143.21 15.71 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.868 -173.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.1 133.77 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.556 ' C ' HD22 ' A' ' 26' ' ' LEU . 22.5 t-20 -126.52 133.7 51.07 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.073 0.233 . . . . 0.0 111.574 -174.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 25' ' ' ASN . 4.5 mm? -118.93 136.25 54.17 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -136.7 139.08 41.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.0 0.428 . . . . 0.0 111.632 -172.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.18 137.88 54.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.484 ' HG2' HG22 ' A' ' 40' ' ' ILE . 36.7 mtm180 -133.16 144.14 49.68 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -107.11 142.18 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.583 ' HG3' HG21 ' A' ' 2' ' ' THR . 77.6 mm-40 -92.78 127.65 38.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.161 0.505 . . . . 0.0 110.214 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -137.03 153.46 50.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.883 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -74.77 -178.56 3.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.44 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -54.87 -36.62 65.29 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -91.6 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -170.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -102.81 135.06 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.829 1.686 . . . . 0.0 111.891 164.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.03 156.76 29.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.119 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.48 140.15 16.48 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -101.58 125.17 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 117.415 0.608 . . . . 0.0 109.427 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.505 HD11 ' CG1' ' A' ' 82' ' ' VAL . 44.8 pt -125.8 144.87 34.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.248 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 140.58 9.26 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.05 146.03 35.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.395 -175.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.404 ' HD1' ' HH ' ' A' ' 63' ' ' TYR . 91.6 m-85 -119.61 132.69 55.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.445 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 m -126.97 133.84 50.5 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.126 0.266 . . . . 0.0 110.805 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -127.16 135.7 51.05 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.9 p -103.44 148.23 26.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.196 0.522 . . . . 0.0 111.294 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -143.08 152.73 42.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.578 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -133.08 136.92 46.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.176 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.5 p -166.22 34.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.242 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -60.25 -40.19 89.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.725 0.298 . . . . 0.0 110.586 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.3 m -128.48 139.03 52.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.283 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.91 94.12 9.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.518 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.0 t -141.05 136.85 32.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.522 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.0 p -62.43 -28.66 69.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.029 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.79 -38.4 66.14 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.775 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -147.87 88.83 1.7 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.404 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -135.72 125.42 25.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.373 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.9 t30 55.91 43.24 27.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.206 0.527 . . . . 0.0 110.776 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -91.37 152.63 20.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.504 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t30 61.79 109.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -115.32 145.03 42.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.008 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -134.22 135.95 43.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.871 0.367 . . . . 0.0 110.499 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' HH ' ' HD1' ' A' ' 43' ' ' PHE . 67.3 t80 -135.22 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.91 141.47 12.2 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.711 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.79 122.5 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.64 HG22 ' HA3' ' A' ' 84' ' ' GLY . 70.0 p -123.28 151.11 42.72 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.088 0.242 . . . . 0.0 111.14 -177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.05 146.29 30.88 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.435 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.04 171.14 42.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.071 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -97.33 124.0 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.314 2.009 . . . . 0.0 112.718 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.64 145.41 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.395 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -117.22 123.64 47.13 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -100.97 108.75 20.56 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.465 0.65 . . . . 0.0 112.244 -171.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 77' ' ' ALA . 22.8 pt -96.51 131.76 42.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.683 166.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -61.26 -14.98 30.31 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -71.78 175.22 5.92 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 170.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -87.47 40.77 0.94 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.212 0.53 . . . . 0.0 110.987 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.699 ' HB3' HD11 ' A' ' 73' ' ' ILE . . . -122.26 23.02 9.97 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.17 -174.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t -68.78 146.58 52.78 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -166.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.02 133.84 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 110.144 -168.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -128.18 144.03 51.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.007 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.9 137.81 10.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.505 ' CG1' HD11 ' A' ' 40' ' ' ILE . 35.4 m -135.44 155.92 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.892 0.377 . . . . 0.0 111.128 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.58 140.99 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.64 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.24 175.06 26.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.534 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.17 129.96 69.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.9 137.57 13.61 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.76 138.29 54.54 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.91 139.43 12.03 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -134.49 138.52 44.76 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.84 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -109.08 134.17 52.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.409 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -104.37 140.41 37.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 110.844 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 94' ' ' GLU . 25.1 m -107.99 137.91 45.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.233 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.4 p -112.3 30.11 7.35 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' H ' HG22 ' A' ' 92' ' ' THR . 84.2 tt0 54.79 88.13 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -132.29 166.91 25.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.979 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -45.42 -29.87 5.18 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.477 1.452 . . . . 0.0 112.691 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.1 m -81.69 140.27 34.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.197 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -93.25 112.39 24.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.956 0.407 . . . . 0.0 110.311 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -138.33 156.41 47.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.893 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -129.29 159.1 37.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.713 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.87 122.04 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.186 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 t -134.64 153.37 52.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.889 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -126.36 143.27 51.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -137.14 147.2 45.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.649 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -117.09 146.39 43.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.89 0.376 . . . . 0.0 111.141 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.21 167.02 26.21 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.22 127.62 49.09 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -112.44 145.38 40.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 110.898 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -129.82 138.38 50.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.54 156.34 26.78 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.613 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.97 148.93 32.23 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.11 157.35 27.3 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.568 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.6 mp -109.87 148.96 30.58 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -121.86 139.19 53.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.806 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.61 109.94 8.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.456 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 7.4 p30 -133.5 124.31 17.98 Favored Pre-proline 0 N--CA 1.464 0.273 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -168.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.48 ' HG2' HG13 ' A' ' 121' ' ' VAL . 3.8 Cg_endo -95.37 176.2 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.526 2.151 . . . . 0.0 109.534 156.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -65.72 150.48 48.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.779 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 78.35 -167.48 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -61.02 -11.99 10.07 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 121' ' ' VAL . 9.4 p -78.75 17.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -170.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.456 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.44 138.91 40.13 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.574 -0.704 . . . . 0.0 109.883 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HG ' HG12 ' A' ' 144' ' ' VAL . 4.3 mp -132.62 151.83 51.83 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.322 -170.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.06 147.35 46.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.316 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.54 134.62 50.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -140.17 154.04 46.82 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.49 -0.484 . . . . 0.0 112.036 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.84 140.88 50.12 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -128.6 140.09 51.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.787 0.327 . . . . 0.0 110.562 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -124.51 135.99 53.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.081 0.467 . . . . 0.0 111.042 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.8 t -116.19 144.69 43.85 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.515 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -89.35 146.15 24.88 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.805 0.691 . . . . 0.0 109.58 -161.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.79 101.1 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.817 1.294 . . . . 0.0 112.682 -144.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -89.71 -176.8 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 112.195 -2.275 . . . . 0.0 106.777 158.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 84.2 p -52.13 -13.1 0.28 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.583 HG23 ' CE ' ' A' ' 18' ' ' MET . 9.7 p -119.25 133.54 65.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 118.295 0.498 . . . . 0.0 109.733 168.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -113.05 139.15 48.93 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.28 128.26 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.722 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.2 116.79 2.79 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 169.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.47 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 22.0 m -126.06 134.05 51.52 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.778 0.789 . . . . 0.0 111.355 -173.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.8 t90 -120.32 128.48 53.32 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 25' ' ' ASN . 17.1 tt -130.23 144.53 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.225 -173.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.17 132.17 45.94 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.78 153.16 23.02 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.545 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.481 HG12 ' HG ' ' A' ' 123' ' ' LEU . 34.5 m -125.18 144.67 34.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.19 178.13 32.02 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.195 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -132.52 173.21 11.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.695 -0.752 . . . . 0.0 109.927 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.622 ' CD ' HG22 ' A' ' 4' ' ' THR . 28.5 mmt85 -117.83 149.09 41.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.39 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.574 -178.943 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.0 p -122.98 160.98 25.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.577 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p -162.28 162.73 28.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.071 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -123.17 156.15 35.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.389 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.91 131.44 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.162 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.0 m -128.19 143.0 51.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.838 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 140.9 12.23 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.71 -173.28 29.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.22 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -124.08 156.22 36.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.136 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.707 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -136.41 145.94 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.483 -176.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -128.18 131.97 48.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -114.77 131.74 56.69 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.376 0.422 . . . . 0.0 110.413 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -91.05 126.59 36.18 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.8 0.687 . . . . 0.0 110.923 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.4 143.2 33.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.801 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.77 153.06 20.98 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.0 109.49 0.66 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.126 -170.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 165.08 -54.55 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.6 mtt -128.24 171.99 11.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.79 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -100.23 165.09 11.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 111.154 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -60.73 167.12 2.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.693 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -134.19 158.23 44.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.801 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.18 151.58 16.88 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.65 143.3 12.47 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.089 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -115.33 139.08 50.3 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -127.99 133.47 49.17 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.602 -174.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.07 137.84 54.47 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -135.97 147.11 47.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.094 0.473 . . . . 0.0 111.542 -173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -132.61 143.66 49.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.649 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -139.83 144.04 37.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.696 0.284 . . . . 0.0 111.018 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -105.89 143.17 34.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.56 125.8 37.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.5 0.667 . . . . 0.0 110.852 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -125.58 153.29 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.889 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.62 -178.32 3.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.305 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -53.07 -35.51 59.65 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -174.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.0 m -92.07 -25.94 0.28 Allowed Pre-proline 0 N--CA 1.468 0.456 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -102.85 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.639 1.56 . . . . 0.0 112.39 162.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 71' ' ' TYR . 78.1 mt -78.12 164.25 25.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.073 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.27 140.13 15.55 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.73 125.02 55.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 117.649 0.724 . . . . 0.0 109.699 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 70' ' ' ALA . 71.8 mt -118.73 138.13 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.26 135.45 8.33 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.0 m -129.5 142.01 50.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.027 0.414 . . . . 0.0 111.068 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.37 128.25 55.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 35.7 m -120.82 131.26 54.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.577 0.227 . . . . 0.0 110.661 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -123.04 137.13 55.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.189 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -97.69 147.58 24.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.148 0.499 . . . . 0.0 111.067 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -116.63 145.72 43.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -104.8 -177.33 3.33 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 124.295 0.997 . . . . 0.0 110.294 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.0 m -55.99 147.82 18.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.007 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -167.3 -68.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.01 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.2 m -134.57 83.91 2.07 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.23 158.1 44.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.432 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 m -57.6 159.62 4.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.113 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.4 p -58.93 -35.0 72.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.349 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.11 -36.86 64.03 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -88.45 118.16 27.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.952 0.406 . . . . 0.0 111.873 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -125.42 146.91 49.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.039 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -111.83 132.9 54.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 110.801 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -137.07 148.35 46.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.778 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 66.91 140.12 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -126.17 148.27 49.46 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -151.73 157.9 42.64 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.844 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -117.66 134.74 54.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.149 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.84 132.08 7.53 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.9 mm -119.03 118.44 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.653 HG22 ' HA3' ' A' ' 84' ' ' GLY . 80.5 p -123.22 151.33 42.37 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.907 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.04 146.17 32.68 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.08 168.18 40.63 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.116 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.22 124.33 0.28 Allowed 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.394 2.063 . . . . 0.0 112.81 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.8 143.01 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.463 170.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.452 ' CD1' HD22 ' A' ' 37' ' ' LEU . 91.3 m-85 -117.11 128.86 55.55 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 170.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -95.9 108.96 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.194 0.521 . . . . 0.0 112.346 -169.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.87 HG21 ' HB3' ' A' ' 77' ' ' ALA . 49.3 mm -96.39 131.39 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.475 171.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -61.63 -35.53 78.19 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.28 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -78.98 -168.61 1.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 44.3 p90 -85.49 45.05 1.15 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.356 0.598 . . . . 0.0 110.477 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.87 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -122.03 22.41 10.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.223 -175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -68.61 154.9 41.04 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -173.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.26 129.88 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.842 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -138.87 142.47 38.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.218 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.04 137.84 9.75 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.56 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.9 m -133.8 156.71 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 111.014 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.94 140.9 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.653 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.07 26.71 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.798 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.14 133.39 60.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.7 131.69 9.66 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -118.71 118.99 33.1 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.52 149.96 16.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -161.47 168.03 24.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.642 0.258 . . . . 0.0 110.947 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -104.56 127.55 52.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.451 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -116.42 136.72 52.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.389 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.566 HG21 ' O ' ' A' ' 95' ' ' TYR . 34.9 m -98.35 142.72 29.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.384 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.3 m -55.8 -41.91 74.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.893 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -104.35 -71.62 0.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.293 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.566 ' O ' HG21 ' A' ' 92' ' ' THR . 38.2 m-85 -156.62 154.42 26.8 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.486 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.96 112.99 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.291 1.327 . . . . 0.0 111.816 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.8 m -57.34 -42.69 82.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.543 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -174.1 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.449 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -98.58 137.39 37.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.534 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -137.02 134.71 36.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.896 0.379 . . . . 0.0 110.602 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -59.07 -34.32 71.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.419 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 103' ' ' SER . 1.2 m 67.18 169.94 0.25 Allowed 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.72 0.295 . . . . 0.0 110.247 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 102' ' ' THR . 53.3 p -68.98 152.13 45.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.109 0.481 . . . . 0.0 111.239 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -152.8 142.75 22.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.553 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -102.66 142.97 32.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.788 0.327 . . . . 0.0 111.023 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.18 157.67 26.57 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.62 125.45 51.01 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.5 m -109.61 135.4 50.64 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.936 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -126.75 137.26 53.21 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.96 158.55 27.72 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.884 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.39 148.83 32.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.99 164.63 29.22 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.073 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.0 mt -108.97 146.94 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -136.25 131.92 35.11 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.532 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -137.85 125.2 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -133.92 124.56 17.71 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -98.08 176.18 0.49 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.57 2.18 . . . . 0.0 109.615 158.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.3 ttm -56.12 145.87 24.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.114 0.483 . . . . 0.0 111.55 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 74.26 -157.12 0.06 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.383 0.673 . . . . 0.0 111.17 171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.02 -11.32 13.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.5 t -78.54 17.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.563 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.15 135.96 44.67 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.309 -0.869 . . . . 0.0 110.212 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.623 HD11 HG12 ' A' ' 144' ' ' VAL . 4.4 mm? -125.49 146.21 49.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -171.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -137.14 138.32 40.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -128.31 133.92 48.82 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.2 m -140.05 154.14 46.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.599 -0.441 . . . . 0.0 112.015 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -123.81 141.89 51.61 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -124.67 149.85 46.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.981 0.419 . . . . 0.0 110.383 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -128.07 136.03 50.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.484 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 m -115.56 144.7 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -89.31 145.96 25.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -158.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 132' ' ' ILE . 12.5 tt -87.97 97.62 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 123.512 1.625 . . . . 0.0 113.655 -146.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.79 -176.77 5.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 112.144 -2.298 . . . . 0.0 107.476 157.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.8 p -52.22 -14.52 0.45 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.83 -0.544 . . . . 0.0 112.325 -175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -120.29 129.52 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 118.335 0.516 . . . . 0.0 109.897 167.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -115.05 139.18 50.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.18 132.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.816 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 117.76 3.06 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 171.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.0 m -126.15 134.26 51.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.798 0.799 . . . . 0.0 110.966 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 34.1 p90 -123.81 138.08 54.56 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.707 HG22 ' CB ' ' A' ' 10' ' ' ALA . 36.3 pt -132.52 151.14 34.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 O-C-N 123.141 0.276 . . . . 0.0 111.411 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.1 131.11 27.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.432 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -140.8 153.29 23.64 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.991 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.623 HG12 HD11 ' A' ' 123' ' ' LEU . 26.8 m -119.38 143.51 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.06 178.12 31.92 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -142.08 169.38 17.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.187 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -118.02 146.51 43.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.338 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 66.5 t80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.558 -179.163 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.6 p -124.03 165.48 17.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.419 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p -152.31 160.65 43.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.992 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.6 p -125.24 156.07 39.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.125 0.488 . . . . 0.0 110.83 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.27 126.77 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.377 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.2 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.17 140.94 12.2 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.9 174.81 31.62 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 119.942 -1.123 . . . . 0.0 112.217 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -116.68 138.95 51.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.91 -0.645 . . . . 0.0 109.597 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -117.41 138.82 51.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.089 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -127.71 131.97 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -111.36 145.1 39.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.64 137.42 37.83 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.891 0.744 . . . . 0.0 111.562 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -109.82 143.44 39.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.0 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -89.7 153.48 20.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.64 146.8 7.11 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.259 -170.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 63.62 40.0 8.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.276 -0.462 . . . . 0.0 110.967 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 78.5 mtp -148.35 171.59 15.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -108.18 138.95 43.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 64.7 mttp -65.29 164.15 14.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.064 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.8 mtt -112.72 144.38 42.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.366 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 137.44 12.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.94 143.14 14.55 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.866 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -107.18 134.42 50.31 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -125.44 133.12 52.56 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.374 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.0 tp -121.55 134.76 55.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.253 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -128.48 148.79 50.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.316 0.579 . . . . 0.0 111.86 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -126.3 140.05 52.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.744 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.55 ' HG2' HG22 ' A' ' 40' ' ' ILE . 38.0 mtp180 -139.48 144.14 37.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.751 -173.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.93 143.1 44.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.67 128.27 38.46 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -129.86 153.49 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.402 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.69 -178.51 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.921 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -52.87 -36.27 58.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.429 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 m -93.71 -25.81 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 135.16 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.692 1.594 . . . . 0.0 112.219 165.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.97 160.69 28.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.82 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.12 140.3 22.08 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.48 124.97 56.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 117.482 0.641 . . . . 0.0 109.36 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.55 HG22 ' HG2' ' A' ' 29' ' ' ARG . 46.2 pt -128.27 143.45 40.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.391 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.35 145.31 16.1 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 t -137.71 141.19 41.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.167 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HD2' ' HH ' ' A' ' 63' ' ' TYR . 93.2 m-85 -113.53 131.58 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -125.84 135.77 52.33 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.678 0.275 . . . . 0.0 110.988 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -126.99 131.93 50.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.337 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 m -112.78 147.73 36.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.001 0.429 . . . . 0.0 111.41 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -134.35 141.32 46.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.181 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -133.94 150.81 51.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.252 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 t -141.62 129.14 21.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.728 0.299 . . . . 0.0 110.518 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -61.38 -42.07 98.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 110.529 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 70.2 p -133.37 164.14 27.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.93 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.52 93.84 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.327 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.6 t -166.6 140.53 4.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.651 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.2 m -60.03 -35.63 75.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.281 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.73 -29.04 69.91 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.382 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.33 115.31 19.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.149 0.474 . . . . 0.0 110.93 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -120.49 139.76 52.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.332 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -102.3 129.42 48.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.995 0.426 . . . . 0.0 110.456 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -59.09 -33.57 70.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.022 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -60.88 109.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.58 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -116.37 133.42 56.04 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -123.58 138.64 54.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.014 0.435 . . . . 0.0 111.118 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.467 ' HH ' ' HD2' ' A' ' 43' ' ' PHE . 71.7 t80 -138.39 130.52 28.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.468 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.09 148.67 20.04 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.941 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.5 123.4 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 t -123.5 155.07 38.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.25 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.51 152.92 41.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.1 171.14 42.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.93 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -96.58 125.61 0.27 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.232 1.955 . . . . 0.0 112.502 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.73 144.2 32.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.767 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -112.67 159.23 19.11 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.4 mtm-85 -95.29 135.39 36.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.801 0.81 . . . . 0.0 112.242 -159.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.6 tt -73.73 130.95 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.042 -172.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -94.72 -43.6 8.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.849 170.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -173.75 96.49 0.11 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.073 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 53.27 26.98 5.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.627 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.22 22.4 10.16 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' HD12 ' A' ' 113' ' ' LEU . 2.6 t -68.73 152.5 45.24 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -172.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.3 tt -154.59 133.82 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.298 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.72 150.03 44.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.444 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.03 137.87 9.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.11 152.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.264 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.53 141.18 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.11 175.14 26.64 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.9 129.29 73.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.94 143.94 17.95 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -134.84 146.98 49.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.862 0.331 . . . . 0.0 110.705 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.8 149.64 17.3 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -135.43 139.21 43.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.582 0.23 . . . . 0.0 110.463 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.56 141.22 45.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.852 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -132.71 136.17 46.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.989 0.423 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 t -108.21 159.14 16.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.269 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.4 m -118.56 127.75 53.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.35 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 45.71 23.26 0.14 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -139.46 77.83 28.25 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -87.95 96.99 0.41 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.733 1.622 . . . . 0.0 112.062 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -137.76 158.19 44.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 111.301 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 51.3 -91.65 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.649 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -111.62 134.3 53.29 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 118.615 0.643 . . . . 0.0 110.879 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -61.92 -44.05 97.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.49 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -152.67 151.17 30.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.615 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 m -126.84 137.34 53.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.946 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.5 p -147.94 156.12 42.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.224 0.535 . . . . 0.0 111.84 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -146.06 144.17 29.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.28 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -107.34 147.1 30.74 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.146 0.279 . . . . 0.0 111.173 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 162.84 27.14 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.33 127.08 51.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.929 0.364 . . . . 0.0 110.189 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.4 t -115.6 138.11 51.39 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.255 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -141.34 149.39 41.1 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.16 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.14 174.44 36.08 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.99 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.61 148.86 33.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.71 155.98 26.09 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.424 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 78' ' ' SER . 6.9 tp -109.06 145.85 34.95 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -144.24 143.63 31.13 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.286 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -135.71 129.9 33.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 172.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.404 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 2.1 p30 -141.2 124.62 9.97 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -170.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -102.32 176.19 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.572 2.182 . . . . 0.0 109.252 157.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.2 mtt -55.53 167.17 0.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.872 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 65.45 -173.79 0.18 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.866 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.69 -11.31 4.8 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.6 t -78.44 17.71 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -167.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.404 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.32 134.13 48.06 Favored 'General case' 0 C--N 1.341 0.232 0 O-C-N 121.535 -0.728 . . . . 0.0 109.882 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 123' ' ' LEU . 4.6 mp -133.42 148.42 51.78 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.637 -171.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -137.11 148.04 46.43 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.526 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.77 134.67 47.07 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -140.11 154.12 46.92 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.677 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -117.57 139.95 50.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.01 151.06 46.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.959 0.409 . . . . 0.0 110.611 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -127.48 136.1 51.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.283 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.9 t -113.95 144.75 42.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 146.16 24.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.131 0.491 . . . . 0.0 109.733 -159.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -87.94 102.64 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.728 1.251 . . . . 0.0 112.908 -144.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -89.68 -176.76 5.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 112.436 -2.166 . . . . 0.0 107.438 156.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.9 p -52.33 -14.21 0.44 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.797 -0.564 . . . . 0.0 112.338 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 135' ' ' VAL . 35.3 m -122.16 126.9 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.344 0.52 . . . . 0.0 110.147 168.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -103.54 139.17 39.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.149 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.14 134.01 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.594 -173.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.08 122.14 4.55 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 171.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -125.99 134.2 51.55 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.496 0.648 . . . . 0.0 111.251 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -115.14 132.94 56.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' A' ' 10' ' ' ALA . 44.9 pt -128.56 145.02 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -176.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.81 131.63 37.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.278 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.89 153.1 23.04 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.752 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.35 144.82 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.15 177.95 32.09 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.437 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -140.06 166.24 25.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.52 -0.84 . . . . 0.0 110.005 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -117.97 149.08 41.53 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.324 0.39 . . . . 0.0 110.554 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.6 t80 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.65 -179.177 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.7 p -116.33 -36.77 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.074 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -150.88 134.29 16.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.571 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.2 m -130.28 140.29 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.235 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -130.08 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.356 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.706 HG22 ' HA3' ' A' ' 145' ' ' GLY . 57.8 p -128.13 143.31 51.05 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.47 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -126.1 140.79 12.35 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.4 172.62 29.4 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.184 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.49 138.39 50.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.744 -0.728 . . . . 0.0 109.108 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -119.54 140.03 51.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.658 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.96 131.93 54.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -114.3 135.14 54.39 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.253 0.346 . . . . 0.0 110.375 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -84.31 123.16 29.87 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.995 0.809 . . . . 0.0 111.177 -174.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -104.12 143.15 33.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.471 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -89.69 153.2 20.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.07 109.59 0.69 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.103 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 169.58 -54.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.3 mtm -128.92 174.08 9.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.956 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -91.97 162.01 14.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 110.759 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -56.65 168.54 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.543 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -126.48 159.63 32.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.734 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.32 146.96 17.86 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.33 143.21 13.66 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.009 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -108.26 132.57 53.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -123.88 132.96 53.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.385 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' C ' HD23 ' A' ' 26' ' ' LEU . 8.2 tt -125.87 131.04 52.45 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HD3' HD11 ' A' ' 40' ' ' ILE . 60.5 mttp -128.07 146.54 50.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.129 0.49 . . . . 0.0 111.887 -174.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.35 132.78 55.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HD3' HD12 ' A' ' 40' ' ' ILE . 75.2 mtm180 -135.91 144.0 45.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.175 0.297 . . . . 0.0 111.357 -175.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -113.0 139.03 49.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -92.81 128.62 38.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.342 0.591 . . . . 0.0 110.657 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -134.76 153.4 52.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.789 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.46 -178.6 3.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.671 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -53.92 -33.47 56.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.39 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -94.27 -25.85 0.26 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -102.89 134.94 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.748 1.632 . . . . 0.0 111.904 164.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.17 156.0 30.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.191 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.07 140.26 15.08 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.58 127.27 56.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.47 0.635 . . . . 0.0 109.877 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.51 HD12 ' HD3' ' A' ' 29' ' ' ARG . 17.6 tt -124.4 135.9 62.29 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.58 134.48 7.7 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.7 t -129.28 139.06 51.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.84 0.32 . . . . 0.0 111.202 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.11 131.45 56.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.7 m -127.95 136.94 52.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -124.85 136.17 53.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.285 174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.8 m -112.42 146.95 37.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -138.49 146.5 42.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -129.82 136.84 50.04 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 p -119.26 -26.65 5.82 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -125.2 116.27 21.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.952 0.406 . . . . 0.0 111.034 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.525 HG21 HD22 ' A' ' 58' ' ' ASN . 31.4 m -132.4 141.88 49.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.183 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.58 93.92 7.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.349 . . . . 0.0 110.398 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.0 p -159.45 173.11 16.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.461 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -58.87 -36.89 75.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.987 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.83 -33.98 66.12 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.5 t0 80.53 -40.18 0.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.159 0.984 . . . . 0.0 111.948 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -117.15 127.14 53.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.782 0.325 . . . . 0.0 110.646 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.525 HD22 HG21 ' A' ' 51' ' ' THR . 89.7 m-20 -130.51 156.41 44.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.245 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -133.22 124.36 27.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.0 0.428 . . . . 0.0 110.794 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -115.97 144.76 43.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.594 176.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -109.02 125.96 52.63 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -125.8 135.92 52.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.455 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -137.1 117.89 14.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.355 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.43 138.43 10.15 Favored Glycine 0 N--CA 1.463 0.486 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.666 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.1 126.92 73.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.672 HG22 ' HA3' ' A' ' 84' ' ' GLY . 68.0 p -123.26 152.03 41.75 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.255 0.347 . . . . 0.0 110.172 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.99 146.49 31.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.545 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -167.95 170.95 42.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.267 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -98.01 123.67 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.486 2.124 . . . . 0.0 112.667 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 145.56 31.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.886 170.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -122.98 132.51 54.18 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -95.83 112.4 24.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -168.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.918 HG21 ' HB3' ' A' ' 77' ' ' ALA . 43.4 mm -96.4 131.41 43.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.505 169.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -61.88 -29.81 70.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -118.55 86.62 2.57 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 43.3 t90 45.64 25.55 0.27 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 170.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.918 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -122.24 22.49 10.12 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m -68.51 151.99 46.02 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -140.25 129.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -133.55 145.23 49.92 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.9 137.69 9.71 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.545 HG12 ' HA3' ' A' ' 68' ' ' GLY . 31.1 m -134.75 154.56 37.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.722 0.296 . . . . 0.0 111.181 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.19 140.75 48.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.672 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.2 175.09 26.75 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.76 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.81 130.5 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.09 136.08 12.41 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.03 142.82 13.97 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -127.37 137.05 52.67 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -110.32 131.04 55.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.715 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.65 126.33 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.3 m -86.61 130.73 34.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.463 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.9 p -74.28 -35.99 63.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.394 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -70.61 -69.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.934 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -176.34 149.42 0.94 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.221 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.52 53.93 0.84 Allowed 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.702 1.601 . . . . 0.0 111.928 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.8 m -56.77 -42.15 78.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.131 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.2 -58.26 3.14 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.021 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -135.24 146.52 48.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.874 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -56.01 -40.59 73.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -161.07 165.71 29.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.403 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.6 m -116.12 135.35 54.01 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.9 p -135.51 154.35 51.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.251 0.548 . . . . 0.0 111.651 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -159.86 159.69 32.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.304 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -130.45 153.98 48.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.972 0.415 . . . . 0.0 111.405 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.14 167.11 26.16 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.86 126.99 53.02 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.6 m -106.38 137.2 44.77 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.897 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.44 132.23 48.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -143.16 157.14 26.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.874 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.52 148.86 32.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.85 162.4 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.504 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.4 mt -108.97 149.42 29.24 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -134.94 137.01 42.71 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.488 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -145.03 127.81 16.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.451 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 10.1 p-10 -142.07 124.51 9.2 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -170.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -100.72 176.16 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.759 2.306 . . . . 0.0 109.385 156.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.455 ' O ' HG22 ' A' ' 121' ' ' VAL . 71.4 mtm -53.99 177.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 63.73 -175.06 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.236 0.541 . . . . 0.0 112.193 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -62.95 -11.39 18.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 118' ' ' MET . 26.8 m -78.11 17.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -165.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.451 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -103.92 138.38 40.57 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.454 0.57 . . . . 0.0 109.798 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.408 ' HG ' HG12 ' A' ' 144' ' ' VAL . 5.3 mp -132.69 153.83 50.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.009 0.433 . . . . 0.0 111.97 -168.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -137.16 140.4 41.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.032 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.74 132.24 53.77 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.8 p -140.13 154.17 46.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.88 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -123.79 141.02 52.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -120.33 138.6 53.62 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.539 0.524 . . . . 0.0 110.451 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -123.96 135.0 53.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.079 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 m -118.26 144.93 45.42 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -89.29 146.53 24.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -157.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.507 HG23 ' CG ' ' A' ' 136' ' ' ASP . 73.6 mt -87.7 97.07 6.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.906 1.336 . . . . 0.0 112.215 -144.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.79 -176.92 5.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.046 -2.343 . . . . 0.0 107.446 157.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.8 p -52.27 -13.46 0.34 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.04 132.11 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.386 0.539 . . . . 0.0 110.195 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.507 ' CG ' HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -108.72 139.2 43.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.23 -0.414 . . . . 0.0 109.991 -178.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.13 122.72 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.13 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.31 114.74 2.22 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -125.81 134.13 51.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.752 0.776 . . . . 0.0 111.244 -175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -114.61 131.23 56.77 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 10' ' ' ALA . 61.9 mt -123.06 134.81 65.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 O-C-N 123.182 0.301 . . . . 0.0 110.259 -175.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.4 125.1 40.03 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 174.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.0 153.2 21.66 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.855 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.408 HG12 ' HG ' ' A' ' 123' ' ' LEU . 35.8 m -122.26 146.29 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.706 ' HA3' HG22 ' A' ' 6' ' ' THR . . . -147.28 173.13 27.53 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.242 -174.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -128.88 154.64 46.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 113.465 -1.368 . . . . 0.0 109.376 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -118.0 149.11 41.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.966 -176.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.5 t80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.033 179.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.4 p -83.37 164.13 20.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.692 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t -157.62 155.07 29.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.658 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 m -128.02 140.66 51.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.772 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.68 136.99 58.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.036 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -128.04 143.09 51.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.95 140.61 11.94 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 173.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 168.4 30.1 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 119.92 -1.134 . . . . 0.0 112.365 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -121.94 135.87 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -127.59 149.03 50.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.19 134.39 54.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.18 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -112.86 142.59 45.35 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 142.1 37.66 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.649 0.593 . . . . 0.0 110.93 -173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -97.41 143.21 28.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.423 -174.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -89.7 153.13 20.95 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.68 142.47 11.93 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.092 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 62.47 35.31 14.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.691 0.396 . . . . 0.0 111.394 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.0 mtt -149.76 167.85 25.34 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -107.68 146.08 32.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.72 0.295 . . . . 0.0 110.921 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 48.9 pttt -56.42 172.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.564 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.65 159.29 40.01 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.856 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.17 142.11 14.73 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.57 143.15 14.74 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.64 135.19 54.42 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.617 ' OD1' HG23 ' A' ' 44' ' ' THR . 92.9 m-20 -126.58 133.22 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 111.367 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.0 tp -120.03 134.95 55.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.019 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -130.22 145.77 51.77 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.291 0.567 . . . . 0.0 112.066 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -120.34 137.82 54.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.042 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -135.26 144.28 46.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.834 0.35 . . . . 0.0 111.378 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -106.64 142.19 36.69 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -92.67 126.93 37.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.311 0.577 . . . . 0.0 110.373 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.99 153.62 41.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.735 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.38 -178.42 3.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.601 -174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.8 p-10 -57.2 -35.42 69.6 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -87.04 -26.11 0.34 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -102.86 130.17 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.569 1.513 . . . . 0.0 112.105 160.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 69' ' ' PRO . 77.2 mt -77.74 155.24 31.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.996 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.64 140.06 18.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -99.79 124.93 53.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 117.397 0.599 . . . . 0.0 109.83 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.471 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.3 mt -120.27 132.88 68.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.77 134.17 8.61 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 88.3 p -127.36 141.98 51.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 111.481 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -113.01 128.08 56.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.769 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.617 HG23 ' OD1' ' A' ' 25' ' ' ASN . 55.0 m -124.45 132.7 53.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.12 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -127.09 136.03 51.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.487 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 m -117.81 145.21 44.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 110.955 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -130.13 141.69 50.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.006 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -109.21 137.68 46.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.193 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.7 p -65.41 157.86 28.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.532 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -57.67 139.23 54.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.628 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.5 p -130.61 162.67 28.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.104 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.13 94.03 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.167 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.8 m -161.9 174.26 13.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.552 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.8 p -58.97 -31.23 68.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.58 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.84 -30.18 68.46 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.027 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 75.35 -75.18 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.308 0.643 . . . . 0.0 111.31 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -135.26 161.86 34.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.806 0.336 . . . . 0.0 110.962 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 56.93 54.02 7.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.54 0.686 . . . . 0.0 110.591 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -55.49 -39.34 70.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.034 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -144.83 158.85 43.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 111.18 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -125.97 147.85 49.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.082 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -123.99 135.96 53.98 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.115 0.483 . . . . 0.0 110.919 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -128.8 119.15 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.221 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.19 135.18 8.19 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.272 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.1 mt -124.02 117.29 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.575 HG22 ' HB ' ' A' ' 82' ' ' VAL . 2.0 m -123.28 148.65 45.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.768 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.82 31.58 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.13 168.93 41.14 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 120.032 -1.08 . . . . 0.0 113.114 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HB2' HD13 ' A' ' 37' ' ' LEU . 71.8 Cg_endo -98.41 122.9 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.555 2.17 . . . . 0.0 113.062 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.9 146.56 30.76 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.328 170.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -121.02 128.93 53.14 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -95.84 108.91 21.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.385 0.612 . . . . 0.0 112.281 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 77' ' ' ALA . 79.8 mt -96.27 131.29 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.177 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -61.43 -35.0 76.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.162 -174.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -69.68 -178.2 1.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -87.4 40.84 0.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 110.778 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.65 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -122.19 22.51 10.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.26 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.2 p -68.68 165.07 20.19 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -171.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.59 129.99 14.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.539 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -131.18 140.26 49.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 171.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.0 137.75 11.3 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.575 ' HB ' HG22 ' A' ' 66' ' ' THR . 35.1 m -136.46 152.64 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.974 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 109' ' ' TYR . 35.9 m -134.17 140.95 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.455 ' N ' HG23 ' A' ' 66' ' ' THR . . . -147.17 174.95 26.78 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.57 -176.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.54 133.09 58.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.64 131.32 9.45 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -114.92 132.28 56.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -115.95 127.85 7.73 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -126.43 145.27 50.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.595 0.236 . . . . 0.0 110.435 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -88.45 145.0 26.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.02 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -96.9 117.96 32.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.982 0.42 . . . . 0.0 110.398 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.8 m -108.12 149.07 28.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.365 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.9 m -58.4 151.12 20.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.066 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.92 -37.62 85.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.907 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -56.02 -55.59 39.82 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.114 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -42.13 126.95 3.84 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.932 1.755 . . . . 0.0 113.141 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.8 m -60.09 -37.56 80.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.335 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -90.63 135.91 33.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 111.225 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -113.35 156.06 24.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 61.2 71.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.394 0.616 . . . . 0.0 110.151 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.29 -41.36 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.452 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 66.0 p -131.21 153.8 49.1 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.005 0.431 . . . . 0.0 111.108 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.3 m -140.98 145.04 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.144 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -150.01 142.11 24.01 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.678 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.11 142.89 39.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.299 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.12 162.36 27.17 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -108.5 125.76 52.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.6 m -108.93 137.94 46.05 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.63 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.585 ' CD2' HG12 ' A' ' 83' ' ' VAL . 81.0 m-85 -125.92 138.89 53.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.73 157.64 27.33 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.841 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.8 148.78 32.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.82 160.37 28.47 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.102 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.5 mp -111.96 147.11 36.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -137.57 141.07 41.34 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.934 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -133.12 116.29 16.11 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -117.62 124.24 29.07 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.38 -172.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -107.03 176.2 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.102 2.535 . . . . 0.0 109.423 157.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.33 170.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.182 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 65.39 -171.35 0.19 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.056 0.455 . . . . 0.0 111.956 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -61.51 -11.3 10.32 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 121' ' ' VAL . 6.3 t -78.38 18.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.13 0.572 . . . . 0.0 112.431 -164.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.91 137.61 41.66 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.233 -0.917 . . . . 0.0 109.662 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.77 148.77 50.88 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -168.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -137.13 142.04 42.26 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.775 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -126.32 132.14 51.69 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 t -140.15 154.08 46.86 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.863 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.14 140.6 52.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -121.56 141.67 50.84 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 123.372 0.42 . . . . 0.0 110.093 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -125.9 132.84 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.575 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.1 m -115.77 144.57 43.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -89.45 146.03 24.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -161.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 132' ' ' ILE . 10.5 tt -87.76 101.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 123.616 1.674 . . . . 0.0 113.697 -146.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -89.74 -176.7 5.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.11 -2.314 . . . . 0.0 107.244 157.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.14 -13.94 0.37 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.821 -0.549 . . . . 0.0 112.354 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.98 132.03 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.392 0.542 . . . . 0.0 109.747 166.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -115.08 139.22 50.07 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -108.15 127.68 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.767 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.41 116.1 2.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.525 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 40.1 m -126.1 134.14 51.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.477 0.639 . . . . 0.0 111.235 -175.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -122.64 133.78 54.51 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 17.7 tt -131.6 146.11 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.636 0.255 . . . . 0.0 111.269 -172.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.01 133.95 53.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.38 153.13 21.81 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.074 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.82 140.0 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -138.91 163.89 25.85 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.395 -173.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -134.15 152.33 51.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 113.485 -1.357 . . . . 0.0 108.801 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -136.76 149.0 47.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.531 -179.627 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -132.7 153.75 50.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.511 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.5 p -159.92 157.59 29.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.907 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.45 HG21 HH21 ' A' ' 29' ' ' ARG . 40.7 m -132.51 139.27 47.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.332 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.58 120.53 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.5 m -128.25 143.09 51.0 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.31 140.86 12.13 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.23 179.81 31.82 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.159 -175.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.6 144.57 46.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -0.622 . . . . 0.0 109.847 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.573 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -122.74 138.52 54.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.944 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -125.46 131.92 52.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -116.81 145.74 43.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -78.52 139.31 38.66 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.827 0.704 . . . . 0.0 111.253 -173.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -106.78 143.31 35.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.115 -177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -89.68 153.41 20.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.5 152.03 3.59 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.602 -0.333 . . . . 0.0 112.392 -168.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 63.75 31.35 14.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.896 -0.652 . . . . 0.0 111.787 -174.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 69.2 mtm -151.19 167.3 28.21 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -109.35 146.18 34.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.848 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 36.8 pttt -54.37 168.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.167 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.8 mtt -117.63 146.38 43.71 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.57 135.29 10.78 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.52 143.15 14.45 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.607 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.514 ' CE2' HD21 ' A' ' 26' ' ' LEU . 62.0 t80 -110.95 135.8 50.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.66 ' HB3' HG22 ' A' ' 44' ' ' THR . 23.0 p30 -131.63 144.57 51.14 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.945 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 24' ' ' PHE . 80.6 mt -124.41 140.51 52.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.239 173.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -129.16 141.89 51.04 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.043 0.449 . . . . 0.0 111.084 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -121.03 130.21 53.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HD3' HD12 ' A' ' 40' ' ' ILE . 40.0 mtm180 -134.39 144.08 47.99 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.265 0.353 . . . . 0.0 110.657 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -107.49 143.22 36.18 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.68 119.16 31.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.195 0.522 . . . . 0.0 109.981 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -127.45 153.4 46.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.991 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -74.7 -178.62 3.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.541 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -56.37 -32.96 65.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.315 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.2 m -93.38 -25.94 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -102.83 136.3 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.728 1.619 . . . . 0.0 111.848 164.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.6 mt -78.06 154.27 31.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.93 140.38 16.38 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.09 127.5 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.501 0.651 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.57 HD12 ' HD3' ' A' ' 29' ' ' ARG . 16.9 tt -123.36 138.39 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.28 139.77 10.58 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 p -135.41 144.93 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.067 0.434 . . . . 0.0 111.424 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -124.68 128.65 49.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.109 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 25' ' ' ASN . 36.8 p -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.855 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -127.28 137.12 52.77 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -111.54 150.73 29.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.003 0.43 . . . . 0.0 111.202 -174.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.24 151.55 50.63 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.141 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.05 147.0 31.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.116 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.3 p -123.31 138.29 54.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 0.0 110.17 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -150.88 151.24 31.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.612 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 p -75.53 166.97 22.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.06 178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.06 134.29 56.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.446 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.6 t -157.63 171.58 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.776 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.0 p -59.65 -25.27 64.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.137 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.78 -8.28 63.43 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 119.579 -0.567 . . . . 0.0 113.349 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 59.44 52.68 5.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.069 0.935 . . . . 0.0 110.563 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.7 t80 63.92 139.29 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.185 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.35 117.68 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.493 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -102.32 110.02 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.165 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -133.82 150.24 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.741 175.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -126.13 142.83 51.36 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.689 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -129.9 138.04 50.71 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.17 128.25 41.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.45 128.15 5.29 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 65' ' ' ILE . 7.6 tp -124.65 122.61 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.732 HG22 ' HA3' ' A' ' 84' ' ' GLY . 30.3 p -123.3 154.95 38.17 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.864 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.72 147.6 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.16 42.3 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.512 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -97.29 127.79 0.27 Allowed 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.452 2.101 . . . . 0.0 112.818 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.66 138.55 36.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.652 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -116.87 128.14 54.96 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -95.85 109.41 21.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.327 0.584 . . . . 0.0 111.852 -170.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 77' ' ' ALA . 79.7 mt -96.31 131.52 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.948 171.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -61.4 -29.22 69.79 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.705 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -73.97 -179.32 3.68 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -86.82 48.24 1.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.598 0.713 . . . . 0.0 110.076 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -122.2 22.62 10.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.003 -175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 t -68.5 148.97 49.81 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -166.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.93 129.95 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.282 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -115.76 133.9 55.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.17 137.71 10.88 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 172.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.77 153.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 117.559 0.679 . . . . 0.0 111.976 -173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.466 HG13 ' CZ ' ' A' ' 107' ' ' PHE . 55.5 t -125.71 140.84 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.732 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.41 174.95 27.0 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.661 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.3 128.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.3 131.26 8.53 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -139.06 155.91 47.58 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.097 0.448 . . . . 0.0 111.018 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.22 150.05 17.57 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -134.68 146.26 49.32 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -98.63 127.21 44.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.845 0.355 . . . . 0.0 110.424 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -105.42 118.61 36.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.475 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.9 m -108.16 140.52 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.209 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.1 m -121.16 135.45 55.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 110.592 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 62.17 55.46 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.583 0.706 . . . . 0.0 110.19 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -146.89 162.39 33.48 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.286 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.13 129.17 33.45 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.371 1.381 . . . . 0.0 111.933 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -66.56 -28.1 68.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.059 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -59.76 -31.51 69.72 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -55.89 -39.46 71.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.612 0.244 . . . . 0.0 110.823 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 63.69 144.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.996 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.29 178.41 7.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.803 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -124.62 141.15 52.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.927 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 85.2 p -140.41 155.89 46.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.182 0.515 . . . . 0.0 111.559 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.92 159.0 26.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.465 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -136.02 159.86 40.4 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 111.403 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.02 167.11 26.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.466 ' CZ ' HG13 ' A' ' 83' ' ' VAL . 61.0 t80 -93.2 124.86 37.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -113.07 140.55 47.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.039 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.2 139.38 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.5 161.9 28.74 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 119.995 -1.097 . . . . 0.0 112.152 -177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.34 148.94 31.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.368 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.448 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -148.04 162.0 28.68 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.61 -177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.448 HD22 ' C ' ' A' ' 112' ' ' GLY . 4.5 mm? -111.87 152.64 27.73 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -116.47 133.47 55.98 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 111.693 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -135.56 109.74 8.32 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.482 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 13.3 p-10 -140.59 124.71 10.58 Favored Pre-proline 0 N--CA 1.463 0.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -165.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -101.23 176.14 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.381 2.054 . . . . 0.0 109.258 155.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.7 mtp -58.69 176.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.349 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 61.64 -174.45 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.901 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -60.63 -11.56 7.62 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.8 t -78.4 17.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -167.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.596 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -104.24 138.02 41.3 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.37 -0.831 . . . . 0.0 110.14 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.64 HD11 HG12 ' A' ' 144' ' ' VAL . 4.5 mm? -122.27 145.52 48.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -168.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -130.66 131.35 44.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.661 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -124.06 129.79 51.47 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -140.12 154.11 46.91 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.606 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -121.61 139.98 52.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.94 150.95 46.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.889 0.376 . . . . 0.0 110.742 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -131.84 136.02 47.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -113.32 144.57 42.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.194 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -89.21 146.24 24.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.782 0.676 . . . . 0.0 109.519 -160.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 pt -87.88 98.09 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 123.309 1.528 . . . . 0.0 114.032 -145.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -89.67 -176.74 5.08 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 112.2 -2.273 . . . . 0.0 106.903 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.3 p -52.32 -12.78 0.28 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.324 -0.86 . . . . 0.0 112.616 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.07 133.89 65.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.334 0.516 . . . . 0.0 109.837 168.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -115.0 139.1 50.13 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -108.18 129.77 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.743 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.23 117.18 2.9 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 169.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.6 m -126.14 134.26 51.37 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.862 0.831 . . . . 0.0 111.476 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -115.85 135.13 54.3 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.573 HG22 ' CB ' ' A' ' 10' ' ' ALA . 41.6 pt -130.84 144.71 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.286 -177.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.49 128.69 25.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.471 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.445 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -136.95 153.07 21.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.612 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.64 HG12 HD11 ' A' ' 123' ' ' LEU . 27.0 m -118.01 140.96 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.13 178.1 31.98 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.401 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -139.8 162.78 34.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.622 -0.789 . . . . 0.0 109.444 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -141.52 149.06 40.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.772 0.32 . . . . 0.0 111.227 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.534 -179.675 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.7 m -124.85 -62.16 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.465 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -128.79 148.63 50.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.207 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.4 m -126.0 139.74 53.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.918 0.389 . . . . 0.0 110.353 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.6 122.59 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.608 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.14 143.06 51.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.07 0.462 . . . . 0.0 111.055 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.34 140.83 12.16 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.89 179.29 31.06 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.031 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -131.16 146.44 52.34 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.628 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -134.27 149.16 50.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.004 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -116.22 136.3 53.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 t -112.9 139.48 48.5 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.79 127.78 32.51 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.88 0.738 . . . . 0.0 111.02 -174.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -85.0 143.31 29.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.582 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -89.74 153.34 20.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 146.89 6.87 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.107 -171.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 61.65 39.07 14.83 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.951 0.442 . . . . 0.0 110.687 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.4 ttm -158.04 153.42 25.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.979 176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -101.94 149.36 24.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.768 0.318 . . . . 0.0 110.895 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 47.4 mtmt -55.71 166.17 0.74 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.741 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.0 mtt -129.04 160.95 31.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.666 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.83 148.22 17.58 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.14 14.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.755 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.575 ' CE1' HD21 ' A' ' 26' ' ' LEU . 61.8 t80 -112.77 135.06 53.94 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.527 ' HB3' HD11 ' A' ' 141' ' ' ILE . 51.2 t30 -131.12 138.29 49.44 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.833 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 24' ' ' PHE . 82.4 mt -122.26 139.61 53.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.289 174.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -130.7 142.57 50.43 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.915 0.388 . . . . 0.0 111.427 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -122.26 133.15 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -137.08 144.09 42.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 0.0 111.079 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -105.09 143.2 33.59 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.59 125.83 37.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.277 0.561 . . . . 0.0 110.188 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -134.99 153.38 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.56 -178.6 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.715 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -56.04 -33.53 65.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.427 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -93.25 -26.06 0.27 Allowed Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -102.77 135.28 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.756 1.637 . . . . 0.0 111.889 164.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 69' ' ' PRO . 4.2 pp -77.97 160.29 28.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.25 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.46 140.21 14.91 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.41 125.51 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.341 0.571 . . . . 0.0 109.935 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' A' ' 70' ' ' ALA . 72.3 mt -119.2 136.12 57.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.87 136.46 8.57 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.1 p -138.2 149.08 45.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.41 0.605 . . . . 0.0 111.59 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -122.2 135.56 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.969 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -130.13 140.04 50.83 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.144 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -125.64 136.99 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.59 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 m -101.27 145.31 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.807 0.337 . . . . 0.0 110.665 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -130.95 147.07 52.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.344 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -134.43 136.94 43.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.72 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -105.55 135.85 46.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 111.017 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -134.33 169.1 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.355 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 p -70.24 168.0 16.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.087 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.01 117.78 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.908 0.385 . . . . 0.0 110.447 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.3 p -159.58 178.94 9.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.579 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.2 p -59.48 -24.82 63.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.241 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.76 -14.12 72.51 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.148 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 59.51 48.32 9.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.934 0.867 . . . . 0.0 110.721 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 59.31 30.61 20.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.846 178.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -128.46 117.58 21.59 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.766 0.317 . . . . 0.0 110.745 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -95.08 -68.48 0.8 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.161 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -139.87 172.81 12.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.141 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -125.97 143.09 51.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -135.29 135.97 41.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -130.11 133.12 46.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.83 135.51 7.87 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.89 123.57 67.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.662 HG22 ' HA3' ' A' ' 84' ' ' GLY . 69.5 p -123.23 153.4 40.18 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.052 0.22 . . . . 0.0 111.001 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 143.95 30.23 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.15 169.56 41.52 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.995 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.591 ' HB3' HD13 ' A' ' 37' ' ' LEU . 74.5 Cg_endo -97.27 124.92 0.22 Allowed 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 122.471 2.114 . . . . 0.0 112.914 176.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.611 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.81 147.02 30.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.719 169.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -121.58 129.31 52.77 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 172.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -95.85 108.84 21.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.384 0.612 . . . . 0.0 111.661 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.26 131.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.242 172.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -61.59 -34.72 76.1 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.956 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -65.71 -179.25 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -88.05 37.47 0.81 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 111.19 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.482 ' O ' HG23 ' A' ' 79' ' ' ILE . . . -122.07 22.47 10.25 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m -68.92 150.58 47.58 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 77' ' ' ALA . 48.0 pt -136.83 144.38 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.463 -167.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -137.1 147.34 46.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.847 172.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 137.87 9.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.518 HG12 ' HA3' ' A' ' 68' ' ' GLY . 32.9 m -134.67 156.58 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.76 0.314 . . . . 0.0 111.015 -174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.565 HG12 ' CD2' ' A' ' 109' ' ' TYR . 35.5 m -128.49 140.94 47.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.21 175.08 26.76 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.696 -176.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.75 129.72 72.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -122.56 137.88 11.57 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -139.05 151.8 47.06 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.558 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -126.07 150.18 17.54 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -125.93 133.08 51.97 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -106.88 131.76 53.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -109.77 139.08 45.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.089 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.6 p -108.02 151.9 25.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 0.0 110.783 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.8 p -72.96 -34.88 66.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -98.59 143.71 28.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.804 0.335 . . . . 0.0 110.423 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -121.79 80.25 40.83 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.527 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.59 -31.52 5.43 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.395 1.397 . . . . 0.0 112.183 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.2 m -112.58 146.02 39.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.015 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -56.63 -38.72 72.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.847 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -128.9 120.66 26.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.696 0.284 . . . . 0.0 110.461 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -150.5 126.27 10.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.727 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -164.96 158.56 17.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.699 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.5 m -128.82 137.57 51.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.109 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.1 t -139.62 133.09 30.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.932 0.396 . . . . 0.0 111.114 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -140.07 155.14 47.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.5 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -132.06 153.17 50.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 111.227 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.29 167.07 26.22 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.99 125.91 47.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.1 m -110.24 142.2 42.14 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.15 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.565 ' CD2' HG12 ' A' ' 83' ' ' VAL . 87.7 m-85 -124.9 137.06 54.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.34 153.43 23.47 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.678 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.25 148.85 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.72 160.04 28.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.377 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.47 HD23 HG22 ' A' ' 79' ' ' ILE . 70.6 mt -108.86 146.04 34.34 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -125.75 140.59 52.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 111.805 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -139.97 110.0 6.48 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.458 ' CG ' ' HB1' ' A' ' 122' ' ' ALA . 53.9 m-20 -132.85 124.29 18.63 Favored Pre-proline 0 CA--C 1.529 0.136 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.472 -170.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -102.04 176.21 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.992 2.462 . . . . 0.0 109.255 156.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.439 ' O ' HG22 ' A' ' 121' ' ' VAL . 71.4 mtm -57.77 166.42 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.512 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 65.39 -174.47 0.18 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.16 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -58.74 -11.66 3.41 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -174.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 118' ' ' MET . 31.3 m -78.42 17.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -170.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.458 ' HB1' ' CG ' ' A' ' 116' ' ' ASN . . . -104.74 143.04 33.64 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.524 ' N ' HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -146.66 155.8 42.71 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.369 -174.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -137.09 148.09 46.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.602 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -126.15 127.53 45.88 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 64.9 p -140.23 154.21 46.81 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.444 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -120.87 150.13 41.53 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -124.72 137.95 54.31 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.487 0.492 . . . . 0.0 110.525 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -122.42 129.22 51.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.301 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.5 m -120.18 144.56 47.64 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -89.51 146.12 24.82 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.531 0.519 . . . . 0.0 109.602 -163.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 132' ' ' ILE . 9.8 tt -87.72 95.91 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-O 123.705 1.717 . . . . 0.0 113.422 -147.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -89.66 -176.84 5.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 111.929 -2.396 . . . . 0.0 107.434 157.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -52.01 -16.27 0.72 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.83 -0.544 . . . . 0.0 112.141 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.33 127.51 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 167.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -115.1 139.16 50.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.2 125.96 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.086 -0.645 . . . . 0.0 111.979 -171.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 108.83 1.12 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 167.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.487 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 30.4 m -126.08 134.26 51.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 117.633 0.716 . . . . 0.0 111.352 -174.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -123.21 132.23 53.97 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.628 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 16.4 tt -130.28 143.77 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.188 0.305 . . . . 0.0 111.079 -171.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.2 53.53 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.82 153.11 20.95 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.709 -176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.3 141.18 47.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.28 178.05 32.14 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.78 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -139.77 171.8 13.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.691 -0.754 . . . . 0.0 110.277 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -117.88 148.95 41.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.503 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.0 t80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.618 -179.368 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.5 p -122.96 163.85 19.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.407 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -153.99 163.1 40.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 146' ' ' TYR . 19.2 m -129.71 143.11 50.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.511 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.98 127.0 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -128.41 143.17 50.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.899 0.381 . . . . 0.0 111.313 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.67 140.87 12.13 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.78 -175.91 30.23 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.32 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.52 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -127.85 148.92 50.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.508 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -121.85 135.25 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.618 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 t -113.93 143.77 44.16 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -78.46 138.63 38.56 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.674 0.609 . . . . 0.0 111.078 -173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.574 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -105.76 143.36 34.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 -175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -89.61 153.29 20.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.014 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.76 151.98 3.9 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.168 -171.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 68.57 21.35 8.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.462 -0.369 . . . . 0.0 111.984 -172.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -150.09 166.03 31.0 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -108.59 156.96 18.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.76 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.574 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 54.2 mtmt -62.52 164.68 7.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.206 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.6 mtm -119.55 153.42 35.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.551 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.18 140.64 13.68 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.11 143.19 14.58 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.813 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -110.12 132.18 54.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -127.12 139.02 53.27 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.165 0.291 . . . . 0.0 111.716 -173.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.604 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -127.99 132.81 49.15 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' N ' HD13 ' A' ' 26' ' ' LEU . 39.0 ttpt -136.18 147.65 47.77 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.02 0.438 . . . . 0.0 110.825 -176.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -132.69 151.18 52.04 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.584 ' CB ' HG22 ' A' ' 40' ' ' ILE . 49.6 ptt85 -150.98 144.45 24.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.144 -176.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -105.78 143.24 34.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -92.4 124.38 36.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.308 0.575 . . . . 0.0 110.091 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -121.37 153.32 37.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.871 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.64 -178.46 3.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.843 -176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -50.66 -42.33 56.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 p -90.26 -25.86 0.3 Allowed Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -102.83 131.95 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.497 1.465 . . . . 0.0 112.218 162.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.4 mt -78.07 162.04 26.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.672 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.19 140.22 23.55 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.32 124.79 54.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 117.821 0.811 . . . . 0.0 109.401 -176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 29' ' ' ARG . 43.8 pt -117.82 142.7 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -146.34 134.41 5.33 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -141.93 154.92 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.909 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -132.93 141.15 48.2 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -130.07 141.29 50.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.168 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -118.65 134.39 55.15 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.6 m -109.77 145.83 35.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.993 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -133.81 140.19 46.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.268 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -145.23 136.8 25.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.749 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t -141.05 137.38 32.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.788 0.327 . . . . 0.0 110.806 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -93.37 -59.87 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.277 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.5 p -127.84 160.36 32.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.159 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.26 102.75 15.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.428 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -124.46 141.67 51.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.587 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.3 m -62.56 -36.2 81.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.396 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.51 -45.93 5.65 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.895 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -97.8 116.3 29.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.928 0.394 . . . . 0.0 111.594 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -129.92 126.87 38.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.267 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 55.22 89.05 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.811 0.339 . . . . 0.0 111.045 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -58.68 -38.97 79.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.223 -176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -141.7 151.54 43.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.802 0.334 . . . . 0.0 110.935 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -126.16 149.12 49.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.229 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -130.51 136.47 48.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.423 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -127.6 133.21 49.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.649 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.29 136.34 8.69 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 65' ' ' ILE . 16.6 tt -125.28 124.59 67.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.649 HG22 ' HA3' ' A' ' 84' ' ' GLY . 82.6 p -123.31 154.7 38.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.315 -175.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.81 147.98 41.52 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.27 171.02 36.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.42 -175.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -99.3 123.48 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.774 2.316 . . . . 0.0 111.945 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.6 143.56 33.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.4 172.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -124.02 159.89 28.87 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -95.16 135.64 36.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.951 0.881 . . . . 0.0 112.873 -162.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 114' ' ' GLN . 16.5 tt -73.92 131.02 35.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.041 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -94.82 -66.52 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.423 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.29 93.52 2.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.678 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 t90 52.68 34.85 16.89 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 111.246 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.97 22.53 10.31 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.67 146.46 52.97 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.0 mt -132.57 129.81 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.576 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -132.18 133.75 44.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.88 137.64 10.59 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.54 ' CG1' HD11 ' A' ' 40' ' ' ILE . 33.9 m -139.22 151.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 117.468 0.634 . . . . 0.0 112.382 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.78 140.93 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.649 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.17 175.14 26.69 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.361 -174.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.638 HG12 ' OH ' ' A' ' 105' ' ' TYR . 35.8 m -112.56 134.45 55.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.83 10.95 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -122.14 133.35 54.75 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.79 138.96 15.27 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -128.79 135.25 48.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.757 0.278 . . . . 0.0 110.356 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -106.94 130.61 54.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.601 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -105.65 128.55 53.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.388 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.7 p -82.73 157.44 23.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.478 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.9 p -68.59 -37.08 79.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.16 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -115.99 130.52 56.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.894 0.378 . . . . 0.0 110.726 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 51.2 68.78 3.02 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.489 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.76 88.97 1.34 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.365 1.377 . . . . 0.0 111.738 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.5 p -122.41 165.29 16.55 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.035 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -57.4 -35.03 69.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.41 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -53.74 -37.58 63.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.576 0.226 . . . . 0.0 111.254 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -129.05 114.64 16.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.871 0.367 . . . . 0.0 110.396 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -170.88 173.06 5.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.4 m -121.09 136.41 54.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.131 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -138.14 141.1 40.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.896 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -142.22 141.84 32.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.466 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.638 ' OH ' HG12 ' A' ' 85' ' ' VAL . 64.6 t80 -109.04 142.89 39.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.488 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.25 159.47 27.1 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -102.54 126.1 49.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 m -116.44 143.91 44.98 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.698 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -143.08 153.07 42.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.03 175.55 35.97 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.12 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.84 148.99 29.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.001 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.81 159.85 27.89 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.953 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.5 mp -121.53 147.63 45.55 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.6 ' O ' HD12 ' A' ' 73' ' ' ILE . 61.2 tt0 -134.42 141.04 46.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.273 0.559 . . . . 0.0 111.851 -174.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -130.6 114.05 14.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.478 ' CB ' ' HB1' ' A' ' 122' ' ' ALA . 16.3 p-10 -134.51 124.69 17.19 Favored Pre-proline 0 N--CA 1.463 0.216 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -166.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -98.79 176.24 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.465 2.11 . . . . 0.0 109.146 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.445 ' O ' HG22 ' A' ' 121' ' ' VAL . 65.2 mtt -55.93 169.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.798 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 65.35 -175.91 0.18 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.209 0.528 . . . . 0.0 112.298 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -59.87 -11.52 5.64 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 118' ' ' MET . 26.8 m -78.26 18.02 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -169.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB1' ' CB ' ' A' ' 116' ' ' ASN . . . -104.19 136.74 43.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.281 0.491 . . . . 0.0 109.863 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.406 ' CD2' HG12 ' A' ' 144' ' ' VAL . 74.5 mt -119.68 142.85 48.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.488 -168.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -135.69 136.21 40.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.288 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -125.33 134.62 52.15 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 m -140.09 154.0 46.91 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.419 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -120.77 141.6 50.34 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -130.76 140.91 50.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 110.239 -175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -125.06 136.15 53.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.213 0.53 . . . . 0.0 111.346 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.6 m -103.94 144.71 31.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -89.28 145.96 25.04 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -158.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.8 96.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 122.732 1.253 . . . . 0.0 112.533 -145.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -89.85 -176.84 5.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 112.174 -2.285 . . . . 0.0 106.871 157.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.2 p -52.32 -13.36 0.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.387 -0.821 . . . . 0.0 112.537 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -119.06 129.64 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 118.424 0.556 . . . . 0.0 110.092 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -115.15 139.12 50.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.617 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.11 134.66 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.525 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.22 121.58 4.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 172.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.4 m -126.13 134.18 51.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.529 0.665 . . . . 0.0 111.256 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -120.57 130.54 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 19.4 tt -131.25 144.62 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.136 -173.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.66 132.91 45.7 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.32 153.31 21.86 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.773 -174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.406 HG12 ' CD2' ' A' ' 123' ' ' LEU . 29.2 m -118.63 139.92 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.48 178.03 30.71 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.343 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 4' ' ' THR . 43.1 p90 -141.0 161.85 36.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.684 -0.758 . . . . 0.0 109.786 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -121.03 145.2 48.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.529 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.508 -179.403 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.537 HG21 ' NH2' ' A' ' 147' ' ' ARG . 36.3 m -82.02 142.01 32.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.57 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -140.78 155.59 46.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.46 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -121.76 140.06 52.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.507 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.52 128.51 76.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.2 m -128.14 142.11 51.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.958 0.408 . . . . 0.0 111.193 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.28 140.9 12.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.55 -179.9 31.89 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.374 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -122.27 140.23 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.936 -0.632 . . . . 0.0 109.65 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.39 138.87 54.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.504 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -125.75 131.78 52.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.5 p -115.92 143.59 45.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.42 -176.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.82 129.42 34.58 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 124.116 0.885 . . . . 0.0 111.374 -173.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.643 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -104.74 143.31 33.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.994 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -89.8 153.4 20.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.217 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.65 152.16 3.69 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.992 -0.443 . . . . 0.0 111.992 -172.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 83.49 -28.09 0.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.529 1.132 . . . . 0.0 111.724 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 86.2 mtp -112.83 162.9 15.26 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -106.98 159.98 15.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.914 0.388 . . . . 0.0 111.081 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 40.9 mtmt -64.62 167.97 6.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.353 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.4 mtt -129.74 154.01 47.62 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.614 -177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.5 147.9 16.73 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 143.33 12.28 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.46 133.46 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -127.38 136.63 52.14 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.433 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.2 tp -130.6 136.31 48.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -139.34 155.32 47.77 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.281 0.562 . . . . 0.0 112.197 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.92 140.37 52.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.097 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.7 mtp-105 -132.62 144.35 50.3 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.212 0.32 . . . . 0.0 110.899 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.42 141.8 36.28 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -92.81 123.2 35.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.141 0.496 . . . . 0.0 110.229 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -145.1 153.52 41.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.85 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.44 -178.5 3.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.882 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -54.77 -40.4 69.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 m -84.45 -26.19 0.38 Allowed Pre-proline 0 N--CA 1.467 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -169.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -102.62 126.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.531 1.487 . . . . 0.0 112.069 160.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.408 HD22 ' CD1' ' A' ' 71' ' ' TYR . 77.6 mt -76.31 154.64 34.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.25 140.17 18.89 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.97 126.13 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 117.206 0.503 . . . . 0.0 109.647 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.455 ' C ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -124.57 134.99 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' N ' HD13 ' A' ' 40' ' ' ILE . . . -135.89 137.29 9.02 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 176.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.7 p -141.77 154.86 45.53 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.004 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -130.34 141.48 50.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.8 p -130.11 143.19 50.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.481 -176.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.76 137.04 55.04 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -115.57 148.55 39.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.913 0.387 . . . . 0.0 111.317 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -132.81 149.29 52.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.005 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -116.11 155.55 28.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.322 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.9 t -97.66 126.44 42.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.772 0.32 . . . . 0.0 110.175 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.1 ttm105 -149.74 148.03 28.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.487 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.4 m -58.23 148.15 28.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.271 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.671 ' HB2' ' OH ' ' A' ' 57' ' ' TYR . . . -57.84 138.16 55.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 110.596 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.2 p -152.94 167.44 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -59.0 -33.92 71.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.563 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.01 3.11 14.29 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.508 -0.607 . . . . 0.0 113.608 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 64.52 144.23 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 117.987 0.894 . . . . 0.0 111.044 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.671 ' OH ' ' HB2' ' A' ' 52' ' ' ALA . 91.1 m-85 -58.1 165.75 1.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.772 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.63 43.97 15.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.096 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -57.75 -37.62 73.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.777 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -99.83 143.17 30.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -125.46 146.42 49.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.429 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -123.5 135.91 54.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.384 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -131.44 120.41 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.77 135.49 8.54 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 65' ' ' ILE . 15.8 tt -126.04 122.57 62.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.653 HG22 ' HA3' ' A' ' 84' ' ' GLY . 24.3 p -123.48 152.37 41.78 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.102 0.252 . . . . 0.0 110.602 -176.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.563 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.0 146.39 30.97 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.51 41.46 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.287 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -99.02 122.3 0.13 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.734 2.289 . . . . 0.0 112.944 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.84 146.68 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.396 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.408 ' CD1' HD22 ' A' ' 37' ' ' LEU . 88.8 m-85 -117.47 126.54 52.79 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 170.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -95.88 108.69 21.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.624 0.726 . . . . 0.0 112.008 -168.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.5 131.46 43.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.95 167.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -61.34 -31.01 70.87 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.289 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -86.71 -177.16 6.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.886 0.374 . . . . 0.0 110.41 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.6 ' CZ3' HD22 ' A' ' 113' ' ' LEU . 86.5 t90 -62.98 -7.02 4.44 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.85 22.26 0.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.7 p -68.76 158.31 34.57 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.2 mt -141.55 129.85 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.898 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -134.15 142.77 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 66' ' ' THR . 9.2 p -139.82 143.91 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.045 0.423 . . . . 0.0 110.82 -172.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.573 HG12 ' CD1' ' A' ' 109' ' ' TYR . 35.9 m -130.36 140.91 47.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.653 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.15 175.15 26.67 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.431 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -115.49 130.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 134.91 11.59 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -122.12 136.2 54.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.0 127.62 7.06 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -133.63 157.76 44.93 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 117.075 0.438 . . . . 0.0 111.598 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -98.47 133.57 42.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.43 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -97.74 132.04 43.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.498 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.8 t -86.19 159.16 19.57 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.541 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 p -81.96 164.3 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.49 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.46 -35.36 73.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.265 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -61.97 140.66 95.75 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.941 -0.552 . . . . 0.0 109.73 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.78 112.2 1.57 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.262 1.308 . . . . 0.0 111.877 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 99' ' ' LYS . 31.0 m -123.02 138.92 54.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.42 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -62.31 -34.99 77.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.495 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.481 ' H ' HG22 ' A' ' 97' ' ' THR . 17.7 ttmm -56.93 143.25 38.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.472 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -117.81 174.4 6.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.646 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -78.36 125.2 29.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.974 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.5 m -125.97 138.85 53.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.656 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.6 p -146.92 166.18 27.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.279 0.561 . . . . 0.0 111.938 -176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -142.09 153.03 43.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.667 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -109.64 151.23 27.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.99 166.99 26.15 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -103.66 127.16 51.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.841 0.321 . . . . 0.0 110.349 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.4 t -105.52 132.07 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.566 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.573 ' CD1' HG12 ' A' ' 83' ' ' VAL . 84.7 m-85 -126.48 134.71 50.86 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 176.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.68 158.9 27.81 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.789 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.67 148.87 32.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.6 159.84 28.32 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.375 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.6 HD22 ' CZ3' ' A' ' 76' ' ' TRP . 5.5 mp -112.1 148.52 33.76 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -137.5 137.24 38.46 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.279 -171.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -133.91 131.16 38.77 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -138.74 124.48 12.31 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -99.04 176.25 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.718 2.279 . . . . 0.0 109.746 159.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.5 ttm -54.51 138.27 40.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.138 0.494 . . . . 0.0 111.861 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 71.81 -153.73 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.457 171.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.97 -11.65 8.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -166.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 121' ' ' VAL . 7.3 t -78.68 17.42 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -166.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.39 143.02 33.55 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.13 -0.981 . . . . 0.0 110.062 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -146.37 153.81 40.93 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 111.403 -174.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p30 -137.29 148.1 46.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.885 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.485 ' CE2' HD12 ' A' ' 123' ' ' LEU . 98.2 m-85 -122.37 131.72 54.03 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 m -139.98 154.2 47.1 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.759 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -121.28 141.14 51.19 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.72 142.32 47.79 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.547 0.53 . . . . 0.0 110.314 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.46 131.54 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.584 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 t -110.7 144.73 39.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -89.23 146.1 24.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 123.79 0.681 . . . . 0.0 109.348 -158.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.508 HG23 ' CG ' ' A' ' 136' ' ' ASP . 68.6 mt -87.83 100.38 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.712 1.244 . . . . 0.0 112.636 -143.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -89.68 -177.0 5.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 112.392 -2.185 . . . . 0.0 107.555 156.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 t -52.25 -15.31 0.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.851 -0.531 . . . . 0.0 112.273 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.39 129.39 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.392 0.542 . . . . 0.0 110.079 170.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.508 ' CG ' HG23 ' A' ' 132' ' ' ILE . 0.7 OUTLIER -102.85 139.24 38.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 119.065 -0.493 . . . . 0.0 109.787 178.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.69 129.76 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.411 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.26 116.94 2.83 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.9 m -126.15 134.27 51.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.714 0.757 . . . . 0.0 111.19 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -109.34 134.14 52.18 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 141' ' ' ILE . 4.6 mp -124.26 136.34 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 O-C-N 123.131 0.269 . . . . 0.0 110.434 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.14 127.46 43.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.38 153.08 22.27 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.05 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.3 t -127.26 145.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.36 178.06 30.59 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.32 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -135.84 170.29 16.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.745 -0.728 . . . . 0.0 110.409 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.537 ' NH2' HG21 ' A' ' 2' ' ' THR . 21.0 mtp-105 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.501 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 117.977 -1.011 . . . . 0.0 112.396 178.887 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.1 p -85.93 163.26 18.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.941 0.401 . . . . 0.0 110.779 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p -161.52 170.84 19.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.044 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.1 p -124.29 157.45 34.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.167 0.508 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.62 125.95 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.505 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 26' ' ' LEU . 31.6 m -128.19 143.11 51.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -177.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.54 140.73 12.0 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.61 176.49 33.14 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.394 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.03 149.84 41.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.941 -0.63 . . . . 0.0 109.667 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.566 ' CB ' HG22 ' A' ' 141' ' ' ILE . . . -130.36 141.71 50.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.187 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -128.0 131.91 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -116.1 145.93 42.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -78.72 142.05 37.4 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.782 0.676 . . . . 0.0 110.944 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -98.04 143.23 28.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.217 -176.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -89.9 153.3 20.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.49 147.67 6.27 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.321 -171.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 68.05 23.08 8.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.739 0.415 . . . . 0.0 111.572 -175.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 69.0 mtm -149.36 166.2 29.73 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.757 -0.589 . . . . 0.0 110.487 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -109.6 155.31 21.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.04 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 25.5 pttm -58.05 168.96 0.87 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.151 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.2 ttm -123.92 146.46 48.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.307 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.43 134.67 10.8 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.07 143.35 14.27 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -118.61 144.42 46.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.631 ' C ' HD22 ' A' ' 26' ' ' LEU . 27.3 p30 -143.96 153.23 42.05 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.752 -174.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.631 HD22 ' C ' ' A' ' 25' ' ' ASN . 4.5 mm? -123.2 142.91 50.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.521 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -136.22 138.42 41.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 111.016 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -118.93 140.45 49.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -133.66 144.21 49.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.975 0.417 . . . . 0.0 110.683 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -101.29 143.29 31.53 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -92.38 117.39 29.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.545 0.688 . . . . 0.0 110.407 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -126.2 153.55 44.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.631 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.59 -178.63 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.773 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -56.69 -33.42 66.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.29 -25.94 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -102.78 140.98 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.714 1.61 . . . . 0.0 111.823 164.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.16 159.97 28.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.061 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.16 140.05 14.88 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.79 127.58 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.527 0.663 . . . . 0.0 109.948 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.27 144.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.388 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.99 137.87 8.73 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.3 t -136.53 141.35 43.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.019 0.41 . . . . 0.0 111.308 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -120.94 131.63 54.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -130.0 142.99 50.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.622 0.249 . . . . 0.0 111.554 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.18 136.38 51.99 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.8 p -121.17 152.32 38.91 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.946 0.403 . . . . 0.0 111.175 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -138.94 157.94 45.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.56 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -119.0 147.84 43.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.81 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -141.61 84.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.756 0.312 . . . . 0.0 110.361 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -58.54 -43.84 89.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.475 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.1 m -138.17 142.63 40.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.486 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.2 94.08 4.05 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.9 m -136.02 161.91 34.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.9 m -58.94 -28.05 65.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.904 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.72 -15.25 73.38 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 121.281 -0.485 . . . . 0.0 113.107 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 60.96 62.54 1.42 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 117.822 0.811 . . . . 0.0 110.929 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -55.05 145.27 21.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.862 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -159.13 -73.84 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.24 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 52.55 33.42 13.43 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -175.16 120.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.569 0.223 . . . . 0.0 110.946 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -126.08 142.02 51.7 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -136.81 136.1 38.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.938 0.399 . . . . 0.0 110.355 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.78 133.62 54.91 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.57 128.64 5.42 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.8 mt -122.18 120.06 60.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.644 HG22 ' HA3' ' A' ' 84' ' ' GLY . 70.2 p -123.28 151.72 42.09 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.139 0.274 . . . . 0.0 111.047 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.97 145.27 30.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.15 170.09 41.81 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 119.882 -1.151 . . . . 0.0 113.085 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -98.72 126.03 0.18 Allowed 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.379 2.053 . . . . 0.0 112.688 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.57 142.84 33.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.482 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -119.99 137.61 53.97 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -95.84 115.79 27.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.518 0.675 . . . . 0.0 112.602 -170.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 77' ' ' ALA . 48.6 mm -96.23 131.6 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.937 170.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -61.27 -35.34 77.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.761 -174.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.5 -178.47 1.43 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 171.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -86.09 48.7 1.65 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.599 0.714 . . . . 0.0 110.026 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -121.9 22.56 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.251 -174.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.4 m -68.56 145.86 53.6 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -167.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 tt -131.92 136.17 57.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.28 -167.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -129.14 143.33 50.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.83 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.96 137.72 10.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.427 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -135.25 154.64 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.915 0.358 . . . . 0.0 111.296 -173.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.7 t -126.58 140.81 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.644 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.08 172.95 27.41 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.758 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.87 132.53 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 132.52 10.11 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -127.22 134.06 50.16 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.13 142.76 14.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -138.58 139.97 38.82 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.68 139.69 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 110.741 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -106.6 144.43 33.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 94' ' ' GLU . 23.4 m -108.05 137.97 45.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.443 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.6 m -57.25 -39.23 75.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.861 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 92' ' ' THR . 48.3 mp0 -86.0 -173.97 4.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.362 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -53.32 154.54 5.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.134 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.51 121.47 8.57 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.348 1.365 . . . . 0.0 112.252 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -137.41 162.23 34.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.488 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -59.38 -36.97 76.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.987 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -73.68 139.64 45.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.676 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 t60 80.75 -42.7 0.2 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.392 1.058 . . . . 0.0 111.72 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.58 112.18 22.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.851 0.358 . . . . 0.0 110.53 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 71.0 p -131.17 161.79 31.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.609 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.2 p -132.67 149.07 52.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.293 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -153.72 143.97 22.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.915 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -110.1 144.23 39.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.996 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -141.96 158.84 26.86 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.85 125.34 50.79 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.7 m -110.94 143.36 41.71 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.302 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -130.79 134.72 47.1 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.57 161.26 28.0 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.963 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.35 148.92 28.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.55 160.34 28.34 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.377 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.6 mt -108.89 151.21 26.59 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -123.69 132.11 53.76 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.759 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -125.21 111.44 15.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -130.74 124.42 20.82 Favored Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -169.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -96.41 176.05 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.739 2.293 . . . . 0.0 109.341 156.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.9 mmm -65.57 147.1 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.775 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 79.31 -164.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.761 0.825 . . . . 0.0 110.817 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.62 -11.88 8.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.67 17.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 134.67 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.525 0.602 . . . . 0.0 109.844 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.5 tt -133.11 140.72 47.79 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.752 0.311 . . . . 0.0 111.184 -168.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -125.43 145.18 50.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.334 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -125.92 129.71 49.84 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.9 t -140.2 154.0 46.77 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.512 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -117.1 145.49 43.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -128.31 132.33 48.66 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.271 0.357 . . . . 0.0 110.043 -176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -118.75 134.6 55.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.856 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.0 m -115.65 144.75 43.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 173.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -89.52 146.02 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.64 0.587 . . . . 0.0 109.484 -160.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -87.74 95.95 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.708 1.242 . . . . 0.0 112.383 -146.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -89.91 -176.92 5.08 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.375 -2.193 . . . . 0.0 106.669 157.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.8 t -52.17 -16.02 0.71 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.303 -0.873 . . . . 0.0 112.179 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.63 129.38 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 118.251 0.478 . . . . 0.0 109.811 169.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -115.06 139.06 50.18 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.406 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.0 t -108.26 128.43 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.578 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.4 112.08 1.62 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 169.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -126.08 134.32 51.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.815 0.808 . . . . 0.0 111.176 -173.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -116.25 136.24 53.19 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.566 HG22 ' CB ' ' A' ' 10' ' ' ALA . 41.3 pt -130.13 147.22 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.169 -175.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.5 128.5 25.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.2 153.1 23.21 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.519 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -125.81 145.88 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.07 32.11 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.133 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.43 165.95 23.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.472 -0.864 . . . . 0.0 109.81 177.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -118.06 148.65 42.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.703 0.287 . . . . 0.0 110.45 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.618 -179.656 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.9 p 48.96 43.12 21.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.15 0.5 . . . . 0.0 111.635 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.3 p -147.06 150.86 35.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.435 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.606 HG22 ' CB ' ' A' ' 147' ' ' ARG . 37.9 p -131.09 155.7 46.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.474 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.04 120.25 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.744 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.8 m -128.34 142.96 50.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.818 0.342 . . . . 0.0 110.823 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.33 140.86 12.18 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.24 167.91 28.99 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.994 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.08 138.85 53.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.88 149.11 51.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.083 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -124.03 138.98 54.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -115.93 140.77 48.91 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.311 0.382 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.78 126.29 30.52 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.8 0.687 . . . . 0.0 111.381 -173.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.656 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -101.63 143.33 31.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.747 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -89.58 153.53 20.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.761 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.53 152.19 3.55 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.49 -167.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 68.54 22.72 7.58 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.491 -0.855 . . . . 0.0 112.652 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.5 mtm -149.88 166.52 29.32 Favored 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -100.91 148.77 24.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.013 0.435 . . . . 0.0 111.397 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.656 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 59.9 mttm -63.32 169.56 3.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.145 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.6 mmm -125.3 155.12 40.71 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.251 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.37 148.35 16.76 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.04 143.03 14.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.717 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.587 ' CE1' HD21 ' A' ' 26' ' ' LEU . 58.2 t80 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.85 135.78 48.79 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.602 -174.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.587 HD21 ' CE1' ' A' ' 24' ' ' PHE . 81.3 mt -120.31 140.25 51.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 40' ' ' ILE . 98.0 mttt -129.65 143.66 50.92 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.887 0.375 . . . . 0.0 111.37 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -125.32 132.29 52.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -139.93 144.15 36.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -98.47 143.44 28.9 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -92.75 136.05 33.57 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.241 0.543 . . . . 0.0 111.119 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -133.42 153.65 51.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.519 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.18 -178.3 3.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.334 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -51.14 -28.41 10.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 t -97.13 -25.82 0.24 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -166.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -102.82 148.08 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.817 1.678 . . . . 0.0 112.983 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.11 164.96 24.54 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.4 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.34 140.24 14.77 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 39' ' ' VAL . 11.5 p -111.04 125.25 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.415 HD11 ' HD3' ' A' ' 27' ' ' LYS . 17.7 tt -126.72 138.38 54.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.54 142.72 14.24 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.407 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 52.8 p -138.91 148.79 44.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.092 0.446 . . . . 0.0 111.668 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -121.42 133.71 55.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.218 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -128.95 137.19 51.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.65 0.262 . . . . 0.0 111.125 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -120.57 136.94 54.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.866 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.6 m -98.58 137.69 36.87 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.696 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -143.2 149.11 37.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.756 -175.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -110.25 141.91 42.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -84.03 4.59 29.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 47.99 93.69 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.426 0.557 . . . . 0.0 112.206 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.1 p -120.7 162.0 20.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.336 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.53 93.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.553 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.5 t -178.34 -175.34 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.807 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.7 p -58.93 -32.94 70.04 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.126 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.19 22.34 10.25 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 121.673 -0.299 . . . . 0.0 112.418 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -53.49 -34.19 57.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.59 0.695 . . . . 0.0 111.565 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -106.14 133.72 50.4 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -55.67 170.16 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -134.65 -155.18 0.64 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.252 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -48.73 140.56 8.31 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.236 -0.29 . . . . 0.0 111.489 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -112.53 152.61 28.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.047 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -120.81 137.4 54.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.135 0.493 . . . . 0.0 111.147 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -123.08 124.82 43.95 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.88 139.49 11.14 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.639 -176.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 65' ' ' ILE . 16.8 tt -125.09 124.21 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.659 HG22 ' HA3' ' A' ' 84' ' ' GLY . 30.0 p -123.26 154.34 38.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.774 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.01 145.62 30.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.05 171.21 42.34 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 119.896 -1.145 . . . . 0.0 112.994 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -97.15 127.1 0.26 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.144 1.896 . . . . 0.0 112.821 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 143.39 33.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.177 169.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -112.55 132.41 55.13 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -95.87 109.03 21.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.409 0.623 . . . . 0.0 111.537 -169.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.6 mm -96.22 131.48 42.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.343 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -61.41 -34.93 76.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.729 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.77 174.98 5.35 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 171.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -85.72 49.79 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.617 0.722 . . . . 0.0 110.346 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.07 22.76 10.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.151 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m -68.62 150.56 47.84 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.835 -163.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.4 mt -129.9 130.13 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -169.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -129.46 140.39 51.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.73 137.82 9.75 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.9 m -135.48 156.99 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.732 0.301 . . . . 0.0 111.114 -175.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.03 140.83 47.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.659 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.19 175.2 26.68 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.067 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.01 134.86 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.92 133.64 10.79 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -122.54 141.26 51.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -103.89 146.08 16.27 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.26 142.71 41.99 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -101.26 129.45 47.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.914 0.387 . . . . 0.0 111.052 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -127.8 148.15 50.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.297 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.8 p -108.08 150.4 27.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.937 0.398 . . . . 0.0 110.628 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -81.16 -27.35 35.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.181 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.13 -36.57 75.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.587 0.232 . . . . 0.0 111.379 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -142.71 157.13 62.42 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.742 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.29 -44.38 0.43 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.335 1.357 . . . . 0.0 111.534 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.5 m -83.66 138.98 33.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.126 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -113.88 129.82 56.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 110.811 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -64.87 -40.85 95.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.722 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -139.61 164.21 30.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.957 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -159.6 171.35 19.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.669 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.9 m -125.24 136.08 53.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.004 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -127.69 139.84 52.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.176 0.512 . . . . 0.0 111.511 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -140.76 155.5 46.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.846 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.984 0.421 . . . . 0.0 111.512 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.2 166.02 26.49 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -105.98 127.98 53.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.948 0.374 . . . . 0.0 110.032 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.8 p -113.89 146.33 40.19 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.815 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -137.41 143.12 41.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.93 159.91 28.17 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.728 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.06 149.02 30.41 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.53 161.65 28.86 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.756 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.1 mt -108.92 147.48 32.14 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -122.04 132.62 54.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.649 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -125.32 109.93 13.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -120.13 124.29 27.88 Favored Pre-proline 0 N--CA 1.464 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -100.14 176.24 0.31 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.353 2.702 . . . . 0.0 109.332 155.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 84.9 mtp -60.07 138.01 57.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.267 0.556 . . . . 0.0 112.245 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 68.15 -148.31 0.14 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.731 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -61.15 -12.08 11.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 121' ' ' VAL . 2.8 t -79.44 17.29 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.21 139.39 39.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.036 0.835 . . . . 0.0 110.282 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 143' ' ' GLY . 15.5 tp -132.62 141.46 48.67 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.659 -168.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 p-10 -133.7 146.43 50.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.792 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.456 ' CZ ' HD21 ' A' ' 123' ' ' LEU . 97.7 m-85 -121.34 134.11 55.13 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -140.16 154.02 46.82 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.351 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -120.47 145.62 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -127.12 140.0 52.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.383 . . . . 0.0 110.462 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -127.95 136.02 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.125 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.574 ' HB3' HG22 ' A' ' 137' ' ' VAL . 7.9 t -112.98 144.74 42.05 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 170.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -89.18 146.19 24.94 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 124.436 1.085 . . . . 0.0 109.384 -158.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 66.1 mt -87.56 104.03 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.947 1.356 . . . . 0.0 112.749 -142.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -89.76 -176.58 5.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 112.056 -2.338 . . . . 0.0 107.304 156.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 85.5 p -52.39 -12.69 0.28 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 p -123.24 131.51 73.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.508 0.594 . . . . 0.0 110.296 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -115.08 139.17 50.11 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 130' ' ' SER . 16.8 m -108.23 140.59 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.242 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.17 119.49 3.6 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.415 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.3 m -126.0 134.17 51.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.637 0.718 . . . . 0.0 111.132 -176.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -119.12 132.13 55.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 19.0 tt -131.79 144.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.569 0.223 . . . . 0.0 111.163 -174.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.53 132.5 48.3 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.57 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -139.6 153.16 22.92 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.811 -176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.5 144.51 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.09 176.95 32.58 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.814 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -135.38 170.25 16.23 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.59 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.606 ' CB ' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -143.08 149.05 37.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.686 0.279 . . . . 0.0 110.82 -178.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.884 -179.119 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.5 p -122.97 160.12 26.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.406 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -166.39 147.21 6.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.538 -178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 146' ' ' TYR . 21.6 m -125.11 141.24 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.09 128.52 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.9 m -128.12 142.96 51.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.39 140.85 11.68 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.69 -168.75 26.18 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.134 -1.032 . . . . 0.0 111.566 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -132.05 153.94 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.175 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -130.0 142.29 50.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.006 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -118.59 131.92 56.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 t -111.05 140.56 45.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.58 128.0 32.91 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.931 0.769 . . . . 0.0 111.298 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -95.88 143.33 27.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.152 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -89.63 153.44 20.74 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.41 151.93 3.54 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.487 -0.387 . . . . 0.0 112.345 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 62.79 33.0 15.66 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.632 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.3 mtt -151.12 170.41 19.48 Favored 'General case' 0 N--CA 1.461 0.101 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -110.19 152.92 25.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.792 0.33 . . . . 0.0 110.826 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 52.1 mttp -65.28 165.01 12.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.14 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.1 mtt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.613 -177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.14 136.82 11.45 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.84 143.25 14.88 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.38 137.4 44.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.32 134.35 50.01 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.295 0.372 . . . . 0.0 111.66 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 26' ' ' LEU . 5.4 mp -122.54 138.69 54.49 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -134.9 143.06 46.74 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.089 0.471 . . . . 0.0 111.617 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -120.42 134.55 55.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.244 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 ttm105 -135.59 144.16 46.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.96 0.41 . . . . 0.0 110.985 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -106.72 143.16 35.23 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -92.4 124.33 36.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 109.786 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.88 153.41 48.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.1 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.55 -178.62 3.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.566 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -57.73 -30.72 65.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 p -95.76 -25.74 0.25 Allowed Pre-proline 0 N--CA 1.469 0.476 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -102.89 136.97 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.71 1.606 . . . . 0.0 111.956 165.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.13 155.13 30.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.1 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.28 15.54 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -101.99 125.93 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 117.346 0.573 . . . . 0.0 110.004 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.418 HD11 ' HB2' ' A' ' 70' ' ' ALA . 73.1 mt -118.44 132.08 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.62 132.55 8.0 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 t -133.54 140.59 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.112 0.456 . . . . 0.0 111.388 -173.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.416 ' HD2' ' HH ' ' A' ' 63' ' ' TYR . 95.8 m-85 -121.17 132.98 55.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.4 m -130.07 134.6 47.48 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.83 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -127.15 137.16 52.9 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.4 p -107.6 152.15 24.67 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 111.359 -172.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -138.29 158.4 44.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.878 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.85 165.65 10.93 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.7 p -59.9 -24.73 64.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.6 mtm-85 58.18 39.53 25.83 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.089 0.471 . . . . 0.0 110.825 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.6 m -123.95 145.16 49.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.951 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.85 124.41 19.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.889 0.376 . . . . 0.0 110.534 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -154.3 151.95 29.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.528 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.6 p -62.29 -32.08 72.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.73 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.13 -45.98 1.12 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -84.51 112.73 20.66 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.821 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -156.59 100.12 1.92 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.828 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.6 m120 56.52 48.57 16.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.316 0.579 . . . . 0.0 110.846 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -68.51 162.62 25.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.621 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -67.16 173.96 3.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.984 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -121.1 150.89 40.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.722 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -119.74 136.0 54.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.001 0.429 . . . . 0.0 110.996 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.416 ' HH ' ' HD2' ' A' ' 43' ' ' PHE . 61.1 t80 -131.24 132.49 44.66 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.02 149.88 20.66 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.7 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 65' ' ' ILE . 16.7 tt -125.6 125.49 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.666 HG22 ' HA3' ' A' ' 84' ' ' GLY . 22.1 p -123.16 155.01 37.89 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.031 0.207 . . . . 0.0 110.52 -176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.547 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -145.56 143.97 30.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.16 159.17 31.66 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.881 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -95.15 124.09 0.34 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.969 1.78 . . . . 0.0 112.481 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.63 144.77 32.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.341 170.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -111.77 132.95 54.31 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -95.77 108.93 21.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.522 0.677 . . . . 0.0 111.668 -168.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 77' ' ' ALA . 76.9 mt -96.23 131.42 43.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.042 172.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.29 -35.07 76.32 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.752 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -67.88 174.71 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -86.77 48.55 1.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.54 0.685 . . . . 0.0 110.205 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' O ' HD12 ' A' ' 73' ' ' ILE . . . -121.96 22.69 10.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.363 -174.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.2 t -68.6 147.54 51.78 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 118.416 0.553 . . . . 0.0 110.382 -163.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.2 mt -128.93 132.71 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -130.77 146.79 52.32 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.621 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.91 137.89 11.43 Favored Glycine 0 N--CA 1.464 0.525 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.585 HG22 ' HB ' ' A' ' 66' ' ' THR . 8.9 p -140.15 144.81 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 117.121 0.46 . . . . 0.0 110.986 -170.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -131.99 140.83 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.666 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 175.09 26.82 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.14 -176.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 130.04 74.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.94 144.13 18.31 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -134.96 148.39 50.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.724 0.262 . . . . 0.0 110.692 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.19 138.38 14.44 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -137.58 147.01 44.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -98.73 127.54 44.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.954 0.407 . . . . 0.0 110.587 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -127.22 148.14 50.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.45 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.1 m -103.8 142.98 33.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 m -95.79 152.59 18.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.778 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 63.94 -83.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.129 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -124.17 152.34 67.18 Favored Pre-proline 0 N--CA 1.464 0.262 0 O-C-N 122.176 -0.327 . . . . 0.0 110.303 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -90.78 122.5 0.84 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.749 1.632 . . . . 0.0 112.711 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.8 p -125.3 145.46 50.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.372 -0.376 . . . . 0.0 109.992 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 46.44 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -75.48 129.79 37.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.57 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -173.27 43.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.352 0.596 . . . . 0.0 110.549 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.64 142.84 58.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.338 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.1 p -125.28 156.16 39.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.425 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.9 m -131.58 142.09 49.83 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -154.52 141.83 19.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.58 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -117.21 147.61 42.35 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.304 0.377 . . . . 0.0 111.045 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.11 159.4 27.03 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -104.66 126.05 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.968 0.384 . . . . 0.0 110.062 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 94.0 p -108.22 137.29 46.45 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.969 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -127.75 140.73 51.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.28 169.2 32.67 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.119 -1.038 . . . . 0.0 112.465 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.67 148.98 30.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.789 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -145.86 158.95 27.84 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.615 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.9 tp -109.22 145.87 35.15 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -128.16 135.99 50.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.296 0.498 . . . . 0.0 111.471 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.39 129.73 25.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -140.99 124.67 10.17 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -96.09 176.16 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.533 2.156 . . . . 0.0 109.193 156.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mtt -61.19 150.68 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.52 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 72.98 -160.48 0.09 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.041 173.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -61.43 -11.37 10.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 121' ' ' VAL . 5.2 t -78.49 17.4 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.4 139.52 39.23 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.446 ' HG ' HG12 ' A' ' 144' ' ' VAL . 4.3 mp -135.88 153.64 51.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.934 0.397 . . . . 0.0 111.078 -171.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -137.06 143.84 42.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.046 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.98 132.61 53.24 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.1 t -140.04 153.92 46.94 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.582 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.27 140.11 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -127.84 146.98 50.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.285 0.366 . . . . 0.0 110.04 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -129.31 135.92 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 t -107.39 144.68 33.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -89.19 145.99 25.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -159.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 136' ' ' ASP . 68.3 mt -87.98 101.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.656 1.217 . . . . 0.0 112.779 -144.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -89.86 -176.89 5.08 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 112.405 -2.18 . . . . 0.0 107.418 156.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 86.3 p -52.04 -15.45 0.56 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.778 -0.577 . . . . 0.0 112.358 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.85 129.22 74.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.894 -0.504 . . . . 0.0 109.729 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 132' ' ' ILE . 2.6 p30 -111.2 139.15 46.82 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 t -108.19 133.96 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.879 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.25 120.22 3.84 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 170.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -126.36 134.24 51.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 117.795 0.798 . . . . 0.0 110.883 -176.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -119.05 136.09 54.31 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.511 HG12 ' HB2' ' A' ' 10' ' ' ALA . 61.7 mt -121.01 140.1 46.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.404 -172.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.1 123.34 25.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -138.76 153.31 22.57 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.787 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.446 HG12 ' HG ' ' A' ' 123' ' ' LEU . 34.6 m -125.13 147.1 29.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.25 178.17 32.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.216 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 4' ' ' THR . 47.0 p90 -138.88 167.18 22.58 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.714 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -117.93 149.02 41.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.605 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.495 -179.383 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.524 ' HB3' ' C ' ' A' ' 148' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 m -159.14 -50.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.659 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t -150.71 147.45 27.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 146' ' ' TYR . 34.4 m -125.3 140.66 52.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.58 126.33 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.073 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.454 HG23 ' C ' ' A' ' 144' ' ' VAL . 15.4 m -128.34 140.28 51.94 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.878 0.371 . . . . 0.0 110.67 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.77 140.82 12.1 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 108.446 -1.861 . . . . 0.0 108.446 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.38 -172.73 30.19 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.781 -1.199 . . . . 0.0 112.877 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -134.2 143.82 48.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.727 -0.736 . . . . 0.0 109.575 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.03 149.13 50.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.228 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -118.73 138.46 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.804 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -111.01 140.15 45.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -78.57 128.36 33.41 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.925 0.766 . . . . 0.0 111.322 -171.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.586 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . . . -95.53 143.31 26.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.03 -177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -89.48 153.34 20.88 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 148.58 5.73 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.302 -170.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 63.43 36.24 11.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.256 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.2 mtt -150.08 174.04 13.19 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -115.85 137.8 51.75 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.817 0.341 . . . . 0.0 110.919 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -53.37 167.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.2 mtm -126.89 156.06 42.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.235 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.31 149.49 17.46 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.6 143.11 12.64 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.407 ' HE2' HD21 ' A' ' 26' ' ' LEU . 72.3 t80 -112.75 139.07 48.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.71 ' HB3' HG22 ' A' ' 44' ' ' THR . 28.9 p-10 -130.59 147.07 52.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 24' ' ' PHE . 77.2 mt -115.95 142.22 47.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.826 170.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -129.7 141.92 50.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.699 0.285 . . . . 0.0 111.433 -170.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -133.98 147.39 51.01 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HG3' HG22 ' A' ' 40' ' ' ILE . 78.5 ttt180 -144.28 144.16 31.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.761 -175.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -110.39 140.95 44.11 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -92.96 125.58 37.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.227 0.536 . . . . 0.0 110.573 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -145.05 153.62 41.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.816 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.48 -178.49 3.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.038 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -53.48 -34.82 59.41 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.94 -26.05 0.3 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -102.8 127.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.673 1.582 . . . . 0.0 111.567 161.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.501 HD22 ' CD2' ' A' ' 71' ' ' TYR . 76.9 mt -75.77 153.4 37.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.169 -175.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.26 22.69 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.92 125.0 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 117.304 0.552 . . . . 0.0 109.695 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.445 HG22 ' HG3' ' A' ' 29' ' ' ARG . 37.0 pt -125.36 147.55 30.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.245 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.46 147.44 17.57 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 p -141.8 146.1 35.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.874 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -120.17 127.63 52.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.71 HG22 ' HB3' ' A' ' 25' ' ' ASN . 35.6 p -128.82 142.98 50.8 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.213 -177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -127.27 137.33 52.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.896 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -97.74 147.51 24.29 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.098 0.475 . . . . 0.0 111.28 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -129.93 148.39 51.79 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.937 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -129.34 164.03 24.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.86 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -139.95 106.42 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.485 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -133.17 154.22 50.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.694 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.7 p -119.43 164.91 15.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.677 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.08 95.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 110.592 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -125.25 145.26 50.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.628 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.4 p -66.29 -27.98 68.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.178 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.9 -45.98 48.09 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -171.16 155.55 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.349 . . . . 0.0 111.054 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -149.24 144.66 26.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 59.28 83.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.586 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -74.4 -179.99 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.47 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -84.13 155.99 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.495 . . . . 0.0 111.52 -173.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -126.13 158.12 36.33 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -149.1 155.23 40.41 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 121.61 0.719 . . . . 0.0 112.214 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -125.85 140.08 52.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.088 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.33 137.51 9.5 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.0 mt -121.0 117.95 54.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.677 HG22 ' HA3' ' A' ' 84' ' ' GLY . 17.0 p -123.29 150.05 44.02 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.329 -175.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.539 ' C ' HG23 ' A' ' 82' ' ' VAL . . . -146.15 149.08 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 171.0 41.32 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 119.855 -1.164 . . . . 0.0 113.067 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -97.74 126.92 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.563 2.175 . . . . 0.0 112.662 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.53 139.49 36.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.548 170.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.501 ' CD2' HD22 ' A' ' 37' ' ' LEU . 87.3 m-85 -131.21 160.06 35.94 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.8 mmt-85 -104.42 108.66 20.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.154 0.502 . . . . 0.0 111.03 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.0 tt -96.39 131.33 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.512 171.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -61.6 -31.98 72.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.642 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.03 -37.83 75.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.649 0.261 . . . . 0.0 111.414 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -126.45 -169.67 2.06 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.26 -18.68 14.78 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t -149.48 137.48 20.47 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 118.148 0.431 . . . . 0.0 111.188 172.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.5 tt -138.94 129.92 34.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -141.71 152.52 43.93 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.864 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.94 137.84 11.38 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 66' ' ' THR . 9.5 p -138.11 143.18 33.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 117.223 0.511 . . . . 0.0 111.01 -171.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.84 140.77 48.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.677 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.06 172.34 27.54 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.529 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.0 t -115.03 130.71 69.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.86 131.71 9.65 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -117.35 140.06 50.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.17 150.07 17.52 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -132.92 134.93 45.2 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -103.23 137.49 41.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.62 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -102.66 146.14 28.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.342 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 94' ' ' GLU . 13.9 m -89.89 137.5 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.497 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 78.2 p -103.95 26.59 8.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.097 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.477 ' H ' HG22 ' A' ' 92' ' ' THR . 77.5 mm-40 49.66 26.46 1.81 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.2 -54.48 0.1 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-O 119.284 -0.389 . . . . 0.0 111.102 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.51 -68.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 121.357 1.371 . . . . 0.0 112.48 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p -125.49 162.83 24.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 110.376 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -58.25 -41.52 84.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.643 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -136.19 128.05 29.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.568 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -135.12 133.56 39.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.263 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -155.59 122.2 5.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.81 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.4 m -126.29 141.0 52.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.041 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.1 m -123.13 143.81 49.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.961 0.41 . . . . 0.0 110.949 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -157.34 157.38 34.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.639 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -132.9 151.97 51.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.034 0.445 . . . . 0.0 111.545 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.03 165.98 26.45 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -106.13 125.79 51.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.886 0.343 . . . . 0.0 110.12 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.6 p -107.54 144.41 34.57 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.883 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -130.76 136.77 49.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -147.92 166.72 28.86 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.848 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.49 148.9 35.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.02 161.04 28.51 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.361 -0.924 . . . . 0.0 112.236 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 113' ' ' LEU . 4.6 mp -133.07 154.42 50.58 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -127.22 147.4 50.21 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.419 0.628 . . . . 0.0 111.971 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -127.75 109.95 12.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 168.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -121.04 124.58 27.35 Favored Pre-proline 0 N--CA 1.464 0.259 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -166.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -97.51 176.12 0.55 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.658 2.239 . . . . 0.0 109.59 156.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 43.0 ttm -64.91 141.22 58.85 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.182 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 79.28 -162.6 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.696 0.799 . . . . 0.0 111.225 173.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -59.43 -11.54 4.6 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 m -78.63 17.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.14 134.32 47.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 118.54 0.609 . . . . 0.0 109.893 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' A' ' 144' ' ' VAL . 75.7 mt -114.96 144.17 44.0 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.916 -169.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -130.95 140.23 50.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.848 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.82 136.02 40.3 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 t -140.4 154.03 46.54 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.443 -175.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.22 139.82 49.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -135.97 134.99 39.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.752 0.31 . . . . 0.0 110.229 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -124.74 134.84 52.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.124 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.3 p -96.79 144.78 26.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -89.16 145.9 25.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -162.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 132' ' ' ILE . 9.7 tt -87.87 102.33 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 123.364 1.554 . . . . 0.0 114.08 -144.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -89.66 -176.86 5.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 112.367 -2.197 . . . . 0.0 107.277 156.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -52.11 -15.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.785 -0.572 . . . . 0.0 112.271 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.4 129.2 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 168.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -113.71 139.15 49.32 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.58 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.9 t -108.21 134.7 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.32 124.71 5.39 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.431 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.5 m -126.21 134.14 51.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 117.459 0.63 . . . . 0.0 111.269 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -119.88 127.59 52.85 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.541 HD11 ' ND2' ' A' ' 25' ' ' ASN . 17.0 tt -130.5 143.44 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.385 -172.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.38 136.39 43.32 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -140.91 153.26 23.68 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.683 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.454 ' C ' HG23 ' A' ' 6' ' ' THR . 30.8 m -116.47 139.95 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -154.91 177.29 32.26 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.471 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.415 ' O ' HG23 ' A' ' 4' ' ' THR . 50.5 p90 -136.31 168.47 19.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.564 -0.818 . . . . 0.0 110.083 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -118.02 147.17 43.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.298 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.524 ' C ' ' HB3' ' A' ' 1' ' ' ALA . 67.5 t80 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.58 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.8 m -52.46 -36.91 55.79 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.696 0.284 . . . . 0.0 111.517 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t -148.3 133.15 18.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.533 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 146' ' ' TYR . 25.4 m -124.92 140.21 53.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.154 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.44 119.99 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -128.22 141.81 51.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.33 140.69 12.47 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 172.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.1 165.11 28.21 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.037 -175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -121.62 145.86 47.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' A' ' 141' ' ' ILE . . . -134.58 149.03 50.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.903 0.382 . . . . 0.0 111.179 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -122.39 135.05 54.62 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 m -115.14 132.92 56.45 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.154 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.82 123.83 30.9 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.316 1.01 . . . . 0.0 110.93 -176.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.48 143.2 33.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.581 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -89.71 153.12 20.96 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.44 109.39 0.68 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.138 -171.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 167.65 -52.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.2 mtm -128.48 173.95 9.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.186 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -91.97 170.07 10.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.305 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -65.63 165.12 12.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.754 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.48 153.07 47.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.943 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.17 135.19 11.46 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.08 143.23 14.22 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -174.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -118.8 139.81 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.9 145.11 45.95 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.959 -176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -124.32 132.05 53.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.607 ' N ' HD13 ' A' ' 26' ' ' LEU . 7.7 mtpm? -125.56 143.06 51.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 111.377 -174.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -124.95 138.24 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -130.72 144.08 51.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.967 0.413 . . . . 0.0 111.137 -177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.69 143.14 45.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.66 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.29 129.32 38.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.289 0.566 . . . . 0.0 110.543 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -131.03 153.49 49.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.763 -174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.6 -178.54 3.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -53.61 -34.35 58.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.605 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 t -94.56 -25.89 0.26 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -102.92 134.22 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.764 1.643 . . . . 0.0 111.877 163.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.4 mt -78.1 160.59 27.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.83 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.43 140.17 24.1 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -100.12 124.88 53.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.319 0.56 . . . . 0.0 110.026 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.4 mt -120.49 135.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.51 140.1 11.35 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.449 ' HG ' ' HG1' ' A' ' 66' ' ' THR . 46.3 p -142.13 150.08 40.65 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.323 0.562 . . . . 0.0 111.774 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.49 133.22 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.087 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -130.07 137.31 50.14 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.967 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -127.18 136.66 52.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -116.67 137.26 52.32 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.028 0.376 . . . . 0.0 110.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -143.36 172.69 12.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -136.62 138.27 40.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.118 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 t -93.63 130.16 39.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.091 0.472 . . . . 0.0 110.917 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -107.35 -174.76 2.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.872 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.9 p -59.42 156.85 12.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.014 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.4 117.23 6.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.621 -177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.4 p -150.97 149.82 30.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.434 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.9 m -64.27 -36.22 83.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.88 -38.29 65.26 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 -175.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 56.68 101.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.754 0.311 . . . . 0.0 110.48 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -55.93 -74.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.29 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 53.89 44.22 29.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.349 0.595 . . . . 0.0 110.861 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -57.35 -43.97 83.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.997 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -108.93 123.87 49.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.622 0.249 . . . . 0.0 110.865 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -126.14 143.34 51.16 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -125.65 135.97 52.73 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.002 0.429 . . . . 0.0 110.768 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -122.33 123.0 40.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 132.29 7.93 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 73.8 mt -120.53 117.54 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.693 HG22 ' HA3' ' A' ' 84' ' ' GLY . 8.8 p -123.3 155.26 37.59 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.886 -173.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.19 36.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.5 157.34 28.5 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.632 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -95.6 122.39 0.28 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 121.992 1.795 . . . . 0.0 111.94 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.77 144.02 32.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.866 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -117.87 130.09 56.04 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -96.03 108.95 21.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.463 0.649 . . . . 0.0 111.863 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.435 HD12 ' O ' ' A' ' 77' ' ' ALA . 69.6 mt -96.26 131.5 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.083 171.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -61.37 -34.42 75.29 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.823 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.28 174.64 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 171.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -85.61 48.05 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.573 0.701 . . . . 0.0 110.437 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 79' ' ' ILE . . . -122.05 22.63 10.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.17 -175.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.2 m -68.58 147.39 52.01 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -164.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 77' ' ' ALA . 47.4 pt -133.06 146.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.643 -168.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -144.21 155.03 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.452 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.81 137.95 11.5 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.2 t -131.9 139.03 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.854 -167.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.39 140.73 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.693 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.28 174.89 26.91 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.647 -177.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.5 t -115.25 128.12 72.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.86 10.34 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -118.26 130.63 56.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.74 134.89 12.47 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -141.32 140.41 33.79 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.004 -176.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -106.94 134.37 50.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.081 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -98.03 146.86 25.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.72 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 m -108.08 141.25 40.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.672 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.603 HG23 ' HD1' ' A' ' 95' ' ' TYR . 5.6 t -100.32 175.82 5.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.135 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -64.53 86.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.796 0.331 . . . . 0.0 110.636 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.603 ' HD1' HG23 ' A' ' 93' ' ' THR . 7.9 m-85 -154.97 168.45 12.03 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.742 -177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -47.9 172.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.422 1.414 . . . . 0.0 112.109 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.4 m -70.74 131.75 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 110.694 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -139.03 142.64 38.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.402 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -80.99 130.53 35.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.765 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.547 ' CD2' HG22 ' A' ' 102' ' ' THR . 7.6 p-80 -134.93 156.64 48.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.842 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -60.91 -28.16 68.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.49 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.547 HG22 ' CD2' ' A' ' 100' ' ' HIS . 64.1 p 53.34 -173.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.628 0.251 . . . . 0.0 110.775 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -62.98 134.77 56.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.257 0.551 . . . . 0.0 111.685 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -153.63 141.8 20.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.903 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -106.66 148.31 28.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.193 0.521 . . . . 0.0 112.385 -172.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.13 162.49 27.16 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -103.15 126.99 50.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.195 0.497 . . . . 0.0 110.619 -178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t -109.43 135.71 50.03 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.629 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -130.3 145.32 51.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -159.04 175.09 36.04 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.452 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.53 150.05 31.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.018 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.53 158.05 27.41 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.009 -177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.492 HD23 ' CE2' ' A' ' 115' ' ' PHE . 16.2 tp -117.8 145.81 44.27 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -123.95 132.26 53.69 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.569 0.622 . . . . 0.0 112.228 -174.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.492 ' CE2' HD23 ' A' ' 113' ' ' LEU . 96.8 m-85 -122.05 122.87 40.27 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 171.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -142.14 124.55 9.16 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -171.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -95.96 176.19 0.8 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.724 2.282 . . . . 0.0 109.364 155.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 86.1 mtp -55.17 138.59 44.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.289 0.566 . . . . 0.0 112.338 -174.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 71.46 -145.25 0.06 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.74 -11.85 29.86 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -166.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 121' ' ' VAL . 4.0 t -78.8 17.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -168.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.49 137.8 41.81 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.176 0.898 . . . . 0.0 110.607 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 143' ' ' GLY . 12.3 tp -130.17 140.98 50.7 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.297 -173.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -125.53 137.11 53.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -118.56 132.6 56.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -139.65 151.44 45.96 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.715 -174.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -122.23 139.82 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -132.25 151.16 51.96 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -131.71 136.1 47.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.012 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 t -109.08 144.85 36.57 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.076 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -89.13 146.19 24.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.201 0.601 . . . . 0.0 109.406 -156.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.735 HG23 ' OD1' ' A' ' 136' ' ' ASP . 40.3 mm -87.66 96.0 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 122.841 1.305 . . . . 0.0 112.225 -142.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -91.9 -177.1 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 112.141 -2.299 . . . . 0.0 107.974 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.0 m -52.27 -17.61 1.21 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.022 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.33 131.0 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.735 ' OD1' HG23 ' A' ' 132' ' ' ILE . 20.5 m-20 -114.97 138.8 50.42 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.2 t -108.32 132.43 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.989 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.33 120.25 3.84 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 168.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.3 m -126.12 134.22 51.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.951 0.875 . . . . 0.0 111.543 -173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -112.94 131.39 55.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 10' ' ' ALA . 64.4 mt -123.53 139.02 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 O-C-N 123.118 0.261 . . . . 0.0 110.616 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.58 124.01 24.76 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.616 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -137.58 153.2 21.94 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.609 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 p -128.65 142.68 43.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.18 177.98 32.09 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.648 -175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.496 ' O ' HG23 ' A' ' 4' ' ' THR . 46.6 p90 -130.93 164.43 25.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.395 -0.903 . . . . 0.0 109.952 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -118.36 149.1 41.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.75 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 72.7 t80 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.871 -1.061 . . . . 0.0 110.957 -178.846 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.2 p -123.06 160.55 26.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.514 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.3 m -158.66 150.52 21.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.27 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.0 p -126.96 155.45 43.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.08 121.16 45.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.772 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.1 m -128.29 140.63 51.77 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.828 0.347 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.64 140.85 12.16 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.06 170.52 30.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.1 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.11 139.24 53.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' A' ' 141' ' ' ILE . . . -129.92 149.06 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.052 -176.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -118.16 138.59 52.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.265 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.2 t -111.97 137.3 50.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -78.68 142.01 37.49 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.973 0.795 . . . . 0.0 111.388 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.84 143.25 33.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.029 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -89.83 153.27 20.79 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.62 139.46 16.67 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.283 -0.484 . . . . 0.0 111.996 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 66.08 37.17 5.34 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.398 -0.401 . . . . 0.0 111.166 -175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 80.1 mtp -149.55 173.92 13.09 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 173.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -109.43 160.19 16.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.871 0.367 . . . . 0.0 111.249 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -86.21 171.69 11.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.921 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.3 mtm -132.39 159.75 38.35 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.807 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.07 144.42 15.41 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.89 142.96 14.14 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.864 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -113.65 133.91 55.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.694 ' CG ' HG22 ' A' ' 44' ' ' THR . 48.5 m-20 -129.14 138.83 52.01 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.28 -177.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.43 ' C ' HD23 ' A' ' 26' ' ' LEU . 8.5 tt -130.16 130.2 44.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.56 154.54 47.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.279 0.562 . . . . 0.0 112.235 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -123.21 141.89 51.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.806 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -132.76 144.03 49.99 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.561 0.538 . . . . 0.0 110.216 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.26 143.31 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -92.68 122.45 35.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.269 0.557 . . . . 0.0 109.735 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -132.52 153.32 51.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.061 -172.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.7 -178.53 3.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.221 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.07 -25.92 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -170.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -102.85 135.71 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.802 1.668 . . . . 0.0 111.941 165.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.98 158.33 29.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.858 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.22 140.25 15.05 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.5 127.2 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 117.418 0.609 . . . . 0.0 110.06 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 70' ' ' ALA . 74.9 mt -120.71 133.1 68.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.19 137.19 8.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 t -140.56 145.35 36.64 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.147 0.474 . . . . 0.0 111.44 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.92 135.08 54.32 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.694 HG22 ' CG ' ' A' ' 25' ' ' ASN . 42.4 p -126.81 141.09 51.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.634 0.254 . . . . 0.0 110.637 -177.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -127.02 134.6 50.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.8 m -115.29 141.76 47.59 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.688 0.28 . . . . 0.0 110.48 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -142.97 147.81 35.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.89 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -172.31 136.67 0.83 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.477 172.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.1 p -177.92 -176.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.005 0.431 . . . . 0.0 110.487 -176.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 -79.56 154.37 28.83 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 51' ' ' THR . 5.8 t -47.19 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 112.307 -176.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.31 158.14 44.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.584 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 p -59.0 171.76 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.0 m -58.78 -36.0 73.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.306 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.81 -16.29 31.43 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.173 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.07 132.82 37.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.71 0.755 . . . . 0.0 111.448 -176.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 59.12 -94.8 0.05 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.166 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.1 m120 58.39 48.06 12.87 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.9 0.773 . . . . 0.0 109.953 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -58.69 139.1 56.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.338 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.1 m120 60.43 103.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.221 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -119.3 134.93 54.95 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.76 141.57 51.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.044 0.45 . . . . 0.0 111.333 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -122.9 132.97 54.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.226 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.27 135.27 8.05 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.71 124.43 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.563 HG22 ' HA3' ' A' ' 84' ' ' GLY . 72.2 p -123.18 149.41 44.66 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.126 0.266 . . . . 0.0 110.847 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.52 30.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.433 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -168.03 166.98 39.83 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.711 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -95.1 128.06 0.43 Allowed 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 122.066 1.844 . . . . 0.0 112.769 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -80.61 142.17 34.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.061 169.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -140.91 160.18 40.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -112.06 108.63 17.99 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.32 0.581 . . . . 0.0 111.473 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.728 HD12 HD13 ' A' ' 79' ' ' ILE . 83.8 mt -96.68 131.49 43.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 165.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -61.21 -25.11 66.82 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.174 -168.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -59.44 -40.71 87.67 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.767 0.258 . . . . 0.0 111.648 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -119.24 158.3 26.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.73 -18.93 42.57 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.608 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 t -149.75 138.1 20.63 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.151 0.432 . . . . 0.0 110.509 169.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.728 HD13 HD12 ' A' ' 73' ' ' ILE . 17.2 tt -140.51 129.87 26.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -142.74 154.08 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.441 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.51 137.79 9.81 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.433 HG12 ' HA3' ' A' ' 68' ' ' GLY . 35.6 m -134.3 155.04 38.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 117.143 0.471 . . . . 0.0 111.296 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.05 141.08 47.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.563 ' HA3' HG22 ' A' ' 66' ' ' THR . . . -147.11 175.03 26.69 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.049 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.42 134.0 66.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.93 133.35 10.61 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -121.95 136.77 54.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.2 145.58 17.14 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -132.86 134.31 44.45 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.585 0.231 . . . . 0.0 110.437 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -109.99 130.27 55.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -121.31 132.65 54.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.79 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.8 m -108.07 133.43 52.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.213 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.5 p -139.95 21.54 2.46 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.53 -53.82 42.02 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.572 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 177.27 -55.11 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.45 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -85.43 166.66 10.58 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.555 1.504 . . . . 0.0 112.224 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.9 p -125.01 154.3 41.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.411 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -175.01 -67.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.077 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -58.78 -34.43 71.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.377 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 64.07 -84.1 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.172 0.295 . . . . 0.0 110.935 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -144.45 140.37 28.92 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.891 0.377 . . . . 0.0 110.872 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.4 m -122.97 134.14 54.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.847 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -125.91 142.52 51.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.041 0.448 . . . . 0.0 111.286 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -150.26 141.96 23.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.271 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -125.1 148.6 48.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.885 0.374 . . . . 0.0 111.35 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.05 161.66 27.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.22 125.09 50.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 84.2 p -107.9 146.96 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.25 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -130.5 138.48 50.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -146.58 162.01 28.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.195 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.86 148.92 39.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.448 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -146.94 152.91 25.0 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.134 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.8 mm? -122.06 145.87 47.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -137.93 136.74 37.3 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.438 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.63 122.13 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -116.06 124.22 30.0 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -106.24 176.17 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.68 2.92 . . . . 0.0 109.112 154.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 71.4 mtm -63.26 151.47 40.44 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.747 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 68.58 -165.31 0.19 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.495 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -57.88 -11.25 2.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 121' ' ' VAL . 10.2 t -78.21 17.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -167.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -104.35 138.61 40.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 121.174 -0.954 . . . . 0.0 110.162 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 123' ' ' LEU . 5.0 mp -127.91 144.46 51.1 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.615 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -134.8 144.06 47.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.385 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.38 137.97 52.89 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.5 t -140.15 152.1 45.8 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.523 -176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -122.26 139.69 53.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -131.12 141.23 50.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.743 0.306 . . . . 0.0 110.865 -174.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -127.36 136.18 51.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.399 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.8 m -113.07 144.69 42.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -89.4 146.3 24.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.616 0.572 . . . . 0.0 109.678 -159.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.1 pt -87.8 95.99 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 123.229 1.49 . . . . 0.0 114.117 -145.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.0 ptt-85 -89.78 -176.76 5.06 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 112.27 -2.241 . . . . 0.0 107.737 157.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.0 t -52.21 -16.03 0.72 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -171.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.73 132.56 68.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 118.187 0.449 . . . . 0.0 110.147 168.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -112.47 139.12 48.31 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.416 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.14 129.03 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.571 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -125.27 119.2 3.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 170.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.5 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 31.4 m -126.04 134.15 51.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 117.757 0.779 . . . . 0.0 111.054 -175.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -122.21 129.59 52.41 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 18.1 tt -129.89 144.95 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.631 0.253 . . . . 0.0 111.362 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -126.11 132.98 51.77 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.26 152.99 21.33 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.863 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.11 139.83 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -155.11 178.05 31.99 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.542 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.78 163.98 28.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.733 -0.734 . . . . 0.0 110.032 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -117.88 149.02 41.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.656 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.4 p90 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.492 179.422 . . . . . . . . 0 0 . 1 stop_ save_